{"from": 0, "facets": null, "took": 59, "therapeutic_areas": [], "total": 746, "data": [{"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24204153"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24204153", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24204153", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24204153", "mined_sentences": [{"text": "An increase in systemic oxidative stress in patients with schizophrenia has been reported, which may be due to the pathophysiology of schizophrenia, the sequelae of the therapeutic drugs used to treat schizophrenia, and/or the high prevalence of smoking among such individuals.34\u201336 Therefore, it is possible that the influence of the GST and SOD2 polymorphisms on development of metabolic abnormalities is more pronounced in patients with schizophrenia, especially under high oxidative stress conditions (eg, smokers).", "section": "introduction_and_background", "t_start": 343, "d_end": 70, "d_start": 58, "t_end": 346}, {"text": "Meanwhile, no study has been published regarding the relationship between SOD2 polymorphisms and metabolic abnormalities in patients with schizophrenia.", "section": "introduction_and_background", "t_start": 74, "d_end": 150, "d_start": 138, "t_end": 77}, {"text": "The present study investigated the possible associations between the most common and potentially functional polymorphisms in three antioxidant enzyme genes, ie, GSTM1, GSTT1, and SOD2, and the risks of being overweight and having metabolic syndrome in Japanese patients with schizophrenia in comparison with the general population, while also paying careful attention to associations with other patient characteristics.", "section": "introduction_and_background", "t_start": 179, "d_end": 287, "d_start": 275, "t_end": 182}, {"text": "The allele frequencies of the SOD2 Val16Ala polymorphism were 14.3% and 13.3% in patients with schizophrenia and controls, respectively.", "section": "results", "t_start": 30, "d_end": 107, "d_start": 95, "t_end": 33}, {"text": "The numbers (%) of SOD2 Ala/Ala and Val/Ala genotypes were three (1.9%) and 38 (24.7%), respectively, in patients with schizophrenia, and were four (2.0%) and 46 (22.3%), respectively, in controls.", "section": "results", "t_start": 19, "d_end": 131, "d_start": 119, "t_end": 22}, {"text": "The genotype frequencies of GSTM1, GSTT1, GSTM1/GSTT1, and SOD2 in the patients with schizophrenia did not differ from those observed in the controls (P=0.831, P=0.394, P=0.164, and P=0.714, respectively) and were comparable with the frequencies observed in the general Japanese population.40,41 Since the frequency of the SOD2 Ala/Ala genotype was too small in both groups, we combined the Ala/Ala and Ala/Val genotypes in the subsequent analyses.", "section": "results", "t_start": 59, "d_end": 97, "d_start": 85, "t_end": 62}, {"text": "The mean age was significantly higher in subjects with the GSTM1 null genotype than in those with the present genotype among the patients with schizophrenia (Supplementary Table 1); whereas the patient age and number of females did not differ according to GSTT1, SOD2, and GSTM1/GSTT1 genotypes (Supplementary Tables 2\u20135).", "section": "results", "t_start": 263, "d_end": 155, "d_start": 143, "t_end": 266}, {"text": "None of the GSTM1, GSTT1, and SOD2 genotypes alone was associated with risk of overweight, metabolic syndrome, or abnormalities in each component of the metabolic syndrome in patients with schizophrenia (Table 2).", "section": "results", "t_start": 30, "d_end": 201, "d_start": 189, "t_end": 33}, {"text": "Because we speculated that the influence of GST and SOD2 polymorphisms on metabolic abnormalities would be more pronounced in patients under high oxidative stress conditions than in the remaining subjects, we also calculated the statistical power with a larger effect size (ie, an OR of 3.0 and 4.0) in the smokers with schizophrenia.", "section": "results", "t_start": 52, "d_end": 332, "d_start": 320, "t_end": 55}, {"text": "The present study showed that none of the GSTM1, GSTT1, and SOD2 genotypes examined were independent risk factors for metabolic abnormalities in patients with schizophrenia.", "section": "discussion", "t_start": 60, "d_end": 171, "d_start": 159, "t_end": 63}, {"text": "SOD2 also plays crucial roles in antioxidant defense mechanisms.31 The Val16Ala polymorphism has been linked to cardiovascular disease and to type 2 diabetes and its complications in the general population, but studies so far have yielded conflicting results.28,29,33 In the present study, we did not find any significant associations between the SOD2 genotype and the risks of being overweight and having metabolic syndrome in patients with schizophrenia or controls.", "section": "discussion", "t_start": 0, "d_end": 454, "d_start": 442, "t_end": 3}, {"text": "Although further study is required to elucidate this relationship in a larger number of subjects, it is possible that the SOD2 Val16Ala polymorphism as a risk factor by itself is not strong enough to demonstrate a significant association with metabolic abnormalities in patients with schizophrenia.", "section": "discussion", "t_start": 122, "d_end": 296, "d_start": 284, "t_end": 125}, {"text": "Therefore, the present study may not have had enough power to clarify whether GSTM1, GSTT1, and SOD2 polymorphisms are independent risk factors for metabolic abnormalities in patients with schizophrenia, and a type 1 error cannot be excluded.", "section": "discussion", "t_start": 96, "d_end": 201, "d_start": 189, "t_end": 99}, {"text": "Demographic and clinical characteristics according to SOD2 genotype in patients with schizophrenia and controls", "section": "table", "t_start": 54, "d_end": 97, "d_start": 85, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 46.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.46799999999999997}, "type": "literature", "id": "d994339b1ad24ce3449ce8120934fc27"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23559003"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23559003", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23559003", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23559003", "mined_sentences": [{"text": "Expression of PPAR\u03b2/\u03b4 in the CNS was significantly reduced in the induction and peak phases of EAE.", "section": "results", "t_start": 14, "d_end": 97, "d_start": 95, "t_end": 18}, {"text": "This indicates that BA has only marginal effects on PPAR\u03b3 expression in the CNS, and it is likely that recovery of PPAR\u03b2/\u03b4 in the CNS on BA treatment can have an important role in amelioration of EAE.", "section": "results", "t_start": 115, "d_end": 198, "d_start": 196, "t_end": 119}, {"text": "As we have demonstrated that BA suppressed EAE through inhibition of microglia activation, we then examined the effect of BA on PPAR\u03b2/\u03b4 expression in microglia.", "section": "results", "t_start": 128, "d_end": 45, "d_start": 43, "t_end": 132}, {"text": "The mRNA level of PPAR\u03b2/\u03b4 was significantly higher in CD11b+ cells isolated from BA-treated EAE mice compared with control mice (Figure 4c).", "section": "results", "t_start": 18, "d_end": 94, "d_start": 92, "t_end": 22}, {"text": "These results show that PPAR\u03b2/\u03b4 induction in microglia via 12/15-LO inhibition was responsible for suppression of microglia activation, indicated by reduced proinflammatory factor expression by microglia, which in turn reduced CNS inflammation in EAE.", "section": "results", "t_start": 24, "d_end": 249, "d_start": 247, "t_end": 28}, {"text": "In this study, we showed that inhibition of 12/15-LO by BA attenuated CNS inflammation of EAE through increased PPAR\u03b2/\u03b4 expression in microglia, which reduced microglia phagocytosis and production of proinflammatory cytokines and chemokines.", "section": "discussion", "t_start": 112, "d_end": 92, "d_start": 90, "t_end": 116}, {"text": "We found that BA was able to induce PPAR\u03b2/\u03b4 expression in microglia in EAE mice.", "section": "discussion", "t_start": 36, "d_end": 73, "d_start": 71, "t_end": 40}, {"text": "PPAR\u03b2/\u03b4 is widely distributed in most tissues with abundant expression in the CNS.35 Our data indicated that induction of PPAR\u03b2/\u03b4 in the CNS, more specifically in microglia, alleviated CNS inflammation of EAE.", "section": "discussion", "t_start": 0, "d_end": 207, "d_start": 205, "t_end": 4}, {"text": "In contrast to the findings that agonists of PPAR\u03b3 significantly reduce T-cell activation, proliferation and secretion of IFN-\u03b3,36, 37, 38, 39, 40, 41 these results point to a distinct mechanism of action of PPAR\u03b2/\u03b4 in amelioration of EAE pathogenesis.", "section": "discussion", "t_start": 208, "d_end": 237, "d_start": 235, "t_end": 212}, {"text": "These results, however, do not rule out the possibilities that 5-LO and its metabolites function in MS and EAE in a PPAR\u03b2/\u03b4-independent manner.", "section": "discussion", "t_start": 116, "d_end": 109, "d_start": 107, "t_end": 120}, {"text": "Abundant PPAR\u03b2/\u03b4 but not PPAR\u03b3 expression is induced in the CNS of EAE mice by BA treatment.", "section": "discussion", "t_start": 9, "d_end": 69, "d_start": 67, "t_end": 13}, {"text": "Recently, it was reported that treatment of mice with a synthetic PPAR\u03b2/\u03b4 agonist, GW0742, ameliorated EAE severity.53 GW0742 did not prevent T-cell activation in the periphery, but it reduced glial cell activation.", "section": "discussion", "t_start": 66, "d_end": 105, "d_start": 103, "t_end": 70}, {"text": "Another study showed that mice systemically deficient in PPAR\u03b2/\u03b4 developed severe EAE symptoms characterized by a striking accumulation of IFN-\u03b3+CD4+ cells in the spinal cord, significantly higher proliferation and cytokine production of CD4+ T cells in the periphery, and enhanced expression of IL-12 family cytokines by myeloid cells.54 Together with our study, these results suggest that different modes of action by PPAR\u03b2/\u03b4 in different experimental conditions should be taken into consideration.", "section": "discussion", "t_start": 57, "d_end": 84, "d_start": 82, "t_end": 61}, {"text": "As we mentioned previously, preferential induction of PPAR\u03b2/\u03b4 in CNS-resident microglia formed the underlying mechanism of treatment effects of BA in EAE.", "section": "discussion", "t_start": 54, "d_end": 152, "d_start": 150, "t_end": 58}, {"text": "In this study, we have identified a previously uncharacterized pathway that inhibition of 12/15-LO induces PPAR\u03b2/\u03b4 in microglia, which alleviates EAE in mice.", "section": "discussion", "t_start": 107, "d_end": 148, "d_start": 146, "t_end": 111}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 46.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.462}, "type": "literature", "id": "1bf32792e6938fa0faccb76b75dbdc43"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26563154"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26563154", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26563154", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26563154", "mined_sentences": [{"text": "Additionally, a trend for association (P\u2009=\u20090.1016) was also observed for ApoA-I levels (best SNP: rs7134858, intron 6, MAF\u2009=\u20090.1560, P\u2009=\u20090.0052).Table 3Gene-based association analysis resultsTraitVariantsTest Statistics P Best SNP(n)SNP Namea-SNP IDb MAF P HDL-C136207.5483 0.0421 p82264-rs1415454240.00070.0016LDL-C136134.18600.4640p32777-rs110578410.28050.0047TG136118.15980.6700p86316-rs7011040.04870.0357ApoA-I136183.55650.1016p55963-rs71348580.15600.0052ApoB136143.72840.3760p22116-rs123703820.06450.0153 ApoA-I apolipoprotein A-I, ApoB apolipoprotein B, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, MAF minor allele frequency, SNP single nucleotide polymorphism, TG triglyceridesAll results were adjusted for covariates: sex, age, body mass index, waist, current smoking (yes/no), minutes of walking or biking to work each day (jobmin), and occupational status [staff: junior (non-professional staff)/senior (professional and administrative staff)]Nominally significant gene-based P-values (P\u2009<\u20090.05) are shown in bold  aRefSeq\u00a0of SCARB1: hg19, NM_005505 (CHIP Bioinformatics) bdbSNP build 139: GRCh37.p10", "section": "results", "t_start": 1079, "d_end": 817, "d_start": 811, "t_end": 1084}, {"text": "HDL-C and ApoA-I variables were in mg/dL and Box-Cox transformedResults were adjusted for covariates: sex, age, waist, current smoking (yes/no), and minutes of walking or biking to work each day (jobmin) for HDL-C; sex and age for ApoA-IThe most significant P-value for each trait is shown in bold, see the single-site association (\u2212log10 P) plot and pairwise correlations (r 2) in Fig.\u00a02 FDR that reached a threshold of <0.20 is shown in bold  a, cRefSeq\u00a0of SCARB1: hg19, NM_005505 (CHIP Bioinformatics) bdbSNP build 139: GRCh37.p10 dDetailed RegulomeDB (version 1.0) scoring scheme is described in Additional file 17: Table S12 or at http://regulome.stanford.edu/help, see functional assignments in Additional file 18: Table S13", "section": "results", "t_start": 459, "d_end": 133, "d_start": 127, "t_end": 464}, {"text": "Although no association between LoF/rare variants and ApoA-I was detected, the group of 23 variants with MAF \u22641\u00a0% yielded nominal association with HDL-C levels (P\u2009=\u20090.0478; Table\u00a05).Table 5Association results for low-frequency and rare SCARB1 variants (MAF <5\u00a0%)MAFNo of VariantsNo of Samples with/without VariantsHDL-CApoA-IStat P Stat P  \u22640.01 23a 93/694126653.8207 0.0478 60151.09850.3707 \u22640.02 26134/653123009.08050.132448439.66970.5166 <0.05 43442/346135697.19740.0737298813.05440.1517 ApoA-I apolipoprotein A-I, HDL-C high-density lipoprotein cholesterol, MAF minor allele frequency, SD standard deviation, SNP single nucleotide polymorphismResults were adjusted for covariates: sex, age, waist, current smoking (yes/no), and minutes of walking or biking to work each day (jobmin) for HDL-C; sex and age for ApoA-INominally significant P-values (P\u2009<\u20090.05) are shown in bold  aIncluding p70201/chr12:125279319 that was observed in one individual with an outlier value (above the mean\u2009+\u20093.5 SD).", "section": "results", "t_start": 236, "d_end": 716, "d_start": 710, "t_end": 241}, {"text": "HDL-C and ApoA-I variables were in mg/dL and Box-Cox transformedResults were adjusted for covariates: sex, age, waist, current smoking (yes/no), and minutes of walking or biking to work each day (jobmin) for HDL-C; sex and age for ApoA-I.Detailed single-site association results are shown in Additional file 14: Table S9 and Additional file 15: Table S10. a, cRefSeq\u00a0of SCARB1: hg19, NM_005505 (CHIP Bioinformatics) bdbSNP build 139: GRCh37.p10.", "section": "results", "t_start": 370, "d_end": 133, "d_start": 127, "t_end": 375}, {"text": "HDL-C and ApoA-I variables were in mg/dL and Box-Cox transformedResults were adjusted for covariates: sex, age, waist, current smoking (yes/no), and minutes of daily walking or biking to work (jobmin) for HDL-C; sex and age for ApoA-IAll nine haplotype regions are shown in Fig.\u00a03 Detailed single-site associations are shown in Additional file 14: Table S9 and Additional file 15: Table S10Detailed haplotype associations are shown in Table\u00a07 and Additional file 16: Table S11Regions with asterisk (*) indicate regions that included the haplotype window exhibiting the most significant association signal (the smallest global P) for the associated traitFor each region, the most significant associated haplotype window is shown in bold SNPs with significant evidence of association with the same trait in both single-site and haplotype analyses (single-site P\u2009<\u20090.05 and global P\u2009<\u20090.05) are shown in bold SNPs with significant evidence of association with different trait in single-site and haplotype analyses (single-site P\u2009<\u20090.05 and global P\u2009<\u20090.05) are shown in italic bold  a, bRefSeq\u00a0of SCARB1: hg19, NM_005505 (CHIP Bioinformatics) cdbSNP build 139: GRCh37.p10 dRare variants of interest with potential effects on lipid traits; see details in Table\u00a06 Fig. 3Haplotype association plots for HDL-C and ApoA-I. Top: The -log10 P-values are presented in the Y-axis.", "section": "results", "t_start": 1094, "d_end": 133, "d_start": 127, "t_end": 1099}, {"text": "Three haplotype regions associated with HDL-C (global P\u2009<\u20090.05) spanning intron 11 and exon 13-3\u2032 UTR in African Blacks also overlapped with a large HDL-C-associated region (Region II in Fig.\u00a04) previously reported in US NHWs [49].Table 9Results for 7 SCARB1 lipid-associated variants in US Non-Hispanic Whites (previous studya) and in African Blacks (this study)SNP Nameb SNP IDc Chr12 Positiond LocationRegDB Scoree AllelesUS Non-Hispanic Whitesa (n\u2009=\u2009623)African Blacks (n\u2009=\u2009788)MA, MAF\u03b2 P MA, MAF\u03b2 P Other Assoc Trait(s)f (SE)(SE)HDL-C\u2003p28957rs11057844125320563Intron 15G/AA, 0.1839\u22120.0395 0.0035 A, 0.23620.36710.1075(0.0135)(0.2278)\u2003p83884rs701106125265636Intron 125C/TT, 0.15270.0394 0.0066 T, 0.25970.24710.2601ApoA-I(0.0144)(0.2192)\u2003p87927rs8388801252615933\u2032 flanking5G/AG, 0.32370.0257 0.0250 A, 0.24140.01980.9314(0.0114)(0.2302)ApoB\u2003p48969rs2343394125300551Intron 25C/TT, 0.28501.2544 0.0082 T, 0.18980.03830.9544(0.4721)(0.6696)\u2003p49690rs4765615125299830Intron 25G/AG, 0.44971.2493 0.0059 A, 0.44260.77710.1338HDL-C, ApoA-I(0.4518)(0.5178)\u2003p50151rs2278986125299369Intron 35T/CC, 0.28901.1926 0.0122 C, 0.19330.13080.8434(0.4735)(0.6619)\u2003p52556rs11057820125296964Intron 45G/AG, 0.48710.8700 0.0436 A, 0.10001.8661 0.0292 (0.4300)(0.8542) ApoB apolipoprotein B, HDL-C high-density lipoprotein cholesterol, MA minor allele, MAF minor allele frequency, RegDB RegulomeDB, SE standard error, SNP single nucleotide polymorphismAll alleles on the reverse strandHDL-C and ApoB values for US Non-Hispanic Whites were in mg/dL, Box-Cox transformed, and adjusted for covariates: sex, age, body mass index, and smoking (past/current/never) for HDL-C; age and smoking for ApoBHDL-C and ApoB values for African Blacks were in mg/dL, Box-Cox transformed, and adjusted for covariates: sex, age, waist, current smoking (yes/no), and daily walking or biking to work (jobmin) for HDL-C; body mass index and staff status for ApoBNominally significant P-values (P\u2009<\u20090.05) are shown in bold  aData from Niemsiri V, et al. Circ Cardiovasc Genet 2014, 7(6):838\u2013847 (Ref [49]) b, dRefSeq of SCARB1: hg19, NM_005505 (CHIP Bioinformatics) cdbSNP version 139: GRCh37.p10 eThe RegulomeDB (version 1.0) scoring scheme is described at the footnote of Additional file 17: Table S12 or at http://regulome.stanford.edu/help  fEvidence is based on SNPs with MAF \u22655\u00a0% exhibiting nominally significant association with either HDL-C or ApoA-I (P\u2009<\u20090.05; Additional file 14: Table S9 and Additional file 15: Table S10) in single-site association results in the current studyTable 10Significant lipid-associated regions (global P\u2009<\u20090.05) that were observed in US Non-Hispanic Whites (previous studya) and African Blacks (this study)Region #Consecutive Haplotype Windows in 623 US Non-Hispanic Whitesa Consecutive Haplotype Windows in 788 African BlacksTraitChr12 Positionb (Location)Length (bp)The Composited Variants, 5\u2032 to 3\u2032 DirectionTraitChr12 Positionb (Location)Length (bp)The Composited Variants, 5\u2032 to 3\u2032 DirectionStart (5\u2032)End (3\u2032)SNP Namec-SNP IDd Major/Minor AllelesStart (5\u2032)End (3\u2032)SNP Namec-SNP IDd Major/Minor Alleles I  ApoB 1253005511252993691183p48969-rs2343394C/T HDL-C 1253005511252994961056p48969-rs2343394C/T(intron 2)(intron 3)p49518-rs144194221G/A(intron 2)(intron 3)p49537-rs7305310C/T p49690-rs4765615 A/Gp49570delC-rs145376237W/Dp49978-rs5891G/A p49690-rs4765615 G/A(p.Val135Ile)p50151-rs2278986T/Cp49759-rs146272788C/Tp49978-rs5891G/A(p.Val135Ile)p50024-rs368880622G/T ApoA-I 125299830125299369462 p49690-rs4765615 G/A(intron 2)(intron 3)p49759-rs146272788C/Tp49978-rs5891G/A(p.Val135Ile)p50024-rs368880622G/Tp50118-rs58710319C/Tp50151-rs2278986T/C II  HDL-C 1252696921252625167177p79828-rs838895C/G HDL-C 1252696921252675012192 p79828-rs838895 C/G(intron 11)(exon 13- 3\u2032 UTR)p80045-rs838893G/A(intron 11)(intron 11)p80045-rs838893G/Ap83088-rs797729A/Gp81863-rs185445624G/A p83884-rs701106 C/Tp82019-rs838890C/Tp86436-rs10396214C/T HDL-C 125267501125267086416p82019-rs838890C/T(p.Arg484Trp, isoform 2)p87004-rs184715678C/A(intron 11)(intron 12)p82264-rs141545424C/A(p.Gly501Gly)p82340-rs77483223G/Ap82369-rs75446635G/Ap82434-rs838889T/C HDL-C 1252656361252625533084 p83884-rs701106 C/T(intron 12)(exon 13- 3\u2032 UTR)p86245-rs188375019C/Tp86276-rs747155C/Tp86316-rs701104G/Tp86481-rs701103G/A(p.Gly499Arg, isoform 2)p86967-rs187492239A/G ApoA-I apolipoprotein A-I, ApoB apolipoprotein B, del/D deletion, HDL-C high-density lipoprotein cholesterol, SNP single nucleotide polymorphism (regular), UTR untranslated region, W wild type allele for deletion on RefSeqAll alleles on the reverse strandResults for a US Non-Hispanic White sample were Box-Cox transformed, and adjusted for covariates: sex, age, body mass index, and smoking (past/current/never) for HDL-C; age and smoking for ApoBResults for an African Black sample were Box-Cox transformed, and adjusted for covariates: sex, age, waist, current smoking (yes/no), and minutes of walking or biking to work each day (jobmin) for HDL-C; sex and age for ApoA-ILocation of each region on SCARB1 gene is shown in Fig.\u00a04 SNPs with significant evidence with the same trait in both single-site and haplotype associations (single-site P and global P\u2009<\u20090.05) observed in each population are shown in bold SNPs with significant evidence with the different trait in single-site and haplotype associations (single-site P and global P\u2009<\u20090.05) in each population are shown in italic bold  aData from Niemsiri V, et al. Circ Cardiovasc Genet 2014, 7(6):838\u2013847 (Ref [49]) b, cRefSeq of SCARB1: hg19, NM_005505 (CHIP Bioinformatics) ddbSNP version 139: GRCh37.p10Fig. 4Lipid-associated SCARB1 common variants and haplotype regions identified in US Non-Hispanic Whites (previous study; Ref [49]) and African Blacks (this study).", "section": "results", "t_start": 2077, "d_end": 1616, "d_start": 1610, "t_end": 2082}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 31.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.316}, "type": "literature", "id": "7f3161f6e8ac06fe01a3ffdda42f9d9d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21192919"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental autoimmune encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21192919", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21192919", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21192919", "mined_sentences": [{"text": "PPAR\u03b4 deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.", "section": "title", "t_start": 0, "d_end": 111, "d_start": 71, "t_end": 4}, {"text": "In this study we have used PPAR\u03b4 deficient mice to determine its physiological role in the regulation of CNS EAE and MS.", "section": "abstract", "t_start": 27, "d_end": 111, "d_start": 109, "t_end": 31}, {"text": "We found that PPAR\u03b4(-/-) mice develop EAE with similar day of onset and disease incidence compared to C57BL/6 wild type mice.", "section": "abstract", "t_start": 14, "d_end": 40, "d_start": 38, "t_end": 18}, {"text": "Interestingly, both male and female PPAR\u03b4(-/-) mice showed prolonged EAE with resistance to remission and recovery.", "section": "abstract", "t_start": 36, "d_end": 71, "d_start": 69, "t_end": 40}, {"text": "PPAR\u03b4(-/-) mice with EAE expressed elevated levels of IFN\u03b3 and IL-17 along with IL-12p35 and IL-12p40 in the brain and spleen.", "section": "abstract", "t_start": 0, "d_end": 23, "d_start": 21, "t_end": 4}, {"text": "These findings indicate that PPAR\u03b4(-/-) mice develop prolonged EAE in association with augmented Th1/Th17 responses, suggesting a critical physiological role for PPAR\u03b4 in the remission and recovery of EAE.", "section": "abstract", "t_start": 29, "d_end": 65, "d_start": 63, "t_end": 33}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 30.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.304}, "type": "literature", "id": "a28973003c529b3fec2f4d013f9aa70b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24816431"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["infantile-onset spinocerebellar ataxia"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24816431", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24816431", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24816431", "mined_sentences": [{"text": "Recessive C10orf2 mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy.", "section": "title", "t_start": 10, "d_end": 82, "d_start": 45, "t_end": 16}, {"text": "Recessive mutations in chromosome 10 open reading frame 2 (C10orf2) are relevant in infantile-onset spinocerebellar ataxia (IOSCA).", "section": "abstract", "t_start": 59, "d_end": 128, "d_start": 124, "t_end": 65}, {"text": "Compound heterozygous mutations c.1460C>T and c.1485-1G>A in C10orf2 were identified as causative of IOSCA.", "section": "abstract", "t_start": 61, "d_end": 105, "d_start": 101, "t_end": 67}, {"text": "We identified novel compound heterozygous mutations of the C10orf2 gene as the cause of IOSCA with sensorimotor polyneuropathy and myopathy.", "section": "abstract", "t_start": 59, "d_end": 92, "d_start": 88, "t_end": 65}, {"text": "Signs of motor neuropathy and myopathy were discovered for the first time in IOSCA patients with C10orf2 mutations.", "section": "abstract", "t_start": 97, "d_end": 81, "d_start": 77, "t_end": 103}, {"text": "These results suggest that the clinical spectrum of IOSCA caused by C10orf2 mutations may be more variable than previously reported.", "section": "abstract", "t_start": 68, "d_end": 56, "d_start": 52, "t_end": 74}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 30.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.3}, "type": "literature", "id": "7880657886b95b9783d3233fb666ec44"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17608547"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17608547", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17608547", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17608547", "mined_sentences": [{"text": "Maternal smoking during early pregnancy, GSTP1 and EPHX1 variants, and risk of isolated orofacial clefts.", "section": "title", "t_start": 51, "d_end": 15, "d_start": 9, "t_end": 55}, {"text": "Infants were genotyped for functional polymorphisms of the detoxification enzymes microsomal epoxide hydrolase-1 (EPHX1 T-->C [Tyr113His], and A-->G [His139Arg]), and glutathione-S transferase Pi-1 (GSTP1 A-->G [Ile105Val] and C-->T [Ala114Val]), and risks for cleft outcomes were measured for gene only and gene-maternal smoking effects.", "section": "abstract", "t_start": 114, "d_end": 328, "d_start": 322, "t_end": 118}, {"text": "Although smoking was associated with an increased risk for isolated cleft lip+/-palate, we found no independent associations of genotypes of EPHX1-codon 113 or GSTP1-codon 105 polymorphisms for either isolated cleft lip+/-palate or isolated cleft palate.", "section": "abstract", "t_start": 141, "d_end": 15, "d_start": 9, "t_end": 145}, {"text": "Infant EPHX1 and GTSP1 polymorphic variants did not appreciably alter the risks for clefts associated with maternal smoking, nor were any EPHX1 combined genotype-specific risks found.", "section": "abstract", "t_start": 7, "d_end": 122, "d_start": 116, "t_end": 11}, {"text": "Our results suggest that genetic variation of the detoxification enzymes EPHX1 and GSTP1 did not increase the risks of orofacial clefting, nor do they influence the risks associated with maternal smoking.", "section": "abstract", "t_start": 73, "d_end": 202, "d_start": 196, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 27.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.27399999999999997}, "type": "literature", "id": "facd554ae694d9c87b33be67e80f6db5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22420334"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22420334", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22420334", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22420334", "mined_sentences": [{"text": "In this work, patients with severe autism had significantly higher serum antiribosomal P protein antibodies than did children with mild to moderate autism (P = 0.01).", "section": "discussion", "t_start": 87, "d_end": 40, "d_start": 35, "t_end": 95}, {"text": "Also, the frequency of increased serum antiribosomal P protein antibodies was significantly higher in children with severe autism (64.7%) than in patients with mild to moderate autism (13.3%) (P < 0.001).", "section": "discussion", "t_start": 53, "d_end": 128, "d_start": 123, "t_end": 61}, {"text": "This might indicate that the extent of the elevation of serum antiribosomal P protein antibodies was linked to the degree of severity of autism as assessed by CARS.", "section": "discussion", "t_start": 76, "d_end": 142, "d_start": 137, "t_end": 84}, {"text": "The relationship between antiribosomal P protein antibodies and the severity of autism might be a causal one in which these autoantibodies might play a role in the pathogenesis of brain damage, the extent of which may determine the clinical severity of autism.", "section": "discussion", "t_start": 39, "d_end": 85, "d_start": 80, "t_end": 47}, {"text": "Because autoantibodies can cross the BBB and combine with brain tissue antigens to form immune complexes that result in neurological damage [10], we have tried to find a possible link between the elevated serum levels of S100B protein and antiribosomal P protein antibodies in autism.", "section": "discussion", "t_start": 253, "d_end": 282, "d_start": 277, "t_end": 261}, {"text": "Serum levels of antiribosomal P protein antibodies in children with severe autism and healthy children.", "section": "figure", "t_start": 30, "d_end": 80, "d_start": 75, "t_end": 38}, {"text": "Positive correlations between serum levels of antiribosomal P protein antibodies and CARS in children with autism.", "section": "figure", "t_start": 60, "d_end": 112, "d_start": 107, "t_end": 68}, {"text": "Relationship between degree of severity of autism and both elevated serum S100B protein levels and increased frequency of serum antiribosomal P protein antibodies in autistic children", "section": "table", "t_start": 142, "d_end": 48, "d_start": 43, "t_end": 150}, {"text": "Patients with severe autism had significantly higher serum antiribosomal P protein antibodies [median (IQR) = 400 (459) U/ml] than children with mild to moderate autism [median (IQR) = 9 (23) U/ml] (P = 0.01) (Figure 2).", "section": "other", "t_start": 73, "d_end": 26, "d_start": 21, "t_end": 81}, {"text": "Also, the frequency of increased serum antiribosomal P protein antibodies was significantly higher in children with severe autism (64.7%) than in patients with mild to moderate autism (13.3%) (P < 0.001) (Table 1).", "section": "other", "t_start": 53, "d_end": 128, "d_start": 123, "t_end": 61}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 27.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.27399999999999997}, "type": "literature", "id": "b199e136eae2fcb9ccf212c0b9920c5e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22418395"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22418395", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22418395", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22418395", "mined_sentences": [{"text": "Association between schizophrenia and genetic variation in DCC: a case-control study.", "section": "title", "t_start": 59, "d_end": 32, "d_start": 20, "t_end": 61}, {"text": "Furthermore we have shown that reduced expression of DCC during development and/or throughout life confers resilience to the development of schizophrenia-like DA and behavioural abnormalities.", "section": "abstract", "t_start": 53, "d_end": 152, "d_start": 140, "t_end": 55}, {"text": "Here we assess whether DCC may contribute to the risk of schizophrenia.", "section": "abstract", "t_start": 23, "d_end": 69, "d_start": 57, "t_end": 25}, {"text": "We examined single nucleotide polymorphisms (SNPs) located in the DCC gene for association with schizophrenia using a case-control sample consisting of 556 unrelated schizophrenic patients and 208 healthy controls.", "section": "abstract", "t_start": 66, "d_end": 108, "d_start": 96, "t_end": 68}, {"text": "These results, together with our previous findings from studies in rodents, point at DCC as a promising novel candidate gene that may contribute to the genetic basis behind individual differences in susceptibility to schizophrenia.", "section": "abstract", "t_start": 85, "d_end": 229, "d_start": 217, "t_end": 87}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 27.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.272}, "type": "literature", "id": "740f4187f095fcbb14c287805d87978b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26675522"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26675522", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26675522", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26675522", "mined_sentences": [{"text": "Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress.", "section": "title", "t_start": 10, "d_end": 39, "d_start": 30, "t_end": 14}, {"text": "Dominant missense variants in HSPB1, locating mostly to the ACD, have been linked to inherited neuropathy.", "section": "abstract", "t_start": 30, "d_end": 104, "d_start": 95, "t_end": 34}, {"text": "Frameshift variant predicting ablation of the entire C-terminus p.(Met169Cfs2*) of HSPB1 and a missense variant p.(Arg127Leu) were identified in patients with dominantly inherited motor-predominant axonal Charcot-Marie-Tooth neuropathy.", "section": "abstract", "t_start": 83, "d_end": 234, "d_start": 225, "t_end": 87}, {"text": "We showed that C-terminal part of HSPB1 is critical for tolerance of unfolded protein stress, and when lacking causes axonal neuropathy in patients.", "section": "abstract", "t_start": 34, "d_end": 134, "d_start": 125, "t_end": 38}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 24.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.24600000000000002}, "type": "literature", "id": "37146ba38647ccb035e7e06d9a85a8b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27428740"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["age-related macular degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27428740", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27428740", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27428740", "mined_sentences": [{"text": "SCARB1 rs5888 is associated with the risk of age-related macular degeneration susceptibility and an impaired macular area.", "section": "title", "t_start": 0, "d_end": 76, "d_start": 45, "t_end": 5}, {"text": "We aimed to test the hypothesis that the single nucleotide polymorphism rs5888 of SCARB1 gene reflecting lipid and antioxidant micronutrient metabolism pathways is associated with ARMD susceptibility and to evaluate if there is any relation between SCARB1 rs5888 and the macular lesion area.", "section": "abstract", "t_start": 82, "d_end": 183, "d_start": 180, "t_end": 87}, {"text": "Regression analysis adjusted by gender and age demonstrated that SCARB1 rs5888 TT genotype significantly decreased the odds for ARMD development (OR: 0.61, 95%; CI: 0.380-0.981, p = 0.04).", "section": "abstract", "t_start": 65, "d_end": 131, "d_start": 128, "t_end": 70}, {"text": "SCARB1 rs5888 and environmental oxidative stress have a prominent role in ARMD susceptibility, early ARMD progression to advanced stage disease and even in the outcome of the disease-an area of macular lesion.", "section": "abstract", "t_start": 0, "d_end": 77, "d_start": 74, "t_end": 5}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 24.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.24}, "type": "literature", "id": "6cc9bde58896e5c255147ee8c4a963e9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24035474"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24035474", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24035474", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24035474", "mined_sentences": [{"text": "Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.", "section": "title", "t_start": 34, "d_end": 64, "d_start": 58, "t_end": 37}, {"text": "We assessed the effects of potential interactions between functional polymorphisms in the NQO1 and SOD2 genes and exposure to smoking and SH infection on bladder cancer risk among 902 cases and 804 population-based controls in Egypt.", "section": "abstract", "t_start": 99, "d_end": 132, "d_start": 126, "t_end": 102}, {"text": "Water pipe and cigarette smoking were more strongly associated with cancer risk among individuals with the TT genotype for SOD2 (OR [CI 95%] = 4.41 [1.86-10.42]) as compared with those with the CC genotype (OR [CI 95%] = 2.26 [0.97-6.74]).", "section": "abstract", "t_start": 123, "d_end": 31, "d_start": 15, "t_end": 126}, {"text": "Our findings suggest that genetic polymorphisms in NQO1 and SOD2 play important roles in the etiology of bladder cancer by modulating the effects of known contributing factors such as smoking and SH infection.", "section": "abstract", "t_start": 60, "d_end": 190, "d_start": 184, "t_end": 63}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 24.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.24}, "type": "literature", "id": "08543b1033b6c629da23f3232e53de96"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20534900"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["noise induced hearing loss"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20534900", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20534900", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20534900", "mined_sentences": [{"text": "SOD2 V16A SNP in the mitochondrial targeting sequence is associated with noise induced hearing loss in Chinese workers.", "section": "title", "t_start": 0, "d_end": 98, "d_start": 73, "t_end": 3}, {"text": "To investigate whether single nucleotide polymorphisms (SNPs) in the Mn-superoxide dismutase gene (SOD2) underlie the susceptibility to noise-induced hearing loss (NIHL).", "section": "abstract", "t_start": 99, "d_end": 167, "d_start": 164, "t_end": 102}, {"text": "The CT genotype of rs4880 (SOD2 V16A SNP) was associated with a higher risk of NIHL (covariates-adjusted OR, 2.18; 95% CI, 1.34-3.54, P=0.002).", "section": "abstract", "t_start": 27, "d_end": 82, "d_start": 79, "t_end": 30}, {"text": "Our results suggest that SOD2 V16A SNP in the mitochondrial targeting sequence is associated with noise induced hearing loss in Chinese workers, and this effect was enhanced by higher levels of noise exposure.", "section": "abstract", "t_start": 25, "d_end": 123, "d_start": 98, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 23.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.23800000000000002}, "type": "literature", "id": "467dc8e05244fe9c8fc559af4bafeb6c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20406305"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental allergic encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20406305", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20406305", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20406305", "mined_sentences": [{"text": "Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.", "section": "title", "t_start": 0, "d_end": 148, "d_start": 110, "t_end": 47}, {"text": "In this study we show that the PPARdelta agonists GW501516 and L165041 ameliorate MOGp35-55-induced EAE in C57BL/6 mice by blocking interferon (IFN)-gamma and interleukin (IL)-17 production by T helper type 1 (Th1) and Th17 cells.", "section": "abstract", "t_start": 31, "d_end": 102, "d_start": 100, "t_end": 39}, {"text": "The inhibition of EAE by PPARdelta agonists was also associated with a decrease in IL-12 and IL-23 and an increase in IL-4 and IL-10 expression in the CNS and lymphoid organs.", "section": "abstract", "t_start": 25, "d_end": 20, "d_start": 18, "t_end": 33}, {"text": "These findings indicate that PPARdelta agonists modulate Th1 and Th17 responses in EAE and suggest their use in the treatment of MS and other autoimmune diseases.", "section": "abstract", "t_start": 29, "d_end": 85, "d_start": 83, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 23.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.23600000000000002}, "type": "literature", "id": "c8350a1892aa4f3e4c4077d889a9bf70"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19753309"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["AMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19753309", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19753309", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19753309", "mined_sentences": [{"text": "A nonsynonymous coding variant in the manganese superoxide dismutase (SOD2) gene (V16A, rs4880) has been implicated in neovascular age-related macular degeneration (AMD).", "section": "abstract", "t_start": 70, "d_end": 167, "d_start": 165, "t_end": 73}, {"text": "We found no detectable association of the V16A variant or any other common SOD2 variation with either neovascular AMD or PCV, as demonstrated by both single-SNP and haplotype analyses.", "section": "abstract", "t_start": 75, "d_end": 116, "d_start": 114, "t_end": 78}, {"text": "We found no evidence to support the role of any common SOD2 variations including the V16A variant in the susceptibility to neovascular AMD or PCV.", "section": "abstract", "t_start": 55, "d_end": 137, "d_start": 135, "t_end": 58}, {"text": "Kimura et al. [33] reported that a nonsynonymous coding variant in the manganese superoxide dismutase (SOD2) gene (V16A, rs4880) was significantly associated with neovascular AMD in a Japanese population.", "section": "introduction_and_background", "t_start": 103, "d_end": 177, "d_start": 175, "t_end": 106}, {"text": "To validate the previously described associations of the SOD2 V16A variant with neovascular AMD in Japanese populations [33,35], we examined this variant together with an additional SNP to increase coverage of the gene in an independent Japanese population with neovascular AMD.", "section": "discussion", "t_start": 57, "d_end": 94, "d_start": 92, "t_end": 60}, {"text": "We found no detectable association of the V16A variant or any other common SOD2 variation with either neovascular AMD or PCV by single-SNP or haplotype analysis.", "section": "discussion", "t_start": 75, "d_end": 116, "d_start": 114, "t_end": 78}, {"text": "Oxidative stress is a hypothesized pathway for the pathophysiology of AMD [56], and SOD2 is a reasonable candidate gene for the disease.", "section": "discussion", "t_start": 84, "d_end": 72, "d_start": 70, "t_end": 87}, {"text": "Kimura et al. [33] and Gotoh et al. [35] reported that opposite alleles at the same variant V16A in the SOD2 gene are positively associated with neovascular AMD in Japanese populations.", "section": "discussion", "t_start": 104, "d_end": 159, "d_start": 157, "t_end": 107}, {"text": "SOD2 maps to chromosome 6q25.3, a region that has not been implicated in AMD by any genome-wide scans [10].", "section": "discussion", "t_start": 0, "d_end": 75, "d_start": 73, "t_end": 3}, {"text": "In conclusion, we found no evidence to support the role of any common SOD2 variation including the V16A variant in the susceptibility to neovascular AMD or PCV.", "section": "discussion", "t_start": 70, "d_end": 151, "d_start": 149, "t_end": 73}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 23.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.23600000000000002}, "type": "literature", "id": "a23ebaaa0d8e53491656a04275157358"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11093066"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0004247"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004247", "label": "mood disorder"}, "name": ["affective disorders"], "id": "EFO_0004247"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11093066", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004247", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11093066", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11093066", "mined_sentences": [{"text": "Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3.", "section": "title", "t_start": 94, "d_end": 61, "d_start": 43, "t_end": 98}, {"text": "The gene that codes for the ABC transporter ABCG1 is located in a chromosomal susceptibility region (21q22.3) for affective disorders.", "section": "abstract", "t_start": 44, "d_end": 132, "d_start": 114, "t_end": 48}, {"text": "Genetic variations in ABCG1 have been associated with affective disorders in Japanese males.", "section": "abstract", "t_start": 22, "d_end": 72, "d_start": 54, "t_end": 26}, {"text": "These findings do not support the hypothesis that ABCG1 is a susceptibility gene for affective disorders or suicidal behavior.", "section": "abstract", "t_start": 50, "d_end": 103, "d_start": 85, "t_end": 54}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 23.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.23600000000000002}, "type": "literature", "id": "fbdefe071bea10f17833006c5ab92a5f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19493484"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["noise-induced hearing loss"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19493484", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19493484", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19493484", "mined_sentences": [{"text": "[Association between SNPs in SOD2 and noise-induced hearing loss].", "section": "title", "t_start": 29, "d_end": 63, "d_start": 38, "t_end": 32}, {"text": "To observe the association between SNPs in SOD2 and noise-induced hearing loss in Chinese Han population.", "section": "abstract", "t_start": 43, "d_end": 77, "d_start": 52, "t_end": 46}, {"text": "In SOD2 gene, the C allele of rs4880 was a risk factor of NIHL, compared with the T allele, OR = 1.76, 95% CI 1.17 approximately 2.63, P = 0.006.", "section": "abstract", "t_start": 3, "d_end": 61, "d_start": 58, "t_end": 6}, {"text": "In Chinese Han population, SOD2 rs4880 SNP in the mitochondrial targeting sequence is associated with noise induced hearing loss.", "section": "abstract", "t_start": 27, "d_end": 127, "d_start": 102, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 23.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.23600000000000002}, "type": "literature", "id": "eda656e62ee382055499a84e5eaec9d4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26318107"}]}, "target": {"id": "ENSG00000111961", "gene_info": {"symbol": "SASH1", "name": "SAM and SH3 domain containing 1", "geneid": "ENSG00000111961"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26318107", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O94885"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26318107", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26318107", "mined_sentences": [{"text": "SASH1, a new potential link between smoking and atherosclerosis.", "section": "title", "t_start": 0, "d_end": 42, "d_start": 36, "t_end": 4}, {"text": "The aim of this study was to further validate the link between smoking, SASH1 and atherosclerosis within the vascular wall and to assess the impact of SASH1 expression on endothelial cell functions.", "section": "abstract", "t_start": 72, "d_end": 69, "d_start": 63, "t_end": 76}, {"text": "We showed that SASH1 expression is increased in atherosclerotic carotids in smokers and its silencing affects endothelial angiogenic functions; therefore we provide a potential link between smoking and atherosclerosis through SASH1 expression.", "section": "abstract", "t_start": 15, "d_end": 196, "d_start": 190, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 22.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.22399999999999998}, "type": "literature", "id": "b6b5924febd818e09d27e9090387592e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22415791"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22415791", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22415791", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22415791", "mined_sentences": [{"text": "Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.", "section": "title", "t_start": 0, "d_end": 60, "d_start": 44, "t_end": 27}, {"text": "We investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates.", "section": "abstract", "t_start": 65, "d_end": 154, "d_start": 138, "t_end": 69}, {"text": "Cigarette smoking and alcohol intake showed no effect modification on the association with the EPHX1 polymorphisms or the imputed EPHX1 phenotype.", "section": "abstract", "t_start": 95, "d_end": 16, "d_start": 0, "t_end": 99}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 22.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.22399999999999998}, "type": "literature", "id": "ee1249f1ffd9f45b6ec50bdc99ee81b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22257321"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003829"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003829", "label": "alcohol dependence"}, "name": ["alcohol dependence"], "id": "EFO_0003829"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22257321", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003829", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22257321", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22257321", "mined_sentences": [{"text": "EPHX1 gene polymorphisms in alcohol dependence and their distribution among the Indian populations.", "section": "title", "t_start": 0, "d_end": 45, "d_start": 28, "t_end": 4}, {"text": "We found significant association between EPHX1 gene Tyr113His polymorphism and alcoholism in the Kota population (T vs. C: OR = .615, 95% CI = .399-.949, p = .027; TT vs. CC + CT: OR = .536, 95% CI = .297-.969, p = .038).", "section": "abstract", "t_start": 41, "d_end": 88, "d_start": 79, "t_end": 45}, {"text": "EPHX1 gene polymorphisms and haplotypes are associated with an increased risk for alcoholism in the Kota population.", "section": "abstract", "t_start": 0, "d_end": 91, "d_start": 82, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.21600000000000003}, "type": "literature", "id": "412c1c2c1f890ad456b6e9e41f8989e5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24861996"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24861996", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24861996", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24861996", "mined_sentences": [{"text": "Association of ABCB1,\u00a0CYP3A4,\u00a0EPHX1,\u00a0FAS,\u00a0SCN1A,\u00a0MICA, and\u00a0BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.", "section": "title", "t_start": 30, "d_end": 205, "d_start": 198, "t_end": 34}, {"text": "This study explored the association between the risk of carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and CBZ dose, dose-adjusted concentration, and ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms in patients of Han ethnicity with epilepsy who were living in northeastern China.", "section": "abstract", "t_start": 210, "d_end": 299, "d_start": 292, "t_end": 214}, {"text": "EPHX1 c.337T>C polymorphisms may contribute to the risk of severe CBZ-SJS/TEN by increasing the concentration of a CBZ metabolite, CBZ-10,11-epoxide, in patients with epilepsy.", "section": "abstract", "t_start": 0, "d_end": 174, "d_start": 167, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.214}, "type": "literature", "id": "20327eb42dee40bf6c41dfdd9bc79e7c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22103900"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22103900", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22103900", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22103900", "mined_sentences": [{"text": "Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.", "section": "title", "t_start": 0, "d_end": 60, "d_start": 44, "t_end": 27}, {"text": "The aim of this study was to use a population-based case-control study to investigate whether or not such genetic polymorphisms in EPHX1 gene can modify the relationship between smoking status and the risk of developing prostate cancer.", "section": "abstract", "t_start": 131, "d_end": 184, "d_start": 178, "t_end": 135}, {"text": "We further analysed the association between the EPHX1 genotypes and smoking.", "section": "abstract", "t_start": 48, "d_end": 74, "d_start": 68, "t_end": 52}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.212}, "type": "literature", "id": "ce06f836c5b1c9b40e8b987f7496c075"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24125961"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24125961", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24125961", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24125961", "mined_sentences": [{"text": "Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.", "section": "title", "t_start": 11, "d_end": 151, "d_start": 144, "t_end": 15}, {"text": "In this study, we sought to investigate the effects of genetic polymorphisms of the microsomal epoxide hydrolase (EPHX1), the sodium channel \u03b1 subunit type I (SCN1A) and the cytochrome P450 3A4 (CYP3A4) genes on plasma CBZ concentrations and pharmacoresistance in Chinese patients with epilepsy.", "section": "abstract", "t_start": 114, "d_end": 293, "d_start": 286, "t_end": 118}, {"text": "These results suggest that the EPHX1 c.416A>G polymorphism affects CBZ metabolism in Chinese patients with epilepsy.", "section": "abstract", "t_start": 31, "d_end": 114, "d_start": 107, "t_end": 35}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.212}, "type": "literature", "id": "a2c18a5ab64486ea1e744323e43e6d5e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24460684"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24460684", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24460684", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24460684", "mined_sentences": [{"text": "Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.", "section": "title", "t_start": 20, "d_end": 60, "d_start": 46, "t_end": 23}, {"text": "BMI1 is a Polycomb group repressor complex gene overexpressed across medulloblastoma subgroups but most significantly in Group 4 tumours.", "section": "abstract", "t_start": 0, "d_end": 83, "d_start": 69, "t_end": 3}, {"text": "Here we demonstrate that human medulloblastoma of Group 4 characterised by the greatest overexpression of BMI1, also display deregulation of cell adhesion molecules.", "section": "abstract", "t_start": 106, "d_end": 45, "d_start": 31, "t_end": 109}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.212}, "type": "literature", "id": "30830a93d3e4eec92f5d27ce52e84775"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18801343"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005411"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005411", "label": "schizoaffective disorder"}, "name": ["schizoaffective disorder"], "id": "EFO_0005411"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18801343", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005411", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18801343", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18801343", "mined_sentences": [{"text": "A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation.", "section": "title", "t_start": 18, "d_end": 88, "d_start": 65, "t_end": 29}, {"text": "However, a putative bona fide functional link between this mutation in the calreticulin gene and schizoaffective disorder has remained speculative.", "section": "abstract", "t_start": 75, "d_end": 120, "d_start": 97, "t_end": 86}, {"text": "Our results point to a previously unknown causal role for dysregulation of calreticulin homeostasis in schizoaffective disorder by both genetic and functional analyses, and shed new light on the possible mechanisms of action of valproate and lithium in the treatment of the disease.", "section": "abstract", "t_start": 75, "d_end": 126, "d_start": 103, "t_end": 86}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.21}, "type": "literature", "id": "40681d42157e67c2d43b88eacd7c1586"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15571513"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15571513", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15571513", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15571513", "mined_sentences": [{"text": "We addressed the question whether HSP-27 becomes induced in the neocortex resected from patients with pharmacoresistant epilepsy.", "section": "abstract", "t_start": 34, "d_end": 127, "d_start": 120, "t_end": 39}, {"text": "HSP-27 was highly expressed in all epilepsy specimens and in the cortex of a patient who died in the final stage of multiple sclerosis (positive control), whereas only low amounts of HSP-27 were detectable in control brains.", "section": "abstract", "t_start": 0, "d_end": 42, "d_start": 35, "t_end": 5}, {"text": "In epilepsy patients, HSP-27 was present in astrocytes and in the walls of blood vessels.", "section": "abstract", "t_start": 22, "d_end": 10, "d_start": 3, "t_end": 27}, {"text": "These results demonstrate that HSP-27 becomes induced in response to epileptic pathology.", "section": "abstract", "t_start": 31, "d_end": 77, "d_start": 69, "t_end": 36}, {"text": "Although the functional aspects of HSP-27 induction during human epilepsy have yet to be elucidated, it can be concluded that HSP-27 is a marker for cortical regions in which a stress response has been caused by seizures.", "section": "abstract", "t_start": 35, "d_end": 72, "d_start": 65, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.21}, "type": "literature", "id": "bfa8c197c7baefc6e1237dbbcae1772f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27034531"}]}, "target": {"id": "ENSG00000114346", "gene_info": {"symbol": "ECT2", "name": "epithelial cell transforming 2", "geneid": "ENSG00000114346"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27034531", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q9H8V3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27034531", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27034531", "mined_sentences": [{"text": "The smoking-related protein HSP90AA1 and DNA methylation of ECT2 mediate the progression from stage 1 bladder cancer cells to metastasis in stage 4 bladder cancer.", "section": "introduction_and_background", "t_start": 60, "d_end": 10, "d_start": 4, "t_end": 63}, {"text": "In Figure 3, our results reveal that ADRM1 regulates KPNA2, which promotes proliferation, and is mediated by the aging-related proteins, HSP90B1, CALR, HSPA5, PDIA3, RPN1, and ECT2, the smoking-related proteins, HUWE1, HSPA5, and ECT2, and the epigenetic regulation of ENO1, HSP90B1, CALR, and PDIA3, through the SUP and ER signaling pathways.", "section": "results", "t_start": 176, "d_end": 192, "d_start": 186, "t_end": 179}, {"text": "The results show the cross-regulation between the transcription of the smoking-related protein COPS5 and the aging-related protein ECT2.", "section": "results", "t_start": 123, "d_end": 77, "d_start": 71, "t_end": 134}, {"text": "The aging-related miRNA miR1-2 and the smoking-related miRNA miR200b act as a switch to depress the proliferation-associated protein KPNA2 in stage 1 and stage 4 bladder cancer cells (Figures 3 and 4) and the metastasis-associated gene ECT2 in stage 4 bladder cancer cells (Figure 4), respectively.", "section": "results", "t_start": 236, "d_end": 45, "d_start": 39, "t_end": 239}, {"text": "The Smoking-Related Protein HSP90AA1 and DNA Methylation of ECT2 Mediate the Metastasis of Bladder Cancer", "section": "results", "t_start": 60, "d_end": 10, "d_start": 4, "t_end": 63}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.21}, "type": "literature", "id": "7febdbdc8f9d98ec07ed613346810ec5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26526202"}]}, "target": {"id": "ENSG00000145331", "gene_info": {"symbol": "TRMT10A", "name": "tRNA methyltransferase 10A", "geneid": "ENSG00000145331"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26526202", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q8TBZ6"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26526202", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26526202", "mined_sentences": [{"text": "tRNA methyltransferase homologue gene TRMT10A mutation in young adult-onset diabetes with intellectual disability, microcephaly and epilepsy.", "section": "title", "t_start": 38, "d_end": 139, "d_start": 132, "t_end": 44}, {"text": "A syndrome of young-onset diabetes mellitus associated with microcephaly, epilepsy and intellectual disability caused by mutations in the tRNA methyltransferase 10 homologue A (TRMT10A) gene has recently been described.", "section": "abstract", "t_start": 177, "d_end": 81, "d_start": 74, "t_end": 183}, {"text": "TRMT10A sequencing should be considered in children or adults with young-onset diabetes who have a history of intellectual disability, microcephaly and epilepsy.", "section": "abstract", "t_start": 0, "d_end": 159, "d_start": 152, "t_end": 6}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 21.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.21}, "type": "literature", "id": "367cac3766a623ff17b4d2c4c21e3541"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25982666"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25982666", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25982666", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25982666", "mined_sentences": [{"text": "Although habitual smoking is well known to induce oxidative stress, there is no epidemiological evidence between plasma HSP 27 and renal dysfunction or smoking habits.", "section": "abstract", "t_start": 120, "d_end": 24, "d_start": 18, "t_end": 125}, {"text": "Elevated HSP 27 levels were independently associated with estimated glomerular filtration rate (eGFR) (p<0.001) and smoking habits (p<0.05).", "section": "abstract", "t_start": 9, "d_end": 122, "d_start": 116, "t_end": 14}, {"text": "HSP 27 levels were significantly decreased stratified by groups of eGFR (p<0.001 for trend) by analysis of co-variance (ANCOVA) adjusted for age, sex, and smoking habits.", "section": "abstract", "t_start": 0, "d_end": 161, "d_start": 155, "t_end": 5}, {"text": "HSP 27 levels were increased with more smoking of cigarettes.", "section": "abstract", "t_start": 0, "d_end": 45, "d_start": 39, "t_end": 5}, {"text": "The present study demonstrated that HSP 27 levels were strongly related to renal dysfunction and habitual smoking in a dose-response manner in a Japanese general population.", "section": "abstract", "t_start": 36, "d_end": 112, "d_start": 106, "t_end": 41}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.20800000000000002}, "type": "literature", "id": "8285e3cf2b0f3b073c51b46385d63082"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15963589"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15963589", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15963589", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15963589", "mined_sentences": [{"text": "Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia.", "section": "title", "t_start": 64, "d_end": 88, "d_start": 76, "t_end": 69}, {"text": "This study aimed to investigate the association between the three polymorphisms of HSP70-1 (HSPA1A), HSP70-hom (HSPA1L) and HSP70-2 (HSPA1B) and schizophrenia.", "section": "abstract", "t_start": 112, "d_end": 157, "d_start": 145, "t_end": 117}, {"text": "There were no significant differences in the allelic or genotype frequencies of the HSPA1A and HSPA1L polymorphisms between the schizophrenia patients and the controls, while there was a marginal difference in the genotype frequency of the HSPA1B polymorphisms, and a significant difference in the allelic frequency of the HSPA1B polymorphisms between the schizophrenia patients and the controls.", "section": "abstract", "t_start": 95, "d_end": 140, "d_start": 128, "t_end": 100}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.20800000000000002}, "type": "literature", "id": "a87e8cb36b6d1a110f0a368dff0a5f7e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22218650"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["reproductive system disease", "nervous system disease", "endocrine system disease", "genetic disorder", "metabolic disease"], "codes": ["EFO_0001379", "EFO_0000618", "EFO_0000589", "EFO_0000512", "EFO_0000508"]}, "path": [["EFO_0001379", "Orphanet_156638", "Orphanet_183637", "Orphanet_101960", "Orphanet_43"], ["EFO_0000512", "Orphanet_275742", "Orphanet_399980", "Orphanet_399983", "Orphanet_399685", "Orphanet_181441", "Orphanet_43"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68356", "Orphanet_43"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_98543", "Orphanet_43"], ["EFO_0000508", "Orphanet_156638", "Orphanet_181441", "Orphanet_43"], ["EFO_0000508", "Orphanet_156638", "Orphanet_183637", "Orphanet_101960", "Orphanet_43"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_43"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_43"], ["EFO_0000589", "Orphanet_68367", "Orphanet_68373", "Orphanet_309810", "Orphanet_79188", "Orphanet_43"], ["EFO_0000508", "Orphanet_68367", "Orphanet_68373", "Orphanet_309810", "Orphanet_79188", "Orphanet_43"], ["EFO_0001379", "Orphanet_156638", "Orphanet_181441", "Orphanet_43"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_43"], ["EFO_0000508", "Orphanet_275742", "Orphanet_399980", "Orphanet_399983", "Orphanet_399685", "Orphanet_181441", "Orphanet_43"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_43"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_98543", "Orphanet_43"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_43", "label": "X-linked adrenoleukodystrophy"}, "name": ["X-linked adrenoleukodystrophy"], "id": "Orphanet_43"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22218650", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_43", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22218650", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22218650", "mined_sentences": [{"text": "SOD2 as a potential modifier of X-linked adrenoleukodystrophy clinical phenotypes.", "section": "title", "t_start": 0, "d_end": 60, "d_start": 32, "t_end": 3}, {"text": "We tested an SOD2 variant C47T (Ala16Val) associated with reduced enzymatic activity as a potential modifier gene of cerebral demyelinating disease by comparing 117 cerebral XALD cases with 105 non-cerebral XALD cases.", "section": "abstract", "t_start": 13, "d_end": 177, "d_start": 174, "t_end": 16}, {"text": "Thus, reduced SOD2 activity may contribute to the development of cerebral demyelination in adolescent and adult XALD patients.", "section": "abstract", "t_start": 14, "d_end": 115, "d_start": 112, "t_end": 17}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.20800000000000002}, "type": "literature", "id": "aa025174c4e49eeb3080c539bed64b8b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16807759"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16807759", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16807759", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16807759", "mined_sentences": [{"text": "Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.", "section": "title", "t_start": 24, "d_end": 67, "d_start": 59, "t_end": 27}, {"text": "Hence, we investigated the association of SOD2 polymorphisms with the development of methamphetamine psychosis, in two independent populations of Japan and Taiwan.", "section": "abstract", "t_start": 42, "d_end": 109, "d_start": 101, "t_end": 45}, {"text": "Our results suggest that Ala/Val polymorphism of the SOD2 gene could be associated with the risk of developing methamphetamine psychosis.", "section": "abstract", "t_start": 53, "d_end": 135, "d_start": 127, "t_end": 56}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.20600000000000002}, "type": "literature", "id": "a1262d77661417a5f27da6ec64da0678"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19760677"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005411"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005411", "label": "schizoaffective disorder"}, "name": ["schizoaffective disorder"], "id": "EFO_0005411"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19760677", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005411", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19760677", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19760677", "mined_sentences": [{"text": "Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder.", "section": "title", "t_start": 23, "d_end": 101, "d_start": 78, "t_end": 34}, {"text": "We have recently reported the first case of mutation in the core promoter sequence of the human calreticulin gene in a family case of schizoaffective disorder.", "section": "abstract", "t_start": 96, "d_end": 157, "d_start": 134, "t_end": 107}, {"text": "To our knowledge, this is the first instance of disease-specific mutations in schizoaffective disorder, which warrants systematic screening of the regulatory and coding regions of the calreticulin gene in this disorder.", "section": "abstract", "t_start": 184, "d_end": 101, "d_start": 78, "t_end": 195}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.204}, "type": "literature", "id": "f5032ecf3dde6f763e1c162ca7e359bd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22928142"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["Infantile-Onset Spinocerebellar Ataxia"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22928142", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22928142", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22928142", "mined_sentences": [{"text": "Novel Autosomal Recessive c10orf2 Mutations Causing Infantile-Onset Spinocerebellar Ataxia.", "section": "title", "t_start": 26, "d_end": 89, "d_start": 52, "t_end": 32}, {"text": "This genetically and phenotypically heterogeneous group includes infantile onset spinocerebellar ataxia (OMIM# 271245) a neurodegenerative disease caused by mutations in the mtDNA helicase gene, c10orf2, with an increased frequency in the Finnish population due to a founder mutation.", "section": "abstract", "t_start": 195, "d_end": 102, "d_start": 65, "t_end": 201}, {"text": "We describe a child of English descent who presented with a severe phenotype of IOSCA as a result of two-novel mutations in the c10orf2 gene.", "section": "abstract", "t_start": 128, "d_end": 84, "d_start": 80, "t_end": 134}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.204}, "type": "literature", "id": "119e18c16113e0cabd1eec1cbb4618ba"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17526865"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17526865", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17526865", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17526865", "mined_sentences": [{"text": "The authors investigated whether polymorphisms in two maternal metabolic genes, cytochrome P-450 1A1 (CYP1A1) MspI and epoxide hydrolase 1 (EPHX1) Tyr113His, affect the association of maternal passive smoking with infant birth weight.", "section": "abstract", "t_start": 140, "d_end": 207, "d_start": 201, "t_end": 144}, {"text": "In the passive smoking group, there was a remarkable decrease in birth weight with the C/C6235 genotype (156.3 g, 95% confidence interval (CI): -283.6, -29.0) for CYP1A1 MspI and with Tyr/His113 (93.8 g, 95% CI: -188.6, -1.1) as compared with His/His113 (244.6 g, 95% CI: -491.0, -1.9) for EPHX1.", "section": "abstract", "t_start": 290, "d_end": 21, "d_start": 15, "t_end": 294}, {"text": "When results were stratified by maternal genotype, passive smoking conferred a significantly negative effect in the EPHX1 Tyr/His113 group (103.5 g, 95% CI: -205.8, -9.2) and in the His/His113 group (687.3 g, 95% CI: -748.3, -178.3).", "section": "abstract", "t_start": 116, "d_end": 65, "d_start": 59, "t_end": 120}, {"text": "The data further showed that there was a significant interaction between maternal passive smoking and maternal EPHX1 genotype for birth weight.", "section": "abstract", "t_start": 111, "d_end": 96, "d_start": 90, "t_end": 115}, {"text": "The authors conclude that the CYP1A1 MspI and EPHX1 genotypes modified the association between maternal passive smoking and infant birth weight in this study, which is suggestive of possible gene-environment interaction.", "section": "abstract", "t_start": 46, "d_end": 118, "d_start": 112, "t_end": 50}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.20199999999999999}, "type": "literature", "id": "ed1c0b08d8ad3d7fa33c906b23d4c974"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26243799"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["reproductive system disease", "metabolic disease", "endocrine system disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0001379", "EFO_0000618", "EFO_0000589", "EFO_0000512", "EFO_0000508"]}, "path": [["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_2855"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000508", "Orphanet_275742", "Orphanet_400008", "Orphanet_399877", "Orphanet_2855"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183731", "Orphanet_325665", "Orphanet_325638", "Orphanet_2855"], ["EFO_0000508", "Orphanet_156619", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"], ["EFO_0000512", "Orphanet_275742", "Orphanet_400008", "Orphanet_399877", "Orphanet_2855"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000512", "Orphanet_183731", "Orphanet_325665", "Orphanet_325638", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_35696", "Orphanet_2855"], ["EFO_0000508", "Orphanet_156638", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_35696", "Orphanet_2855"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_35696", "Orphanet_2855"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183530", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_2855"], ["EFO_0001379", "Orphanet_156638", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_2855", "label": "Perrault syndrome"}, "name": ["Perrault syndrome"], "id": "Orphanet_2855"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26243799", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_2855", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26243799", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26243799", "mined_sentences": [{"text": "Perrault syndrome: hydroxysteroid (17-beta) dehydrogenase 4, HSD17B4, 5q21; histidyl-tRNA synthetase 2, mitochondrial, HARS2, 5q31.3; leucyl-tRNA synthetase 2, mitochondrial, LARS2, 3p21.3; caseinolytic mitochondrial matrix peptidase proteolytic subunit, CLPP, 19p13.3; chromosome 10 open reading frame 2, C10orf2, 10q24", "section": "results", "t_start": 306, "d_end": 16, "d_start": 0, "t_end": 312}, {"text": "Then with similar genomic strategies with linkage analysis or whole-exome sequencing (WES), mutations in HARS2, LARS2, CLPP and C10orf2 have been found in the context of Perrault syndrome (Pierce et al., 2011, 2013; Jenkinson et al., 2013; Morino et al., 2014).", "section": "results", "t_start": 128, "d_end": 186, "d_start": 170, "t_end": 134}, {"text": "Perrault syndrome: HARS2, 5q31.3; LARS2, 3p21.3; CLPP, 19p13.3; C10orf2, 10q24", "section": "results", "t_start": 64, "d_end": 16, "d_start": 0, "t_end": 70}, {"text": "In POI associated with somatic features, causative perturbations have been found by WES for HSB17B4, LARS2, CLPP and C10orf2 in Perrault syndrome (Pierce et al., 2010, 2013; Jenkinson et al., 2013; Morino et al., 2014) (detailed in \u2018Mitochondrial Genes Causing POI\u2019 section and Table V).", "section": "results", "t_start": 117, "d_end": 144, "d_start": 128, "t_end": 123}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 20.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.2}, "type": "literature", "id": "0a5a6e5f7355d18708ca39f44e4507f5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21076037"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21076037", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21076037", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21076037", "mined_sentences": [{"text": "SR-BI has been identified on astrocytes and vascular smooth muscle cells in Alzheimer's disease brain and has been shown to mediate adhesion of microglia to fibrillar amyloid-\u03b2 (A\u03b2).", "section": "abstract", "t_start": 0, "d_end": 94, "d_start": 76, "t_end": 4}, {"text": "Here we report that SR-BI mediates perivascular macrophage response and regulates A\u03b2-related pathology and cerebral amyloid angiopathy in an Alzheimer's mouse model.", "section": "abstract", "t_start": 20, "d_end": 151, "d_start": 141, "t_end": 24}, {"text": "To evaluate the role of SR-BI in Alzheimer's disease pathogenesis, we inactivated one SR-BI allele in J20 transgenic mice.", "section": "abstract", "t_start": 24, "d_end": 51, "d_start": 33, "t_end": 28}, {"text": "These results reveal that SR-BI, a scavenger receptor primarily involved in high-density lipoprotein cholesterol transport, plays an essential role in Alzheimer's disease and cerebral amyloid angiopathy.", "section": "abstract", "t_start": 26, "d_end": 169, "d_start": 151, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.188}, "type": "literature", "id": "1322eefbfa36700f7558ea0f2fcf4750"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23643870"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathies"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23643870", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23643870", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23643870", "mined_sentences": [{"text": "Physico-chemical properties of R140G and K141Q mutants of human small heat shock protein HspB1 associated with hereditary peripheral neuropathies.", "section": "title", "t_start": 89, "d_end": 144, "d_start": 122, "t_end": 93}, {"text": "Some physico-chemical properties of R140G and K141Q mutants of human small heat shock protein HspB1 associated with hereditary peripheral neuropathy were analyzed.", "section": "abstract", "t_start": 94, "d_end": 147, "d_start": 127, "t_end": 98}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.188}, "type": "literature", "id": "6bbda9af8ebc8f2fdc557c3205e50c70"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17927981"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100", "EFO_1000783"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000783", "label": "diabetic neuropathy"}, "name": ["diabetic neuropathy"], "id": "EFO_1000783"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17927981", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000783", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17927981", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17927981", "mined_sentences": [{"text": "SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.", "section": "title", "t_start": 0, "d_end": 89, "d_start": 71, "t_end": 3}, {"text": "These profound changes in sensory neurons led us to explore the effects of decreased SOD2 on the development of diabetic neuropathy (DN) in mice.", "section": "abstract", "t_start": 85, "d_end": 130, "d_start": 112, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.188}, "type": "literature", "id": "e624481b311b867f8d9c924aafead62e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21904539"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["Depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21904539", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21904539", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21904539", "mined_sentences": [{"text": "Cardiomyocyte-Restricted Deletion of PPAR\u03b2/\u03b4 in PPAR\u03b1-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation.", "section": "title", "t_start": 37, "d_end": 142, "d_start": 133, "t_end": 41}, {"text": "The present study demonstrates that cardiomyocyte-restricted deletion of PPAR\u03b2/\u03b4 in PPAR\u03b1-null mice causes impaired mitochondrial biogenesis and defense, but no further depression of fatty acid oxidation.", "section": "abstract", "t_start": 73, "d_end": 178, "d_start": 169, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18600000000000003}, "type": "literature", "id": "4612bac6700510d84ddae5da8f26cf73"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22507216"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000677", "label": "mental or behavioural disorder"}, "name": ["psychiatric disorders"], "id": "EFO_0000677"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22507216", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000677", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22507216", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22507216", "mined_sentences": [{"text": "Novel evidence of the involvement of calreticulin in major psychiatric disorders.", "section": "title", "t_start": 37, "d_end": 79, "d_start": 59, "t_end": 48}, {"text": "We also sequenced the 600-bp CALR promoter, and the highly conserved intron 1 sequence in an independent sample of patients afflicted with major psychiatric disorders and controls.", "section": "abstract", "t_start": 29, "d_end": 165, "d_start": 145, "t_end": 32}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18600000000000003}, "type": "literature", "id": "2ce89b2ce8865e649f27f04d46aeedc5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15692831"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15692831", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15692831", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15692831", "mined_sentences": [{"text": "Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.", "section": "title", "t_start": 24, "d_end": 117, "d_start": 109, "t_end": 28}, {"text": "SNPs of EPHX1 were analyzed by means of polymerase chain reaction amplification and DNA sequencing using DNA extracted from the blood leukocytes of 96 Japanese epileptic patients, including 58 carbamazepine-administered patients.", "section": "abstract", "t_start": 8, "d_end": 168, "d_start": 160, "t_end": 12}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18600000000000003}, "type": "literature", "id": "b672993c4b5ecf0701a9fc4f5e37b680"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25429433"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25429433", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25429433", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25429433", "mined_sentences": [{"text": "Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.", "section": "title", "t_start": 6, "d_end": 78, "d_start": 60, "t_end": 17}, {"text": "Calreticulin is down-regulated in the cortical neurons of patients with Alzheimer's disease (AD) and may be a potential biomarker for the diagnosis of AD.", "section": "abstract", "t_start": 0, "d_end": 90, "d_start": 72, "t_end": 11}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.184}, "type": "literature", "id": "9ea047f07e63e4d15b85382afaa0fb19"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11820740"}]}, "target": {"id": "ENSG00000139083", "gene_info": {"symbol": "ETV6", "name": "ETS variant 6", "geneid": "ENSG00000139083"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia-telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11820740", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/P41212"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11820740", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11820740", "mined_sentences": [{"text": "TEL1 from Saccharomyces cerevisiae suppresses chromosome aberrations induced by ionizing radiation in ataxia-telangiectasia cells without affecting cell cycle checkpoints.", "section": "title", "t_start": 0, "d_end": 122, "d_start": 102, "t_end": 3}, {"text": "The TEL1 gene from Saccharomyces cerevisiae has been shown to be the closest sequence homologue to ATM, the gene mutated in ataxia-telangiectasia (A-T) patients.", "section": "abstract", "t_start": 4, "d_end": 144, "d_start": 124, "t_end": 7}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.184}, "type": "literature", "id": "79ca8fed3bb732d4f3aad6f7cfaa81ae"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23948568"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23948568", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23948568", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23948568", "mined_sentences": [{"text": "Structure and properties of G84R and L99M mutants of human small heat shock protein HspB1 correlating with motor neuropathy.", "section": "title", "t_start": 84, "d_end": 122, "d_start": 113, "t_end": 88}, {"text": "Some properties of G84R and L99M mutants of HspB1 associated with peripheral distal neuropathies were investigated.", "section": "abstract", "t_start": 44, "d_end": 95, "d_start": 84, "t_end": 48}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.184}, "type": "literature", "id": "4e18d402a82f8f1cd5077e975d166237"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8277336"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8277336", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8277336", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8277336", "mined_sentences": [{"text": "Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease.", "section": "title", "t_start": 23, "d_end": 100, "d_start": 82, "t_end": 27}, {"text": "The localization of two small heat shock proteins, alpha B crystallin and 28-kDa heat shock protein (HSP28), was studied immunochemically and immunohistochemically in cerebral cortex of patients with Alzheimer's disease (AD) and control groups.", "section": "abstract", "t_start": 101, "d_end": 218, "d_start": 200, "t_end": 105}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1993-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.184}, "type": "literature", "id": "7a7ecb8bda1a083c2d5e0f7eacacc080"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22176143"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathies"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22176143", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22176143", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22176143", "mined_sentences": [{"text": "HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients.", "section": "title", "t_start": 0, "d_end": 40, "d_start": 29, "t_end": 4}, {"text": "The significant HSPB1 mutation frequency in both phenotypes indicates its relevance in the pathogenesis of these neuropathies.", "section": "abstract", "t_start": 16, "d_end": 124, "d_start": 113, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.182}, "type": "literature", "id": "aa329766b55a6645486931039c975495"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22031878"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22031878", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22031878", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22031878", "mined_sentences": [{"text": "Small heat-shock protein HSPB1 mutants stabilize microtubules in Charcot-Marie-Tooth neuropathy.", "section": "title", "t_start": 25, "d_end": 94, "d_start": 85, "t_end": 29}, {"text": "Mutations in the small heat shock protein HSPB1 (HSP27) are causative for Charcot-Marie-Tooth (CMT) neuropathy.", "section": "abstract", "t_start": 42, "d_end": 109, "d_start": 100, "t_end": 46}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.182}, "type": "literature", "id": "049525efe292e265d2beb3bdc938ce9d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26555147"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["Epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26555147", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26555147", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26555147", "mined_sentences": [{"text": "Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.", "section": "title", "t_start": 34, "d_end": 164, "d_start": 156, "t_end": 38}, {"text": "Five SNPs in two candidate genes influencing CBZ transport and metabolism, namely ABCB1 or EPHX1, and CBZ response SCN1A (sodium channel) were genotyped in 145 epileptic patients treated with CBZ as monotherapy and 100 age and sex matched healthy controls.", "section": "abstract", "t_start": 91, "d_end": 168, "d_start": 160, "t_end": 95}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.182}, "type": "literature", "id": "897a37a3ae00e62f82137354f686fbb2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23500038"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_0005782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005782", "label": "age-related hearing impairment"}, "name": ["age-related hearing loss"], "id": "EFO_0005782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23500038", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005782", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23500038", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23500038", "mined_sentences": [{"text": "A functional and genetic analysis of SOD2 promoter variants and their contribution to age-related hearing loss.", "section": "title", "t_start": 37, "d_end": 109, "d_start": 86, "t_end": 40}, {"text": "Here, we have investigated the role of SOD2 promoter variants in age related hearing loss (ARHL).", "section": "abstract", "t_start": 39, "d_end": 88, "d_start": 65, "t_end": 42}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.182}, "type": "literature", "id": "13db8bed422feba1bef028871a8de26a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11922659"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253", "EFO_0001356"], ["EFO_0000618", "EFO_0003782", "EFO_0000253", "EFO_0001356"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253", "EFO_0001356"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001356", "label": "familial amyotrophic lateral sclerosis"}, "name": ["familial amyotrophic lateral sclerosis"], "id": "EFO_0001356"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11922659", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001356", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11922659", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11922659", "mined_sentences": [{"text": "Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.", "section": "title", "t_start": 38, "d_end": 124, "d_start": 87, "t_end": 40}, {"text": "The aim of this study is to determine the effects of hNT Neuron transplants on motor neuron function in a mouse model of familial amyotrophic lateral sclerosis (FALS) in which there is a substitution of Alanine for Glycine at position 93 of the human SOD1 gene (G93A).", "section": "abstract", "t_start": 53, "d_end": 158, "d_start": 121, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.182}, "type": "literature", "id": "a4d18bcc9f2b87107be8cd290be79c30"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17879369"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17879369", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17879369", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17879369", "mined_sentences": [{"text": "Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers.", "section": "title", "t_start": 56, "d_end": 37, "d_start": 17, "t_end": 74}, {"text": "In response to certain types of DNA damage, ataxia telangiectasia and rad3-related (ATR) phosphorylates checkpoint kinase 1 (CHEK1) resulting in cell cycle arrest and subsequent DNA repair.", "section": "abstract", "t_start": 125, "d_end": 64, "d_start": 44, "t_end": 129}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18}, "type": "literature", "id": "bd9316c27405cadaa3b1c1b0fe32829b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25558953"}]}, "target": {"id": "ENSG00000165246", "gene_info": {"symbol": "NLGN4Y", "name": "neuroligin 4, Y-linked", "geneid": "ENSG00000165246"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25558953", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/Q8NFZ3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25558953", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25558953", "mined_sentences": [{"text": "Behavioral phenotypes in males with XYY and possible role of increased NLGN4Y expression in autism features.", "section": "title", "t_start": 71, "d_end": 97, "d_start": 92, "t_end": 76}, {"text": "Expression of NLGN4Y, a gene that may be involved in synaptic function, is increased in boys with XYY, and the level of expression correlates with overall social responsiveness and autism symptoms.", "section": "abstract", "t_start": 14, "d_end": 186, "d_start": 181, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18}, "type": "literature", "id": "4863a38f2b654f94b8368e39cfeb9c8d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22189180"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22189180", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22189180", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22189180", "mined_sentences": [{"text": "The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.", "section": "title", "t_start": 87, "d_end": 130, "d_start": 125, "t_end": 95}, {"text": "Serum neurokinin A levels were elevated in some autistic children and they were significantly correlated to the severity of autism and to serum levels of anti-ribosomal P protein antibodies.", "section": "abstract", "t_start": 169, "d_end": 129, "d_start": 124, "t_end": 177}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18}, "type": "literature", "id": "02e6b64f07c17162bcf0e52043fb5079"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25295643"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003821", "EFO_0005295"], ["EFO_0000618", "EFO_0003821", "EFO_0005295"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005295", "label": "migraine with aura"}, "name": ["migraine with aura"], "id": "EFO_0005295"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25295643", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005295", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25295643", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25295643", "mined_sentences": [{"text": "Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?", "section": "title", "t_start": 3, "d_end": 63, "d_start": 46, "t_end": 6}, {"text": "In a case-control study, we investigated the association between migraine and superoxide dismutase 1 (SOD1) and superoxide dismutase 2 (SOD2) genes in a cohort of 490 consecutive unrelated Caucasian migraineurs (migraine with aura [MwA], n=107; migraine without aura [MwoA], n=246; chronic migraine [CM], n=137) and 246 healthy controls recruited at our Headache and Pain Unit and stored in the Interinstitutional Multidisciplinary BioBank (BioBIM).", "section": "abstract", "t_start": 136, "d_end": 229, "d_start": 212, "t_end": 139}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 18.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.18}, "type": "literature", "id": "bf45e6d28470283941be6b4fcd7e9760"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16098614"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental autoimmune encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16098614", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16098614", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16098614", "mined_sentences": [{"text": "Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.", "section": "title", "t_start": 24, "d_end": 129, "d_start": 89, "t_end": 70}, {"text": "In contrast, the effect of PPARdelta (PPARdelta) agonists in EAE is not yet known.", "section": "abstract", "t_start": 27, "d_end": 63, "d_start": 61, "t_end": 35}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "aaf071d4704af0097d7e7e6b704acbf6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26160761"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's Disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26160761", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26160761", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26160761", "mined_sentences": [{"text": "PPAR\u03b2/\u03b4 Agonist Provides Neuroprotection by Suppression of IRE1\u03b1-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.", "section": "title", "t_start": 0, "d_end": 169, "d_start": 151, "t_end": 4}, {"text": "Two recent studies demonstrated that peroxisome proliferator-activated receptor \u03b2/\u03b4 (PPAR\u03b2/\u03b4) agonists exerted neuroprotective effects in mouse model of Parkinson's disease (PD).", "section": "abstract", "t_start": 85, "d_end": 171, "d_start": 153, "t_end": 89}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "85f5a5fdf6a18a1d94dcf12c340a3c97"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12392603"}]}, "target": {"id": "ENSG00000179399", "gene_info": {"symbol": "GPC5", "name": "glypican 5", "geneid": "ENSG00000179399"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["Bipolar disorder"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12392603", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/P78333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12392603", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12392603", "mined_sentences": [{"text": "Mutation screening of two candidate genes from 13q32 in families affected with Bipolar disorder: human peptide transporter (SLC15A1) and human glypican5 (GPC5).", "section": "title", "t_start": 154, "d_end": 94, "d_start": 79, "t_end": 157}, {"text": "Mutation analysis of 2 candidate genes for Bipolar disorder on chromosome 13q32 did not identify any potentially causative mutations within the coding regions or splice junctions of the SLC15A1 or GPC5 genes in 7 families showing linkage to 13q32.", "section": "abstract", "t_start": 197, "d_end": 58, "d_start": 43, "t_end": 200}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "563b821582d7ee253a7bb1e297962124"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18575922"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18575922", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18575922", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18575922", "mined_sentences": [{"text": "Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia.", "section": "title", "t_start": 15, "d_end": 84, "d_start": 49, "t_end": 18}, {"text": "Genetic analysis revealed that 1) PEO1 has a major role in determining familial PEO, since it accounts for 26.8% of familial cases, followed by ANT1 (14.6%) and POLG1 (9.8%); 2) no mutations in any of the known genes were found in 53.7% of probands of this series.", "section": "abstract", "t_start": 34, "d_end": 82, "d_start": 80, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "b14dc2be0be15d8f62039e22ef776779"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25577368"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25577368", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25577368", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25577368", "mined_sentences": [{"text": "S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model.", "section": "title", "t_start": 92, "d_end": 123, "d_start": 116, "t_end": 97}, {"text": "As previously shown, immunization with ocular antigens, like heat shock protein 27 (HSP 27), leads to retinal ganglion cell loss in an autoimmune glaucoma model.", "section": "abstract", "t_start": 84, "d_end": 153, "d_start": 146, "t_end": 89}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "7c6ea3e84cac4650b3a300d1e165bf3b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19753309"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0001365", "EFO_0004683"], ["EFO_0003966", "EFO_0001365", "EFO_0004683"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004683", "label": "wet macular degeneration"}, "name": ["neovascular age-related macular degeneration"], "id": "EFO_0004683"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19753309", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004683", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19753309", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19753309", "mined_sentences": [{"text": "SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.", "section": "title", "t_start": 0, "d_end": 70, "d_start": 27, "t_end": 3}, {"text": "A nonsynonymous coding variant in the manganese superoxide dismutase (SOD2) gene (V16A, rs4880) has been implicated in neovascular age-related macular degeneration (AMD).", "section": "abstract", "t_start": 70, "d_end": 162, "d_start": 119, "t_end": 73}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "cd609038023a3f81013b274781581a08"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22683713"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_0001063"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001063", "label": "deafness"}, "name": ["deafness"], "id": "EFO_0001063"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22683713", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001063", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22683713", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22683713", "mined_sentences": [{"text": "Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness.", "section": "title", "t_start": 46, "d_end": 155, "d_start": 148, "t_end": 51}, {"text": "Using exome sequencing, we identify SERAC1 mutations as the cause of MEGDEL syndrome, a recessive disorder of dystonia and deafness with Leigh-like syndrome, impaired oxidative phosphorylation and 3-methylglutaconic aciduria.", "section": "abstract", "t_start": 36, "d_end": 130, "d_start": 123, "t_end": 41}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17800000000000002}, "type": "literature", "id": "5c805cbb81c7057536dc8303abf6d226"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16511840"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16511840", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16511840", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16511840", "mined_sentences": [{"text": "A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia.", "section": "title", "t_start": 24, "d_end": 100, "d_start": 88, "t_end": 35}, {"text": "The 5'-flanking region of the human calreticulin gene was screened in 100 cases of schizophrenia by PCR/SSCA between -485 and +1 basepair (bp) relative to the transcription start site.", "section": "abstract", "t_start": 36, "d_end": 95, "d_start": 83, "t_end": 47}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "5edb5d65eb1f6e01931585139eac49be"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22545112"}]}, "target": {"id": "ENSG00000161955", "gene_info": {"symbol": "TNFSF13", "name": "tumor necrosis factor superfamily member 13", "geneid": "ENSG00000161955"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["bipolar disorder"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22545112", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/O75888"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22545112", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22545112", "mined_sentences": [{"text": "Whilst other studies have observed increased TNFSF13 expression in reactive astrocytes in multiple sclerosis [53] and in cells surrounding tumor tissue [54], the absence of TNFSF13 expression changes in patients with bipolar disorder suggests at least a degree of diagnostic specificity for the TNFSF13 mRNA change between the two psychiatric groups.", "section": "discussion", "t_start": 45, "d_end": 232, "d_start": 217, "t_end": 51}, {"text": "The alteration in TNFSF13 gene expression showed relative disease specificity, as it was observed in the schizophrenia and not the bipolar disorder cases and showed relative brain region specificity in schizophrenia, as it was observed in the DLPFC and not in the OFC.", "section": "discussion", "t_start": 18, "d_end": 146, "d_start": 131, "t_end": 24}, {"text": "Gene expression levels of TNFSF13-FAS receptor pathway genes of interest relative to three housekeeping genes in dorsolateral prefrontal cortex from patients with bipolar disorder.", "section": "figure", "t_start": 26, "d_end": 178, "d_start": 163, "t_end": 32}, {"text": "Gene expression levels of TNFSF13, FAS receptor and BID relative to three housekeeping genes in OFC from patients with schizophrenia, patients with bipolar disorder and unaffected controls.", "section": "figure", "t_start": 26, "d_end": 163, "d_start": 148, "t_end": 32}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "f3bc38bf595f8ac7616063fe3c601011"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18438697"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18438697", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18438697", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18438697", "mined_sentences": [{"text": "Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's disease.", "section": "title", "t_start": 29, "d_end": 75, "d_start": 57, "t_end": 33}, {"text": "To examine the genetic association of those genes with Alzheimer's disease (AD) risk, we used the TaqMan technique to genotype five SNP sites for SIRT1, six for PPARD and eight for the PGC-1alpha gene, in 326 Finnish AD cases and 463 controls and conducted a single allele and genotypic distribution comparison as well as estimated haplotype frequencies between cases and controls.", "section": "abstract", "t_start": 161, "d_end": 73, "d_start": 55, "t_end": 165}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "075424e3c4c53e49958b4edf2a85eb03"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/7545545"}]}, "target": {"id": "ENSG00000139083", "gene_info": {"symbol": "ETV6", "name": "ETS variant 6", "geneid": "ENSG00000139083"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/7545545", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/P41212"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/7545545", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/7545545", "mined_sentences": [{"text": "TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1.", "section": "title", "t_start": 0, "d_end": 80, "d_start": 60, "t_end": 3}, {"text": "Patients with the genetic disorder ataxia telangiectasia (AT) have mutations in the AT mutated (ATM) gene, which is homologous to TEL1 and the checkpoint gene MEC1.", "section": "abstract", "t_start": 130, "d_end": 55, "d_start": 35, "t_end": 133}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1995-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "83897b62dd746990f19cbd625484d13e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/7671310"}]}, "target": {"id": "ENSG00000139083", "gene_info": {"symbol": "ETV6", "name": "ETS variant 6", "geneid": "ENSG00000139083"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/7671310", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/P41212"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/7671310", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/7671310", "mined_sentences": [{"text": "TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene.", "section": "title", "t_start": 0, "d_end": 118, "d_start": 98, "t_end": 3}, {"text": "The closest homolog to TEL1 is the human ataxia telangiectasia gene.", "section": "abstract", "t_start": 23, "d_end": 61, "d_start": 41, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1995-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "0b8210dd2c12bf860444daabb7fe019c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10037719"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSP"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10037719", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10037719", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10037719", "mined_sentences": [{"text": "Comparison of the oligomer symmetry in alphaA-crystallin, HSP 27, and HSP 16.3.", "section": "title", "t_start": 58, "d_end": 72, "d_start": 70, "t_end": 63}, {"text": "Site-directed spin labeling was used to investigate quaternary interactions along a conserved sequence in the alpha-crystallin domain of alphaA-crystallin, heat-shock protein 27 (HSP 27), and Mycobacterium tuberculosis heat-shock protein (HSP 16.3).", "section": "abstract", "t_start": 179, "d_end": 241, "d_start": 239, "t_end": 184}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1999-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "b263a975b3a41ade68e44992dc64cccd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24047924"}]}, "target": {"id": "ENSG00000146282", "gene_info": {"symbol": "RARS2", "name": "arginyl-tRNA synthetase 2, mitochondrial", "geneid": "ENSG00000146282"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001429"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001429", "label": "Subdural Effusion"}, "name": ["Subdural effusions"], "id": "EFO_1001429"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24047924", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001429", "target": "http://identifiers.org/uniprot/Q5T160"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24047924", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24047924", "mined_sentences": [{"text": "Subdural effusions and lack of early pontocerebellar hypoplasia in siblings with RARS2 mutations.", "section": "title", "t_start": 81, "d_end": 17, "d_start": 0, "t_end": 85}, {"text": "RARS2 mutations should be considered in infants presenting with seizures, subdural effusions, decelerating head growth and evidence of cerebral atrophy even in the absence of pontocerebellar hypoplasia on imaging.", "section": "abstract", "t_start": 0, "d_end": 91, "d_start": 74, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "321d0de9bc14f53b6ddd6600677b5b50"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18930810"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18930810", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18930810", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18930810", "mined_sentences": [{"text": "Association between haplotypes of manganese superoxide dismutase (SOD2), smoking, and lung cancer risk.", "section": "title", "t_start": 66, "d_end": 79, "d_start": 73, "t_end": 69}, {"text": "This study suggests that subjects with the SOD2 TCG haplotype may be at decreased risk for lung adenocarcinoma and that this association may depend on smoking amount.", "section": "abstract", "t_start": 43, "d_end": 157, "d_start": 151, "t_end": 46}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "3d5f5605bd4a1e23e784e31df3055f72"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26400460"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26400460", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26400460", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26400460", "mined_sentences": [{"text": "SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.", "section": "title", "t_start": 0, "d_end": 112, "d_start": 98, "t_end": 3}, {"text": "Therefore, we examined SOD2 variants in association with ototoxicity among cisplatin-treated childhood medulloblastoma patients.", "section": "abstract", "t_start": 23, "d_end": 117, "d_start": 93, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17600000000000002}, "type": "literature", "id": "8d5dae85500ea5fc2b4def1884273ace"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26340046"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26340046", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26340046", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26340046", "mined_sentences": [{"text": "Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.", "section": "title", "t_start": 35, "d_end": 120, "d_start": 113, "t_end": 38}, {"text": "A direct correlation was observed between high heterotopia burden, female gender, and trigonal location in this large cohort of FLNA-negative bilateral PVNH patients with epilepsy.", "section": "abstract", "t_start": 128, "d_end": 178, "d_start": 171, "t_end": 131}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "7e903ec2b725431919c508d5700a704c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12622406"}]}, "target": {"id": "ENSG00000185532", "gene_info": {"symbol": "PRKG1", "name": "protein kinase, cGMP-dependent, type I", "geneid": "ENSG00000185532"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003888"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003888", "label": "attention deficit hyperactivity disorder"}, "name": ["ADHD"], "id": "EFO_0003888"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12622406", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003888", "target": "http://identifiers.org/uniprot/Q13976"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12622406", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12622406", "mined_sentences": [{"text": "A drosophila model for attention deficit hyperactivity disorder (ADHD): No evidence of association with PRKG1 gene.", "section": "title", "t_start": 104, "d_end": 68, "d_start": 65, "t_end": 108}, {"text": "The aim of this study was to investigate for the presence of linkage disequilibrium between the protein kinase G gene (PRKG1) and adult ADHD in a sample of nuclear families.", "section": "abstract", "t_start": 119, "d_end": 139, "d_start": 136, "t_end": 123}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "ba18868f99aff9bad4714cfcaac90d3a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27276192"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27276192", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27276192", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27276192", "mined_sentences": [{"text": "Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.", "section": "title", "t_start": 11, "d_end": 122, "d_start": 114, "t_end": 15}, {"text": "The aim of this study was to evaluate the impact of polymorphisms in the EPHX1 (c.416A\u2009>\u2009G, c.337T\u2009>\u2009C) and CYP3A4*22 genes involved in carbamazepine (CBZ) metabolism and pharmacoresistance among 118 Tunisian patients with epilepsy under maintenance dose of CBZ.", "section": "abstract", "t_start": 73, "d_end": 230, "d_start": 223, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "048afe945845c0ccca5cd44d1a991ecd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25339146"}]}, "target": {"id": "ENSG00000125257", "gene_info": {"symbol": "ABCC4", "name": "ATP binding cassette subfamily C member 4", "geneid": "ENSG00000125257"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516", "EFO_0004190"], ["EFO_0003966", "EFO_0000516", "EFO_0004190"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004190", "label": "open-angle glaucoma"}, "name": ["open-angle glaucoma"], "id": "EFO_0004190"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25339146", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004190", "target": "http://identifiers.org/uniprot/O15439"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25339146", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25339146", "mined_sentences": [{"text": "Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.", "section": "title", "t_start": 31, "d_end": 138, "d_start": 120, "t_end": 34}, {"text": "The purpose of this study is to evaluate the association between variants in prostaglandin-endoperoxide synthase 1 (PTGS1), prostaglandin F (2\u03b1) receptor (PTGFR), and multidrug resistance protein 4 (MRP4) genes and intraocular pressure (IOP) response to latanoprost in Chinese patients with primary open-angle glaucoma (POAG).", "section": "abstract", "t_start": 199, "d_end": 317, "d_start": 299, "t_end": 202}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "7ddffb685f094a783940d800acbe677c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25051967"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL Syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25051967", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25051967", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25051967", "mined_sentences": [{"text": "MEGDEL Syndrome in a Child From Palestine: Report of a Novel Mutation in SERAC1 Gene.", "section": "title", "t_start": 73, "d_end": 14, "d_start": 0, "t_end": 78}, {"text": "MEGDEL syndrome was recently found to be caused by mutations in SERAC1, encoding a protein essential for mitochondrial function, phospholipid remodeling, and intracellular cholesterol trafficking.", "section": "abstract", "t_start": 64, "d_end": 14, "d_start": 0, "t_end": 69}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "02b9ee928dba3cb11d948aaa0d718f47"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23918762"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23918762", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23918762", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23918762", "mined_sentences": [{"text": "Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1.", "section": "title", "t_start": 212, "d_end": 75, "d_start": 61, "t_end": 217}, {"text": "Using whole exome sequencing, we identified two novel homozygous mutations in SERAC1 recently reported to harbor mutations in MEGDEL syndrome.", "section": "abstract", "t_start": 78, "d_end": 140, "d_start": 126, "t_end": 83}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "5da4f8f445fb9f98ddc658db09155960"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24070129"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["Glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24070129", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24070129", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24070129", "mined_sentences": [{"text": "Association of SOD2 Mutation (c.47T > C) with Various Primary Angle Closure Glaucoma Clinical Indices.", "section": "title", "t_start": 15, "d_end": 83, "d_start": 76, "t_end": 18}, {"text": "We investigated whether the c.47T>C polymorphism (SNP rs4880) in the manganese superoxide dismutase (SOD2) gene is a risk factor for primary angle closure glaucoma (PACG) in the Saudi population.", "section": "abstract", "t_start": 101, "d_end": 162, "d_start": 155, "t_end": 104}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.174}, "type": "literature", "id": "80178f5e073d89d525d58331fbbc0dc0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23575574"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0001358"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001358", "label": "post-traumatic stress disorder"}, "name": ["post-traumatic stress disorder"], "id": "EFO_0001358"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23575574", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001358", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23575574", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23575574", "mined_sentences": [{"text": "Effect of calreticulin on Ca2+/CaM kinaseII\u03b1 and endoplasmic reticulum stress in hippocampal in a rat model of post-traumatic stress disorder.", "section": "title", "t_start": 10, "d_end": 140, "d_start": 111, "t_end": 21}, {"text": "The purpose of the present study was to examine the changes in the molecular chaperone calreticulin (CRT), calcium signaling pathway Ca(2+)-calmodulin (CaM)-CaM kinaseII\u03b1 (CaMKII\u03b1), and the endoplasmic reticulum (ER) apoptotic modulator caspase-12 in hippocampal neurons of rats exposed to single-prolonged stress (SPS), a model of post-traumatic stress disorder (PTSD).", "section": "abstract", "t_start": 87, "d_end": 367, "d_start": 364, "t_end": 98}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "552c9f2c8d943545e6c8fe6e56959fab"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21598178"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21598178", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21598178", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21598178", "mined_sentences": [{"text": "Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms.", "section": "title", "t_start": 86, "d_end": 79, "d_start": 73, "t_end": 113}, {"text": "We determined the association between charred meat consumption, cigarette smoking, microsomal epoxide hydrolase (mEH) polymorphisms (rs1051740 and rs2234922), and colorectal adenomas and hyperplastic polyps (HPs) and explored gene-environment interactions.", "section": "abstract", "t_start": 83, "d_end": 80, "d_start": 64, "t_end": 110}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "be8685a902f23272f1634351c65fcbb6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22994552"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["childhood medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22994552", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22994552", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22994552", "mined_sentences": [{"text": "Maternal variation in EPHX1, a xenobiotic metabolism gene, is associated with childhood medulloblastoma: an exploratory case-parent triad study.", "section": "title", "t_start": 22, "d_end": 102, "d_start": 78, "t_end": 26}, {"text": "However, the maternal EPHX1 rs1051740 genotype (RR = 3.26, P = .01) was associated with medulloblastoma risk.", "section": "abstract", "t_start": 22, "d_end": 102, "d_start": 88, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "35fda9ada519d25172035546723d505c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19223528"}]}, "target": {"id": "ENSG00000157456", "gene_info": {"symbol": "CCNB2", "name": "cyclin B2", "geneid": "ENSG00000157456"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "endocrine system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0001379", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0002422", "EFO_0000232", "EFO_1000478"], ["EFO_0001379", "EFO_0003769", "EFO_1000478"], ["EFO_0000616", "EFO_0003833", "EFO_1000478"], ["EFO_0000616", "EFO_0003769", "EFO_1000478"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_1000478"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000478", "label": "Pituitary Gland Adenoma"}, "name": ["pituitary adenomas"], "id": "EFO_1000478"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19223528", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000478", "target": "http://identifiers.org/uniprot/O95067"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19223528", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19223528", "mined_sentences": [{"text": "HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.", "section": "title", "t_start": 26, "d_end": 73, "d_start": 56, "t_end": 30}, {"text": "Finally, we report an increased CCNB2 expression in human pituitary adenomas of different histotypes that is directly correlated with HMGA1 and HMGA2 expression.", "section": "abstract", "t_start": 32, "d_end": 75, "d_start": 58, "t_end": 36}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "9ff4064284796210dee90d59824c0f24"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22200564"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22200564", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22200564", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22200564", "mined_sentences": [{"text": "Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin.", "section": "title", "t_start": 47, "d_end": 42, "d_start": 35, "t_end": 50}, {"text": "This study investigated the role of mitochondrial oxidative stress in epilepsy resulting from mitochondrial dysfunction using cross-bred mutant mice lacking mitochondrial manganese superoxide dismutase (MnSOD or SOD2) and a lipophilic metalloporphyrin catalytic antioxidant.", "section": "abstract", "t_start": 212, "d_end": 77, "d_start": 70, "t_end": 215}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "37cad4a5d93608c59219a28c66dd1671"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/2241267"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/2241267", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/2241267", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/2241267", "mined_sentences": [{"text": "A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis.", "section": "title", "t_start": 37, "d_end": 101, "d_start": 93, "t_end": 46}, {"text": "In two siblings with systemic lupus erythematosus (SLE), who experienced two episodes of psychosis each, a longitudinal study of autoantibodies, including antibodies to ribosomal P proteins, is described.", "section": "abstract", "t_start": 179, "d_end": 97, "d_start": 89, "t_end": 188}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1990-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "097fbaf5f457491473428933b9c0ab2c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17303250"}]}, "target": {"id": "ENSG00000135404", "gene_info": {"symbol": "CD63", "name": "CD63 molecule", "geneid": "ENSG00000135404"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0001358"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001358", "label": "post-traumatic stress disorder"}, "name": ["posttraumatic stress disorder"], "id": "EFO_0001358"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17303250", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001358", "target": "http://identifiers.org/uniprot/P08962"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17303250", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17303250", "mined_sentences": [{"text": "Baseline level of platelet-leukocyte aggregates, platelet CD63 expression, and soluble P-selectin concentration in patients with posttraumatic stress disorder: a pilot study.", "section": "title", "t_start": 58, "d_end": 157, "d_start": 129, "t_end": 61}, {"text": "Platelet-leukocyte aggregates (PLA) and CD63 expression were measured by flow cytometry, and soluble (s)P-selectin concentration was determined in sera of 20 Croatian male combat veterans with PTSD and 20 healthy civilians.", "section": "abstract", "t_start": 40, "d_end": 196, "d_start": 193, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "9cf6f720bfe6e5482fce0ef762435f2b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25279756"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25279756", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25279756", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25279756", "mined_sentences": [{"text": "Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.", "section": "title", "t_start": 28, "d_end": 85, "d_start": 67, "t_end": 31}, {"text": "Quantitative polymerase chain reaction assays revealed that a highly ranked gene, superoxide dismutase 2 (SOD2), is upregulated in PD patients compared to healthy controls in 192 whole blood samples from two independent clinical trials, the Harvard Biomarker Study (HBS) and the Diagnostic and Prognostic Biomarkers in Parkinson's disease (PROBE).", "section": "abstract", "t_start": 106, "d_end": 337, "d_start": 319, "t_end": 109}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "72210b57a7be88e3af5dec5edd9adda3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/3496538"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/3496538", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/3496538", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/3496538", "mined_sentences": [{"text": "Association between lupus psychosis and anti-ribosomal P protein antibodies.", "section": "title", "t_start": 55, "d_end": 34, "d_start": 26, "t_end": 63}, {"text": "In 18 of 20 patients with psychosis secondary to systemic lupus erythematosus (SLE), autoantibodies to ribosomal P proteins were detected by immunoblotting and measured with a new radioimmunoassay using a synthetic peptide as antigen.", "section": "abstract", "t_start": 113, "d_end": 34, "d_start": 26, "t_end": 122}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1987-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "6c4553b1564e60ba7cda230bca3f034f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/6852922"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/6852922", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/6852922", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/6852922", "mined_sentences": [{"text": "Elevated antibody levels against measles virus P protein in sera of patients with multiple sclerosis.", "section": "title", "t_start": 47, "d_end": 99, "d_start": 82, "t_end": 55}, {"text": "Of the 24 multiple sclerosis sera, 5 showed a statistically significant increase in antibody titer to the P protein as compared with the control sera.", "section": "abstract", "t_start": 106, "d_end": 27, "d_start": 10, "t_end": 114}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1983-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.172}, "type": "literature", "id": "3af78e5f46368ea5558f35c6d55e0612"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22644205"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003821"], ["EFO_0000618", "EFO_0005774", "EFO_0003821"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003821", "label": "migraine disorder"}, "name": ["migraine"], "id": "EFO_0003821"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22644205", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003821", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22644205", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22644205", "mined_sentences": [{"text": "Actually there are no studies in medical literature as to the efficacy of treating PC6 acupoint for gastrointestinal symptoms in migraine attacks.", "section": "abstract", "t_start": 83, "d_end": 136, "d_start": 129, "t_end": 85}, {"text": "Our study aimed at verifying if pressure applied to the acupoint PC6 was effective on nausea during migraine.", "section": "abstract", "t_start": 65, "d_end": 107, "d_start": 100, "t_end": 67}, {"text": "The patients were treated randomly for a total of six migraine attacks: three with the application of a device, the Sea-Band(\u00ae) wristband, which applies continual pressure to the PC6 acupoint (phase SB), and three without it (phase C).", "section": "abstract", "t_start": 179, "d_end": 61, "d_start": 54, "t_end": 181}, {"text": "Our results encourage the application of PC6 acupressure for the treatment of migraine-associated nausea.", "section": "abstract", "t_start": 41, "d_end": 85, "d_start": 78, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 17.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.17}, "type": "literature", "id": "7edd7c22dcc5b42a37be30c0cbcc507a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27161188"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["NIHL"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27161188", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27161188", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27161188", "mined_sentences": [{"text": "The aim of this meta-analysis was to clarify the association between SOD2 C47T polymorphism and NIHL.", "section": "abstract", "t_start": 69, "d_end": 99, "d_start": 96, "t_end": 72}, {"text": "All full-text, English-written studies containing sufficient and complete case-and-control data about the relationship between SOD2 C47T polymorphism and NIHL were included.", "section": "abstract", "t_start": 127, "d_end": 157, "d_start": 154, "t_end": 130}, {"text": "Three eligible studies, comprising 1094 subjects, were identified. pooled odds ratios (ORs) and 95% confidence intervals (CI) were calculated to evaluate the strength of the association between SOD2 C47T polymorphism and NIHL.", "section": "abstract", "t_start": 194, "d_end": 224, "d_start": 221, "t_end": 197}, {"text": "The present meta-analysis suggests that SOD2 C47T polymorphism is significantly associated with increased risk of NIHL in the Chinese population.", "section": "abstract", "t_start": 40, "d_end": 117, "d_start": 114, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 16.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.168}, "type": "literature", "id": "090c8993c076b14ccc06472ce729d172"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10739641"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10739641", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10739641", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10739641", "mined_sentences": [{"text": "Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.", "section": "title", "t_start": 42, "d_end": 99, "d_start": 81, "t_end": 44}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 16.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.166}, "type": "literature", "id": "62321114d7b58cd8a91adfe8a8f47aee"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22792172"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_54247"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_54247"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_54247"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_54247", "label": "Posterior cortical atrophy"}, "name": ["PCAs"], "id": "Orphanet_54247"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22792172", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_54247", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22792172", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22792172", "mined_sentences": [{"text": "Intraluminal IGFBP-3 increased NO generation, determined by DAF-FM fluorescence, in rat PCAs pressurized at 70 mmHg: i) bright field image of pressure-mounted artery; ii) DAF-FM fluorescence image of the arterial segment with vehicle intraluminally applied; iii) image of an artery treated with IGFBP-3, iv) image of an artery treated with L-NAME and IGFBP-3; and v) image of an artery treated with SRB1-Ab and IGFBP-3.", "section": "figure", "t_start": 399, "d_end": 91, "d_start": 88, "t_end": 402}, {"text": "A representative real-time PCR trace showing the detection of mRNA of rat scavenger receptor-B1 (SRB1) (CT: 29.0\u00b10.2) in posterior cerebral arteries (PCAs) relative to that of \u03b2-actin (CT: 22.9\u00b10.2, n\u200a=\u200a3).", "section": "figure", "t_start": 97, "d_end": 153, "d_start": 150, "t_end": 100}, {"text": "Immunohistochemical localization of eNOS and SRB1 in rat PCAs.", "section": "figure", "t_start": 45, "d_end": 60, "d_start": 57, "t_end": 48}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 16.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.162}, "type": "literature", "id": "a6e5cee0ccd33fed43e6bb887c41ef03"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26300886"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26300886", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26300886", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26300886", "mined_sentences": [{"text": "So far, four DAMPs have been ascribed a non-redundant, essential function in the context of anthracycline-induced ICD, namely (1) the pre-apoptotic exposure of the endoplasmic reticulum chaperone calreticulin (CALR) and various heat-shock proteins (HSPs) on the outer leaflet of the plasma membrane, which ensues the activation of an ER stress response orchestrated around the phosphorylation of eukaryotic translation initiation factor 2A, 65\u2009kDa (EIF2A) and the overgeneration of reactive oxygen species (ROS) (31\u201336); (2) the production of type I interferons (IFNs), which depends on Toll-like receptor 3 (TLR3) signaling (37\u201340); (3) the secretion of ATP, which relies on the activation of autophagy (41, 42); and (4) the release of the non-histone chromatin-binding protein high mobility group box 1 (HMGB1) into the extracellular space, which correlates with cell death induction (43, 44).", "section": "introduction_and_background", "t_start": 210, "d_end": 252, "d_start": 249, "t_end": 213}, {"text": "Several approaches are being conceived to address this issue, including the implementation of combinatorial therapeutic regimens including (1) ER stressors, recombinant CALR or recombinant HSPs, to complement for defects in the CALR or HSP exposure pathway; (2) TLR3 agonists or recombinant type I IFNs, to correct problems in the secretion of type I IFN; (3) autophagy inducers or inhibitors of extracellular ATP-degrading enzymes, to maximize the amount of ATP secreted in the course of cell death; and (4) recombinant HMGB1, TLR4 agonists or cytotoxic agents, to restore HMGB1-dependent immunostimulation (225).", "section": "conclusion_and_future_work", "t_start": 169, "d_end": 238, "d_start": 236, "t_end": 172}, {"text": "Clinical studies assessing the prognostic and predictive value of ICD-associated CALR and HSP signaling in cancer patients.", "section": "table", "t_start": 81, "d_end": 92, "d_start": 90, "t_end": 84}, {"text": "Calreticulin, HSPs, and the ER Stress Response", "section": "other", "t_start": 0, "d_end": 17, "d_start": 14, "t_end": 11}, {"text": "In particular, ICD is etiologically associated with the phosphorylation of EIF2A on S51 (48), and this appears to be required for the exposure of CALR and HSPs on the surface of dying cells (34).", "section": "other", "t_start": 146, "d_end": 158, "d_start": 155, "t_end": 149}, {"text": "In some settings, soluble HSPs and CALR operate as cytokines, stimulating the NF-\u03baB-dependent secretion of pro-inflammatory mediators like interleukin-6 (IL-6) and tumor necrosis factor \u03b1 (TNF\u03b1) (52, 53).", "section": "other", "t_start": 35, "d_end": 29, "d_start": 26, "t_end": 38}, {"text": "Accumulating clinical evidence indicates that various parameters linked to ICD-associated CALR and HSP signaling may have prognostic or predictive value for cancer patients (Table 1).", "section": "other", "t_start": 90, "d_end": 101, "d_start": 99, "t_end": 93}, {"text": "These data indicate that cancer cells expose and/or shed CALR as well as HSPs even in the absence of chemotherapy (at least to some degree), possibly as a result of oncogenic stress and/or adverse microenvironmental conditions.", "section": "other", "t_start": 57, "d_end": 76, "d_start": 73, "t_end": 60}, {"text": "Moreover, they suggest that membrane-bound CALR and HSPs have a different biological activity than their soluble counterparts.", "section": "other", "t_start": 43, "d_end": 55, "d_start": 52, "t_end": 46}, {"text": "Other processes and parameters linked to CALR and/or HSP exposure and their immunostimulatory effects have been shown to influence disease outcome in cancer patients.", "section": "other", "t_start": 41, "d_end": 55, "d_start": 53, "t_end": 44}, {"text": "Taken together, these clinical observations suggest that CALR, HSPs and various processes associated with their exposure, secretion and signaling functions may have prognostic, predictive and therapeutic value.", "section": "other", "t_start": 57, "d_end": 66, "d_start": 63, "t_end": 60}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 16.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.16}, "type": "literature", "id": "eb467649971cbe9155d3770984580ae0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25755106"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25755106", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25755106", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25755106", "mined_sentences": [{"text": "Familial periventricular nodular heterotopia, epilepsy and Melnick-Needles Syndrome caused by a single FLNA mutation with combined gain-of-function and loss-of-function effects.", "section": "title", "t_start": 103, "d_end": 53, "d_start": 46, "t_end": 106}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.154}, "type": "literature", "id": "b5700da63c17ff1a044e9565bbb58917"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23500098"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23500098", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23500098", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23500098", "mined_sentences": [{"text": "A peroxisome proliferator-activated receptor-\u03b4 agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.", "section": "title", "t_start": 2, "d_end": 159, "d_start": 141, "t_end": 45}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.154}, "type": "literature", "id": "96fcbd0baf675ff16f232215f43e39b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20178975"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20178975", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20178975", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20178975", "mined_sentences": [{"text": "Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth neuropathy.", "section": "title", "t_start": 35, "d_end": 104, "d_start": 95, "t_end": 39}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.154}, "type": "literature", "id": "13bf8b6e8d3697b9d60a3e32c9c1ed7c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16979821"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16979821", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16979821", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16979821", "mined_sentences": [{"text": "PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease.", "section": "title", "t_start": 0, "d_end": 93, "d_start": 75, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.152}, "type": "literature", "id": "51cabc516cdbe784465fce9b6dc20ffc"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25091951"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25091951", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25091951", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25091951", "mined_sentences": [{"text": "Novel ADAM9 homozygous mutation in a consanguineous Egyptian family with severe cone-rod dystrophy and cataract.", "section": "title", "t_start": 6, "d_end": 110, "d_start": 103, "t_end": 10}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.152}, "type": "literature", "id": "d4d437c4b446fe4750a5d81fad51b5ec"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25965061"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0003782"], ["EFO_0000618", "EFO_0003782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003782", "label": "motor neuron disease"}, "name": ["Motor Neuron Diseases"], "id": "EFO_0003782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25965061", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003782", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25965061", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25965061", "mined_sentences": [{"text": "Characterization of Mutants of Human Small Heat Shock Protein HspB1 Carrying Replacements in the N-Terminal Domain and Associated with Hereditary Motor Neuron Diseases.", "section": "title", "t_start": 62, "d_end": 166, "d_start": 146, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.152}, "type": "literature", "id": "3071b64ed783db29e5a9322f9cc71254"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16123448"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["age-related macular degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16123448", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16123448", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16123448", "mined_sentences": [{"text": "SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration.", "section": "title", "t_start": 0, "d_end": 135, "d_start": 104, "t_end": 3}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.152}, "type": "literature", "id": "2fd1d67c52e1f7ef11a4c50857a90a7a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17431908"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0002461", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669", "Orphanet_90652"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_90652", "label": "Otopalatodigital syndrome type 2"}, "name": ["Otopalatodigital syndrome type 2"], "id": "Orphanet_90652"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17431908", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_90652", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17431908", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17431908", "mined_sentences": [{"text": "Otopalatodigital syndrome type 2 in two siblings with a novel filamin A 629G>T mutation: clinical, pathological, and molecular findings.", "section": "title", "t_start": 62, "d_end": 31, "d_start": 0, "t_end": 70}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "5a5baf63102017c72efb05dbed358524"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25592770"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25592770", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25592770", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25592770", "mined_sentences": [{"text": "Activation of the nuclear receptor PPAR\u03b4 is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.", "section": "title", "t_start": 35, "d_end": 109, "d_start": 91, "t_end": 39}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "b82cecb0253e5c27aa63d373000f0398"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25776471"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005774", "label": "brain disease"}, "name": ["brain diseases"], "id": "EFO_0005774"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25776471", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005774", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25776471", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25776471", "mined_sentences": [{"text": "PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects.", "section": "title", "t_start": 0, "d_end": 84, "d_start": 71, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "cd16de09f3591f5bb0865b4edc7a35f2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11471167"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11471167", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11471167", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11471167", "mined_sentences": [{"text": "Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking.", "section": "title", "t_start": 16, "d_end": 127, "d_start": 121, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "958d1c24f08a13e87a79647bfe716c47"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25220807"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0003782"], ["EFO_0000618", "EFO_0003782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003782", "label": "motor neuron disease"}, "name": ["motor neuron diseases"], "id": "EFO_0003782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25220807", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003782", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25220807", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25220807", "mined_sentences": [{"text": "Characterization of human small heat shock protein HspB1 that carries C-terminal domain mutations associated with hereditary motor neuron diseases.", "section": "title", "t_start": 51, "d_end": 145, "d_start": 125, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "260e7dc5e354fdd2add8e0e259605b51"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18815298"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18815298", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18815298", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18815298", "mined_sentences": [{"text": "Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein.", "section": "title", "t_start": 20, "d_end": 12, "d_start": 0, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "36e9c05a5f8762fcb7c0ceef60a4aaa8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17127560"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253", "EFO_0001356"], ["EFO_0000618", "EFO_0003782", "EFO_0000253", "EFO_0001356"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253", "EFO_0001356"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001356", "label": "familial amyotrophic lateral sclerosis"}, "name": ["familial amyotrophic lateral sclerosis"], "id": "EFO_0001356"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17127560", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001356", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17127560", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17127560", "mined_sentences": [{"text": "Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis.", "section": "title", "t_start": 24, "d_end": 115, "d_start": 78, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "84176b30132a25cbee292ae0f7e0a1ad"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22723845"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22723845", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22723845", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22723845", "mined_sentences": [{"text": "Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease.", "section": "title", "t_start": 6, "d_end": 146, "d_start": 128, "t_end": 9}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "c2a461767431a25f943729fc64708e00"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27207918"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["Addiction"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27207918", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27207918", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27207918", "mined_sentences": [{"text": "Association of Superoxide Dismutase 2 (SOD2) Genotype with Gray Matter Volume Shrinkage in Chronic Alcohol Users: Replication and Further Evaluation of an Addiction Gene Panel.", "section": "title", "t_start": 39, "d_end": 163, "d_start": 155, "t_end": 42}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "8667218b84168f247828e86d044120fd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26452339"}]}, "target": {"id": "ENSG00000160305", "gene_info": {"symbol": "DIP2A", "name": "disco interacting protein 2 homolog A", "geneid": "ENSG00000160305"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005424"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005424", "label": "dyslexia"}, "name": ["dyslexia"], "id": "EFO_0005424"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26452339", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005424", "target": "http://identifiers.org/uniprot/Q14689"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26452339", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26452339", "mined_sentences": [{"text": "Genetic variant in DIP2A gene is associated with developmental dyslexia in Chinese population.", "section": "title", "t_start": 19, "d_end": 70, "d_start": 63, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 15.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.15}, "type": "literature", "id": "cfef5d147c50ce39e6ec745c0ad60efb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22815492"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22815492", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22815492", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22815492", "mined_sentences": [{"text": "Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A.", "section": "title", "t_start": 88, "d_end": 43, "d_start": 25, "t_end": 96}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "fcd7f41146a16e1ad4cec0919c253f84"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19874267"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19874267", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19874267", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19874267", "mined_sentences": [{"text": "A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease.", "section": "title", "t_start": 2, "d_end": 115, "d_start": 97, "t_end": 10}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "1ea5d4cdc1bf0984c4adb7628c84f261"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22545112"}]}, "target": {"id": "ENSG00000161955", "gene_info": {"symbol": "TNFSF13", "name": "tumor necrosis factor superfamily member 13", "geneid": "ENSG00000161955"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22545112", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/O75888"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22545112", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22545112", "mined_sentences": [{"text": "By data-mining approaches, we identified significant expression changes in death receptor signaling pathways in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, particularly implicating the Tumor Necrosis Factor Superfamily member 6 (FAS) receptor and the Tumor Necrosis Factor [ligand] Superfamily member 13 (TNFSF13) in schizophrenia.", "section": "abstract", "t_start": 336, "d_end": 184, "d_start": 172, "t_end": 342}, {"text": "In schizophrenia, we confirmed and replicated significantly increased expression of TNFSF13 mRNA in the DLPFC.", "section": "abstract", "t_start": 84, "d_end": 15, "d_start": 3, "t_end": 90}, {"text": "We concluded that increased TNFSF13 expression may be one of several cell-death cytokine abnormalities that contribute to the observed brain pathology in schizophrenia, and while increased TNFSF13 may be associated with lower brain pH, the change is not necessarily causally related to brain pH.", "section": "abstract", "t_start": 28, "d_end": 166, "d_start": 154, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "d0222fbffb9baa84b1715eb7986503f6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24621497"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24621497", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24621497", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24621497", "mined_sentences": [{"text": "Involvement of peroxisome proliferator-activated receptor \u03b2/\u03b4 (PPAR \u03b2/\u03b4) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE).", "section": "title", "t_start": 63, "d_end": 127, "d_start": 111, "t_end": 68}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "c3daa19663c439c3a20f032de8296a3d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19806217"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["age-related macular degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19806217", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19806217", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19806217", "mined_sentences": [{"text": "rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration.", "section": "title", "t_start": 18, "d_end": 101, "d_start": 70, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "ed0277fdcdb57ed29d686c6c3ba514d7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26689116"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["chronic progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26689116", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26689116", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26689116", "mined_sentences": [{"text": "Novel mutation in C10orf2 associated with multiple mtDNA deletions, chronic progressive external ophthalmoplegia and premature aging.", "section": "title", "t_start": 18, "d_end": 111, "d_start": 68, "t_end": 24}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "4d2abdf7a45e23d113956a85e84344b8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25950802"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["Age-Related Macular Degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25950802", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25950802", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25950802", "mined_sentences": [{"text": "Netrin-1 - DCC Signaling Systems and Age-Related Macular Degeneration.", "section": "title", "t_start": 11, "d_end": 68, "d_start": 37, "t_end": 13}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "20ab873e20be944f3cb16f28f9365e2b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26696693"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's Disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26696693", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26696693", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26696693", "mined_sentences": [{"text": "Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOE\u03b54 Allele.", "section": "title", "t_start": 40, "d_end": 107, "d_start": 89, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "f084ae42656796ae5c58b30cb187d6a2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19778569"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004280"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004280", "label": "movement disorder"}, "name": ["tardive dyskinesia"], "id": "EFO_0004280"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19778569", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004280", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19778569", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19778569", "mined_sentences": [{"text": "Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.", "section": "title", "t_start": 153, "d_end": 37, "d_start": 20, "t_end": 156}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "8b3ee75ca37c646356be38633d92c1a4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25417767"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516", "EFO_0004190"], ["EFO_0003966", "EFO_0000516", "EFO_0004190"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004190", "label": "open-angle glaucoma"}, "name": ["open angle glaucoma"], "id": "EFO_0004190"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25417767", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004190", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25417767", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25417767", "mined_sentences": [{"text": "Association of SOD2 polymorphisms with primary open angle glaucoma in a Chinese population.", "section": "title", "t_start": 15, "d_end": 65, "d_start": 47, "t_end": 18}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14800000000000002}, "type": "literature", "id": "b687e3ef696ee628394d73feacbc9324"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21182888"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21182888", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21182888", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21182888", "mined_sentences": [{"text": "Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation.", "section": "title", "t_start": 23, "d_end": 103, "d_start": 95, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "d23959c14d90e83fbccd74c22c073b90"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22507216"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22507216", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22507216", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22507216", "mined_sentences": [{"text": "We have recently reported mutations in the CALR promoter that co-occur with psychosis.", "section": "abstract", "t_start": 43, "d_end": 84, "d_start": 76, "t_end": 46}, {"text": "As for the psychosis-linked CALR promoter mutations identified to-date, the IVSI mutation was not detected in the control pool.", "section": "abstract", "t_start": 28, "d_end": 19, "d_start": 11, "t_end": 31}, {"text": "Our present findings identify the site of action of VPA in the CALR promoter, and introduce a novel mutation in a case of substance-induced psychosis in the first intron of CALR.", "section": "abstract", "t_start": 63, "d_end": 148, "d_start": 140, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "8f25ad360c8d0fc233769dce73b23521"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22740120"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005424"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005424", "label": "dyslexia"}, "name": ["dyslexia"], "id": "EFO_0005424"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22740120", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005424", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22740120", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22740120", "mined_sentences": [{"text": "Filamin A mutation associated with normal reading skills and dyslexia in a family with periventricular heterotopia.", "section": "title", "t_start": 0, "d_end": 68, "d_start": 61, "t_end": 8}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "b2285b69f465ada2282283683245586c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19237226"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19237226", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19237226", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19237226", "mined_sentences": [{"text": "Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease.", "section": "title", "t_start": 38, "d_end": 108, "d_start": 90, "t_end": 42}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "2dd925f71d663cb4ce0fe907d20d7a43"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24635117"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24635117", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24635117", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24635117", "mined_sentences": [{"text": "A PPAR-\u03b2/\u03b4 agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease.", "section": "title", "t_start": 2, "d_end": 112, "d_start": 94, "t_end": 7}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "46a7fb3d59782714538d1c3029848ea2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27275382"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005411"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005411", "label": "schizoaffective disorder"}, "name": ["schizoaffective disorder"], "id": "EFO_0005411"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27275382", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005411", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27275382", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27275382", "mined_sentences": [{"text": "Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.", "section": "title", "t_start": 68, "d_end": 138, "d_start": 115, "t_end": 79}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "e5f994151d8e5095a3e654d4af019ed9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23223018"}]}, "target": {"id": "ENSG00000179399", "gene_info": {"symbol": "GPC5", "name": "glypican 5", "geneid": "ENSG00000179399"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "EFO_0003105"], ["EFO_0000618", "EFO_0003105"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003105", "label": "spina bifida"}, "name": ["spina bifida"], "id": "EFO_0003105"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23223018", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003105", "target": "http://identifiers.org/uniprot/P78333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23223018", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23223018", "mined_sentences": [{"text": "Copy number variation analysis implicates the cell polarity gene glypican 5 as a human spina bifida candidate gene.", "section": "title", "t_start": 65, "d_end": 98, "d_start": 87, "t_end": 74}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "36ab551c99beb1a2ebf492aa97b4d2db"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24817818"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24817818", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24817818", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24817818", "mined_sentences": [{"text": "Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients.", "section": "title", "t_start": 11, "d_end": 81, "d_start": 73, "t_end": 15}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "28ffe5be5e40bac0703de0588b1bbae2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17623484"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17623484", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17623484", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17623484", "mined_sentences": [{"text": "Since HSP27 may act as a motor neuron survival factor, we analyzed the genetic contribution of the human HSPB1 gene (HSPB1) to the etiology of amyotrophic lateral sclerosis (ALS).", "section": "abstract", "t_start": 105, "d_end": 176, "d_start": 174, "t_end": 109}, {"text": "In a cohort of sporadic ALS patients, we identified three rare genetic variations and one of which (c.-217T>C) targeted a conserved nucleotide of the Heat Shock Element (HSE) in the HSPB1 promoter.", "section": "abstract", "t_start": 182, "d_end": 26, "d_start": 24, "t_end": 186}, {"text": "Therefore, our study suggests that the functional HSPB1 variant may represent a genetic modifier in the pathogenesis of motor neuron disease; however, it is necessary to confirm this HSPB1 variant in additional ALS patients.", "section": "abstract", "t_start": 50, "d_end": 213, "d_start": 211, "t_end": 54}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "90f83156549743b36611bcdf9f951f6b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20692050"}]}, "target": {"id": "ENSG00000179399", "gene_info": {"symbol": "GPC5", "name": "glypican 5", "geneid": "ENSG00000179399"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20692050", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/P78333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20692050", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20692050", "mined_sentences": [{"text": "Association to the Glypican-5 gene in multiple sclerosis.", "section": "title", "t_start": 19, "d_end": 55, "d_start": 38, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "afd45bfe2245f1a398772def4e452ef2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24014582"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24014582", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24014582", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24014582", "mined_sentences": [{"text": "Progressive external ophthalmoplegia (PEO) due to a mutation in the C10orf2 (PEO1) gene mimicking a myasthenic crisis.", "section": "title", "t_start": 77, "d_end": 40, "d_start": 38, "t_end": 80}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "cf9b72f60f7ab6e12993ad2d9a568378"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27106785"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental autoimmune encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27106785", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27106785", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27106785", "mined_sentences": [{"text": "You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.", "section": "title", "t_start": 64, "d_end": 170, "d_start": 130, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "569bd4bdc4a817db2e085697fbe99871"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11673795"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["bipolar affective disorder"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11673795", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11673795", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11673795", "mined_sentences": [{"text": "Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder.", "section": "title", "t_start": 10, "d_end": 131, "d_start": 106, "t_end": 14}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "788689de7c4fec5739d668f5bcb75f6d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17543364"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17543364", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17543364", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17543364", "mined_sentences": [{"text": "Borna disease virus P protein inhibits nitric oxide synthase gene expression in astrocytes.", "section": "title", "t_start": 20, "d_end": 12, "d_start": 0, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "fb999082246d320b6549307316a9cef0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17376152"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17376152", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17376152", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17376152", "mined_sentences": [{"text": "A polymorphism in SOD2 is associated with development of Alzheimer's disease.", "section": "title", "t_start": 18, "d_end": 75, "d_start": 57, "t_end": 21}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "29f8310200718368f0a4ea315ea517fc"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23439384"}]}, "target": {"id": "ENSG00000110104", "gene_info": {"symbol": "CCDC86", "name": "coiled-coil domain containing 86", "geneid": "ENSG00000110104"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23439384", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q9H6F5"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23439384", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23439384", "mined_sentences": [{"text": "Expression and differential response to haloperidol treatment of Cyclon/CCDC86 mRNA in schizophrenia patients.", "section": "title", "t_start": 72, "d_end": 99, "d_start": 87, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.146}, "type": "literature", "id": "0ef0f2b5f4caebeef70c5612e49369b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20460118"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20460118", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20460118", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20460118", "mined_sentences": [{"text": "Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.", "section": "title", "t_start": 0, "d_end": 84, "d_start": 66, "t_end": 8}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "48f5d598341c0d5959b1323bca135fc5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25530507"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25530507", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25530507", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25530507", "mined_sentences": [{"text": "PPAR\u03b2/\u03b4 and \u03b3 in a rat model of Parkinson's disease: possible involvement in PD symptoms.", "section": "title", "t_start": 0, "d_end": 50, "d_start": 32, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "1ba5eb4ce4e9341d03a7fb165d3e2467"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16825994"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16825994", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16825994", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16825994", "mined_sentences": [{"text": "Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma.", "section": "title", "t_start": 62, "d_end": 107, "d_start": 93, "t_end": 67}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "c508943ed9be875f6e3f4baafb7b73c6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22178419"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22178419", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22178419", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22178419", "mined_sentences": [{"text": "Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease.", "section": "title", "t_start": 28, "d_end": 127, "d_start": 109, "t_end": 32}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "69d8f5c45a82bc72d691e0f5f83f220f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18344398"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18344398", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18344398", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18344398", "mined_sentences": [{"text": "Asymmetrical late onset motor neuropathy associated with a novel mutation in the small heat shock protein HSPB1 (HSP27).", "section": "title", "t_start": 106, "d_end": 39, "d_start": 30, "t_end": 110}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "6d19c83872695fcd6e7e8277a19450b6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17082176"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17082176", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17082176", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17082176", "mined_sentences": [{"text": "Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.", "section": "title", "t_start": 22, "d_end": 75, "d_start": 69, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "45961c0b390d9ecf348f72e56f80a60f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22660636"}]}, "target": {"id": "ENSG00000048740", "gene_info": {"symbol": "CELF2", "name": "CUGBP, Elav-like family member 2", "geneid": "ENSG00000048740"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["reproductive system disease", "nervous system disease", "genetic disorder", "muscular disease", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002970", "EFO_0002461", "EFO_0000512", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_275742", "Orphanet_399980", "Orphanet_399983", "Orphanet_399685", "Orphanet_481"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_98505", "Orphanet_206701", "Orphanet_206707", "Orphanet_481"], ["EFO_0000512", "Orphanet_275742", "Orphanet_399980", "Orphanet_399983", "Orphanet_399685", "Orphanet_481"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_481"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_481"], ["EFO_0002970", "Orphanet_183497", "Orphanet_98505", "Orphanet_206701", "Orphanet_206707", "Orphanet_481"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_481"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_98505", "Orphanet_206701", "Orphanet_206707", "Orphanet_481"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_481", "label": "Kennedy disease"}, "name": ["SBMA"], "id": "Orphanet_481"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22660636", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_481", "target": "http://identifiers.org/uniprot/O95319"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22660636", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22660636", "mined_sentences": [{"text": "Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.", "section": "title", "t_start": 79, "d_end": 46, "d_start": 43, "t_end": 83}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "fbd2d66f85acb06aa55414f8559090f6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23918762"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001176"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001176", "label": "sensorineural hearing loss"}, "name": ["sensorineural deafness"], "id": "EFO_1001176"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23918762", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001176", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23918762", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23918762", "mined_sentences": [{"text": "Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1.", "section": "title", "t_start": 212, "d_end": 140, "d_start": 119, "t_end": 217}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "a597e4dd4ad02eb7bd76136e8e3ddea6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18006575"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18006575", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18006575", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18006575", "mined_sentences": [{"text": "Reactive oxygen species and fatigue-induced prolonged low-frequency force depression in skeletal muscle fibres of rats, mice and SOD2 overexpressing mice.", "section": "title", "t_start": 129, "d_end": 83, "d_start": 74, "t_end": 132}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "eddf76378127a7307a124f8e66c4285b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26970947"}]}, "target": {"id": "ENSG00000146282", "gene_info": {"symbol": "RARS2", "name": "arginyl-tRNA synthetase 2, mitochondrial", "geneid": "ENSG00000146282"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26970947", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q5T160"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26970947", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26970947", "mined_sentences": [{"text": "RARS2 mutations cause early onset epileptic encephalopathy without ponto-cerebellar hypoplasia.", "section": "title", "t_start": 0, "d_end": 42, "d_start": 34, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "a97953c8ffe6b530156e13de91a2bc4b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27158370"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27158370", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27158370", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27158370", "mined_sentences": [{"text": "One eye of each rat was intravitreally pretreated with recombinant adeno-associated virus expressing SOD2 (AAV-SOD2) or recombinant AAV expressing GFP (AAV-GFP) 21 days before glaucoma induction.", "section": "abstract", "t_start": 101, "d_end": 183, "d_start": 176, "t_end": 104}, {"text": "AAV mediated pre-treatment with SOD2 is able to attenuate oxidative stress and improve mitochondrial dysfunction of RGC and optic nerve secondary to glaucoma.", "section": "abstract", "t_start": 32, "d_end": 156, "d_start": 149, "t_end": 35}, {"text": "Thus, SOD2 may be used to prevent the retinal RGCs from glaucoma, which provides a promising strategy for glaucoma therapy.", "section": "abstract", "t_start": 6, "d_end": 63, "d_start": 56, "t_end": 9}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14400000000000002}, "type": "literature", "id": "0c9984e124e3167af1d50c252f5292be"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24860980"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24860980", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24860980", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24860980", "mined_sentences": [{"text": "Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.", "section": "title", "t_start": 36, "d_end": 165, "d_start": 147, "t_end": 47}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "e83d386201722fad69c51801029e1cb1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23523122"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental autoimmune encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23523122", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23523122", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23523122", "mined_sentences": [{"text": "Recombinant murine calreticulin fragment 39-272 expands CD1d(hi)CD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice.", "section": "title", "t_start": 19, "d_end": 147, "d_start": 107, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "22cb1a98dbf9b5a24df29f7d13930b3e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23746548"}]}, "target": {"id": "ENSG00000139083", "gene_info": {"symbol": "ETV6", "name": "ETS variant 6", "geneid": "ENSG00000139083"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005425"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005425", "label": "language impairment"}, "name": ["language impairment"], "id": "EFO_0005425"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23746548", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005425", "target": "http://identifiers.org/uniprot/P41212"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23746548", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23746548", "mined_sentences": [{"text": "Alleles of a polymorphic ETV6 binding site in DCDC2 confer risk of reading and language impairment.", "section": "title", "t_start": 25, "d_end": 97, "d_start": 79, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "5df31efd33d9d5b0935e4bc57374baa9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12576225"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12576225", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12576225", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12576225", "mined_sentences": [{"text": "C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease.", "section": "title", "t_start": 4, "d_end": 107, "d_start": 89, "t_end": 15}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "49fe7635562e5481180a35a412611f74"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17212772"}]}, "target": {"id": "ENSG00000161955", "gene_info": {"symbol": "TNFSF13", "name": "tumor necrosis factor superfamily member 13", "geneid": "ENSG00000161955"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17212772", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/O75888"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17212772", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17212772", "mined_sentences": [{"text": "A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis.", "section": "title", "t_start": 0, "d_end": 104, "d_start": 87, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "5f95f273be22797ec8a35ca24d62fec2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22492046"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22492046", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22492046", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22492046", "mined_sentences": [{"text": "Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS.", "section": "title", "t_start": 8, "d_end": 122, "d_start": 120, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "f3441369315efbb83739d13d22eaff04"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10963362"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10963362", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10963362", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10963362", "mined_sentences": [{"text": "Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain.", "section": "title", "t_start": 24, "d_end": 93, "d_start": 75, "t_end": 35}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "3eb5b0acc5d46230119f6cb778a8a865"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20155818"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental autoimmune encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20155818", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20155818", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20155818", "mined_sentences": [{"text": "Genetic ablation of steroid receptor coactivator-3 promotes PPAR-beta-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis.", "section": "title", "t_start": 60, "d_end": 158, "d_start": 118, "t_end": 68}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "f2958a8c9d5e295881ec47374beaebc1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24321043"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "infectious disease"], "codes": ["EFO_0005741", "EFO_0000618"]}, "path": [["EFO_0005741", "EFO_0000763", "EFO_0007527"], ["EFO_0000618", "EFO_0007527"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007527", "label": "tropical spastic paraparesis"}, "name": ["tropical spastic paraparesis"], "id": "EFO_0007527"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24321043", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007527", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24321043", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24321043", "mined_sentences": [{"text": "Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.", "section": "title", "t_start": 57, "d_end": 220, "d_start": 193, "t_end": 68}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "6b025096997b78a4c5b81eab865a98be"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25407822"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0001358"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001358", "label": "post-traumatic stress disorder"}, "name": ["post-traumatic stress disorder"], "id": "EFO_0001358"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25407822", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001358", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25407822", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25407822", "mined_sentences": [{"text": "Changes in the glucocorticoid receptor and Ca\u00b2\u207a/calreticulin-dependent signalling pathway in the medial prefrontal cortex of rats with post-traumatic stress disorder.", "section": "title", "t_start": 48, "d_end": 164, "d_start": 135, "t_end": 59}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "7c1d241c2e7e71e2057128e5d026c270"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11289100"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11289100", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11289100", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11289100", "mined_sentences": [{"text": "A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas.", "section": "title", "t_start": 24, "d_end": 60, "d_start": 54, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "2002e6bce32e4cd63330e1040b2b0cd2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24401274"}]}, "target": {"id": "ENSG00000167996", "gene_info": {"symbol": "FTH1", "name": "ferritin heavy chain 1", "geneid": "ENSG00000167996"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["drug abuse"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24401274", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P02794"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24401274", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24401274", "mined_sentences": [{"text": "Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.", "section": "title", "t_start": 9, "d_end": 43, "d_start": 34, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "5c2ab6cb47c0a6101554e0322e3f02e4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23963299"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23963299", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23963299", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23963299", "mined_sentences": [{"text": "Targeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1.", "section": "title", "t_start": 133, "d_end": 113, "d_start": 104, "t_end": 137}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "2e4b0d86d9ae1f6ed34ecfdccf7ce313"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16630050"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16630050", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16630050", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16630050", "mined_sentences": [{"text": "Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin.", "section": "title", "t_start": 14, "d_end": 68, "d_start": 58, "t_end": 41}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "7a66dcb3cee4b01fd5c80fb6e56f76ce"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11815396"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11815396", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11815396", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11815396", "mined_sentences": [{"text": "Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.", "section": "title", "t_start": 51, "d_end": 108, "d_start": 92, "t_end": 78}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "1c5721c0bb12d0273938d878e740c28d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19598248"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["drug dependence"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19598248", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19598248", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19598248", "mined_sentences": [{"text": "Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice.", "section": "title", "t_start": 8, "d_end": 78, "d_start": 64, "t_end": 35}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "0bc07b65d645b1cac707c1f008c280c1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16029924"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16029924", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16029924", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16029924", "mined_sentences": [{"text": "The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking.", "section": "title", "t_start": 24, "d_end": 157, "d_start": 151, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "8bd87d1da2b2dfcc5be0a67bb57ba91f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17611777"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17611777", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17611777", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17611777", "mined_sentences": [{"text": "CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.", "section": "title", "t_start": 30, "d_end": 81, "d_start": 75, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "3dd1d731d2ec98396dcefa8577fe1dd9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11352855"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11352855", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11352855", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11352855", "mined_sentences": [{"text": "The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.", "section": "title", "t_start": 24, "d_end": 98, "d_start": 82, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "2eb27770498ae12fe606f7b021702998"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21379329"}]}, "target": {"id": "ENSG00000048740", "gene_info": {"symbol": "CELF2", "name": "CUGBP, Elav-like family member 2", "geneid": "ENSG00000048740"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["late-onset Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21379329", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/O95319"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21379329", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21379329", "mined_sentences": [{"text": "Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.", "section": "title", "t_start": 105, "d_end": 65, "d_start": 36, "t_end": 110}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "81cc7946a9ac457027fed05469f23cc4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17376920"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17376920", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17376920", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17376920", "mined_sentences": [{"text": "Functional characterization of the major and minor phosphorylation sites of the P protein of Borna disease virus.", "section": "title", "t_start": 80, "d_end": 105, "d_start": 93, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "09a761e29bde8ce4e3bfa96315e2cf68"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/1417136"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/1417136", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/1417136", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/1417136", "mined_sentences": [{"text": "Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus.", "section": "title", "t_start": 39, "d_end": 62, "d_start": 54, "t_end": 47}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1992-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "288c5f7526abfdd610c0ef120e4444b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15218174"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15218174", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15218174", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15218174", "mined_sentences": [{"text": "The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein.", "section": "title", "t_start": 102, "d_end": 29, "d_start": 17, "t_end": 110}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "453c5443f559440e622da79addd91d39"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15345661"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["NIHL"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15345661", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15345661", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15345661", "mined_sentences": [{"text": "We evaluated whether susceptibility to noise-induced hearing loss (NIHL) is associated with SOD2, PON1, and PON2 polymorphisms in workers exposed to prolonged loud noise.", "section": "abstract", "t_start": 92, "d_end": 70, "d_start": 67, "t_end": 95}, {"text": "Regression analysis showed that PON2 (SC+CC) [odds ratio (OR) = 5.01; 95% confidence interval (CI), 1.11-22.54], SOD2 IVS3-23T/G and IVS3-60T/G (OR = 5.09; 95% CI, 1.27-20.47), age (OR = 1.22; 95% CI, 1.09-1.36), and smoking (OR = 49.49; 95% CI, 5.09-480.66) were associated with NIHL.", "section": "abstract", "t_start": 113, "d_end": 283, "d_start": 280, "t_end": 116}, {"text": "Our data suggest that SOD2 and PON2 polymorphisms, by exerting variable local tissue antioxidant roles, could predispose to NIHL.", "section": "abstract", "t_start": 22, "d_end": 127, "d_start": 124, "t_end": 25}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "a59e43d24620733a7edae15eb8b3e16c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23680149"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["malignant glioma"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23680149", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23680149", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23680149", "mined_sentences": [{"text": "In vivo RNAi screen for BMI1 targets identifies TGF-\u03b2/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.", "section": "title", "t_start": 24, "d_end": 125, "d_start": 110, "t_end": 27}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "7dac8335eb271ec7abc233204a43bdab"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24997715"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["Epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24997715", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24997715", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24997715", "mined_sentences": [{"text": "The Expanding MEGDEL Phenotype: Optic Nerve Atrophy, Microcephaly, and Myoclonic Epilepsy in a Child with SERAC1 Mutations.", "section": "title", "t_start": 106, "d_end": 88, "d_start": 81, "t_end": 111}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.142}, "type": "literature", "id": "058f9949f1c8388c2a481026b71f659e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26822830"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease", "genetic disorder"], "codes": ["EFO_0003966", "EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_399"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_399"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_399"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_399"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_399"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_399"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_399"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183521", "Orphanet_306719", "Orphanet_399"], ["EFO_0000618", "EFO_0005772", "Orphanet_306719", "Orphanet_399"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_399"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_399"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_399"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_399", "label": "Huntington disease"}, "name": ["Huntington disease"], "id": "Orphanet_399"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26822830", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_399", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26822830", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26822830", "mined_sentences": [{"text": "Huntington disease: Boosting PPAR\u03b4 blocks neurodegeneration.", "section": "title", "t_start": 29, "d_end": 17, "d_start": 0, "t_end": 33}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "16920e817dffb92014fda988f9790c56"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8733130"}]}, "target": {"id": "ENSG00000135862", "gene_info": {"symbol": "LAMC1", "name": "laminin subunit gamma 1", "geneid": "ENSG00000135862"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["immune system disease", "endocrine system disease", "genetic disorder", "cardiovascular disease", "nervous system disease", "metabolic disease"], "codes": ["EFO_0000589", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0001379", "EFO_0000319"]}, "path": [["EFO_0000508", "Orphanet_183530", "Orphanet_183539", "Orphanet_93547", "Orphanet_567"], ["EFO_0000319", "EFO_0003777", "Orphanet_98054", "Orphanet_156532", "Orphanet_567"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_331220", "Orphanet_567"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_363294", "Orphanet_138047", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183545", "Orphanet_96346", "Orphanet_117573", "Orphanet_567"], ["EFO_0000508", "Orphanet_98056", "Orphanet_183539", "Orphanet_93547", "Orphanet_567"], ["EFO_0000508", "Orphanet_156638", "Orphanet_183634", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_331220", "Orphanet_567"], ["EFO_0000508", "Orphanet_98054", "Orphanet_156532", "Orphanet_567"], ["EFO_0000508", "Orphanet_68335", "Orphanet_98127", "Orphanet_102020", "Orphanet_98142", "Orphanet_262182", "Orphanet_567"], ["EFO_0000589", "EFO_0005769", "EFO_0005754", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_330197", "Orphanet_567"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_567"], ["EFO_0001379", "Orphanet_156638", "Orphanet_183634", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_363294", "Orphanet_138047", "Orphanet_567"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_567", "label": "22q11.2 deletion syndrome"}, "name": ["DiGeorge syndrome"], "id": "Orphanet_567"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8733130", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_567", "target": "http://identifiers.org/uniprot/P11047"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8733130", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8733130", "mined_sentences": [{"text": "Isolation of a novel gene from the DiGeorge syndrome critical region with homology to Drosophila gdl and to human LAMC1 genes.", "section": "title", "t_start": 114, "d_end": 51, "d_start": 35, "t_end": 118}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "40ff0d33d43900b8d5f12b4f78937a3a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12484240"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12484240", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12484240", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12484240", "mined_sentences": [{"text": "Role of EPHX genotype in the associations of smoking and diet with colorectal adenomas.", "section": "title", "t_start": 8, "d_end": 51, "d_start": 45, "t_end": 11}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "aad9f376986b1041c2a3820b052e9239"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11692079"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11692079", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11692079", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11692079", "mined_sentences": [{"text": "In this investigation, we examined the potential association between the risk of Parkinson's disease and genetic variation within the EPHX1 and EPHX2 genes.", "section": "abstract", "t_start": 134, "d_end": 99, "d_start": 81, "t_end": 138}, {"text": "EPHX1 and EPHX2 genotype data were obtained from 133 idiopathic Parkinson's disease patients and 212 control subjects matched on age, gender and ethnicity.", "section": "abstract", "t_start": 0, "d_end": 82, "d_start": 53, "t_end": 4}, {"text": "Therefore, common polymorphisms within EPHX1 and EPHX2 do not appear to be important risk factors for Parkinson's disease.", "section": "abstract", "t_start": 39, "d_end": 120, "d_start": 102, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "a094cdd4c5f5a9ce7b32e7c5d8a8c41c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20150973"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_307058", "Orphanet_306708", "Orphanet_278"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183521", "Orphanet_307058", "Orphanet_306708", "Orphanet_278"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_278", "label": "Corticobasal degeneration"}, "name": ["Corticobasal Degeneration"], "id": "Orphanet_278"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20150973", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_278", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20150973", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20150973", "mined_sentences": [{"text": "The Small Heat Shock Protein HSP25/27 (HspB1) Is Abundant in Cultured Astrocytes and Associated with Astrocytic Pathology in Progressive Supranuclear Palsy and Corticobasal Degeneration.", "section": "title", "t_start": 39, "d_end": 184, "d_start": 160, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "ddf6f1d0df18a7f6aaffd862e736d6d2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10716893"}]}, "target": {"id": "ENSG00000167996", "gene_info": {"symbol": "FTH1", "name": "ferritin heavy chain 1", "geneid": "ENSG00000167996"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10716893", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P02794"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10716893", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10716893", "mined_sentences": [{"text": "Increased expression of mRNA encoding ferritin heavy chain in brain structures of a rat model of absence epilepsy.", "section": "title", "t_start": 38, "d_end": 112, "d_start": 105, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "d63baf917d479360baeff61b0b0cd0df"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20150973"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease", "genetic disorder"], "codes": ["EFO_0003966", "EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183521", "Orphanet_307058", "Orphanet_306708", "Orphanet_683"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_1000631", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "Orphanet_307058", "Orphanet_306708", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_683", "label": "Progressive supranuclear palsy"}, "name": ["Progressive Supranuclear Palsy"], "id": "Orphanet_683"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20150973", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_683", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20150973", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20150973", "mined_sentences": [{"text": "The Small Heat Shock Protein HSP25/27 (HspB1) Is Abundant in Cultured Astrocytes and Associated with Astrocytic Pathology in Progressive Supranuclear Palsy and Corticobasal Degeneration.", "section": "title", "t_start": 39, "d_end": 154, "d_start": 125, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "fec3684092e4819bf329968d8ff6cfe0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10708460"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10708460", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10708460", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10708460", "mined_sentences": [{"text": "Characterization of the P protein-binding domain on the 10-kilodalton protein of Borna disease virus.", "section": "title", "t_start": 24, "d_end": 93, "d_start": 81, "t_end": 32}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "f87518ff5eb1fe06d68eefc221a9a836"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15509569"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15509569", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15509569", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15509569", "mined_sentences": [{"text": "Overlap of interaction domains indicates a central role of the P protein in assembly and regulation of the Borna disease virus polymerase complex.", "section": "title", "t_start": 63, "d_end": 119, "d_start": 107, "t_end": 71}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "75e9236312533999d1a46a09c59ae66f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23401890"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23401890", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23401890", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23401890", "mined_sentences": [{"text": "Mutations in the phospholipid remodeling gene SERAC1 cause MEGDEL syndrome.", "section": "title", "t_start": 46, "d_end": 73, "d_start": 59, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "4698c5231ff7e8344964700c7c3c0246"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20333534"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20333534", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20333534", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20333534", "mined_sentences": [{"text": "Protein kinase C-dependent phosphorylation of Borna disease virus P protein is required for efficient viral spread.", "section": "title", "t_start": 66, "d_end": 58, "d_start": 46, "t_end": 74}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "677531e2db6254266670817e100101cf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23212700"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23212700", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23212700", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23212700", "mined_sentences": [{"text": "Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia.", "section": "title", "t_start": 15, "d_end": 161, "d_start": 149, "t_end": 18}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "bd0ad30d3d22805b232272f68dc9ea13"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22639527"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's Disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22639527", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22639527", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22639527", "mined_sentences": [{"text": "Improvements in a Mouse Model of Alzheimer's Disease Through SOD2 Overexpression are Due to Functional and Not Structural Alterations.", "section": "title", "t_start": 61, "d_end": 51, "d_start": 33, "t_end": 64}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "2a37cf54b302fbfe0dc4f6e97dd91401"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25295643"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003821"], ["EFO_0000618", "EFO_0005774", "EFO_0003821"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003821", "label": "migraine disorder"}, "name": ["migraine"], "id": "EFO_0003821"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25295643", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003821", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25295643", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25295643", "mined_sentences": [{"text": "In a case-control study, we investigated the association between migraine and superoxide dismutase 1 (SOD1) and superoxide dismutase 2 (SOD2) genes in a cohort of 490 consecutive unrelated Caucasian migraineurs (migraine with aura [MwA], n=107; migraine without aura [MwoA], n=246; chronic migraine [CM], n=137) and 246 healthy controls recruited at our Headache and Pain Unit and stored in the Interinstitutional Multidisciplinary BioBank (BioBIM).", "section": "abstract", "t_start": 136, "d_end": 72, "d_start": 65, "t_end": 139}, {"text": "We also found a mild correlation between SOD2 rs4880 genotype and the type of acute migraine treatment (p=0.048) in MwA patients.", "section": "abstract", "t_start": 41, "d_end": 91, "d_start": 84, "t_end": 44}, {"text": "These observations lead to the hypothesis that SOD2 polymorphism may cause a defective control of the oxidative phenomena linked to cortical spreading depression, the neurophysiological hallmark of migraine aura, causing an overstimulation of trigeminal neurons and UAs triggering.", "section": "abstract", "t_start": 47, "d_end": 205, "d_start": 198, "t_end": 50}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "f3343c00c8750c7a55b01c528e003ea3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/9268312"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/9268312", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/9268312", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/9268312", "mined_sentences": [{"text": "Borna disease virus P-protein is phosphorylated by protein kinase Cepsilon and casein kinase II.", "section": "title", "t_start": 20, "d_end": 12, "d_start": 0, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 14.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1997-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.14}, "type": "literature", "id": "6d911d7094753b6d8b0a33df4a8e311c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24346136"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000677", "label": "mental or behavioural disorder"}, "name": ["psychiatric disorders"], "id": "EFO_0000677"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24346136", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000677", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24346136", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24346136", "mined_sentences": [{"text": "Notably, deficits in cognitive flexibility have been observed in DA-related psychopathologies associated with mPFC dysfunction, including schizophrenia, depression and drug abuse.8, 9, 10 We have previously proposed that reduced DCC confers protection against developing traits associated with these psychiatric disorders and that this protection results from selective changes in mPFC function.22 The greater cognitive flexibility observed in adult dcc haploinsufficient mice, which is associated with reduced excitability of layer V mPFC pyramidal neurons, extends and further supports dcc haploinsufficiency as a model of resilience.", "section": "results", "t_start": 229, "d_end": 320, "d_start": 300, "t_end": 231}, {"text": "Our current findings, together with our previous reports, suggest that reduced dcc expression confers resilience against developing neuroanatomical, neurochemical and behavioral traits associated with mental disorders involving mPFC dysfunction.13,17,26,37,47,48 In order to further substantiate this hypothesis, we measured the level of DCC expression in postmortem brains of depressed human subjects that committed suicide.", "section": "results", "t_start": 338, "d_end": 216, "d_start": 201, "t_end": 340}, {"text": "Adolescence is a vulnerable period for neurodevelopmental psychiatric disorders that involve alterations in mPFC circuitry and cognitive dysfunction.63 Our findings in the dcc conditional mice suggest that reduced DCC function within DA neurons, specifically during adolescence, confers resilience against these disorders.", "section": "discussion", "t_start": 214, "d_end": 78, "d_start": 58, "t_end": 216}, {"text": "Finally, we measured DCC expression in postmortem brains of depressed suicide completers to begin corroborating a link between DCC and psychiatric disorders of mPFC dysfunction.", "section": "other", "t_start": 21, "d_end": 155, "d_start": 135, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.138}, "type": "literature", "id": "0d5f678aaa5a320d2cedd5539b221482"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20712757"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["bipolar disorder"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20712757", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20712757", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20712757", "mined_sentences": [{"text": "Single marker association analysis did not reveal significant association with bipolar disorder; however, haplotypes in the SOD2 gene showed nominal association (global chi(2) = 8.94, p = 0.03; broad model).", "section": "abstract", "t_start": 124, "d_end": 94, "d_start": 79, "t_end": 127}, {"text": "Interaction analysis revealed a significant interaction between SOD2 and GPX3 haplotypes, which further increases risk for bipolar disorder (odds ratio = 2.247, chi(2) = 9.526, p = 0.002, corrected p = 0.029).", "section": "abstract", "t_start": 64, "d_end": 138, "d_start": 123, "t_end": 67}, {"text": "Further characterization of the SOD2 and GPX3 interaction using larger cohorts is required to determine the role of these oxidative pathway genes as risk factors for bipolar disorder.", "section": "abstract", "t_start": 32, "d_end": 181, "d_start": 166, "t_end": 35}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.138}, "type": "literature", "id": "10c7c81eae858d2677bf048b0736e564"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25728673"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25728673", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25728673", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25728673", "mined_sentences": [{"text": "Among these HSPs, HSPB1 was the most highly-induced gene (Fig. 1A).", "section": "results", "t_start": 18, "d_end": 15, "d_start": 12, "t_end": 22}, {"text": "Heat shock pretreatment at 42.5\u00b0C for one hour significantly increased HSF1 phosphorylation at Ser326 (a marker for increased HSF1 transcription activity by heat stress (19)) (Fig. 3A) and mRNA expression of HSPs including HSP70 (Fig. 3B) and HSPB1 (Fig. 3C) at a recovery times of eight to 24 hours.", "section": "results", "t_start": 243, "d_end": 211, "d_start": 208, "t_end": 247}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.136}, "type": "literature", "id": "95724715037aea518e19308b8e801a88"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18628683"}]}, "target": {"id": "ENSG00000165246", "gene_info": {"symbol": "NLGN4Y", "name": "neuroligin 4, Y-linked", "geneid": "ENSG00000165246"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18628683", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/Q8NFZ3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18628683", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18628683", "mined_sentences": [{"text": "We hypothesize that sequence variants in NLGN4Y are associated with autism or mental retardation.", "section": "abstract", "t_start": 41, "d_end": 73, "d_start": 68, "t_end": 46}, {"text": "The coding sequences and splice junctions of the NLGN4Y gene were analyzed in 335 male samples (290 with autism and 45 with mental retardation).", "section": "abstract", "t_start": 49, "d_end": 110, "d_start": 105, "t_end": 54}, {"text": "The absence of p.I679V in 2986 control Y chromosomes and the high similarity of NLGN4 and NLGN4Y are consistent with the hypothesis that p.I679V contributes to the etiology of autism.", "section": "abstract", "t_start": 90, "d_end": 181, "d_start": 176, "t_end": 95}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.136}, "type": "literature", "id": "2916953005432b6bbe289eda8266093b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27055860"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27055860", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27055860", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27055860", "mined_sentences": [{"text": "To identify markers of disks, large homolog 2 (DLG2), FAT atypical cadherin 3 (FAT3), kinectin1 (KTN1), deleted in colorectal carcinoma (DCC), and glycogen synthase kinase-3\u03b2 (GSK3\u03b2) that contribute to the genetic susceptibility to schizophrenia, we systematically screened for polymorphisms in the functional regions of these genes.", "section": "abstract", "t_start": 137, "d_end": 244, "d_start": 232, "t_end": 139}, {"text": "The results first suggested that the allelic and genotypic frequencies of the DCC polymorphism rs2229080 were nominally associated with schizophrenia.", "section": "abstract", "t_start": 78, "d_end": 148, "d_start": 136, "t_end": 80}, {"text": "Our results point to the polymorphisms of DCC and GSK3\u03b2 as contributors to the genetic basis of individual differences in the susceptibility to schizophrenia.", "section": "abstract", "t_start": 42, "d_end": 156, "d_start": 144, "t_end": 44}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.136}, "type": "literature", "id": "4100f62419dc6fd8b9348851269f05d1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27262845"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27262845", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27262845", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27262845", "mined_sentences": [{"text": "Four of the most important HSPs including HspB1 (Hsp27), Hsp60, Hsp70, and Hsp90 were induced by aspirin pretreatment and were suppressed by BAPTA-AM.", "section": "abstract", "t_start": 42, "d_end": 30, "d_start": 27, "t_end": 46}, {"text": "Comparing to other HSPs, HspB1 presented the largest increase after aspirin treatments, 86-fold higher than the baseline (the level before HS).", "section": "abstract", "t_start": 25, "d_end": 22, "d_start": 19, "t_end": 29}, {"text": "These findings suggested that multiple HSPs participated in aspirin's anti-heat stress function but HspB1 may contribute the most.", "section": "abstract", "t_start": 100, "d_end": 42, "d_start": 39, "t_end": 104}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.136}, "type": "literature", "id": "06ff7ef339917d9cdd5ef43a5f0334bd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24345775"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24345775", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24345775", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24345775", "mined_sentences": [{"text": "When stress signaling chaperones were quantified by RNA-Seq in the Sydney TRC cohort, there were no significant differences between schizophrenia cases and controls in their mRNA expression levels: HSPA1A (ANCOVA F(1,33) = 0.01, p = 0.99), HSP90AA1 (ANCOVA F(1,33) = 2.85, p = 0.10), DNAJB1 (ANCOVA F(1,33) = 0.02, p = 0.88) or HSPB1 (ANCOVA F(1,33) = 0.38, p = 0.54) (Figure 3A\u2013D).", "section": "results", "t_start": 328, "d_end": 144, "d_start": 132, "t_end": 332}, {"text": "Similarly, in the Stanley cohort, there were no significant differences in mRNA levels of HSPA1A (ANCOVA F(2, 89) = 0.10, p = 0.90), HSP90AA1 (ANCOVA F(2, 89) = 0.69, p = 0.50), DNAJB1 (ANCOVA F(2, 85) = 0.11, p = 0.89) or HSPB1 (ANCOVA F(2, 90) = 0.73, p = 0.48) between schizophrenia, bipolar disorder and control groups (Figure 3E\u2013H).", "section": "results", "t_start": 223, "d_end": 284, "d_start": 272, "t_end": 227}, {"text": "We did not replicate the previous report of increased HSPA1A, HSPA1B and HSPB1 expression in the DLPFC found in 14 patients with schizophrenia relative to controls34.", "section": "discussion", "t_start": 73, "d_end": 141, "d_start": 129, "t_end": 77}, {"text": "In this study, we first used RNA sequencing in a cohort of 20 males with schizophrenia and matched controls to test if expression of stress receptor co-factors and chaperone genes FKBP5, FKBP4, PTGES3, BAG1, HSPA1A, HSP90AA1, DNAJB1 and HSPB1 was altered in the dorsolateral prefrontal cortex (DLPFC) of people with schizophrenia.", "section": "other", "t_start": 237, "d_end": 85, "d_start": 73, "t_end": 241}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 13.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.134}, "type": "literature", "id": "f468c17c0378789fe59fcf4aaab5c3a5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26362775"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26362775", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26362775", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26362775", "mined_sentences": [{"text": "However, whether PPAR\u03b4 is involved in depression is unknown.", "section": "abstract", "t_start": 17, "d_end": 47, "d_start": 38, "t_end": 21}, {"text": "In this study, PPAR\u03b4 was firstly investigated in the chronic mild stress (CMS) and learned helplessness (LH) models of depression.", "section": "abstract", "t_start": 15, "d_end": 128, "d_start": 119, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 12.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.128}, "type": "literature", "id": "23018b9614de466cbc9fdf756c26b449"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24346136"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24346136", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24346136", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24346136", "mined_sentences": [{"text": "Notably, deficits in cognitive flexibility have been observed in DA-related psychopathologies associated with mPFC dysfunction, including schizophrenia, depression and drug abuse.8, 9, 10 We have previously proposed that reduced DCC confers protection against developing traits associated with these psychiatric disorders and that this protection results from selective changes in mPFC function.22 The greater cognitive flexibility observed in adult dcc haploinsufficient mice, which is associated with reduced excitability of layer V mPFC pyramidal neurons, extends and further supports dcc haploinsufficiency as a model of resilience.", "section": "results", "t_start": 229, "d_end": 150, "d_start": 138, "t_end": 231}, {"text": "Our recent report linking schizophrenia to an SNP in the DCC gene that may be implicated in the regulation of DCC expression is consistent with this.26 However, we have not yet determined the functional consequences of the SNP.", "section": "results", "t_start": 57, "d_end": 38, "d_start": 26, "t_end": 59}, {"text": "Our recent report of an association between schizophrenia and a genetic variation in DCC that may involve dysregulation of DCC expression26 further substantiates this idea.", "section": "discussion", "t_start": 85, "d_end": 56, "d_start": 44, "t_end": 87}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 12.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.128}, "type": "literature", "id": "9adf0f3e323b491ade267d059429d3d0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26666259"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004238", "label": "hearing loss"}, "name": ["hearing loss"], "id": "EFO_0004238"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26666259", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004238", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26666259", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26666259", "mined_sentences": [{"text": "Recommendation 36: The CF Foundation and the ECFS recommend that a schedule for detecting drug toxicity (including hearing loss, visual loss, renal impairment and liver function test abnormalities) should be set in place at the time of NTM treatment initiation and implemented throughout treatment based on the specific drugs prescribed", "section": "results", "t_start": 236, "d_end": 126, "d_start": 115, "t_end": 238}, {"text": "Recommendation 36: The CF Foundation and the ECFS recommend that a schedule for detecting drug toxicity (including hearing loss, visual loss, renal impairment and liver function test abnormalities) should be set in place at the time of NTM treatment initiation and implemented throughout treatment based on the specific drugs prescribed", "section": "table", "t_start": 236, "d_end": 126, "d_start": 115, "t_end": 238}, {"text": "Recommendation 36: The CF Foundation and the ECFS recommend that a schedule for detecting drug toxicity (including hearing loss, visual loss, renal impairment and liver function test abnormalities) should be set in place at the time of NTM treatment initiation and implemented throughout treatment based on the specific drugs prescribed.", "section": "other", "t_start": 236, "d_end": 126, "d_start": 115, "t_end": 238}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 12.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.126}, "type": "literature", "id": "f8222d4e414864c24cbbc510b434c546"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23107649"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23107649", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23107649", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23107649", "mined_sentences": [{"text": "RRM2B mutations are emerging as one of the leading causes of both paediatric and adult-onset mitochondrial disease associated with disruption of mitochondrial DNA maintenance. RRM2B mutations represent the third most common cause of Mendelian PEO and multiple mitochondrial DNA deletions in adults (13%), following mutations in POLG (27%) and PEO1 (14%), based on data from both Oxford and Newcastle centres.", "section": "discussion", "t_start": 343, "d_end": 245, "d_start": 243, "t_end": 346}, {"text": "The presence of significant bulbar weakness, hearing loss and gastrointestinal symptoms should guide clinicians towards RRM2B genetic analysis before POLG and PEO1, given that these key features are more common components of the clinical spectrum (bulbar dysfunction 42% versus 37% and 12%; sensorineural hearing loss 36% versus 11% and 9%; and gastrointestinal symptoms 19% versus unreported and 9% in RRM2B versus POLG and PEO1-related PEO syndromes, respectively) (Horvath et al., 2006; Fratter et al., 2011).", "section": "discussion", "t_start": 159, "d_end": 450, "d_start": 438, "t_end": 162}, {"text": "Individuals harbouring recessively inherited compound heterozygous RRM2B mutations (Patients 19, 20, 21 and 22) presented at an earlier age (mean age of onset 7 years) with a more severe and multisystem disorder, whereas patients with single heterozygous mutations, inferring autosomal-dominant transmission, had a later average age of disease onset (46 years), as is seen with PEO1 mutations (Horvath et al., 2006), and developed a predominantly myopathic phenotype consisting of PEO, ptosis, proximal muscle weakness and bulbar dysfunction, with exceptions noted (Patients 3 and 14).", "section": "discussion", "t_start": 378, "d_end": 483, "d_start": 481, "t_end": 381}, {"text": "We would, therefore, recommend RRM2B over POLG and PEO1 genetic analysis in patients with PEO-plus or Kearns\u2013Sayre syndrome before a muscle biopsy is performed to exclude a single mitochondrial DNA deletion, if there is a Mendelian pattern of inheritance. RRM2B analysis should also be considered in patients with mitochondrial neurogastrointestinal encephalopathy if blood/urinary deoxyuridine and thymidine levels are undetectable and thymidine phosphorylase activity is normal in white cells and platelets, based on the previous report of mitochondrial neurogastrointestinal encephalopathy secondary to compound heterozygous missense mutations in RRM2B (Shaibani et al., 2009), Case 20 reported here and because gastrointestinal symptoms were a prominent finding in our cohort of adult patients.", "section": "discussion", "t_start": 51, "d_end": 92, "d_start": 90, "t_end": 54}, {"text": "PEO, ptosis and proximal muscle weakness are well recognized as the predominant clinical features seen in adult patients with POLG and PEO1 (C10ORF2; Twinkle) mutations.", "section": "conclusion_and_future_work", "t_start": 135, "d_end": 2, "d_start": 0, "t_end": 138}, {"text": "Thus, the prominence of bulbar dysfunction, gastrointestinal problems and hearing loss, in the absence of conspicuous CNS features, would support early prioritization of screening of RRM2B over POLG and PEO1 in adults with PEO and muscle-restricted multiple mitochondrial DNA deletions.", "section": "conclusion_and_future_work", "t_start": 203, "d_end": 225, "d_start": 223, "t_end": 206}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 12.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.124}, "type": "literature", "id": "f4b30bbba9d07fa9c2c7b4a25cc71457"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20090922"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516", "EFO_0004190"], ["EFO_0003966", "EFO_0000516", "EFO_0004190"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004190", "label": "open-angle glaucoma"}, "name": ["open angle glaucoma"], "id": "EFO_0004190"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20090922", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004190", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20090922", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20090922", "mined_sentences": [{"text": "Normal human trabecular meshwork (NTM) and primary open angle glaucoma trabecular meshwork (GTM) cells were obtained and cultured under identical culture protocol.", "section": "results", "t_start": 34, "d_end": 69, "d_start": 51, "t_end": 36}, {"text": "Normal human trabecular meshwork (NTM) and primary open angle glaucoma trabecular meshwork (GTM) cells were obtained and cultured under identical culture protocol.", "section": "figure", "t_start": 34, "d_end": 69, "d_start": 51, "t_end": 36}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 12.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.12}, "type": "literature", "id": "6ae5997c547279cbd1978345d55ba0df"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23761811"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23761811", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23761811", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23761811", "mined_sentences": [{"text": "The Cox regression model was used for multivariate survival analysis: patient gender, age, smoking status, histological type, pathological stage (IA and IB) and ADAM9 high/low expression were entered into the Cox proportional hazard regression model.", "section": "results", "t_start": 161, "d_end": 97, "d_start": 91, "t_end": 165}, {"text": "Multivariate survival analysis revealed that ADAM9 expression, instead of other factors such as patients\u2019 gender, age, smoking status, histological type and pathological stage (IA and IB), was an independent predictor of prognosis for this group of surgically resected stage I NSCLC cases (HR, 3.385; 95% CI, 1.224\u20139.360; P=0.019).", "section": "discussion", "t_start": 45, "d_end": 125, "d_start": 119, "t_end": 49}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11800000000000001}, "type": "literature", "id": "fbcc0367d1a7cfefdccaacea6fd1a879"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21205987"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "cardiovascular disease"], "codes": ["EFO_0000618", "EFO_0000319"]}, "path": [["EFO_0000319", "EFO_0004264", "EFO_0003763", "EFO_0004277"], ["EFO_0000618", "EFO_0005774", "EFO_0004277"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004277", "label": "brain infarction"}, "name": ["brain infarction"], "id": "EFO_0004277"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21205987", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004277", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21205987", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21205987", "mined_sentences": [{"text": "Here, we report a novel finding that selective PPAR\u03b4 genetic deletion in vascular smooth muscle cells (VSMCs) resulted in increased cerebrovascular permeability and brain infarction in mice after middle cerebral artery occlusion (MCAO).", "section": "abstract", "t_start": 47, "d_end": 180, "d_start": 165, "t_end": 51}, {"text": "Furthermore, inhibition of MMP-9 activity by lentiviral MMP-9 short hairpin RNA effectively improves cerebrovascular permeability and reduces brain infarction in VSMC-selective PPAR\u03b4 conditional knockout mice after MCAO.", "section": "abstract", "t_start": 177, "d_end": 157, "d_start": 142, "t_end": 181}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11599999999999999}, "type": "literature", "id": "080b1c18671346297e1927bfd40309f0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11255266"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11255266", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11255266", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11255266", "mined_sentences": [{"text": "Components of cigarette smoke are examples of exogenous substrates subject to such bioactivation, and smoking exposure may thus modify the risk associated with the EPHX polymorphism.", "section": "abstract", "t_start": 164, "d_end": 108, "d_start": 102, "t_end": 167}, {"text": "EPHX genotype distribution did not differ significantly between unaffected controls and ovarian cancer cases (overall, low malignant potential, or invasive) either overall or after stratification by smoking status.", "section": "abstract", "t_start": 0, "d_end": 205, "d_start": 199, "t_end": 3}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11599999999999999}, "type": "literature", "id": "352bf6480dedb23db3d70ffa63c821ab"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23580200"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004720"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004720", "label": "prion disease"}, "name": ["prion disease"], "id": "EFO_0004720"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23580200", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004720", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23580200", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23580200", "mined_sentences": [{"text": "Park et al. found reduced mitochondria in an in vivo model of prion disease, which occurred concurrently with a decrease in SOD2 (Park et al., 2011).", "section": "discussion", "t_start": 124, "d_end": 74, "d_start": 62, "t_end": 127}, {"text": "A decline in SOD2 protein level and function does not seem to be a prion-disease-specific pathway.", "section": "discussion", "t_start": 13, "d_end": 79, "d_start": 67, "t_end": 16}, {"text": "During prion disease, increased superoxide due to the conversion of PrPC to PrPSc, coupled with a loss of SOD2 and therefore its antioxidant activity, might begin a cycle of heightened oxidative damage within mitochondria, eventuating in their loss.", "section": "discussion", "t_start": 106, "d_end": 19, "d_start": 7, "t_end": 109}, {"text": "SOD2 mimetics have been proposed as potential therapeutics for prion disease (Fukuuchi et al., 2006).", "section": "discussion", "t_start": 0, "d_end": 75, "d_start": 63, "t_end": 3}, {"text": "One such mimetic demonstrated an ability to extend the lifespan of prion-infected mice with reduced vacuolation within the hippocampus in early and terminal disease (Brazier et al., 2008), and therefore might indicate that a restoration of SOD2 function is crucial for cellular survival in prion disease.", "section": "discussion", "t_start": 240, "d_end": 302, "d_start": 290, "t_end": 243}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11599999999999999}, "type": "literature", "id": "ac15744880b57563cdf4ff6d7ced2d42"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23750231"}]}, "target": {"id": "ENSG00000104164", "gene_info": {"symbol": "BLOC1S6", "name": "biogenesis of lysosomal organelles complex 1 subunit 6", "geneid": "ENSG00000104164"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23750231", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q9UL45"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23750231", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23750231", "mined_sentences": [{"text": "The protein products of three of these affected genes, PLDN, COG7, and PRDX1, are decreased in mice null for the schizophrenia susceptibility factor dysbindin [37].", "section": "results", "t_start": 55, "d_end": 125, "d_start": 113, "t_end": 58}, {"text": "The protein products of three of these affected genes, PLDN, COG7, and PRDX1, are decreased in mice null for the schizophrenia susceptibility factor dysbindin [37].", "section": "figure", "t_start": 55, "d_end": 125, "d_start": 113, "t_end": 58}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11599999999999999}, "type": "literature", "id": "ed20c58c5ca87d8406075cd34b0ac3ac"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27196068"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27196068", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27196068", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27196068", "mined_sentences": [{"text": "In this study, we examined the effects of ABCG1 and ABCG4 on amyloid precursor protein (APP) processing, the product of which, amyloid \u03b2 (A\u03b2), is involved in the pathogenesis of Alzheimer's disease.", "section": "abstract", "t_start": 42, "d_end": 196, "d_start": 178, "t_end": 46}, {"text": "ABCG1 and ABCG4 may inhibit the development of Alzheimer's disease and can be targets for the treatment of Alzheimer's disease.", "section": "abstract", "t_start": 0, "d_end": 65, "d_start": 47, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11599999999999999}, "type": "literature", "id": "dac33b7ea80066cbfbacfae93c01be3e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22135673"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22135673", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22135673", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22135673", "mined_sentences": [{"text": "GW0742 was the first PPAR\u03b4 agonist to show beneficial effects in a mouse model of EAE [14, 20].", "section": "other", "t_start": 21, "d_end": 84, "d_start": 82, "t_end": 25}, {"text": "In accord with these findings, PPAR\u03b4-null mice with EAE had impaired Th1/Th17 and Th2/Treg responses, which may contribute to the extended recovery time in PPAR\u03b4-null mice compared to WT mice.", "section": "other", "t_start": 31, "d_end": 54, "d_start": 52, "t_end": 35}, {"text": "The prolonged EAE in PPAR\u03b4-null mice was associated with sustained levels of IFN\u03b3, IL-17, IL-12p35, and IL-12p40, consistent with the hypothesis that PPAR\u03b4 regulates inflammatory responses associated with EAE [19].", "section": "other", "t_start": 21, "d_end": 16, "d_start": 14, "t_end": 25}, {"text": "PPAR\u03b4-null mice with EAE also exhibited a severe inflammatory response in their spinal cord\u2014they had a higher frequency of CD4+ cells that had an accumulation of IFN-\u03b3 or IL-17A compared to WT mice [20].", "section": "other", "t_start": 0, "d_end": 23, "d_start": 21, "t_end": 4}, {"text": "Intriguingly, PPAR\u03b4 also appears to play a protective role in the spinal cords of steroid-receptor-coactivator-3-(SRC-3-) null mice with EAE.", "section": "other", "t_start": 14, "d_end": 139, "d_start": 137, "t_end": 18}, {"text": "The attenuated EAE symptoms in SRC-3-null mice are thought to occur via upregulation of PPAR\u03b4.", "section": "other", "t_start": 88, "d_end": 17, "d_start": 15, "t_end": 92}, {"text": "To further examine the mechanisms by which PPAR\u03b4 is protective in models of EAE, studies have used in vitro models of aggregating brain cells.", "section": "other", "t_start": 43, "d_end": 78, "d_start": 76, "t_end": 47}, {"text": "These results further suggest that in models of EAE, the protective effects of PPAR\u03b4 agonists may be due to their anti-inflammatory properties rather than their effects on myelin genes or oligodendrocytes.", "section": "other", "t_start": 79, "d_end": 50, "d_start": 48, "t_end": 83}, {"text": "Collectively, the findings above indicate that PPAR\u03b4 agonists ameliorate the inflammatory responses in EAE and may represent therapeutic avenues to ameliorate MS progression.", "section": "other", "t_start": 47, "d_end": 105, "d_start": 103, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "be3da83137781671cc90d59865d26b4b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20624891"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20624891", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20624891", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20624891", "mined_sentences": [{"text": "Previously, it was reported that treatment of mice with a synthetic ligand activator of PPAR-delta, GW0742, ameliorates experimental autoimmune encephalomyelitis (EAE), indicating a possible role for this nuclear receptor in the control of central nervous system (CNS) autoimmune inflammation.", "section": "abstract", "t_start": 88, "d_end": 165, "d_start": 163, "t_end": 97}, {"text": "We show that mice deficient in PPAR-delta (PPAR-delta(-/-)) develop a severe inflammatory response during EAE characterized by a striking accumulation of IFN-gamma(+)IL-17A(-) and IFN-gamma(+)IL-17A(+) CD4(+) cells in the spinal cord.", "section": "abstract", "t_start": 31, "d_end": 108, "d_start": 106, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "7caf3d1ac2dba9c6ae0164beeefd09a8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21050879"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003821"], ["EFO_0000618", "EFO_0005774", "EFO_0003821"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003821", "label": "migraine disorder"}, "name": ["migraine"], "id": "EFO_0003821"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21050879", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003821", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21050879", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21050879", "mined_sentences": [{"text": "Although flunarizine (FLN) has been widely used for migraine prophylaxis with clear success, the mechanisms of its actions in migraine prophylaxis are not completely understood.", "section": "abstract", "t_start": 22, "d_end": 59, "d_start": 52, "t_end": 24}, {"text": "Blockades of these currents might help explain the mechanism underlying the preventive effect of FLN on migraine attacks.", "section": "abstract", "t_start": 97, "d_end": 111, "d_start": 104, "t_end": 99}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "f2b075037c990bdcd64b634aab131463"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20001953"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20001953", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20001953", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20001953", "mined_sentences": [{"text": "In contrast with PPAR\u03b3, agonists of PPAR\u03b4 are more effective when given at later stages of EAE and increase myelin gene expression, suggesting effects on OL (oligodendrocyte) maturation.", "section": "abstract", "t_start": 36, "d_end": 93, "d_start": 91, "t_end": 40}, {"text": "We show that effects of GW0742 are mediated through PPAR\u03b4 since no amelioration of EAE clinical scores was observed in PPAR\u03b4-null mice.", "section": "abstract", "t_start": 52, "d_end": 85, "d_start": 83, "t_end": 56}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "b992c50542201c7988455bf2e545c487"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21445251"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette-smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21445251", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21445251", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21445251", "mined_sentences": [{"text": "EPHX1 is a key enzyme in metabolizing some exogenous carcinogens such as products of cigarette-smoking.", "section": "abstract", "t_start": 0, "d_end": 101, "d_start": 85, "t_end": 4}, {"text": "Moreover, cigarette-smoking status may influence the association of EPHX1 enzyme activity and the related cancer risk.", "section": "abstract", "t_start": 68, "d_end": 26, "d_start": 10, "t_end": 72}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "c3081663814dda8749674373a249ad65"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16696328"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16696328", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16696328", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16696328", "mined_sentences": [{"text": "The histopathological differentiation, lymph node metastasis, clinical stages and smoking history were correlated to the expression of HSP 70, but not to the expression of HSP 27.", "section": "abstract", "t_start": 172, "d_end": 88, "d_start": 82, "t_end": 177}, {"text": "It is suggested that the HSP 70 expression is a powerful and significant prognostic indicator and is related to histopathological differentiation, lymph node metastasis, patients' clinical stages, smoking history, whereas HSP 27 expression is not.", "section": "abstract", "t_start": 222, "d_end": 203, "d_start": 197, "t_end": 227}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "95be0e5d1b392a7fa36d40680afc352c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26694816"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26694816", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26694816", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26694816", "mined_sentences": [{"text": "Since other small HSP such as HSPB1 and HSPB8 have previously been reported to share TLR agonist activity with HSPB5 [16\u201318], the present study addressed the question whether small HSPs other than HSPB5 display similar expression profiles during lesional development in MS.", "section": "introduction_and_background", "t_start": 30, "d_end": 184, "d_start": 181, "t_end": 34}, {"text": "The group of small HSPs consists of eleven members, HSPB1-HSPB10 and the recently described HSPB11 [19, 20].", "section": "introduction_and_background", "t_start": 52, "d_end": 22, "d_start": 19, "t_end": 56}, {"text": "Grey matter from non-neurological cases and NAGM, intracortical demyelination and subpial lesions from MS cases were double labelled with HLA-DR (pink) and the small HSPs (brown), HSPB1 (a), HSPB6 (b), HSPB8 (c) or HSPB11 (d).", "section": "results", "t_start": 180, "d_end": 169, "d_start": 166, "t_end": 184}, {"text": "In the present study, we examined the expression of four small HSPs during MS, and found significant increases in transcript levels for HSPB1, HSPB6 and HSPB8 but not for HSPB11 in NAWM from MS patients compared to white matter from non-neurological controls.", "section": "discussion", "t_start": 136, "d_end": 66, "d_start": 63, "t_end": 140}, {"text": "Our data clarify that several small HSPs including HSPB1, HSPB6 and HSPB8 are selectively induced in astrocytes as a secondary response to the development of MS lesions in WM but not GM areas of the CNS.", "section": "conclusion_and_future_work", "t_start": 51, "d_end": 39, "d_start": 36, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "97adb210e0f7c6e3177a6f41a1936c60"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16528373"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "endocrine system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0001379", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0002422", "EFO_0000232", "EFO_1000478"], ["EFO_0001379", "EFO_0003769", "EFO_1000478"], ["EFO_0000616", "EFO_0003833", "EFO_1000478"], ["EFO_0000616", "EFO_0003769", "EFO_1000478"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_1000478"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000478", "label": "Pituitary Gland Adenoma"}, "name": ["pituitary adenomas"], "id": "EFO_1000478"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16528373", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000478", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16528373", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16528373", "mined_sentences": [{"text": "The high level of expression of BMI1 protein observed in mantle-cell lymphomas and pituitary adenomas is associated in some cases with amplification of BMI1 locus.", "section": "abstract", "t_start": 32, "d_end": 100, "d_start": 83, "t_end": 35}, {"text": "A significant finding of the study is the identification of unique PcG profiles for some tumors, such as testicular germ-cell tumors, which have high levels of HPH1 expression and loss of RING1 and/or BMI1; pituitary adenomas, which expressed every PcG protein analyzed; and clear-cell renal-cell carcinoma, which was the only tumor other than testicular germ-cell tumors that did not express RING1.", "section": "abstract", "t_start": 201, "d_end": 224, "d_start": 207, "t_end": 204}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.114}, "type": "literature", "id": "05b870b9337cce77e96442ae00affa9a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25261893"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["Smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25261893", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25261893", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25261893", "mined_sentences": [{"text": "Thus, random-effect model was used when heterogeneity identified.Table 1 Overall and stratified meta-analyses of the association between the EPHX1 Tyr113His polymorphism and cancer risk  Variables  No a  Case/control  Homozygote comparison  Heterozygote comparison  Dominant model  Recessive model  Additive model  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  Total 4520091/273961.05(0.95\u2009~\u20091.16)0.370.00(50.8)0.94(0.88\u2009~\u20091.01)0.080.0(54.0)0.96(0.90\u2009~\u20091.03)0.260.0(56.8)1.08(0.99\u2009~\u20091.18)0.080.0(37.4)1.00(0.95\u2009~\u20091.05)0.940.0(57.7) Cancer type Blood72419/23191.05(0.76\u2009~\u20091.46)0.760.03(56.1)0.89(0.73\u2009~\u20091.01)0.240.06(49.8)0.92(0.75\u2009~\u20091.13)0.420.02(60.3) 1.17(0.96\u2009~\u20091.41)  0.12  0.14(37.3) 0.97(0.82\u2009~\u20091.15)0.760.01(65.9)Prostate31706/11921.54(0.57\u2009~\u20094.16)0.860.00(88.9)1.31(0.82\u2009~\u20092.01)0.260.00(79.7)1.39(0.80\u2009~\u20092.41)0.240.00(87.1)1.29(0.62\u2009~\u20092.65)0.500.0(82.2)1.27(0.81\u2009~\u20091.97)0.300.00(89.7)Esophageal3593/1086 1.09(0.78\u2009~\u20091.51)  0.63  0.19(40.5) 1.01(0.52\u2009~\u20091.93)0.990.00(86.0)1.08(0.63\u2009~\u20091.84)0.790.00(81.6) 1.16(0.85\u2009~\u20091.58)  0.34  0.20(38.4) 1.09(0.84\u2009~\u20091.41)0.510.07(61.9)Colorectal95512/6787 0.98(0.86\u2009~\u20091.11)  0.75  0.85(0.0)  1.00(0.93\u2009~\u20091.08)  0.98  0.79(0.0)  0.99(0.93\u2009~\u20091.07)  0.98  0.80(0.0)  0.98(0.87\u2009~\u20091.11)  0.76  0.87(0.0)  1.00(0.94\u2009~\u20091.05)  0.87  0.84(0.0) Other72425/28721.20(0.90\u2009~\u20091.59)0.220.06(50.4)1.00(0.81\u2009~\u20091.24)0.990.01(66.7)1.04(0.84\u2009~\u20091.29)0.740.00(69.4) 1.18(0.98\u2009~\u20091.42)  0.08  0.40(2.8) 1.06(0.91\u2009~\u20091.23)0.450.01(65.5)Lung92065/54290.80(0.57\u2009~\u20091.12)0.200.00(62.5)0.80(0.65\u2009~\u20090.98)0.030.00(65.0)0.81(0.68\u2009~\u20090.98)0.030.01(62.5)0.91(0.66\u2009~\u20091.25)0.570.01(61.7)0.87(0.75\u2009~\u20091.01)0.080.0(65.5)Head and neck3825/821 1.04(0.74\u2009~\u20091.47)  0.81  0.98(0.0)  0.87(0.71\u2009~\u20091.07)  0.19  0.82(0.0)  0.90(0.74\u2009~\u20091.10)  0.30  0.85(0.0)  1.11(0.80\u2009~\u20091.54)  0.53  0.99(0.0)  0.96(0.83\u2009~\u20091.12)  0.61  0.91(0.0) Breast cancer44546/6890 1.02(0.90\u2009~\u20091.17)  0.73  0.15(43.0)  0.99(0.91\u2009~\u20091.07)  0.73  0.60(0.0)  0.99(0.92\u2009~\u20091.07)  0.35  0.99(0.0) 1.14(0.89\u2009~\u20091.46)0.310.05(62.6) 1.00(0.97\u2009~\u20091.03)  0.93  0.68(0.0)  Source of control PB3116035/231111.03(0.93\u2009~\u20091.14)0.540.06(29.7)0.97(0.92\u2009~\u20091.03)0.280.10(25.1)0.98(0.93\u2009~\u20091.04)0.450.06(30.4) 1.03(0.96\u2009~\u20091.11)  0.38  0.14(21.9) 1.00(0.95\u2009~\u20091.04)0.910.03(34.7)HB113517/36270.94(0.77\u2009~\u20091.15)0.560.08(40.9)0.81(0.69\u2009~\u20090.96)0.010.00(59.4)0.85(0.74\u2009~\u20090.98)0.030.03(49.4)1.05(0.86\u2009~\u20091.27)0.660.05(45.7)0.93(0.84\u2009~\u20091.03)0.160.05(45.3) Ethnicity Caucasian2611757/18447 0.94(0.87\u2009~\u20091.03)  0.17  0.29(11.7)  0.93(0.87\u2009~\u20091.00) 0.040.09(28.7)0.93(0.87\u2009~\u20091.00)0.040.06(31.7) 0.97(0.89\u2009~\u20091.05)  0.45  0.49(0.0) 0.96(0.91\u2009~\u20091.00)0.070.08(29.6)Mixed75645/5502 1.17(1.02\u2009~\u20091.34)  0.03  0.42(0.7)  1.00(0.93\u2009~\u20091.09)  0.96  0.57(0.0)  1.03(0.96\u2009~\u20091.11)  0.44  0.53(0.0)  1.17(1.02\u2009~\u20091.33)  0.02  0.44(0.0)  1.05(0.99\u2009~\u20091.11)  0.11  0.43(0.0) Asian112534/32051.46(1.05\u2009~\u20092.03)0.040.00(75.1)1.04(0.77\u2009~\u20091.40)0.810.00(81.7)1.16(0.88\u2009~\u20091.53)0.300.00(56.8)1.39(1.10\u2009~\u20091.76)0.010.01(60.7)1.19(0.99\u2009~\u20091.42)0.050.0(79.4) Smoking status Smoker91786/2114 0.99(0.80\u2009~\u20091.23)  0.95  0.42(1.4) 0.85(0.66\u2009~\u20091.10)0.210.03(52.1)0.89(0.71-1.11)0.300.05(47.8) 1.07(0.87\u2009~\u20091.31)  0.56  0.43(0.5)  0.97(0.88\u2009~\u20091.08)  0.60  0.13(36.7) Non-smoker81357/19471.45(0.89\u2009~\u20092.37)0.140.00(71.4)1.19(0.88\u2009~\u20091.60)0.270.01(63.6)1.27(0.92\u2009~\u20091.74)0.140.00(71.7)1.29(0.92~1.82)0.140.05(50.0)1.23(0.97\u2009~\u20091.57)0.090.00(75.8)PB: population based; HB: hospital based. P b: P-values for heterogeneity from Q test; I2 refers to the proportion of total variation owing to between-study heterogeneity.Bold font marks where fixed effect model used.Table 2 Overall and stratified meta-analyses of the association between the EPHX1 His139Arg polymorphism and cancer risk  Variables  No a  Case/control  Homozygote comparison  Heterozygote comparison  Dominant model  Recessive model  Additive model  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  OR (95% CI)  P  P b (I 2 )  Total 5419437/272891.05(0.93\u2009~\u20091.18)0.730.09(21.3)0.96(0.91\u2009~\u20091.01)0.150.02(31.5)0.97(0.92\u2009~\u20091.03)0.300.00(40.1) 1.02(0.93\u2009~\u20091.13)  0.66  0.23(12.0) 0.99(0.94\u2009~\u20091.04)0.570.00(44.9) Cancer type Other113160/4581 0.94(0.75\u2009~\u20091.20)  0.64  0.53(0.0)  0.97(0.87\u2009~\u20091.10)  0.51  0.56(0.0)  0.97(0.87\u2009~\u20091.06)  0.47  0.53(0.0)  0.96(0.76\u2009~\u20091.21)  0.71  0.53(0.0)  0.97(0.89\u2009~\u20091.05)  0.50  0.46(0.0) Blood92929/3629 0.87(0.67\u2009~\u20091.13)  0.29  0.90(0.0)  0.90(0.81\u2009~\u20091.00)  0.05  0.25(21.4)  0.90(0.81\u2009~\u20090.99)  0.04  0.47(0.0)  0.90(0.70\u2009~\u20091.17)  0.44  0.82(0.0)  0.91(0.83\u2009~\u20090.99)  0.04  0.80(0.0) Esophageal3593/10811.30(0.50\u2009~\u20093.38)0.590.07(61.8)1.02(0.65\u2009~\u20091.62)0.920.03(72.6)1.06(0.66\u2009~\u20091.73)0.800.01(77.3)1.30(0.54\u2009~\u20093.13)0.560.10(56.5)1.10(0.71\u2009~\u20091.69)0.670.01(79.2)Colorectal105552/70891.14(0.85\u2009~\u20091.53)0.390.02(53.5) 0.92(0.85\u2009~\u20090.99)  0.03  0.97(0.0)  0.94(0.87\u2009~\u20091.01)  0.09  0.73(0.0) 1.17(0.87\u2009~\u20091.58)0.290.02(54.0) 0.97(0.91\u2009~\u20091.03)  0.28  0.11(36.8) Lung144767/84111.14(0.83\u2009~\u20091.56)0.420.02(49.3)1.10(0.94\u2009~\u20091.27)0.240.00(63.4)1.10(0.93\u2009~\u20091.29)0.270.00(71.9) 0.97(0.80\u2009~\u20091.17)  0.76  0.16(27.2) 1.07(0.93\u2009~\u20091.24)0.360.00(74.1)Head and neck41035/1075 1.28(0.81\u2009~\u20092.02)  0.30  0.99(0.0)  0.84(0.70\u2009~\u20091.01)  0.06  0.69(0.0)  0.88(0.73\u2009~\u20091.05)  0.14  0.70(0.0)  1.35(0.85\u2009~\u20092.13)  0.20  1.0(0.0)  0.94(0.81\u2009~\u20091.01)  0.41  0.78(0.0) Breast cancer31401/1423 1.04(0.69\u2009~\u20091.59)  0.85  0.49(0.0)  0.91(0.77\u2009~\u20091.07)  0.04  0.66(0.0)  0.92(0.79\u2009~\u20091.08)  0.30  0.67(0.0)  1.09(0.93\u2009~\u20091.13)  0.70  0.49(0.0)  0.95(0.83\u2009~\u20091.09)  0.44  0.66(0.0)  Source of control HB165010/5638 1.14(0.93\u2009~\u20091.41)  0.21  0.99(0.0)  0.96(0.88\u2009~\u20091.05)  0.37  0.20(22.7)  0.98(0.90\u2009~\u20091.06)  0.63  0.32(11.4)  1.17(0.95\u2009~\u20091.44)  0.15  0.99(0.0)  1.00(0.94\u2009~\u20091.08)  0.94  0.66(0.0) PB3614191/213511.04(0.89\u2009~\u20091.22)0.610.01(39.4)0.96(0.90\u2009~\u20091.03)0.220.01(39.4)0.97(0.90\u2009~\u20091.04)0.400.00(50.7)1.04(0.90\u2009~\u20091.21)0.560.05(30.0)0.99(0.92\u2009~\u20091.05)0.640.00(57.2) Ethnicity Asian132957/3770 0.97(0.75\u2009~\u20091.27)  0.84  0.51(0.0)  0.99(0.89\u2009~\u20091.11)  0.90  0.26(18.6)  0.99(0.89\u2009~\u20091.10)  0.88  0.14(30.6)  0.98(0.76\u2009~\u20091.28)  0.90  0.59(0.0) 1.01(0.90\u2009~\u20091.13)0.900.09(37.1)Caucasian3212294/178311.10(0.93\u2009~\u20091.30)0.260.03(34.8)0.95(0.88\u2009~\u20091.02)0.180.01(44.0)0.97(0.89\u2009~\u20091.04)0.390.00(52.8) 1.07(0.95\u2009~\u20091.21)  0.27  0.11(24.4) 0.99(0.92\u2009~\u20091.06)0.710.00(57.3)Mixed73921/5262 0.90(0.73\u2009~\u20091.12)  0.35  0.81(0.0)  0.94(0.86\u2009~\u20091.04)  0.22  0.43(0.0)  0.94(0.86\u2009~\u20091.03)  0.16  0.69(0.0)  0.92(0.74\u2009~\u20091.14)  0.45  0.71(0.0)  0.95(0.88\u2009~\u20091.02)  0.15  0.93(0.0) African2265/4260.81(0.22\u2009~\u20092.96)0.750.08(21.3) 1.09(0.79\u2009~\u20091.50)  0.60  0.78(0.0)  1.06(0.78\u2009~\u20091.45)  0.69  0.46(0.0) 0.78(0.23\u2009~\u20092.73)0.700.08(66.6) 1.03(0.94\u2009~\u20091.01)  0.84  0.22(34.7)  Smoking status Smoker92331/25421.08(0.64\u2009~\u20091.83)0.770.01(61.5)1.19(0.88\u2009~\u20091.60)0.270.00(76.6)1.16(0.85\u2009~\u20091.58)0.350.00(79.9)1.04(0.68~1.60)0.860.06(46.8)1.09(0.84\u2009~\u20091.41)0.520.00(80.1)Non-smoker81498/2336 1.25(0.90\u2009~\u20091.75)  0.19  0.67(0.0)  1.05(0.91\u2009~\u20091.21)  0.49  0.78(0.0)  1.08(0.94\u2009~\u20091.23)  0.30  0.71(0.0)  1.24(0.89\u2009~\u20091.72)  0.21  0.71(0.0)  1.08(0.96\u2009~\u20091.22)  0.19  0.60(0.0) PB: population based; HB: hospital based. P b: P-values for heterogeneity from Q test; I2 refers to the proportion of total variation owing to between-study heterogeneity.Bold font marks where fixed effect model used.", "section": "results", "t_start": 141, "d_end": 3051, "d_start": 3045, "t_end": 145}, {"text": "In the subgroup analysis by source of controls, smoking status and ethnicity, no significant association with cancer risk was observed in all subgroups (Table\u00a02).Figure 3 Forest plot for association of EPHX1 His139Arg polymorphism and cancer risk (dominant model, GA\u2009+\u2009GG vs. AA).", "section": "results", "t_start": 202, "d_end": 54, "d_start": 48, "t_end": 206}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11199999999999999}, "type": "literature", "id": "a623e2c0aa4c9f7e317112ad45740492"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25281868"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25281868", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25281868", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25281868", "mined_sentences": [{"text": "Of this latter group, one had signs and symptoms suggestive of sensory neuropathy (chronic PEO/CN phenotype; C10orf2 mutation), and one had reduced vibration sense at the malleolus and absent right ankle jerk at age 73 years (chronic PEO phenotype; single mitochondrial DNA deletion).", "section": "results", "t_start": 109, "d_end": 93, "d_start": 91, "t_end": 115}, {"text": "Three nuclear genes were associated with PEO in the present study: POLG, C10orf2 and RRM2B.", "section": "discussion", "t_start": 73, "d_end": 43, "d_start": 41, "t_end": 79}, {"text": "Other patients with C10orf2 had chronic PEO with no CNS features.", "section": "discussion", "t_start": 20, "d_end": 42, "d_start": 40, "t_end": 26}, {"text": "Peripheral neuropathy has been reported in only a small number of patients with PEO and C10orf2 or RRM2B mutations (Fratter et al., 2010; Pitceathly et al., 2012).", "section": "discussion", "t_start": 88, "d_end": 82, "d_start": 80, "t_end": 94}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11199999999999999}, "type": "literature", "id": "88c7ad50caaa6f452e3e7cb5e1d45488"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17251466"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17251466", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17251466", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17251466", "mined_sentences": [{"text": "The effects of SOD2 modulation on the EAE optic nerve were gauged by computerized analysis of optic nerve volume, myelin fiber area, and retinal ganglion cell loss at 1, 3, and 12 months after sensitization for EAE.", "section": "abstract", "t_start": 15, "d_end": 40, "d_start": 38, "t_end": 18}, {"text": "Increasing SOD2 levels twofold in the optic nerve by virally mediated gene transfer ameliorated myelin fiber injury by 51% and RGC loss fourfold, limiting it to 7% in EAE at 1 year.", "section": "abstract", "t_start": 11, "d_end": 169, "d_start": 167, "t_end": 14}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11199999999999999}, "type": "literature", "id": "05f6ff20b8961a66864082960b0f3d57"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18606951"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["bipolar disorder"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18606951", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18606951", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18606951", "mined_sentences": [{"text": "Additional genotyping in PPARD yielded 4 SNPs in 1 haplotype block that were significantly associated with bipolar disorder (P < .01), the most significant being rs9462082 (P < .001).", "section": "abstract", "t_start": 25, "d_end": 122, "d_start": 107, "t_end": 29}, {"text": "We found evidence for association of bipolar disorder with PPARD, a gene in the Wnt signaling pathway.", "section": "abstract", "t_start": 59, "d_end": 52, "d_start": 37, "t_end": 63}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "36bb33c01f6246485113dd4f1b21025d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21484998"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002461", "EFO_0000508"]}, "path": [["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_669", "label": "Otopalatodigital syndrome"}, "name": ["otopalatodigital syndrome"], "id": "Orphanet_669"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21484998", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_669", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21484998", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21484998", "mined_sentences": [{"text": "The otopalatodigital syndrome spectrum is caused by distinct FLNA missense mutations or in-frame deletions disrupting the development of craniofacial and long bones.", "section": "abstract", "t_start": 61, "d_end": 28, "d_start": 4, "t_end": 64}, {"text": "The in-frame deletion in the carboxyl-terminal domain of FLNA caused a phenotype in which PH was associated with skeletal features suggestive of the otopalatodigital syndrome spectrum in boys.", "section": "abstract", "t_start": 57, "d_end": 173, "d_start": 149, "t_end": 60}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "83d4a0673f4db76bdc241f060d583779"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/9513044"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/9513044", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/9513044", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/9513044", "mined_sentences": [{"text": "Characterization of the cross-linked complexes involving calreticulin and heat shock proteins (HSPs) showed an average mass of 400-600 kDa by gel filtration chromatography.", "section": "abstract", "t_start": 57, "d_end": 98, "d_start": 95, "t_end": 68}, {"text": "Overall, the consistent association of glycosylated and unglycosylated calreticulin with P-SG50 and unglycosylated HSPs suggests that P-SG/calreticulin is an active member of the cast of glycone/aglycone chaperones that cooperate to achieve cellular recovery from acute heat stress.", "section": "abstract", "t_start": 71, "d_end": 118, "d_start": 115, "t_end": 82}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1998-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "6b1bd67da2e6c435bb4512e619eb8fcf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22118311"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22118311", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22118311", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22118311", "mined_sentences": [{"text": "Microsomal epoxide hydrolase (EPHX) is an important enzyme that metabolizes harmful reactive epoxides from smoking.", "section": "abstract", "t_start": 30, "d_end": 113, "d_start": 107, "t_end": 33}, {"text": "A strong correlation between the EPHX1 113 mutant homozygote and smoking-related COPD was noted.", "section": "abstract", "t_start": 33, "d_end": 71, "d_start": 65, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "58ac6c93b1ae1e5e91afcab262bea6e7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20803511"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20803511", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20803511", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20803511", "mined_sentences": [{"text": "Patients were selected to present additional features previously described for PEO1 mutations, namely early age of onset, progressive external ophthalmoplegia (PEO), or epilepsy.", "section": "abstract", "t_start": 79, "d_end": 162, "d_start": 160, "t_end": 82}, {"text": "Whereas PEO1 mutations were not found in our cohort, POLG frequently caused ataxia with PEO (47%), psychiatric comorbidities (20%) and, more rarely, with epilepsy (14%).", "section": "abstract", "t_start": 8, "d_end": 90, "d_start": 88, "t_end": 11}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "aeb83b301b8cacb265276b130302911e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22926168"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22926168", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22926168", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22926168", "mined_sentences": [{"text": "Recent studies suggest a variety of factors characterize substantia nigra neurons vulnerable to Parkinson's disease, including the transcription factors pituitary homeobox 3 (Pitx3) and orthodenticle homeobox 2 (Otx2) and the trophic factor receptor deleted in colorectal cancer (DCC), but there is limited information on their expression and localization in adult humans.", "section": "abstract", "t_start": 280, "d_end": 114, "d_start": 96, "t_end": 282}, {"text": "Our data show that, at the age when Parkinson's disease typically occurs, there are no significant differences in the expression of transcription factors in brainstem dopamine neurons, but those most vulnerable to Parkinson's disease rely more on the trophic factor receptor DCC than other brainstem dopamine neurons.", "section": "abstract", "t_start": 275, "d_end": 54, "d_start": 36, "t_end": 277}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "78e070c97b4383df8621d5cd9bae0241"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20886582"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20886582", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20886582", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20886582", "mined_sentences": [{"text": "This study examined interaction effect between smoking and two single nucleotide polymorphisms (SNPs)-CYP1A1 c.1384A>G (p.Ile462Val) and EPHX1 c.337T>C (p.Tyr113His)-in modulating colorectal cancer (CRC) risk.", "section": "abstract", "t_start": 137, "d_end": 53, "d_start": 47, "t_end": 141}, {"text": "There was significant multiplicative interaction for CRC risk between smoking and EPHX1 c.337T>C (odds ratio [OR]\u2009=\u20091.37, 95% confidence interval [CI]\u2009=\u20091.03-1.81, P\u2009=\u20090.03), particularly among smokers with a history of greater than 20 pack-years of smoking (OR\u2009=\u20091.52, 95% CI\u2009=\u20091.07-2.16, P\u2009=\u20090.02).", "section": "abstract", "t_start": 82, "d_end": 76, "d_start": 70, "t_end": 86}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "a1e9a2d97a8ff967e52730cb1efadb01"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20803511"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20803511", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20803511", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20803511", "mined_sentences": [{"text": "Patients were selected to present additional features previously described for PEO1 mutations, namely early age of onset, progressive external ophthalmoplegia (PEO), or epilepsy.", "section": "abstract", "t_start": 79, "d_end": 176, "d_start": 169, "t_end": 82}, {"text": "Whereas PEO1 mutations were not found in our cohort, POLG frequently caused ataxia with PEO (47%), psychiatric comorbidities (20%) and, more rarely, with epilepsy (14%).", "section": "abstract", "t_start": 8, "d_end": 161, "d_start": 154, "t_end": 11}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "421851d602a8946792a8214a32212e76"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25558953"}]}, "target": {"id": "ENSG00000165246", "gene_info": {"symbol": "NLGN4Y", "name": "neuroligin 4, Y-linked", "geneid": "ENSG00000165246"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25558953", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q8NFZ3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25558953", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25558953", "mined_sentences": [{"text": "We measured expression in blood of two Y genes NLGN4Y and RPS4Y in 26 boys with XYY and 11 male controls and evaluated whether NLGN4Y expression correlates with anxiety, ADHD, depression and autistic behaviors (from questionnaires) in boys with XYY.", "section": "abstract", "t_start": 47, "d_end": 185, "d_start": 176, "t_end": 52}, {"text": "Results from the SRS total and autistic mannerisms scales, but not from the attention, anxiety or depression measures, correlated with peripheral expression of NLGN4Y in boys with XYY.", "section": "abstract", "t_start": 160, "d_end": 107, "d_start": 98, "t_end": 165}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "a0ee8f332d257873746d5194b9d99e7c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22676229"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22676229", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22676229", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22676229", "mined_sentences": [{"text": "This includes association with female sex in two of the external AC data sets (DCC and GSE10072, data not shown), successful validation in patient cohorts of different ethnicity, higher proliferation in smoking compared to never-smoking cases within AC1 [13], and association of AC1 with increased EGFR activity (GSE11969 and our original data).", "section": "discussion", "t_start": 79, "d_end": 209, "d_start": 203, "t_end": 81}, {"text": "Notably, the DCC-derived classifier also included, besides genes associated with proliferation, genes reported to be affected by smoking in airway epithelial cells, such as CX3CL1GPX2UCHL1HLF[28], CYP1B1[28], and S100A8[34], with expression consistent with previous reports.", "section": "discussion", "t_start": 13, "d_end": 135, "d_start": 129, "t_end": 15}, {"text": "Association of the AC1/AC2 and DCC signature with smoking history in normal airway epithelial samples, and adjacent lung tissue", "section": "table", "t_start": 31, "d_end": 56, "d_start": 50, "t_end": 33}, {"text": "We applied this signature to the DCC, GSE10072, Beer et al., GSE11969, GSE12667, and GSE32863 gene expression data sets comprising a total of 811 AC cases, of which 687 had available smoking status.", "section": "other", "t_start": 33, "d_end": 189, "d_start": 183, "t_end": 35}, {"text": "For former smokers in GSE7895 with available data on time since smoking cessation there was no difference between AC1 and AC2 classified cases, or between DCC-classification (p\u2009=\u20090.46 and p\u2009=\u20090.14, respectively, Wilcoxon\u2019s test).", "section": "other", "t_start": 155, "d_end": 70, "d_start": 64, "t_end": 157}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "91dc5e0416bf8e16c0b8bba0c52cba6c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17885617"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17885617", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17885617", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17885617", "mined_sentences": [{"text": "After adjusting for covariates, including sex, age, and smoking status, NQO1*2 (rs1800566) affected all five metabolites, CYP2E1 (rs2031920) affected most metabolites but not catechol, EPHX1 (rs1051740 or rs2234922) affected catechol and S-phenylmercapturic acid, and GSTT1 and GSTM1 affected S-phenylmercapturic acid.", "section": "abstract", "t_start": 185, "d_end": 62, "d_start": 56, "t_end": 189}, {"text": "Significant interactions were also detected between benzene exposure and all four genes and between smoking status and NQO1*2 and EPHX1 (rs1051740).", "section": "abstract", "t_start": 130, "d_end": 106, "d_start": 100, "t_end": 134}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "66a2546e7170b1aa3cacaff5a331e62e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8814840"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8814840", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8814840", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8814840", "mined_sentences": [{"text": "The stroma stained strongly positive for HSP 27, but negatively for HSP 90 and glandular epithelium showed positive apical staining for both HSPs.", "section": "abstract", "t_start": 41, "d_end": 144, "d_start": 141, "t_end": 46}, {"text": "The distribution of HSPs, primarily HSP 27, may aid in identifying different cell populations within prostatic carcinomas and thus help forecast biological behaviour.", "section": "abstract", "t_start": 36, "d_end": 23, "d_start": 20, "t_end": 41}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "3437b19d76e73c940e211c3cc7b7cf14"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24274658"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24274658", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24274658", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24274658", "mined_sentences": [{"text": "A considerable number of NTM lung disease and non-NTM BE patients in our study reported feelings of anxiety (23.8% and 21.3%, respectively) as well as depression (27.4% and 21.3%, respectively).", "section": "discussion", "t_start": 25, "d_end": 160, "d_start": 151, "t_end": 27}, {"text": "Consistently higher rates of depression and anxiety among NTM lung disease patients and non-NTM BE patients may stem from increased respiratory symptoms as well as other comorbidities.", "section": "discussion", "t_start": 58, "d_end": 38, "d_start": 29, "t_end": 60}, {"text": "Twenty-three 23 patients (27.4%) with NTM lung disease and 10 patients (21.3%) with non-NTM BE reported symptoms of depression (P\u2009=\u20090.53).", "section": "other", "t_start": 38, "d_end": 125, "d_start": 116, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "002189391e216260ab8887707e8ff972"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22574128"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "endocrine system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0001379", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0002422", "EFO_0000232", "EFO_1000478"], ["EFO_0001379", "EFO_0003769", "EFO_1000478"], ["EFO_0000616", "EFO_0003833", "EFO_1000478"], ["EFO_0000616", "EFO_0003769", "EFO_1000478"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_1000478"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000478", "label": "Pituitary Gland Adenoma"}, "name": ["pituitary adenomas"], "id": "EFO_1000478"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22574128", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000478", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22574128", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22574128", "mined_sentences": [{"text": "Human pituitary adenomas show expression of BMI1 in 54% (our data) to up to 100% [34].", "section": "discussion", "t_start": 44, "d_end": 23, "d_start": 6, "t_end": 47}, {"text": "These data show that over expression of Bmi1 does not only induce the generation of tumors in mice but this over expression is also commonly seen in established human pituitary adenomas and BMI1 could therefore be considered as a potential drug target for pituitary tumors.", "section": "discussion", "t_start": 190, "d_end": 184, "d_start": 167, "t_end": 193}, {"text": "Immunohistochemistry of human pituitary adenomas show over expression of BMI1, which is visualized by a nuclear signal (O).", "section": "figure", "t_start": 73, "d_end": 47, "d_start": 30, "t_end": 76}, {"text": "To analyze whether BMI1 is over expressed in human pituitary adenomas, we performed immunohistochemistry.", "section": "other", "t_start": 19, "d_end": 68, "d_start": 51, "t_end": 22}, {"text": "These results show that a significant portion of human pituitary adenomas has over expression of BMI1.", "section": "other", "t_start": 97, "d_end": 72, "d_start": 55, "t_end": 100}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "b9cf55540d3af07830c8aae96c870399"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8940623"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8940623", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8940623", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8940623", "mined_sentences": [{"text": "LBHIs of both familial and sporadic ALS were negatively stained for SOD2.", "section": "abstract", "t_start": 68, "d_end": 38, "d_start": 36, "t_end": 71}, {"text": "These results indicate that SOD1 may be involved in the formative process of LBHIs especially in familial ALS but not always in that of SIs or BBs, and imply that SOD2 may have no connection with any of these ALS-related abnormal structures.", "section": "abstract", "t_start": 163, "d_end": 108, "d_start": 106, "t_end": 166}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 11.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.11}, "type": "literature", "id": "8e01726edba799820915f58aa614079a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25522158"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25522158", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25522158", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25522158", "mined_sentences": [{"text": "The genetic interaction between mitochondria function and schizophrenia may be revealed by DRD2 linked to NDUFS7 through protein-protein interactions of FLNA and ARRB2.", "section": "abstract", "t_start": 153, "d_end": 70, "d_start": 58, "t_end": 156}, {"text": "The genetic network of hemostatic process implicates the interactions between antipsychotic target genes such as DRD2/3 and HTR2A and coagulation factor genes such as F7, F3, and F10 through bridging of actin-binding protein(FLNA) which implicates the bottleneck of this network to cascade the following coagulation function with different candidate genes in schizophrenia.", "section": "figure", "t_start": 225, "d_end": 371, "d_start": 359, "t_end": 228}, {"text": "The genetic interaction for mitochondria function and schizophrenia were illustrated by DRD2 linked to NDUFS7 through protein-protein interactions of FLNA and ARRB2[83,84].", "section": "other", "t_start": 150, "d_end": 66, "d_start": 54, "t_end": 153}, {"text": "However, FLNA is one of the novel schizophrenia candidate genes[20] which was involved in the glutamate receptor signaling subnetwork, and might result in brain structure change such as enlargement of the cerebroventricular system, reduced size in cortical region, and abnormal laminar organization with differential genetic changes including abnormal expression of multiple proteins that are involved in cellular functionality such as neuron migration, cell proliferation, axonal outgrowth, and apoptosis[111].", "section": "other", "t_start": 9, "d_end": 46, "d_start": 34, "t_end": 12}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10800000000000001}, "type": "literature", "id": "d30cee1abad486f9b386125ab9d34e72"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24346136"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24346136", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24346136", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24346136", "mined_sentences": [{"text": "Notably, deficits in cognitive flexibility have been observed in DA-related psychopathologies associated with mPFC dysfunction, including schizophrenia, depression and drug abuse.8, 9, 10 We have previously proposed that reduced DCC confers protection against developing traits associated with these psychiatric disorders and that this protection results from selective changes in mPFC function.22 The greater cognitive flexibility observed in adult dcc haploinsufficient mice, which is associated with reduced excitability of layer V mPFC pyramidal neurons, extends and further supports dcc haploinsufficiency as a model of resilience.", "section": "results", "t_start": 229, "d_end": 162, "d_start": 153, "t_end": 231}, {"text": "We chose the BA44 because it is part of the prefrontal cortex and because a number of studies, including those conducted by the authors of the present paper, identify it as a prefrontal cortex subregion in which genes that have been associated with depression are differentially expressed.49, 50, 51, 52 We used quantitative real-time PCR (qRT\u2013PCR) to assess DCC levels in prefrontal cortex samples of subjects from the Quebec Suicide Brain Bank (Douglas Institute).", "section": "results", "t_start": 359, "d_end": 258, "d_start": 249, "t_end": 361}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10800000000000001}, "type": "literature", "id": "047244feeb06495441287e8f92be0e1a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20704535"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20704535", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20704535", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20704535", "mined_sentences": [{"text": "After adjustments for other risk factors, such as age, gender, drinking history and family history of cancer, the interactions between the HSP70-1 and HSP70-hom genotypes and smoking were confirmed [I(AB), 2.56 and 5.12, respectively].", "section": "abstract", "t_start": 151, "d_end": 181, "d_start": 175, "t_end": 159}, {"text": "In addition, smoking along with HSP70-1 G+190C and HSP70-hom T+2437C, may increase the risk of lung cancer.", "section": "abstract", "t_start": 51, "d_end": 19, "d_start": 13, "t_end": 59}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10800000000000001}, "type": "literature", "id": "cb649c6780f2b0c60db33b2800ef8746"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21097530"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21097530", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21097530", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21097530", "mined_sentences": [{"text": "Stratification by smoking and age (<40 and \u226540 years) showed that the effect of the GSTT1 null and EPHX1 high activity genotypes only concerned (older) smokers, in agreement with the roles of the respective enzymes in detoxification and metabolic activation.", "section": "abstract", "t_start": 99, "d_end": 24, "d_start": 18, "t_end": 103}, {"text": "In conclusion, polymorphisms of GSTT1, EPHX1, MTHFR, MTR and NAT2 differentially affect the frequency of CTAs, CSAs and CTGs, showing interaction with smoking and age.", "section": "abstract", "t_start": 39, "d_end": 157, "d_start": 151, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10800000000000001}, "type": "literature", "id": "24290b2bab1054e08a77498c9667ce40"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25933618"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100", "EFO_1000783"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000783", "label": "diabetic neuropathy"}, "name": ["diabetic neuropathy"], "id": "EFO_1000783"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25933618", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000783", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25933618", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25933618", "mined_sentences": [{"text": "Oxidative stress and microvascular damage have been implicated in the pathogenesis of diabetic neuropathy, with manganese superoxide dismutase 2 (SOD2) responsible for superoxide detoxification in mitochondria.", "section": "abstract", "t_start": 146, "d_end": 104, "d_start": 86, "t_end": 149}, {"text": "Whether cutaneous SOD2 levels can predict the development of diabetic neuropathy remains to be determined in prospective studies.", "section": "abstract", "t_start": 18, "d_end": 79, "d_start": 61, "t_end": 21}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10800000000000001}, "type": "literature", "id": "35850054a8888fa336b80d7207a2c057"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21182888"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000677", "label": "mental or behavioural disorder"}, "name": ["psychoses"], "id": "EFO_0000677"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21182888", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000677", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21182888", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21182888", "mined_sentences": [{"text": "Development-dependent, tissue-specific expression of the calreticulin (CALR) gene in the gray matter coincides with the expression of psychoses phenotypes.", "section": "abstract", "t_start": 71, "d_end": 142, "d_start": 134, "t_end": 74}, {"text": "We propose that CALR is not only a promising candidate in the spectrum of psychoses, but also, a gene that may be important in the human-unique brain processes.", "section": "abstract", "t_start": 16, "d_end": 82, "d_start": 74, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.106}, "type": "literature", "id": "96d1c868d32dd659be609c4e62712880"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27275382"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000677", "label": "mental or behavioural disorder"}, "name": ["psychiatric disorders"], "id": "EFO_0000677"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27275382", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000677", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27275382", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27275382", "mined_sentences": [{"text": "We have previously reported low frequency mutations in the proximal promoter of the human calreticulin (CALR) gene that co-occur with the spectrum of major psychiatric disorders.", "section": "abstract", "t_start": 104, "d_end": 176, "d_start": 156, "t_end": 107}, {"text": "We conclude that deviation from normalcy in the level of CALR in either direction is associated with major psychiatric disorders.", "section": "abstract", "t_start": 57, "d_end": 127, "d_start": 107, "t_end": 60}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.106}, "type": "literature", "id": "04e6364eb0e4068c30bbce243552df22"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20858900"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20858900", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20858900", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20858900", "mined_sentences": [{"text": "In vitro, both Dm-HSP67Bc and human HSPB8 protected against mutated ataxin-3-mediated toxicity and decreased the aggregation of a mutated form of HSPB1 (P182L-HSPB1) associated with peripheral neuropathy.", "section": "abstract", "t_start": 146, "d_end": 202, "d_start": 182, "t_end": 150}, {"text": "The K141E and K141N mutated forms of human HSPB8 that are associated with peripheral neuropathy were significantly less efficient than wild-type HSPB8 in decreasing the aggregation of both mutated ataxin 3 and P182L-HSPB1.", "section": "abstract", "t_start": 216, "d_end": 94, "d_start": 74, "t_end": 220}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.106}, "type": "literature", "id": "005c470651c88443bc46cfcc1a9cb5c2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23065639"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastomas"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23065639", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23065639", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23065639", "mined_sentences": [{"text": "Furthermore, analysis of a large collection of primary human medulloblastomas revealed that tumours with a BMI1(high) TP53(low) molecular profile are significantly enriched in Group 4 human medulloblastomas.", "section": "abstract", "t_start": 107, "d_end": 76, "d_start": 61, "t_end": 110}, {"text": "Importantly, Bmi1 overexpression at the GCP stage does not induce tumour formation, suggesting that BMI1 overexpression in GCP-derived human medulloblastomas probably occurs during later stages of oncogenesis and might serve to enhance tumour cell survival.", "section": "abstract", "t_start": 100, "d_end": 156, "d_start": 141, "t_end": 103}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.106}, "type": "literature", "id": "97e3e62803cccf86fcfcc343f0ef4e49"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11496103"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11496103", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11496103", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11496103", "mined_sentences": [{"text": "Seventy-seven cases of ALS were screened for mutations in the manganese superoxide dismutase gene (SOD2).", "section": "abstract", "t_start": 99, "d_end": 25, "d_start": 23, "t_end": 102}, {"text": "We therefore conclude that mutations in SOD2 do not appear to cause ALS.", "section": "abstract", "t_start": 40, "d_end": 70, "d_start": 68, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.106}, "type": "literature", "id": "79a6db1d43693e6ee6ba1ac1047be553"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23372645"}]}, "target": {"id": "ENSG00000111961", "gene_info": {"symbol": "SASH1", "name": "SAM and SH3 domain containing 1", "geneid": "ENSG00000111961"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23372645", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O94885"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23372645", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23372645", "mined_sentences": [{"text": "SASH1 showed the strongest association to smoking and PPARG the strongest association to plaques.", "section": "abstract", "t_start": 0, "d_end": 48, "d_start": 42, "t_end": 4}, {"text": "Modules containing SASH1 and PPARG did not show evidence for the \"smoking\u2192gene expression\u2192plaques\" causality model.", "section": "abstract", "t_start": 19, "d_end": 72, "d_start": 66, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "dedc7475c934702b8fcbb93ac3942f84"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12975295"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12975295", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12975295", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12975295", "mined_sentences": [{"text": "Autosomal dominant PEO is caused by mutations in at least 3 genes: adenine nucleotide translocator-1 (ANT1), encoding the muscle-specific adenine nucleotide translocator; chromosome 10 open reading frame 2 (C10orf2), encoding Twinkle helicase; and polymerase gamma (POLG), encoding the alpha subunit of polymerase gamma.", "section": "abstract", "t_start": 207, "d_end": 21, "d_start": 19, "t_end": 213}, {"text": "To further investigate the frequency and genotype-phenotype correlations of mutations in the POLG gene, we used single-stranded conformational polymorphism analysis and direct sequencing to screen 30 patients with familial or sporadic PEO and multiple mitochondrial DNA deletions in muscle but without mutations in ANT1 and C10orf2.", "section": "abstract", "t_start": 324, "d_end": 237, "d_start": 235, "t_end": 330}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "fe893eb5e3b57e431589dd9062f03736"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25813534"}]}, "target": {"id": "ENSG00000073350", "gene_info": {"symbol": "LLGL2", "name": "LLGL2, scribble cell polarity complex component", "geneid": "ENSG00000073350"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25813534", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q6P1M3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25813534", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25813534", "mined_sentences": [{"text": "Longitudinal analysis with a generalized estimating equation and with adjustment for age, gender, body mass index and smoking status revealed that rs2116519 of family with sequence similarity 78, member B (FAM78B; P=0.0266), rs6929846 of butyrophilin, subfamily 2, member A1 (BTN2A1; P=0.0013), rs146021107 of pancreatic and duodenal homeobox 1 (PDX1; P=0.0031) and rs1671021 of lethal giant larvae homolog 2 (Drosophila) (LLGL2; P=0.0372) were significantly (P<0.05) associated with the prevalence of hypertension.", "section": "abstract", "t_start": 423, "d_end": 124, "d_start": 118, "t_end": 427}, {"text": "Longitudinal analysis with a generalized linear mixed-effect model and with adjustment for age, gender, body mass index and smoking status among individuals not taking anti-hypertensive medication revealed that rs6929846 of BTN2A1 was significantly associated with systolic (P=0.0017), diastolic (P=0.0008) and mean (P=0.0005) BP, and that rs2116519 of FAM78B, rs146021107 of PDX1 and rs1671021 of LLGL2 were significantly associated with diastolic (P=0.0495), systolic (P=0.0132), and both diastolic (P=0.0468) and mean (0.0471) BP, respectively.", "section": "abstract", "t_start": 398, "d_end": 130, "d_start": 124, "t_end": 402}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "b586e03cc6ca8a3537c2c9d55aa513ee"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24260161"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24260161", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24260161", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24260161", "mined_sentences": [{"text": "We found positive interaction odds ratios (ORs) for both maternal and paternal smoking during pregnancy, EPHX1 H139R, and childhood brain tumors (P(interaction)\u200a=\u200a0.02; 0.10), such that children with the high-risk (greater PAH activation) genotype were at a higher risk of brain tumors relative to children with the low-risk genotype when exposed to tobacco smoke during pregnancy.", "section": "abstract", "t_start": 105, "d_end": 85, "d_start": 79, "t_end": 109}, {"text": "A dose-response pattern for paternal smoking was observed among children with the EPHX1 H139R high-risk genotype only (OR(no exposure)\u200a=\u200a1.0; OR(\u22643 hours/day)\u200a=\u200a1.32, 95% CI: 0.52-3.34; OR(>3 hours/day\u200a)=\u200a3.18, 95% CI: 0.92-11.0; P(trend\u200a)=\u200a0.07).", "section": "abstract", "t_start": 82, "d_end": 43, "d_start": 37, "t_end": 86}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "4bd119cb60d047bc48216a1a3b9c7d4b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15654505"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15654505", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15654505", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15654505", "mined_sentences": [{"text": "The P values of odds ratios to habitual smoking for CYP17A1, ESR1, EPHX1, GSTT2, ALDH2, NOS2A, OGG1, and SLC6A4 and those of odds ratios to habitual drinking for CYP1B1, ESR1, HSD17B3, GSTM3, COMT, ADH1C, ALDH2, NOS3, and NUDT1 were under 0.05.", "section": "abstract", "t_start": 67, "d_end": 46, "d_start": 40, "t_end": 71}, {"text": "In the final model, the only significant variables selected for smoking were OGG1, SLC6A4, EPHX1, ESR1, and CYP17A1, and for drinking, ALDH2 and NUDT1.", "section": "abstract", "t_start": 91, "d_end": 70, "d_start": 64, "t_end": 95}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "ff954d3afcace81e619fe87f287b366e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21301859"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21301859", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21301859", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21301859", "mined_sentences": [{"text": "Mutations in the progressive external ophthalmoplegia 1 (PEO1), adenine nucleotide translocator 1 (ANT1) and DNA polymerase gamma (POLG) genes were reported in patients with progressive external ophthalmoplegia and parkinsonism.", "section": "abstract", "t_start": 57, "d_end": 52, "d_start": 17, "t_end": 60}, {"text": "In order to define the molecular basis of progressive external ophthalmoplegia and parkinsonism, we screened for mutations in PEO1, ANT1, POLG genes and the whole mitochondrial genome in two families.", "section": "abstract", "t_start": 126, "d_end": 77, "d_start": 42, "t_end": 129}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "3024b1e0ef9967e72c551c19d4e4963a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26754576"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26754576", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26754576", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26754576", "mined_sentences": [{"text": "939.3\u2009\u00b1\u200910.70.499\u2003LDL cholesterol (mg/dl)118.2\u2009\u00b1\u200944.5119.0\u2009\u00b1\u200945.4112.0\u2009\u00b1\u200939.40.470\u2003Total cholesterol (mg/dl)189.4\u2009\u00b1\u200958.9188.8\u2009\u00b1\u200953.4179.6\u2009\u00b1\u200947.50.350*Adjusted for age, sex, cigarette smoking, and body mass index (BMI)Data are presented as mean\u2009\u00b1\u2009SDCAD, Coronary artery disease; SCARB1, scavenger receptor class B type 1", "section": "results", "t_start": 278, "d_end": 189, "d_start": 173, "t_end": 283}, {"text": "When data were analyzed separately for men or women, SCARB1 (rs5888) TT genotype as compared to CC genotype was associated with increased odds of PCAD in women (adjusted OR\u2009=\u20092.1, 95\u00a0% CI\u2009=\u20091.2 to 4.0; p\u2009=\u20090.014), but not in men (adjusted OR\u2009=\u20091.3, 95\u00a0% CI\u2009=\u20090.7 to 2.5; p\u2009=\u20090.336).Table 5Unadjusted and adjusted odds ratios for the effect of rs5888 genotypes on premature coronary artery disease in whole and in men and women separatelyUnadjustedAdjusted*rs5888 (C\u2009>\u2009T)Odds ratio (95\u00a0% CI) p-valueOdds ratio (95\u00a0% CI) p-valueAll participants0.1640.046\u2003CC1.0 (Ref.)-1.0 (Ref.)\u2013\u2003CT1.1 (0.9 to 1.5)0.4481.2 (0.9 to 1.6)0.204\u2003TT1.4 (1.0 to 2.1)0.0581.7 (1.1 to 2.6)0.013\u2003CT\u2009+\u2009TT1.2 (0.9 to 1.5)0.2141.3 (1.0 to 1.7)0.077\u2003Allele T vs. C1.2 (1.0 to 1.4)0.0821.3 (1.0 to 1.5)0.020Male sex0.7810.583\u2003CC1.0 (Ref.)\u20131.0 (Ref.)\u2013\u2003CT1.0 (0.7 to 1.5)0.8741.2 (0.8 to 1.8)0.448\u2003TT1.2 (0.7 to 2.1)0.4911.3 (0.7 to 2.5)0.336\u2003CT\u2009+\u2009TT1.1 (0.7 to 1.6)0.7151.2 (0.8 to 1.9)0.348\u2003Allele T vs. C1.1 (0.8 to 1.4)0.5441.2 (0.9 to 1.5)0.311Female sex0.1460.044\u2003CC1.0 (Ref.)\u20131.0 (Ref.)\u2013\u2003CT1.2 (0.8 to 1.7)0.3541.1 (0.7 to 1.8)0.551\u2003TT1.7 (1.0 to 2.9)0.0502.1 (1.2 to 4.0)0.014\u2003CT\u2009+\u2009TT1.3 (0.9 to 1.8)0.1671.3 (0.9 to 2.0)0.202\u2003Allele T vs. C1.2 (1.0 to 1.6)0.0701.3 (1.0 to 1.8)0.037*Adjusted for diabetes, hypertension, cigarette smoking, opium addiction, BMI, and family history of CAD as well as triglyceride, HDL-C, and LDL-CCAD, coronary artery disease; BMI, body mass index; CI, confidence interval; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; Ref., the reference category", "section": "results", "t_start": 53, "d_end": 1310, "d_start": 1294, "t_end": 58}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "ee4a4aec20d226b679754cefed42d5df"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23546289"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23546289", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23546289", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23546289", "mined_sentences": [{"text": "In the present study, we examined the involvement of changes in small heat shock proteins (HSPs) such as HSPB1, HSPB5 and HSPB8 in mitochondrial dysfunction of the failing heart.", "section": "abstract", "t_start": 105, "d_end": 94, "d_start": 91, "t_end": 109}, {"text": "In the failing heart, HSPB1 and HSPB8 contents and phosphorylated small HSP contents in the mitochondrial fraction were decreased, suggesting that a reduction in mitochondrial translocation of these small HSPs led to impaired mitochondrial energy-producing ability.", "section": "abstract", "t_start": 22, "d_end": 208, "d_start": 205, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "bc0b1c885d82eb31ff093acea672b764"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23805041"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataracts"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23805041", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23805041", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23805041", "mined_sentences": [{"text": "Therefore, the present study focused on quantitative relationships of SOD2, ALDH1A1, and MGST1 messenger ribonucleic acid (mRNA) levels between patients presenting with cataracts with and without PEX.", "section": "introduction_and_background", "t_start": 70, "d_end": 177, "d_start": 169, "t_end": 73}, {"text": "In the ALCs, the SOD2 mRNA copies/\u00b5g of total RNA was about ninefold higher in the patients with PEX and cataract (median=23,288 mRNA copies/\u00b5g of total RNA) compared to the control cataract group (median=2,600 mRNA copies/\u00b5g of total RNA), and statistical significance was found (p=0.0015, Mann\u2013Whitney U test; Figure 1A).", "section": "results", "t_start": 17, "d_end": 112, "d_start": 105, "t_end": 20}, {"text": "Our results revealed statistically significant higher mRNA levels of SOD2, ALDH1A1, and MGST1 in the ALCs of patients with PEX and cataract compared to the control cataract subjects suggesting that the pathways for regulating and responding to oxidative stress were present and transcriptionally responsive.", "section": "discussion", "t_start": 69, "d_end": 138, "d_start": 131, "t_end": 72}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "de50ed91f3ef48130d0c41edabfb7735"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11879807"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease", "genetic disorder"], "codes": ["EFO_0003966", "EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183521", "Orphanet_307058", "Orphanet_306708", "Orphanet_683"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_1000631", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "Orphanet_307058", "Orphanet_306708", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_683", "label": "Progressive supranuclear palsy"}, "name": ["PSP"], "id": "Orphanet_683"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11879807", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_683", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11879807", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11879807", "mined_sentences": [{"text": "Marked increases in SOD1 (Cu/ZnSOD) activity and glutathione levels were measured within most PSP brain regions examined, whereas, only the subthalamic nucleus exhibited a significant increase (+68%) in SOD2 (MnSOD) activity.", "section": "abstract", "t_start": 203, "d_end": 96, "d_start": 94, "t_end": 206}, {"text": "Immunolocalization of the SOD1 and SOD2 proteins in paraffin-embedded tissue sections revealed a marked increase in the density of SOD immunopositive profiles (particularly glia) in the typical PSP brain, particularly within the white matter.", "section": "abstract", "t_start": 35, "d_end": 196, "d_start": 194, "t_end": 38}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "ac7c10daf86d6b74aed27e03b2524061"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15029199"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastomas"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15029199", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15029199", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15029199", "mined_sentences": [{"text": "We also demonstrate linked overexpression of BMI1 and patched (PTCH), suggestive of SHH pathway activation, in a substantial fraction of primary human medulloblastomas.", "section": "abstract", "t_start": 45, "d_end": 166, "d_start": 151, "t_end": 48}, {"text": "Together with the rapid induction of Bmi1 expression on addition of Shh or on overexpression of the Shh target Gli1 in cerebellar granule cell cultures, these findings implicate BMI1 overexpression as an alternative or additive mechanism in the pathogenesis of medulloblastomas, and highlight a role for Bmi1-containing polycomb complexes in proliferation of cerebellar precursor cells.", "section": "abstract", "t_start": 178, "d_end": 276, "d_start": 261, "t_end": 181}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "44602e54387e44677b2ee19d0ee9ed2c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8630119"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8630119", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8630119", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8630119", "mined_sentences": [{"text": "To study antibodies directed against ribosomal P proteins, a sensitive and specific marker of depression and psychosis in systemic lupus erythematosus (SLE), in pediatric patients with SLE.", "section": "abstract", "t_start": 47, "d_end": 117, "d_start": 109, "t_end": 56}, {"text": "Elevated serum levels of antibodies to ribosomal P protein can distinguish SLE-associated psychosis from primary psychosis of childhood.", "section": "abstract", "t_start": 49, "d_end": 98, "d_start": 90, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.10400000000000001}, "type": "literature", "id": "d698847ae1bc482d2e5fcee585a03104"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22779044"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003829"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003829", "label": "alcohol dependence"}, "name": ["alcoholism"], "id": "EFO_0003829"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22779044", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003829", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22779044", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22779044", "mined_sentences": [{"text": "For example, a number of genes had already been found by other studies to be associated with the context of alcoholism, including PTGDS (P < 10\u221215), the gene with the lowest p-value; MIF (P < 10\u221213); BRCA1 (P <10\u221213); IL4 (P < 10\u22127); and the three types of peroxisome proliferator-activated receptor genes (PPARs), PPARA (P < 10\u221215), PPARD (P < 10\u221215), and PPARG (P < 10\u22125). PTGDS codes for prostaglandin D2 synthase, which is negatively correlated with alcohol intake48.", "section": "results", "t_start": 334, "d_end": 117, "d_start": 108, "t_end": 338}, {"text": "Similar to the case of the context \u201calcoholism,\u201d the proposed method identified as significant a promising mix of already-corroborated and potentially-related genes for the context \u201cobesity.\u201d For instance, TGFB1 (P < 10\u22127), a tissue growth factor that regulates proliferation, migration, and differentiation of diverse cells, is linked to abdominal obesity and insulin and glucose imbalance62. PPARD (P < 10\u22127) activates other genes that direct fatty acid catabolism and thermogenesis; underexpression of PPARD results in obesity63, while PPARD agonists mimic exercise and make promising targets for treatment of metabolic syndromes63\u201365. UBB (P < 10\u22126) is one of several genes that codes for ubiquitin, a protein-recycling regulator involved in lipid metabolism and whose levels are inversely associated with BMI66.", "section": "results", "t_start": 394, "d_end": 45, "d_start": 36, "t_end": 398}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "ff9430629e2169ed778de56102340772"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25560755"}]}, "target": {"id": "ENSG00000110955", "gene_info": {"symbol": "ATP5B", "name": "ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide", "geneid": "ENSG00000110955"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25560755", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P06576"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25560755", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25560755", "mined_sentences": [{"text": "For each layer, 5 transcripts (ATP5C1, FBXW7, UCHL5, SDHB and UQCRQ for layer 3; ATP5B, COPS4, MRPL33, NDUFB2 and PSMB4 for layer 5) that displayed significantly lower expression in schizophrenia subjects by microarray and by qPCR were selected.", "section": "results", "t_start": 81, "d_end": 194, "d_start": 182, "t_end": 85}, {"text": "Consistent with the array results, the mean expression levels of ATP5C1, UQCRQ, COX4I1, IDH3B, SDHB, FBXW7 and UCHL5 in layer 3 pyramidal cells and of ATP5B, NDUFB2, MRPL33, COPS4 and PSMB4 in layer 5 pyramidal cells were significantly lower in the schizophrenia subjects (Table 3); in addition, qPCR and microarray results were significantly correlated across subjects (Table 3).", "section": "results", "t_start": 151, "d_end": 261, "d_start": 249, "t_end": 155}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "a2e25a6afa6ade0323551cbe9562324b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23259001"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0004698"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004698", "label": "insomnia"}, "name": ["insomnia"], "id": "EFO_0004698"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23259001", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004698", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23259001", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23259001", "mined_sentences": [{"text": "Danggui (Radix A. sinensis), Chaihu (Radix Bupleuri), and Gancao (Radix Glycyrrhizae) and Shenmen (HT7), Sanyinjiao (SP6), Neiguan (PC6), Zusanli (ST36), Sishencong (EX-HN1), and Baihui (GV20) were the common Chinese herbs and acupoints, respectively, in the combined Chinese herbal medicine and traditional needle acupuncture treatment for insomnia in deficiency of both the heart and spleen, hyperactivity of fire due to yin deficiency, and liver-qi stagnation transforming into fire.", "section": "results", "t_start": 132, "d_end": 348, "d_start": 341, "t_end": 134}, {"text": "Sanyinjiao (SP6), Baihui (GV20), Shenmen (HT7), Sishencong (EX-HN1), and Neiguan (PC6) and shenmen, subcortex, heart, kidney, sympathesis, spleen, and liver were the commonly used acupoints and auricular points, respectively, in the combined traditional needle acupuncture and auricular acupressure for insomnia.", "section": "results", "t_start": 82, "d_end": 310, "d_start": 303, "t_end": 84}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "7a643361f0bf20c683054a8fa54d13c7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23874478"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSP"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23874478", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23874478", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23874478", "mined_sentences": [{"text": "The expressions of HSP 70, HSP 90 and HSP 27 in the hearts from mice subjected to ISO or vehicle at 3days,7 days, 14days and 84 days.", "section": "figure", "t_start": 38, "d_end": 21, "d_start": 19, "t_end": 43}, {"text": "Plasma concentrations of HSP 70, HSP 90 and HSP 27 in different stages of heart failure compared with control subjects.", "section": "figure", "t_start": 44, "d_end": 27, "d_start": 25, "t_end": 49}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "0cf247db521c879facf5f5e157eb0732"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22206016"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22206016", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22206016", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22206016", "mined_sentences": [{"text": "*1,000-fold permutation test. **Best models selected with maximum cross-validation consistency (CVC) and maximum testing balance accuracy (TBA). Labels: Smk: smoking, Ex3: EPHX1 Tyr113His, Ex4: EPHX1 His139Arg, SULT: SULT1A1 Arg213His, Tbc: tobacco chewing, Alc: alcohol consumption, 2A: CYP1A1*2A, P1: GSTP1 Ile105Val, 2C: CYP1A1*2C.", "section": "table", "t_start": 172, "d_end": 164, "d_start": 158, "t_end": 176}, {"text": "For a 2-locus interaction, combination of smoking and EPHX1 Tyr113His was most significant with CVC of 10/10 and TBA of 0.6407 (p<0.001).", "section": "other", "t_start": 54, "d_end": 48, "d_start": 42, "t_end": 58}, {"text": "The 3 locus model consisted of smoking, EPHX1 Tyr113His and EPHX1 His139Arg with TBA of 0.6497 (p<0.001) and CVC of 10/10.", "section": "other", "t_start": 40, "d_end": 37, "d_start": 31, "t_end": 44}, {"text": "The 4 loci interaction model of smoking, EPHX1 Tyr113His, EPHX1 His139Arg and SULT1A1 Arg213His, was the best model identified, with maximum CVC (10/10) and TBA (0.6503, p<0.001).", "section": "other", "t_start": 41, "d_end": 38, "d_start": 32, "t_end": 45}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "87b3499dc5da5fed4a95250e1ca714e6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25471284"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25471284", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25471284", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25471284", "mined_sentences": [{"text": "By 24 hours, multiple HSPs were expressed above the fold-change threshold (i.e., HSPA5, HSP90B1, HSPB1, HSPA7, and HSP90AA1; bold in Figure\u00a05).", "section": "results", "t_start": 97, "d_end": 25, "d_start": 22, "t_end": 101}, {"text": "However, all of the transcripts encoding the HSPs which had been up-regulated at Tc,Max were either down-regulated (HSPA5) or below the fold-change threshold, with the exception of HSPB1 (Figure\u00a05).", "section": "results", "t_start": 181, "d_end": 48, "d_start": 45, "t_end": 185}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "18612cc5fd4c77f6992e3795cd497c5d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27124111"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27124111", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27124111", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27124111", "mined_sentences": [{"text": "3 normal and 3 glaucoma donors used (donor cell strains indicated) B. A hypoxic environment (1%O2) was able to induce HIF1\u03b1 expression in NTM cells at both 6 hours and 24 hours.", "section": "figure", "t_start": 138, "d_end": 22, "d_start": 15, "t_end": 140}, {"text": "To determine if hypoxia is one of the drivers of glaucoma in vivo, we subjected NTM cells to a 1%O2 environment to induce hypoxia in the cells for 6 hours and for 24 hours.", "section": "other", "t_start": 80, "d_end": 56, "d_start": 49, "t_end": 82}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "7036ec300fe3d864985a5212026ef6f5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26688829"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26688829", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26688829", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26688829", "mined_sentences": [{"text": "Of the 7 sera and CSF samples with Abs to ribosomal P proteins, these autoantibodies are associated with CNS manifestations such as psychosis (P = 0.017) and PNS mononeuropathy multiplex (P = 0.040).", "section": "results", "t_start": 52, "d_end": 140, "d_start": 132, "t_end": 61}, {"text": "Abs to ribosomal P proteins are associated with psychosis and MM", "section": "table", "t_start": 17, "d_end": 56, "d_start": 48, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 10.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.1}, "type": "literature", "id": "a83d8e701f11d0855d8eea1d3c5fd1aa"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26471271"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["seizure disorder"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26471271", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26471271", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26471271", "mined_sentences": [{"text": "For 14 families maternal samples were available with additional paternal samples for 3 of them (families 2, 24 and 39) and results of parental carrier testing compatible with a de novo mutation for 10 index patients.Fig. 1 a Patient age at onset of the seizure disorder (red) and at genetic diagnosis (blue) with diagnostic latency (black line); b schematic structure of the corresponding Filamin A protein (not to scale) with the two NH2-terminal actin binding calponin homology domains (CHD1-2) and 24 immunoglobulin-like filamin repeat domains interrupted by two hinge regions (red triangles)", "section": "results", "t_start": 389, "d_end": 268, "d_start": 253, "t_end": 397}, {"text": "Identification of the underlying FLNA mutation should prompt inclusion in regular intensified medical care in an epilepsy center as well as cardiovascular surveillance by physicians familiar with the wide phenotypic spectrum of FLNA mutation carriers.", "section": "conclusion_and_future_work", "t_start": 33, "d_end": 120, "d_start": 113, "t_end": 36}, {"text": "Asymptomatic FLNA mutation carriers may have epileptic discharges, but there is currently no evidence, that they may benefit from antiepileptic medication. FLNA-associated seizures may occur at any age, onset during adolescence or in adulthood is not uncommon.", "section": "conclusion_and_future_work", "t_start": 13, "d_end": 53, "d_start": 45, "t_end": 16}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.098}, "type": "literature", "id": "9100c4c5c633e49016fec35243afe719"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26362775"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26362775", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26362775", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26362775", "mined_sentences": [{"text": "Emerging data have demonstrated that peroxisome proliferator-activated receptor \u03b4 (PPAR\u03b4) activation confers a potentially neuroprotective role in some neurodegenerative diseases.", "section": "abstract", "t_start": 83, "d_end": 177, "d_start": 152, "t_end": 87}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.098}, "type": "literature", "id": "3f5a3681c65c40941bf29a362b979eb2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26628385"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_1000845"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000845", "label": "brain edema"}, "name": ["brain edema"], "id": "EFO_1000845"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26628385", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000845", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26628385", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26628385", "mined_sentences": [{"text": "Overexpression of PPAR\u03b2/\u03b4 by adenoviruses treatment significantly ameliorated brain injury with improvement in neurological deficits, brain edema, blood-brain barrier impairment, and neural cell apoptosis at 24 hours after SAH in rats, whereas downregulation of PPAR\u03b2/\u03b4 by small interfering RNAs administration resulted in the reverse effects of the above.", "section": "abstract", "t_start": 18, "d_end": 144, "d_start": 134, "t_end": 22}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.096}, "type": "literature", "id": "e5f50a37ee2d9a3255d3527e9e2b1362"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21289283"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21289283", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21289283", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21289283", "mined_sentences": [{"text": "Western blotting revealed that CHK1 was constitutively phosphorylated at the ataxia telangiectasia response kinase target site Ser345 and the autophosphorylation site Ser296 in neuroblastoma cell lines.", "section": "abstract", "t_start": 31, "d_end": 97, "d_start": 77, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.094}, "type": "literature", "id": "99db38d41569a170b46e836c336d0950"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26592768"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26592768", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26592768", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26592768", "mined_sentences": [{"text": "Activation of ER\u03b1 but not ER\u03b2 increases ADAM9 expression in cultured human neuronal cells, implicating that ER\u03b1-activation functions in the direct mechanism underlying the estrogen-mediated preventative effects against A\u03b2 production and further reduction in the risk of Alzheimer's disease.", "section": "abstract", "t_start": 40, "d_end": 288, "d_start": 270, "t_end": 44}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.094}, "type": "literature", "id": "c24b4c108a6cb957760e6f74b807a45d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15921884"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15921884", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15921884", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15921884", "mined_sentences": [{"text": "Therefore, this PTZ-model of repeated seizure activity exhibited a cortical pattern of HSP-27 expression which is most comparable to that known from patients with epilepsy.", "section": "abstract", "t_start": 87, "d_end": 170, "d_start": 163, "t_end": 92}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.094}, "type": "literature", "id": "d13fad90d81ecafaf6d085be42f309e2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24142626"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["Ataxia Telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24142626", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24142626", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24142626", "mined_sentences": [{"text": "The ATR-CHEK1 pathway is upregulated and overactivated in Ataxia Telangiectasia (AT) cells, which lack functional ATM protein.", "section": "abstract", "t_start": 8, "d_end": 78, "d_start": 58, "t_end": 12}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "0563b8e7d56c154ca0531803be9e3596"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24203089"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathies"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24203089", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24203089", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24203089", "mined_sentences": [{"text": "Calretinin (CALR) is often used as an immunohistochemical marker for the histopathological diagnosis of human intestinal neuropathies.", "section": "abstract", "t_start": 12, "d_end": 132, "d_start": 121, "t_end": 15}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "b0e367d57b1383047fcdb570ddfe82c2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23990930"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23990930", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23990930", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23990930", "mined_sentences": [{"text": "Many HSPs are increased to protect against stress in disease states [13] however in the present study HSP 27 was reduced.", "section": "discussion", "t_start": 102, "d_end": 8, "d_start": 5, "t_end": 107}, {"text": "Wataba et al [16] showed that HSP 27 and 70 were increased in syncytial knots, avascular villi and the presence of thrombus whereas both were reduced in the presence of infarction suggesting different stresses evoke different responses in HSPs in the placenta and the response may very depending on the area of the placenta exposed to the stress.", "section": "discussion", "t_start": 30, "d_end": 242, "d_start": 239, "t_end": 35}, {"text": "Since HSP 27 can modulate actin polymerisation one study investigated changes in small HSPs in the myometrium at labor [22].", "section": "discussion", "t_start": 6, "d_end": 90, "d_start": 87, "t_end": 11}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "70a8608adfee2c53462ed610aa9eabee"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24898650"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24898650", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24898650", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24898650", "mined_sentences": [{"text": "Upregulation of heat shock proteins, such as Hsp70 and HspB1/Hsp27, have been associated with an amelioration of the deficits in animal models of Alzheimer's disease (AD).", "section": "abstract", "t_start": 55, "d_end": 164, "d_start": 146, "t_end": 59}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "708464f34687636afff73accc1d37537"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24141048"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathies"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24141048", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24141048", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24141048", "mined_sentences": [{"text": "HspB1 is a small heat shock protein implicated in neuronal survival and neurite growth; mutations in HspB1 have been identified in hereditary motor neuronopathies and Charcot Marie Tooth Type 2 neuropathies.", "section": "abstract", "t_start": 0, "d_end": 205, "d_start": 194, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "34533691527e783b1e4f2cd34c994f76"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25913325"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004280"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004280", "label": "movement disorder"}, "name": ["movement disorders"], "id": "EFO_0004280"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25913325", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004280", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25913325", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25913325", "mined_sentences": [{"text": "Importantly, humans with mutation in DCC show mirror movement disorders pointing to the significance of DCC in the development of spinal circuits for coordinated movement.", "section": "abstract", "t_start": 37, "d_end": 70, "d_start": 53, "t_end": 39}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "7bf855567f790e38d29598f0c7f3a0a7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25858624"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["brain glioma"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25858624", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25858624", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25858624", "mined_sentences": [{"text": "The expression of the BMI1 gene in 41 cases of human brain glioma was determined by quantitative real-time PCR.", "section": "abstract", "t_start": 22, "d_end": 64, "d_start": 53, "t_end": 25}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.092}, "type": "literature", "id": "d3cb903f4002b7b23a51e7a16ef2ac82"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20502693"}]}, "target": {"id": "ENSG00000111961", "gene_info": {"symbol": "SASH1", "name": "SAM and SH3 domain containing 1", "geneid": "ENSG00000111961"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20502693", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O94885"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20502693", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20502693", "mined_sentences": [{"text": "The proportion of variability of expression explained by the best cis eSNP varied from 3.1% for CLEC10A to 27.2% for GFRA2 while the proportion explained by smoking varied from 2.8% for SMAD6 to 21.6% for SASH1.", "section": "figure", "t_start": 205, "d_end": 163, "d_start": 157, "t_end": 209}, {"text": "Among the 18 expression traits associated with smoking, SASH1, P2RY6 and PTGDS were systematically retrieved in all screening/validation replicates (Table S3). SASH1 is a tumor suppressor gene [49], P2RY6 encodes a G-protein-coupled receptor involved in the proinflammatory response to UDP in monocytes [50] and PTGDS encodes a prostaglandin D synthase involved in smooth muscle contraction/relaxation and inhibition of platelet aggregation, two functions known to be modified by tobacco consumption.", "section": "other", "t_start": 56, "d_end": 53, "d_start": 47, "t_end": 60}, {"text": "Among the 18 gene expressions independently associated with smoking, four were individually correlated with the number of carotid plaques, PTGDS (P\u200a=\u200a1.8\u00d710\u22127) negatively and MMP25 (P\u200a=\u200a3.5\u00d710\u22124), SASH1 (P\u200a=\u200a1.4\u00d710\u22125) and WWC3 (P\u200a=\u200a6.3\u00d710\u22124) positively (Table 7).", "section": "other", "t_start": 197, "d_end": 66, "d_start": 60, "t_end": 201}, {"text": "In a multivariate model including the four expression traits and smoking, as well as age and gender, PTGDS (P\u200a=\u200a5.7\u00d710\u22124) and SASH1 (P\u200a=\u200a0.012) remained significantly associated with the number of plaques whereas MMP25 (P\u200a=\u200a0.09), WWC3 (P\u200a=\u200a0.10) and smoking (P\u200a=\u200a0.5) were no longer significant, suggesting that the association between smoking and atherosclerosis was mostly reflected (or mediated) by its effect on the expression of these four genes.", "section": "other", "t_start": 126, "d_end": 71, "d_start": 65, "t_end": 130}, {"text": "The fact that PTGDS and SASH1 expression remained associated with carotid plaques after adjustment on smoking status may indicate a broader implication of these genes in atherosclerosis than the sole effect induced by smoking.", "section": "other", "t_start": 24, "d_end": 108, "d_start": 102, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "e32acc19b0927dd077ab110d5d0c3cd8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19773341"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002461", "EFO_0000508"]}, "path": [["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_669", "label": "Otopalatodigital syndrome"}, "name": ["otopalatodigital syndrome"], "id": "Orphanet_669"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19773341", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_669", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19773341", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19773341", "mined_sentences": [{"text": "FLNA missense mutations are associated with the otopalatodigital syndrome (OPD) spectrum of skeletal disorders, clustering in discrete domains.", "section": "abstract", "t_start": 0, "d_end": 72, "d_start": 48, "t_end": 3}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "ca90096a74240b6207d020c2f20b93b0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22040534"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "nervous system disease", "endocrine system disease", "genetic disorder", "skin disease", "metabolic disease", "digestive system disease"], "codes": ["EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0000701", "EFO_0001379", "EFO_0000405", "EFO_0003966"]}, "path": [["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_79226", "Orphanet_79168", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98712", "Orphanet_909"], ["EFO_0001379", "Orphanet_156638", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98712", "Orphanet_909"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_909"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000405", "Orphanet_156601", "Orphanet_101940", "Orphanet_284385", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_156601", "Orphanet_101940", "Orphanet_284385", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_156638", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_79226", "Orphanet_79168", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183484", "Orphanet_909"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183484", "Orphanet_909"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_909"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_909"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_909"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68356", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_98497", "Orphanet_207015", "Orphanet_207018", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_909", "label": "Cerebrotendinous xanthomatosis"}, "name": ["CTX"], "id": "Orphanet_909"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22040534", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_909", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22040534", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22040534", "mined_sentences": [{"text": "We found that, compared to their wild-type littermates, transgenic mice lacking PPAR\u03b4 in the skeletal muscle had a reduced proportion of proliferating myoblasts and that the regenerated fibers were smaller in caliber at both five days and two weeks after CTX injury.", "section": "discussion", "t_start": 80, "d_end": 257, "d_start": 255, "t_end": 84}, {"text": "Defective regeneration of skeletal muscles and gene expression patterns in Ppar\u03b4-cKO mice after injury with cardiotoxin. (A) and (B) Tibialis anterior (TA) muscles from six-week-old wild-type and peroxisome proliferator-activated receptor \u03b4 conditional knockout (Ppar\u03b4-cKOmice were injected with cardiotoxin (CTX) to induce injury.", "section": "figure", "t_start": 196, "d_end": 311, "d_start": 309, "t_end": 239}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "aa0d09a74ba31b2f554c1eef01c58bb9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17564249"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17564249", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17564249", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17564249", "mined_sentences": [{"text": "Microsomal epoxide hydrolase (EPHX1) is an important gene because of its role in the metabolism of components of cigarette smoke; thus it may be an important potential modifier of the risk of developing smoking-related lung disease, such as chronic obstructive pulmonary disease (COPD).", "section": "abstract", "t_start": 30, "d_end": 209, "d_start": 203, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "5dfc50fa26b40e7b18749ffe316240ea"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22928041"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["tobacco smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22928041", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22928041", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22928041", "mined_sentences": [{"text": "Microsomal epoxide hydrolase (EPHX1) plays an important role in both the activation and detoxification of PAHs, which are carcinogens found in cooked meat and tobacco smoking.", "section": "abstract", "t_start": 30, "d_end": 173, "d_start": 159, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "b879df47bd7903b2ad467ad4e4dd07e9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15571513"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15571513", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15571513", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15571513", "mined_sentences": [{"text": "HSP-27 was highly expressed in all epilepsy specimens and in the cortex of a patient who died in the final stage of multiple sclerosis (positive control), whereas only low amounts of HSP-27 were detectable in control brains.", "section": "abstract", "t_start": 0, "d_end": 133, "d_start": 116, "t_end": 5}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "9e33fca63213f51331b5f96e15adf66d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22516022"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100", "EFO_1000783"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000783", "label": "diabetic neuropathy"}, "name": ["diabetic neuropathy"], "id": "EFO_1000783"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22516022", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000783", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22516022", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22516022", "mined_sentences": [{"text": "A specific peripheral nervous system-targeting construct is required to examine the consequences of SOD2 knockout in diabetic neuropathy.", "section": "abstract", "t_start": 100, "d_end": 135, "d_start": 117, "t_end": 103}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "09f3ab1da97193e33e9bb561df4f5631"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22516022"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22516022", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22516022", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22516022", "mined_sentences": [{"text": "We hypothesized that targeted SOD2 deletion in the peripheral nervous system using cre-lox technology under control of the nestin promoter would accelerate neuropathy in a type 2 model of diabetes, the BKS.db/db mouse.", "section": "abstract", "t_start": 30, "d_end": 165, "d_start": 156, "t_end": 33}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 9.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.09}, "type": "literature", "id": "fffb70ecc591f87781ee4f2c51b08ea2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23585889"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23585889", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23585889", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23585889", "mined_sentences": [{"text": "These findings indicate that the interaction of calreticulin with amyloid precursor protein and the \u03b3-secretase complex regulates the proteolytic processing of amyloid precursor protein by the \u03b3-secretase complex, pointing to calreticulin as a potential target for therapy in Alzheimer's disease.", "section": "abstract", "t_start": 48, "d_end": 294, "d_start": 276, "t_end": 59}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08800000000000001}, "type": "literature", "id": "a27780e3870d8e50dcf78ca0df2e5bc0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25139876"}]}, "target": {"id": "ENSG00000160305", "gene_info": {"symbol": "DIP2A", "name": "disco interacting protein 2 homolog A", "geneid": "ENSG00000160305"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "cardiovascular disease"], "codes": ["EFO_0000618", "EFO_0000319"]}, "path": [["EFO_0000319", "EFO_0004264", "EFO_0003763", "EFO_0004277"], ["EFO_0000618", "EFO_0005774", "EFO_0004277"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004277", "label": "brain infarction"}, "name": ["brain infarction"], "id": "EFO_0004277"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25139876", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004277", "target": "http://identifiers.org/uniprot/Q14689"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25139876", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25139876", "mined_sentences": [{"text": "Recombinant FSTL1 reduced brain infarction and improved neurological deficits 24 and 72 hours after MCAO via activation of its receptor DIP2A and downstream phosphorylation of Akt.", "section": "abstract", "t_start": 136, "d_end": 41, "d_start": 26, "t_end": 140}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08800000000000001}, "type": "literature", "id": "6792d640a52255bc393e32053bad2724"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20888935"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002461", "EFO_0000508"]}, "path": [["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_669", "label": "Otopalatodigital syndrome"}, "name": ["otopalatodigital syndrome"], "id": "Orphanet_669"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20888935", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_669", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20888935", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20888935", "mined_sentences": [{"text": "High phenotypic diversity, ranging from PH to otopalatodigital syndrome and frontometaphyseal dysplasia has been described in association with FLNA mutations.", "section": "abstract", "t_start": 143, "d_end": 70, "d_start": 46, "t_end": 146}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "b83c7ff4ec100b9271f01e11ccde5073"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23950959"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataracts"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23950959", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23950959", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23950959", "mined_sentences": [{"text": "We have analyzed the cellular consequences of the stable expression of either wild type HspB5 or its cataracts and myopathies inducing R120G mutant in growing and oxidative stress treated HeLa cells that originally express only HspB1.", "section": "abstract", "t_start": 228, "d_end": 109, "d_start": 101, "t_end": 232}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "720525d943d529c617b4b095d7a92cbb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15730872"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15730872", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15730872", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15730872", "mined_sentences": [{"text": "In particular, a recent report that DCC is regulated through the ubiquitin-proteosome system via Siah/Sina proteins, is consistent with a potential involvement in genetic and sporadic forms of Parkinson's disease.", "section": "abstract", "t_start": 36, "d_end": 211, "d_start": 193, "t_end": 38}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "8ac84061419215cee236d9820881d114"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22521462"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22521462", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22521462", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22521462", "mined_sentences": [{"text": "These observations suggest that overexpression of HSPB1(R136W) in neurons is sufficient to cause pathological and electrophysiological changes in mice that are seen in patients with hereditary motor neuropathy.", "section": "abstract", "t_start": 50, "d_end": 208, "d_start": 199, "t_end": 54}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "2c2228742240f2e250948289759c2ae1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23291093"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23291093", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23291093", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23291093", "mined_sentences": [{"text": "We report that DCC is enriched in dendritic spines of pyramidal neurons in wild-type mice, and we demonstrate that selective deletion of DCC from neurons in the adult forebrain results in the loss of long-term potentiation (LTP), intact long-term depression, shorter dendritic spines, and impaired spatial and recognition memory.", "section": "abstract", "t_start": 15, "d_end": 256, "d_start": 247, "t_end": 17}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "bc86b6b334924b44b0c923d54054b7ae"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22521462"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0003782"], ["EFO_0000618", "EFO_0003782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003782", "label": "motor neuron disease"}, "name": ["motor neuron disease"], "id": "EFO_0003782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22521462", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003782", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22521462", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22521462", "mined_sentences": [{"text": "The small heat shock protein HSPB1 is a multifunctional, \u03b1-crystallin-based protein that has been shown to be neuroprotective in animal models of motor neuron disease and peripheral nerve injury.", "section": "abstract", "t_start": 29, "d_end": 165, "d_start": 146, "t_end": 33}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "07995bbe8a8f82b8c1fcd71c9905bb5f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17623484"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0003782"], ["EFO_0000618", "EFO_0003782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003782", "label": "motor neuron disease"}, "name": ["motor neuron disease"], "id": "EFO_0003782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17623484", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003782", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17623484", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17623484", "mined_sentences": [{"text": "Therefore, our study suggests that the functional HSPB1 variant may represent a genetic modifier in the pathogenesis of motor neuron disease; however, it is necessary to confirm this HSPB1 variant in additional ALS patients.", "section": "abstract", "t_start": 50, "d_end": 139, "d_start": 120, "t_end": 54}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "ace6bd253c5df0e3826bcd534922db27"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25155585"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["malignant glioma"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25155585", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25155585", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25155585", "mined_sentences": [{"text": "With the aim to better understand the resistance/susceptibility processes associated to temozolomide (TMZ) treatment, the current study was performed in three human malignant glioma cell lines by focusing on several levels: (a) apoptotic index and senescence, (b) DNA damage, and (c) interaction of HSPB1 with players of the DNA damage response.", "section": "abstract", "t_start": 299, "d_end": 180, "d_start": 165, "t_end": 303}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "33cf6f65576fa4008c500209a814a168"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8979274"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8979274", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8979274", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8979274", "mined_sentences": [{"text": "Although alpha B-crystallin is thought to be one of the small HSPs, the distribution of HSP28 in the lenses of human embryos was different from that of alpha B-crystallin which we previously reported.", "section": "abstract", "t_start": 88, "d_end": 65, "d_start": 62, "t_end": 92}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "26fc17b0cd3b4ffbb64087d7cc678cd2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25389776"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25389776", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25389776", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25389776", "mined_sentences": [{"text": "Manipulation of these signaling molecules and the related NTM signal transduction pathways may provide targets for developing improved treatments for glaucoma.", "section": "abstract", "t_start": 58, "d_end": 157, "d_start": 150, "t_end": 60}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "c2836db2361a18dde6ab607eeb944d6d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25526772"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["malignant gliomas"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25526772", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25526772", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25526772", "mined_sentences": [{"text": "Elevated expression of BMI1 mRNA in pediatric malignant gliomas", "section": "results", "t_start": 23, "d_end": 62, "d_start": 46, "t_end": 26}, {"text": "In summary, we demonstrated that BMI1 is over-expressed in pediatric gliomas, particularly in high-grade malignant gliomas, in both CD133+ and CD133\u2212 cells; and silencing this gene with lentivirus-mediated shRNA led to elimination of the tumor-forming capacity, particularly of CD133+ tumor cells, in vivo in two independent and patient-specific PDOX mouse models, thereby supporting the development of new targeted therapies against BMI1 in pGBM.", "section": "conclusion_and_future_work", "t_start": 33, "d_end": 121, "d_start": 105, "t_end": 36}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "0bfce430cffd7b26c621a7531da716bf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25372290"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25372290", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25372290", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25372290", "mined_sentences": [{"text": "Our results showed that the SOD2 Val16Ala polymorphism has an impact on the relationship between VPA exposure and \u03b3-GT elevation in patients with epilepsy.", "section": "abstract", "t_start": 28, "d_end": 153, "d_start": 146, "t_end": 31}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.086}, "type": "literature", "id": "52b81d2c2303f3e29feffba12d28813a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21960593"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002461", "EFO_0000508"]}, "path": [["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_669", "label": "Otopalatodigital syndrome"}, "name": ["otopalatodigital syndrome"], "id": "Orphanet_669"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21960593", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_669", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21960593", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21960593", "mined_sentences": [{"text": "Filaminopathies A caused by mutations in the X-linked FLNA gene are responsible for a wide spectrum of rare diseases including 2 main phenotypes, the X-linked dominant form of periventricular nodular heterotopia (FLNA-PVNH) and the otopalatodigital syndrome spectrum of disorders.", "section": "abstract", "t_start": 54, "d_end": 256, "d_start": 232, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "3f95601f29408842964c83d6729ce6a1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25945080"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25945080", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25945080", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25945080", "mined_sentences": [{"text": "\u2191 plasma LDL cholesterol ; the rare variant 5\u2019UTR confers higher PPAR\u03b2/\u03b4 expression\u2193 plasma cholesterol level in Alzheimer's disease subject but not in controls \u2193 plasma HDL concentrations in woman. \u2191 Coronary heart disease \u2191 plasma cholesterol \u2191 and \u2193 body mass index in women and men, respectively. \u2193 and \u2191 HDL cholesterol in women and men, respectively.\u2193 obesity risk in Chinese Han population \u2191 fasting insulin levels and \u2193insulin sensitivity in Polycystic ovary syndrome\u2191 fasting plasma glucose in HGT or diabetic Chinese subject/ impaired insulin sensitivity \u2193 stature in both adults and children Associated with elite-level endurance athletes \u2191 risk of chronic kidney disease", "section": "table", "t_start": 65, "d_end": 131, "d_start": 113, "t_end": 69}, {"text": "Because of the link between cholesterol metabolism and Alzheimer's disease (AD) pathogenesis, Holzapfel et al. [Holzapfel et al., 2006] investigated three frequent polymorphisms located in exons 4 (rs2016520) and 9 (rs3734254 and rs9794) of PPARD for their putative influence on the risk of Alzheimer's disease and on cholesterol, 24S-hydroxycholesterol and 27-hydroxycholesterol plasma levels.", "section": "other", "t_start": 241, "d_end": 73, "d_start": 55, "t_end": 245}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "85ebc70c45d6852b2b14fa52b14d9daf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23507144"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23507144", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23507144", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23507144", "mined_sentences": [{"text": "The role of peroxisome proliferator activator receptor (PPAR)\u03b2/\u03b4 in the pathogenesis of Alzheimer's disease has only recently been explored through the use of PPAR\u03b2/\u03b4 agonists.", "section": "abstract", "t_start": 159, "d_end": 106, "d_start": 88, "t_end": 163}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "9db35d10e8f3fff42f45268dc39696d1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23811400"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23811400", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23811400", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23811400", "mined_sentences": [{"text": "Recently, PPAR\u03b2/\u03b4 activation emerged as the focus of a novel approach for the treatment of a wide range of neurodegenerative diseases.", "section": "abstract", "t_start": 10, "d_end": 132, "d_start": 107, "t_end": 14}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "1d6e16f0297ff8bff8ab6d4b0857edcd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18005074"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18005074", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18005074", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18005074", "mined_sentences": [{"text": "These findings demonstrate that reduced DCC during development results in a behavioural phenotype opposite to that observed in developmental models of schizophrenia and identify DCC as a critical factor in the development of DA function.", "section": "abstract", "t_start": 40, "d_end": 163, "d_start": 151, "t_end": 42}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "3cc3110e7c7477acb68f8d2fc34f7f3a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21670152"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21670152", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21670152", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21670152", "mined_sentences": [{"text": "HspB1, an sHsp commonly associated with senile plaques in Alzheimer's disease (AD), prevents the toxic effects of A\u03b2 aggregates in vitro.", "section": "abstract", "t_start": 0, "d_end": 76, "d_start": 58, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "74aecc1da83d68cb75fb02087f05a028"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23426996"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23426996", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23426996", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23426996", "mined_sentences": [{"text": "Microsomal epoxide hydrolase (EPHX1) is an enzyme involved in the detoxification the products of smoking and is proposed to be a genetic factor for the development of chronic obstructive pulmonary disease (COPD).", "section": "abstract", "t_start": 30, "d_end": 103, "d_start": 97, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "4d26189f0001bbe17ecad4a8fccceea4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11480169"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11480169", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11480169", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11480169", "mined_sentences": [{"text": "In subgroup of passive smoking analysis, the polymorphisms of EPHX1 were highly associted with birthweight for those with passive smoking (beta +/- SE = -234 g +/- 88, P = 0.0088); The significant association of EPHX1 polymorphisms with reduced birthweight were showed for those with working stress (beta +/- SE = -157 g +/- 59, P = 0.0079).", "section": "abstract", "t_start": 62, "d_end": 29, "d_start": 23, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "bcbc0cbc0b651843d6f0b8bc61538318"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20178975"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20178975", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20178975", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20178975", "mined_sentences": [{"text": "Here we investigated the biochemical consequences of HSPB1 mutations that are known to cause peripheral neuropathy.", "section": "abstract", "t_start": 53, "d_end": 113, "d_start": 93, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "0ae0889a81540169a2fa84a5515bbf22"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14519498"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14519498", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14519498", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14519498", "mined_sentences": [{"text": "Human, neuronally committed hNT or NT2-N cells, originally derived from the Ntera2/D1 (NT2) clone after exposure to retinoic acid (RA), represent a potentially important source of cells to treat neurodegenerative diseases.", "section": "abstract", "t_start": 28, "d_end": 220, "d_start": 195, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "36a2987b2c3e6e1720533fb88a4d13eb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17293612"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17293612", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17293612", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17293612", "mined_sentences": [{"text": "Notably, the human ABCG1 gene maps to chromosome 21q22.3, and individuals with Down syndrome (DS) typically manifest with Alzheimer's disease (AD) neuropathology in their 30s.", "section": "abstract", "t_start": 19, "d_end": 140, "d_start": 122, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "be6eb85070c513da143aa4ae7fe1f09a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19239689"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_1001457"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001457", "label": "cognitive disorder"}, "name": ["cognitive deficits"], "id": "EFO_1001457"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19239689", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001457", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19239689", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19239689", "mined_sentences": [{"text": "These findings indicate that although ABCG1 may play a role in maintaining cellular or tissue cholesterol homeostasis, it is unlikely that excess ABCG1 expression contributes to the cognitive deficits in DS individuals.", "section": "abstract", "t_start": 38, "d_end": 199, "d_start": 182, "t_end": 42}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "b6f05680da7e9d54825cef34505bdd2c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12110949"}]}, "target": {"id": "ENSG00000048740", "gene_info": {"symbol": "CELF2", "name": "CUGBP, Elav-like family member 2", "geneid": "ENSG00000048740"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["immune system disease", "endocrine system disease", "genetic disorder", "cardiovascular disease", "nervous system disease", "metabolic disease"], "codes": ["EFO_0000589", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0001379", "EFO_0000319"]}, "path": [["EFO_0000508", "Orphanet_183530", "Orphanet_183539", "Orphanet_93547", "Orphanet_567"], ["EFO_0000319", "EFO_0003777", "Orphanet_98054", "Orphanet_156532", "Orphanet_567"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_331220", "Orphanet_567"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_363294", "Orphanet_138047", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183545", "Orphanet_96346", "Orphanet_117573", "Orphanet_567"], ["EFO_0000508", "Orphanet_98056", "Orphanet_183539", "Orphanet_93547", "Orphanet_567"], ["EFO_0000508", "Orphanet_156638", "Orphanet_183634", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_331220", "Orphanet_567"], ["EFO_0000508", "Orphanet_98054", "Orphanet_156532", "Orphanet_567"], ["EFO_0000508", "Orphanet_68335", "Orphanet_98127", "Orphanet_102020", "Orphanet_98142", "Orphanet_262182", "Orphanet_567"], ["EFO_0000589", "EFO_0005769", "EFO_0005754", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_330197", "Orphanet_567"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_567"], ["EFO_0001379", "Orphanet_156638", "Orphanet_183634", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_363294", "Orphanet_138047", "Orphanet_567"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_567", "label": "22q11.2 deletion syndrome"}, "name": ["DiGeorge syndrome"], "id": "Orphanet_567"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12110949", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_567", "target": "http://identifiers.org/uniprot/O95319"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12110949", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12110949", "mined_sentences": [{"text": "We did not find BRUNOL3 mutations in 92 DiGeorge syndrome-like patients without chromosomal deletions and in 8 parents with congenital heart defect children.", "section": "abstract", "t_start": 16, "d_end": 56, "d_start": 40, "t_end": 22}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "2e5bb7c4a1d8363a598fb792cb843c5e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26727713"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26727713", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26727713", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26727713", "mined_sentences": [{"text": "Interruption of natalizumab (NTM) treatment in multiple sclerosis (MS) patients may be followed by disease reactivation.", "section": "abstract", "t_start": 29, "d_end": 64, "d_start": 47, "t_end": 31}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.084}, "type": "literature", "id": "505d1f567a5498d4a9aa7d76add15f57"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19422681"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19422681", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19422681", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19422681", "mined_sentences": [{"text": "In addition, PPAR-beta agonists were shown to have trophic effects on oligodendrocytes in vitro, and to confer partial protection in experimental autoimmune encephalomyelitis (EAE), an animal model of MS.", "section": "abstract", "t_start": 13, "d_end": 178, "d_start": 176, "t_end": 21}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "7e5bd968e70244a351a7285e84d211f3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16684786"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16684786", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16684786", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16684786", "mined_sentences": [{"text": "Human Filamin A gene (FLNA) mutations are associated with classical X-linked bilateral periventricular nodular heterotopia (PNH), featuring contiguous heterotopic nodules, mega cisterna magna, cardiovascular malformations and epilepsy.", "section": "abstract", "t_start": 22, "d_end": 233, "d_start": 226, "t_end": 25}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "0934a071884011862e414c9083db5194"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22135673"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22135673", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22135673", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22135673", "mined_sentences": [{"text": "Although data regarding PPAR\u03b4 are limited, studies have demonstrated that administration of PPAR\u03b4 agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.", "section": "abstract", "t_start": 24, "d_end": 246, "d_start": 228, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "dd05eba88ade18ef8cac164b2d6791e8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22135673"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22135673", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22135673", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22135673", "mined_sentences": [{"text": "Although data regarding PPAR\u03b4 are limited, studies have demonstrated that administration of PPAR\u03b4 agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.", "section": "abstract", "t_start": 24, "d_end": 221, "d_start": 204, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "f4a9cad3c09f96e7a95d30c14f812c69"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22879602"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["experimental autoimmune encephalomyelitis"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22879602", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22879602", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22879602", "mined_sentences": [{"text": "Furthermore, gemfibrozil treatment also led to the recruitment of PPAR-\u03b2 to the PLP promoter in vivo in the spinal cord of experimental autoimmune encephalomyelitis mice and suppression of experimental autoimmune encephalomyelitis symptoms in PLP-T cell receptor transgenic mice.", "section": "abstract", "t_start": 66, "d_end": 163, "d_start": 123, "t_end": 71}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "3b2463e979dbcf25bc4470710dd27f04"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17167170"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17167170", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17167170", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17167170", "mined_sentences": [{"text": "These results demonstrate that subtype-selective PPARdelta agonists possess antiapoptotic properties in vitro, which may underlie their potential neuroprotective potential in in vivo experimental models of cerebral ischemia and Parkinson's disease (PD).", "section": "abstract", "t_start": 49, "d_end": 246, "d_start": 228, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "4a114c824eb03e02cb9736d82de4b1c3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26864581"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26864581", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26864581", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26864581", "mined_sentences": [{"text": "These results suggest that PPAR\u03b4 activation ameliorates A\u03b21-42-induced hippocampal neurotoxicity, and it might play a crucial role in Alzheimer's disease.", "section": "abstract", "t_start": 27, "d_end": 152, "d_start": 134, "t_end": 31}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "759a331a66f0c8ce83089c5b2af7de0c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17167170"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17167170", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17167170", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17167170", "mined_sentences": [{"text": "These findings suggest that PPARdelta agonists could be useful tools for understanding the role of PPARdelta in other neurodegenerative disorders, as well as attractive therapeutic candidates for stroke and neurodegenerative diseases such as PD.", "section": "abstract", "t_start": 28, "d_end": 232, "d_start": 207, "t_end": 36}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "8a7216ab960a54c358a2b25a27de64b6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21956108"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21956108", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21956108", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21956108", "mined_sentences": [{"text": "Taken together, our results demonstrate that ADAM10 activity is regulated by inhibition of ADAM9, and this regulation may be used to control shedding of amyloid precursor protein by enhancing \u03b1-secretase activity, a key regulatory step in the etiology of Alzheimer disease.", "section": "abstract", "t_start": 91, "d_end": 271, "d_start": 255, "t_end": 95}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "615cad5332c29a41031f54a59291dc64"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21785432"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathies"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21785432", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21785432", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21785432", "mined_sentences": [{"text": "Our findings demonstrate the pathogenic role of \u03b1-tubulin deacetylation in mutant HSPB1-induced neuropathies and offer perspectives for using HDAC6 inhibitors as a therapeutic strategy for hereditary axonopathies.", "section": "abstract", "t_start": 82, "d_end": 107, "d_start": 96, "t_end": 86}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "7704972e1a35f49a33691df654e934d9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24925903"}]}, "target": {"id": "ENSG00000185532", "gene_info": {"symbol": "PRKG1", "name": "protein kinase, cGMP-dependent, type I", "geneid": "ENSG00000185532"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24925903", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q13976"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24925903", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24925903", "mined_sentences": [{"text": "In this way, removal of cGKI could be linked to impaired cerebellar long-term depression at Purkinje cell synapses.", "section": "abstract", "t_start": 24, "d_end": 87, "d_start": 78, "t_end": 27}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "55db4db2add46bd88b4355f66c100524"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23728742"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23728742", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23728742", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23728742", "mined_sentences": [{"text": "Mutations in the small heat shock protein HSPB1 (HSP27) are a cause of axonal Charcot-Marie-Tooth neuropathy (CMT2F) and distal hereditary motor neuropathy.", "section": "abstract", "t_start": 42, "d_end": 107, "d_start": 98, "t_end": 46}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "225152c3ba2994519e56d7b015010cb4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20516053"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20516053", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20516053", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20516053", "mined_sentences": [{"text": "We genotyped participants from the Copenhagen City Heart Study (n = 10,038) and the Copenhagen General Population Study (n = 37,022) for the T113C and A139G variants in the EPHX1 gene and measured lung function and recorded COPD hospitalisation and asthma and smoking history.", "section": "abstract", "t_start": 173, "d_end": 266, "d_start": 260, "t_end": 177}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "05d49726ca240c45a09160c4afa5f6dd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15618730"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15618730", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15618730", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15618730", "mined_sentences": [{"text": "Five novel single nucleotide polymorphisms (SNPs) were found in the EPHX1 gene from 96 Japanese epileptic patients.", "section": "abstract", "t_start": 68, "d_end": 104, "d_start": 96, "t_end": 72}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "699b5babb0a069f29c605d9683cbadb7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20514530"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20514530", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20514530", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20514530", "mined_sentences": [{"text": "While HspB1 shows constitutive expression in some areas of the mammalian retina, of particular interest is the upregulation of the protein in response to ischemia and oxidative stress, traumatic nerve injury, and elevated intraocular pressure and glaucoma.", "section": "abstract", "t_start": 6, "d_end": 254, "d_start": 247, "t_end": 10}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "f0332daed170fadca47fc83f41f7a043"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21228703"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21228703", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21228703", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21228703", "mined_sentences": [{"text": "A possible modification of smoking on microsomal epoxide hydrolase genotypes was found.", "section": "abstract", "t_start": 38, "d_end": 33, "d_start": 27, "t_end": 65}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "b1ef183672f462081d2aae2499d27fa6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10676631"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10676631", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10676631", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10676631", "mined_sentences": [{"text": "Thus, EPHX1 polymorphisms may be one of the factors of importance in susceptibility to smoking-related cancers of the upper aerodigestive tract.", "section": "abstract", "t_start": 6, "d_end": 93, "d_start": 87, "t_end": 10}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "cdf6aec7df7264f4997f07ac6bd32f76"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24013430"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": [], "codes": []}, "path": [["EFO_0000618"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000618", "label": "nervous system disease"}, "name": ["central nervous system disorders"], "id": "EFO_0000618"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24013430", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000618", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24013430", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24013430", "mined_sentences": [{"text": "Since EPHX1 is highly expressed in the liver, can interact with various signaling pathways and is involved in central nervous system disorders, the association of EPHX1 polymorphism with the HELLP syndrome and eclampsia may hint to EPHX being a further key player in the pathogenesis of preeclampsia.", "section": "abstract", "t_start": 232, "d_end": 141, "d_start": 110, "t_end": 235}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "9b8159f4408c503841520f4fb43a065d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18325928"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18325928", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18325928", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18325928", "mined_sentences": [{"text": "We have investigated the distribution of mutations in these seven genes in a cohort of 112 familial and isolated patients with a diagnosis of distal motor neuropathy and found nine different disease-causing mutations in HSPB8, HSPB1, BSCL2 and SETX in 17 patients of whom 10 have been previously reported.", "section": "abstract", "t_start": 227, "d_end": 164, "d_start": 155, "t_end": 231}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "e8ce858ec586cba4873dfc004dcd4e98"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17380322"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17380322", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17380322", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17380322", "mined_sentences": [{"text": "The objective of this study was to investigate the effect of EPHX1 genotype on risk of myocardial infarction (MI) and to determine whether smoking interacts with genotype to modify risk.", "section": "abstract", "t_start": 61, "d_end": 145, "d_start": 139, "t_end": 65}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "0a292f9d8656b97d7c22b4e16e8804ff"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25965061"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25965061", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25965061", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25965061", "mined_sentences": [{"text": "Physico-chemical properties of the mutations G34R, P39L and E41K in the N-terminal domain of human heat shock protein B1 (HspB1), which have been associated with hereditary motor neuron neuropathy, were analyzed.", "section": "abstract", "t_start": 122, "d_end": 195, "d_start": 186, "t_end": 126}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "df55da82b226bbbd8c520f151b6fb0ef"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17760257"}]}, "target": {"id": "ENSG00000145604", "gene_info": {"symbol": "SKP2", "name": "S-phase kinase-associated protein 2, E3 ubiquitin protein ligase", "geneid": "ENSG00000145604"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17760257", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q13309"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17760257", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17760257", "mined_sentences": [{"text": "The expressive level of SKP2 protein in lung carcinoma tissues was closely related to cell differentiation and lymph node metastasis, but not to age, sex, smoking history, tumor site and size, and TNM staging, etc.", "section": "abstract", "t_start": 24, "d_end": 161, "d_start": 155, "t_end": 27}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "5ee81b0745119fb6327da76ec6dd99be"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15345661"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15345661", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15345661", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15345661", "mined_sentences": [{"text": "Regression analysis showed that PON2 (SC+CC) [odds ratio (OR) = 5.01; 95% confidence interval (CI), 1.11-22.54], SOD2 IVS3-23T/G and IVS3-60T/G (OR = 5.09; 95% CI, 1.27-20.47), age (OR = 1.22; 95% CI, 1.09-1.36), and smoking (OR = 49.49; 95% CI, 5.09-480.66) were associated with NIHL.", "section": "abstract", "t_start": 113, "d_end": 223, "d_start": 217, "t_end": 116}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "0eb3447e67a8f85c48cc7f7711db0e03"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11922659"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11922659", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11922659", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11922659", "mined_sentences": [{"text": "These results suggest that hNT Neuron transplantation may be a promising therapeutic strategy for ALS.", "section": "abstract", "t_start": 27, "d_end": 100, "d_start": 98, "t_end": 29}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "db8db8eec2056ae1645b08dc744880d3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11161607"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11161607", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11161607", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11161607", "mined_sentences": [{"text": "In the present study we investigated the susceptibility of mice with a partial deficiency of SOD2 to the neurotoxins 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP), 3-nitropropionic acid (3-NP), and malonate, which are commonly used animal models of Parkinson's and Huntington's disease.", "section": "abstract", "t_start": 93, "d_end": 265, "d_start": 255, "t_end": 96}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "397edf3be20213135a57d922950eca73"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23500038"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["noise-induced hearing loss"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23500038", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23500038", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23500038", "mined_sentences": [{"text": "Genetic variation in superoxide dismutase 2 (SOD2) is implicated in several ageing pathologies and with noise-induced hearing loss.", "section": "abstract", "t_start": 45, "d_end": 129, "d_start": 104, "t_end": 48}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08199999999999999}, "type": "literature", "id": "191937db7ee0ec960de97bf6e7b3fb27"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21685825"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21685825", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21685825", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21685825", "mined_sentences": [{"text": "Moreover, reports from in vivo studies using models of ischemia reperfusion and Parkinson disease also have shown neuroprotection conferred by PPAR-\u03b4.", "section": "abstract", "t_start": 143, "d_end": 96, "d_start": 80, "t_end": 148}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "dc4e9ba282ef12da9736b522735ba78a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22528839"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22528839", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22528839", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22528839", "mined_sentences": [{"text": "These results highlight the fact that gemfibrozil regulates microglial activation by inhibiting inflammatory gene expression in a PPAR-\u03b2 dependent pathway and further reinforce its therapeutic application in several neuroinflammatory and neurodegenerative diseases.", "section": "abstract", "t_start": 130, "d_end": 263, "d_start": 238, "t_end": 135}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "b9f7682e5ee0de17b627fb707e8e7511"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22606049"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22606049", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22606049", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22606049", "mined_sentences": [{"text": "The SNPs of ABCA-1, ACAT-1 and PCSK9; ACAT-1, LDL-R, MTHFR and PCSK9; and ABCA-1, LIPC, PCSK9 and PPARD were shown interactions with cigarette smoking to influence SBP, DBP and PP levels (P < 0.05-0.001); respectively.", "section": "abstract", "t_start": 98, "d_end": 149, "d_start": 133, "t_end": 102}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "2d04d9a812d6847457d03210a1ee3077"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26300727"}]}, "target": {"id": "ENSG00000110955", "gene_info": {"symbol": "ATP5B", "name": "ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide", "geneid": "ENSG00000110955"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26300727", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P06576"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26300727", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26300727", "mined_sentences": [{"text": "The down regulation of ATP5B we have identified in differentiated motor neurons from sporadic ALS patients in the present microarray analysis correlates with previous findings of reduced cytochrome oxidase and ATP synthase activities described in neurodegenerative disorders (Sch\u00e4gger and Ohm, 1995; Bosetti et al., 2002; Sergeant et al., 2003; Basso et al., 2004; Pamplona et al., 2005).", "section": "discussion", "t_start": 23, "d_end": 96, "d_start": 94, "t_end": 27}, {"text": "For example, ATP5B deregulation was previously characterized in western Pacific ALS-parkinsonism-dementia complex (Shiraki, 1975).", "section": "discussion", "t_start": 13, "d_end": 82, "d_start": 80, "t_end": 17}, {"text": "The genes ATP5B, E2F1, HTRA2, LETM1, LRRK2, POLG, SIRT3, SOD1, VDAC1 have been specifically described in the context of neuronal death in ALS.", "section": "discussion", "t_start": 10, "d_end": 140, "d_start": 138, "t_end": 14}, {"text": "The mitochondrial protein ATP5B was also correlated to pathogenesis of neurodegenerative disorders (Yoon et al., 2009), actually the Western Pacific ALS-parkinsonism-dementia complex (Kisby et al., 2006).", "section": "discussion", "t_start": 26, "d_end": 151, "d_start": 149, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "203289ae5c65261ee385799563c9ce49"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21723904"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000677", "label": "mental or behavioural disorder"}, "name": ["psychoses"], "id": "EFO_0000677"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21723904", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000677", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21723904", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21723904", "mined_sentences": [{"text": "Tissue-specific expression of the CALR gene in the brain gray matter in late-adolescence and early adulthood coincides with the expression of the psychoses phenotypes.", "section": "abstract", "t_start": 34, "d_end": 154, "d_start": 146, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "967492d5ce8647df91d2cd2db175c0ae"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21998667"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21998667", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21998667", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21998667", "mined_sentences": [{"text": "CALR, CLIC1, IRAK4, GSTO1, CypA had significant associations with ALS (in bold type).", "section": "figure", "t_start": 0, "d_end": 68, "d_start": 66, "t_end": 3}, {"text": "From the panel of the candidate biomarkers we validated 12 proteins (PRDX2, GSTO1, CLIC1, HSC70, CypA, PDI, ERp57, CALR, PA28a, IRAK4, FUBP1, ROA2) for the following reasons: they are also expressed in the central nervous system (CNS), they are associated with neurodegenerative processes, some of them specifically with ALS [11], [19]\u2013[24], and are easily detectable by commercially available specific antibodies.", "section": "other", "t_start": 115, "d_end": 323, "d_start": 321, "t_end": 118}, {"text": "CALR, CLIC1, IRAK4, GSTO1 and CypA are ALS-specific biomarkers", "section": "other", "t_start": 0, "d_end": 41, "d_start": 39, "t_end": 3}, {"text": "Univariate logistic analysis showed that CALR, CLIC1, IRAK4, GSTO1 and CypA were associated with ALS (Fig. 2B).", "section": "other", "t_start": 41, "d_end": 99, "d_start": 97, "t_end": 44}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "c382435cff3993cea25182e18fba5e97"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12612583"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0002461", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90650"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669", "Orphanet_90650"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90650"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_90650", "label": "Otopalatodigital syndrome type 1"}, "name": ["otopalatodigital syndrome types 1"], "id": "Orphanet_90650"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12612583", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_90650", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12612583", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12612583", "mined_sentences": [{"text": "We identified localized mutations in FLNA that conserve the reading frame and lead to a broad range of congenital malformations, affecting craniofacial structures, skeleton, brain, viscera and urogenital tract, in four X-linked human disorders: otopalatodigital syndrome types 1 (OPD1; OMIM 311300) and 2 (OPD2; OMIM 304120), frontometaphyseal dysplasia (FMD; OMIM 305620) and Melnick-Needles syndrome (MNS; OMIM 309350).", "section": "abstract", "t_start": 37, "d_end": 277, "d_start": 245, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "40b33d6644dfdf996ac887703683afcf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20726836"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["addiction"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20726836", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20726836", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20726836", "mined_sentences": [{"text": "Binding a critical pentapeptide region on the scaffolding protein filamin A regulates signaling of mu opioid receptors (MORs) so that their activation should not result in the opioid tolerance, dependence and addiction associated with current opioid painkillers.", "section": "abstract", "t_start": 66, "d_end": 217, "d_start": 209, "t_end": 74}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "a4de014b6867dc8596527e6ed9582910"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22515798"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22515798", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22515798", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22515798", "mined_sentences": [{"text": "Considering the cognitive functions and deficits of the relevant areas in mild cognitive impairment and Alzheimer disease, acupuncture on PC6 could potentially affect both psychiatric and neurological disorders.", "section": "abstract", "t_start": 138, "d_end": 120, "d_start": 104, "t_end": 140}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "470703450f6d79361507595531387a16"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25448276"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25448276", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25448276", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25448276", "mined_sentences": [{"text": "The data showed that SM caused robust activation of CHK1, monitored by multi-site phosphorylation analysis and that this activation was dependent on the ataxia telangiectasia and Rad3-related (ATR) protein kinase.", "section": "abstract", "t_start": 52, "d_end": 173, "d_start": 153, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "b04fe13d964e0d7cac23ad9ee4b06549"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21723904"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21723904", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21723904", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21723904", "mined_sentences": [{"text": "We have previously reported cases of psychosis-associated mutations in the CALR gene promoter.", "section": "abstract", "t_start": 75, "d_end": 45, "d_start": 37, "t_end": 78}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "eee90e0e6ea41a2e5a01233adadde183"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/7642141"}]}, "target": {"id": "ENSG00000151726", "gene_info": {"symbol": "ACSL1", "name": "acyl-CoA synthetase long-chain family member 1", "geneid": "ENSG00000151726"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/7642141", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P33121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/7642141", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/7642141", "mined_sentences": [{"text": "Northern hybridization revealed a strong depression of ACS1 transcripts in a strain grown on the nonfermentable carbon sources, acetate or ethanol.", "section": "abstract", "t_start": 55, "d_end": 50, "d_start": 41, "t_end": 58}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1995-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "0321d07dba694dec9cff52b5cc842a3d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18801343"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18801343", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18801343", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18801343", "mined_sentences": [{"text": "We previously reported a G>C point mutation located at position -48 within the calreticulin gene core promoter in one individual suffering from paranoid schizophrenia that has also been diagnosed with affective disorder.", "section": "abstract", "t_start": 79, "d_end": 165, "d_start": 153, "t_end": 90}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "2e07875691cd3a5aad11329c52599cd5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22214149"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22214149", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22214149", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22214149", "mined_sentences": [{"text": "Based on logistic regression, the main effects of GSTP1 rs947894, EPHX1 rs1051740, CYP1A1 rs4646903, CYP2D6 rs1065852 and rs1135840 were found to be significant (P < 0.05) while the confounding factors of sex, cigarette smoking, alcohol consumption and the intensity of benzene exposure were controlled.", "section": "abstract", "t_start": 66, "d_end": 226, "d_start": 210, "t_end": 70}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "3d1648e9143a721f6699ec6233572267"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10766137"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10766137", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10766137", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10766137", "mined_sentences": [{"text": "The increased immunostaining of HSP 60 and HSP 27 in the glaucomatous eyes may reflect a role of these proteins as a cellular defense mechanism in response to stress or injury in glaucoma.", "section": "abstract", "t_start": 43, "d_end": 186, "d_start": 179, "t_end": 48}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "bd4ca6c42deadef8f63b598db627cbde"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20465487"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004992"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004992", "label": "Otitis media"}, "name": ["otitis media"], "id": "EFO_0004992"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20465487", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004992", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20465487", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20465487", "mined_sentences": [{"text": "The aim of this study was to investigate the relationship between child characteristics, parental and environmental factors and the occurrence of acute respiratory illness (ARI) and acute otitis media (AOM) among Finnish children attending day care centres (DCCs).", "section": "abstract", "t_start": 258, "d_end": 199, "d_start": 188, "t_end": 261}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "be448d50ee327d7108e76b8a81900834"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15122254"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15122254", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15122254", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15122254", "mined_sentences": [{"text": "We observed the additional HSPB1 mutations in four families with distal HMN and in one individual with CMT neuropathy.", "section": "abstract", "t_start": 27, "d_end": 116, "d_start": 107, "t_end": 31}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "8b878787a27c9726eaec413158126767"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14568994"}]}, "target": {"id": "ENSG00000185532", "gene_info": {"symbol": "PRKG1", "name": "protein kinase, cGMP-dependent, type I", "geneid": "ENSG00000185532"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14568994", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q13976"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14568994", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14568994", "mined_sentences": [{"text": "To investigate the function of cGKI in long-term depression (LTD) and cerebellar learning, we have generated conditional knockout mice lacking cGKI selectively in PCs.", "section": "abstract", "t_start": 31, "d_end": 58, "d_start": 49, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "18e903542267962695ab7d72ea077388"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18614560"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18614560", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18614560", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18614560", "mined_sentences": [{"text": "In total, 1,017 white COPD patients and 912 nondiseased age and sex matched smoking controls were genotyped for six single nucleotide polymorphisms (SNPs) in EPHX1 (including the fast and slow variants and associated haplotypes), and eight SNPs in the two genes encoding GCL.", "section": "abstract", "t_start": 158, "d_end": 82, "d_start": 76, "t_end": 162}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "1b194cb16ce75e0d8026d0b4c7617515"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24943672"}]}, "target": {"id": "ENSG00000179399", "gene_info": {"symbol": "GPC5", "name": "glypican 5", "geneid": "ENSG00000179399"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24943672", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/P78333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24943672", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24943672", "mined_sentences": [{"text": "Single nucleotide polymorphisms (SNPs) in the genes encoding interferon response factor (IRF)-5, IRF-8 and glypican-5 (GPC5) have been associated with disease activity in multiple sclerosis (MS) patients treated with interferon (IFN)-\u03b2.", "section": "abstract", "t_start": 119, "d_end": 188, "d_start": 171, "t_end": 122}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "2780329ba81608d19974d208a0066561"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23562302"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["age-related macular degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23562302", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23562302", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23562302", "mined_sentences": [{"text": "Our data supports further evaluation of the role for SCARB1 in the transport of macular pigment and the possible modulation of age-related macular degeneration risk through combating the effects of oxidative stress within the retina.", "section": "abstract", "t_start": 53, "d_end": 158, "d_start": 127, "t_end": 58}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "2f1ed66b066133a1a9962cc822f92beb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25558953"}]}, "target": {"id": "ENSG00000165246", "gene_info": {"symbol": "NLGN4Y", "name": "neuroligin 4, Y-linked", "geneid": "ENSG00000165246"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003888"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003888", "label": "attention deficit hyperactivity disorder"}, "name": ["ADHD"], "id": "EFO_0003888"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25558953", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003888", "target": "http://identifiers.org/uniprot/Q8NFZ3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25558953", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25558953", "mined_sentences": [{"text": "We measured expression in blood of two Y genes NLGN4Y and RPS4Y in 26 boys with XYY and 11 male controls and evaluated whether NLGN4Y expression correlates with anxiety, ADHD, depression and autistic behaviors (from questionnaires) in boys with XYY.", "section": "abstract", "t_start": 47, "d_end": 173, "d_start": 170, "t_end": 52}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "23f367ab9a04c88ce77fb1ddc2f4b79a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8242611"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["malignant gliomas"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8242611", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8242611", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8242611", "mined_sentences": [{"text": "These results demonstrate that reduced expression of DCC occurs in human malignant gliomas and may be part of a common genetic pathway leading to neoplastic transformation and/or tumor progression.", "section": "abstract", "t_start": 53, "d_end": 89, "d_start": 73, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1993-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "05bd928e1e53ddb42780b5211fa2c399"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24816431"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24816431", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24816431", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24816431", "mined_sentences": [{"text": "Signs of motor neuropathy and myopathy were discovered for the first time in IOSCA patients with C10orf2 mutations.", "section": "abstract", "t_start": 97, "d_end": 24, "d_start": 15, "t_end": 103}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "72e06261e48c98f24729f7e6825306e5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25220807"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25220807", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25220807", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25220807", "mined_sentences": [{"text": "Physico-chemical properties of four mutants (T164A, T180I, P182S and R188W) of human small heat shock protein HspB1 (Hsp27) associated with neurodegenerative diseases were analyzed by means of fluorescence spectroscopy, dynamic light scattering, size-exclusion chromatography and measurement of chaperone-like activity.", "section": "abstract", "t_start": 110, "d_end": 165, "d_start": 140, "t_end": 114}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "c6a6ac8c36a6e6b77bcc61c146952f9b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17127560"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17127560", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17127560", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17127560", "mined_sentences": [{"text": "Previously, we showed the postponement of motor deficit symptoms in a G93A mouse model of amyotrophic lateral sclerosis (ALS) by transplanting hNT cells into the lumbar spinal cord.", "section": "abstract", "t_start": 143, "d_end": 123, "d_start": 121, "t_end": 145}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "bad804779f07d4d1c443d17cb5b21184"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 194, "d_start": 182, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "a90afcf19ceac79194078f0855a80dde"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25295643"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003821", "EFO_0005296"], ["EFO_0000618", "EFO_0005774", "EFO_0003821", "EFO_0005296"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005296", "label": "migraine without aura"}, "name": ["migraine without aura"], "id": "EFO_0005296"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25295643", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005296", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25295643", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25295643", "mined_sentences": [{"text": "In a case-control study, we investigated the association between migraine and superoxide dismutase 1 (SOD1) and superoxide dismutase 2 (SOD2) genes in a cohort of 490 consecutive unrelated Caucasian migraineurs (migraine with aura [MwA], n=107; migraine without aura [MwoA], n=246; chronic migraine [CM], n=137) and 246 healthy controls recruited at our Headache and Pain Unit and stored in the Interinstitutional Multidisciplinary BioBank (BioBIM).", "section": "abstract", "t_start": 136, "d_end": 265, "d_start": 245, "t_end": 139}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "7ca7af71094b46e27e1ee3815788bbb9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 92, "d_start": 67, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "a6260587159bb36435962fb2366af66c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000677", "label": "mental or behavioural disorder"}, "name": ["psychiatric disorders"], "id": "EFO_0000677"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000677", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 171, "d_start": 151, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "4e26002860a5ef1dd9536dcbdf8fdc3d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["bipolar disorder"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 227, "d_start": 212, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "cc35b69c7b387c9f947c1aaaa338711c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 137, "d_start": 119, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "cc665e638bb2084380f9f70777e60b32"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 113, "d_start": 103, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "c4f2a4f0619c37e49c464c1982edc828"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19546321"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004280"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004280", "label": "movement disorder"}, "name": ["movement disorders"], "id": "EFO_0004280"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19546321", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004280", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19546321", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19546321", "mined_sentences": [{"text": "In model systems overproduction of mitochondrial O(2)(-) resulting from the loss of SOD2 function leads to movement disorders and drastic reduction in life span in vertebrates and invertebrates alike.", "section": "abstract", "t_start": 84, "d_end": 124, "d_start": 107, "t_end": 87}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "f915613243fce124e259142028f55169"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20800516"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20800516", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20800516", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20800516", "mined_sentences": [{"text": "Gene expression profiling of normal and SOD2 deficient erythroblasts identified the Parkinson's disease locus DJ-1 (Park7) as a differentially expressed transcript.", "section": "abstract", "t_start": 40, "d_end": 102, "d_start": 84, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "2d88b547443dd4036b04e07231681a10"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17127560"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17127560", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17127560", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17127560", "mined_sentences": [{"text": "hNT cells, derived from a human teratocarcinoma cell line, are versatile neuron-like cells that have been studied as possible treatment vehicles for neurodegenerative diseases.", "section": "abstract", "t_start": 0, "d_end": 174, "d_start": 149, "t_end": 2}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "25b074106ee991051318db7f857bd5d2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23785434"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23785434", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23785434", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23785434", "mined_sentences": [{"text": "Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder.", "section": "abstract", "t_start": 17, "d_end": 206, "d_start": 197, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "8a7cbb11686fff285ab42eeb9b57e485"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25295643"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25295643", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25295643", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25295643", "mined_sentences": [{"text": "These observations lead to the hypothesis that SOD2 polymorphism may cause a defective control of the oxidative phenomena linked to cortical spreading depression, the neurophysiological hallmark of migraine aura, causing an overstimulation of trigeminal neurons and UAs triggering.", "section": "abstract", "t_start": 47, "d_end": 160, "d_start": 151, "t_end": 50}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "47bc38d975d2c2f2174a4c421eb3038d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/9006653"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/9006653", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/9006653", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/9006653", "mined_sentences": [{"text": "Spheroids in the spinal cord showed intense SOD1-IR and SOD2-IR in HS, in sharp contrast with the occasional weak SOD1-IR and SOD2-IR observed in spheroids from patients with amyotrophic lateral sclerosis (ALS).", "section": "abstract", "t_start": 56, "d_end": 208, "d_start": 206, "t_end": 59}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 8.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1997-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.08}, "type": "literature", "id": "7f6312c7f36261c9f36833f57b352bb1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15378534"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0002461", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669", "Orphanet_90652"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_90652", "label": "Otopalatodigital syndrome type 2"}, "name": ["otopalatodigital syndrome type 2"], "id": "Orphanet_90652"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15378534", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_90652", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15378534", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15378534", "mined_sentences": [{"text": "Mutations in FLNA have been shown to cause a broad range of congenital malformations, including otopalatodigital syndrome type 2 in which a missense mutation occurring in exon 5 of FLNA results in omphalocele as part of the phenotype.", "section": "abstract", "t_start": 13, "d_end": 127, "d_start": 96, "t_end": 16}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "668eb3aa58d680e82052d92f66109c6b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12409306"}]}, "target": {"id": "ENSG00000074590", "gene_info": {"symbol": "NUAK1", "name": "NUAK family kinase 1", "geneid": "ENSG00000074590"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia-telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12409306", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O60285"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12409306", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12409306", "mined_sentences": [{"text": "In addition, we also demonstrated that ARK5, when activated by Akt, phosphorylated the ATM protein that is mutated in the human genetic disorder ataxia-telangiectasia and also induced the phosphorylation of p53.", "section": "abstract", "t_start": 39, "d_end": 165, "d_start": 145, "t_end": 42}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "417f352d6f1f936780be78c0bac96be3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20633457"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20633457", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20633457", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20633457", "mined_sentences": [{"text": "These findings suggest that manual needling with PC6 could revert some of the deleterious effects on vascular functioning produced by chronic cigarette smoking.", "section": "abstract", "t_start": 49, "d_end": 158, "d_start": 142, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "3963dea756d22652adef6ceb52ecf69f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20871226"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20871226", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20871226", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20871226", "mined_sentences": [{"text": "X-linked intestinal pseudo-obstruction, a rare disorder caused by mutations in FLNA, the gene encoding the cytoskeletal protein filamin A, has been regarded as a hereditary enteric neuropathy largely on the basis of sparse and incomplete pathologic studies.", "section": "abstract", "t_start": 128, "d_end": 190, "d_start": 181, "t_end": 136}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "d2b218624c5e94e5bee5d61d2ae41d11"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11914408"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11914408", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11914408", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11914408", "mined_sentences": [{"text": "Missense mutations and distal truncations consistent with partial loss of FLN1 function cause familial BPNH with the classical clinical phenotype including epilepsy and mild mental retardation, if any.", "section": "abstract", "t_start": 74, "d_end": 163, "d_start": 156, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "60d431e621ff782428cce86446b7c9da"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23479505"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23479505", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23479505", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23479505", "mined_sentences": [{"text": "In the present study, we employed different human tumor cell models with endogenous and exogenous expression of HMGA2 and show that upon DNA damage, the presence of HMGA2 caused an increased and sustained phosphorylation of the ataxia telangiectasia and Rad3-related kinase (ATR) and its downstream target checkpoint kinase 1 (CHK1).", "section": "abstract", "t_start": 327, "d_end": 248, "d_start": 228, "t_end": 330}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "ef7a68a81ac0397b48b2599564be23e3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26395641"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004720"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004720", "label": "prion disease"}, "name": ["prion disease"], "id": "EFO_0004720"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26395641", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004720", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26395641", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26395641", "mined_sentences": [{"text": "Diseases included neurodegenerative disorders, prion disease, autoimmunity, fibrosis-related disease, the host immune response to cancer, and hematologic diseases associated with calreticulin mutations.", "section": "abstract", "t_start": 179, "d_end": 59, "d_start": 47, "t_end": 190}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "a2ea2c5bd513228965fb7d681900c14e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18345717"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004992"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004992", "label": "Otitis media"}, "name": ["otitis media"], "id": "EFO_0004992"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18345717", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004992", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18345717", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18345717", "mined_sentences": [{"text": "Children attending day care centers (DCCs) frequently carry antibacterial-resistant organisms in their nasopharynx, leading to acute otitis media (AOM) that may be refractory to antibacterial treatment.", "section": "abstract", "t_start": 37, "d_end": 144, "d_start": 133, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "126be71dcc3316fad35bac143c1bf7bb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11124296"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["age-related macular degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11124296", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11124296", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11124296", "mined_sentences": [{"text": "We also observed a weak association of microsomal epoxide hydrolase exon-3 polymorphism with age-related macular degeneration (odds ratio = 2.20, 95% confidence interval = 4.", "section": "abstract", "t_start": 39, "d_end": 124, "d_start": 93, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "caba91085c838898b184cffc974b8e22"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10998440"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0005235"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005235"], ["EFO_0000616", "EFO_0005784", "EFO_0005235"], ["EFO_0000616", "EFO_0003833", "EFO_0005235"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005235", "label": "primitive neuroectodermal tumor"}, "name": ["primitive neuroectodermal tumor"], "id": "EFO_0005235"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10998440", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005235", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10998440", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10998440", "mined_sentences": [{"text": "We investigated 10 cell lines and 15 fresh tumors of childhood rhabdomyosarcoma, 7 cell lines of Ewing's sarcoma, and 4 cell lines of primitive neuroectodermal tumor (PNET) for the expression and mutation of DCC gene by RT-PCR analysis and PCR-single stranded conformation polymorphism (SSCP) analysis.", "section": "abstract", "t_start": 208, "d_end": 164, "d_start": 134, "t_end": 210}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "5ba2ef5e59c8d68846e6f746528ffc67"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17661394"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17661394", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17661394", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17661394", "mined_sentences": [{"text": "Our data thus indicate a nonessential role for HSPB1 in embryonic development and for maintenance of tissues under physiological conditions, but also shows that it plays an important role by acting synergistically with other HSPs during stress conditions to exert cytoprotection and anti-apoptotic effects.", "section": "abstract", "t_start": 47, "d_end": 228, "d_start": 225, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "d6e48eba98184877e8c0b925327acecb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23711372"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["infantile autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23711372", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23711372", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23711372", "mined_sentences": [{"text": "The modulation of the HDL receptor scavenger receptor B1 (SRB1) was evaluated in skin fibroblasts isolated from patients with Rett syndrome (RTT), a genetic form of infantile autism.", "section": "abstract", "t_start": 58, "d_end": 180, "d_start": 165, "t_end": 61}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "0bd123fe45c76416f29f7a33b57c4902"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19952982"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19952982", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19952982", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19952982", "mined_sentences": [{"text": "In a logistic regression model adjusted for history of phenytoin use during the first trimester and maternal epilepsy (N=157 pregnancies), the maternal EPHX1 113 H [per rare allele odds ratio (OR): 2.43, 95% confidence interval (CI): 1.16-5.10, P=0.02] and 139 R (per rare allele OR: 2.33, 95% CI: 1.09-5.00, P=0.03) alleles were associated with CFAs in the child.", "section": "abstract", "t_start": 152, "d_end": 116, "d_start": 109, "t_end": 156}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "0d5fe5def123b62fe6f5c14e9732f30a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22748019"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22748019", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22748019", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22748019", "mined_sentences": [{"text": "The expression of Pbx1 in dopaminergic neurons and its regulation of DCC expression make it an important player in defining the axonal guidance of the midbrain dopaminergic neurons, with possible implications for the normal physiology of the nigro-striatal system as well as processes related to the degeneration of neurons during the course of Parkinson's disease.", "section": "abstract", "t_start": 69, "d_end": 363, "d_start": 345, "t_end": 71}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "831156be72b4599b40b6dd2050844f6a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20970342"}]}, "target": {"id": "ENSG00000100401", "gene_info": {"symbol": "RANGAP1", "name": "Ran GTPase activating protein 1", "geneid": "ENSG00000100401"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20970342", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P46060"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20970342", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20970342", "mined_sentences": [{"text": "These results suggest that nuclear localization of RanGAP1 and depression of RanGTP activity in the nucleus may be mechanistically tied to meiosis-specific diffusion of nuclear proteins into the cytoplasm.", "section": "abstract", "t_start": 51, "d_end": 72, "d_start": 63, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "3922012b63f5128c3ae35a4c801113e0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27206843"}]}, "target": {"id": "ENSG00000167996", "gene_info": {"symbol": "FTH1", "name": "ferritin heavy chain 1", "geneid": "ENSG00000167996"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27206843", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P02794"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27206843", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27206843", "mined_sentences": [{"text": "Using human neuroblastoma SH-SY5Y cells to model human neurons, we investigated the effect of Pb on proteins of iron homeostasis: the Alzheimer's amyloid precursor protein (APP), which stabilizes the iron exporter ferroportin (FPN1); and, the heavy subunit of the iron-storage protein, ferritin (FTH).", "section": "abstract", "t_start": 296, "d_end": 144, "d_start": 134, "t_end": 298}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "041d051544085afdf705352c398235c7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26887567"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26887567", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26887567", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26887567", "mined_sentences": [{"text": "Although none of the 3 other mutation carriers displayed Parkinsonian signs, a pathogenic relationship with Parkinson's disease remains a possibility, based on the known molecular pathology of HSPB1.", "section": "abstract", "t_start": 193, "d_end": 126, "d_start": 108, "t_end": 197}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "b5535e045153c53d8c582c1411e1acb9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26887567"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26887567", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26887567", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26887567", "mined_sentences": [{"text": "We report 3 siblings of a German family with late onset distal motor neuropathy due to the c.404C>G mutation in heat-shock 27-kDa protein 1 gene (HSPB1/HSP27).", "section": "abstract", "t_start": 146, "d_end": 78, "d_start": 69, "t_end": 150}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "8a9ab13c81672755edbd5023bc6b83b8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19778569"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19778569", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19778569", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19778569", "mined_sentences": [{"text": "We investigated the role of the NQO1 polymorphism Pro187Ser and SOD2 (Ala9Val) in a group of well-characterized schizophrenia patients (N=223) assessed for TD.", "section": "abstract", "t_start": 64, "d_end": 124, "d_start": 112, "t_end": 67}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "c3aceed7147eaf78287fb272964f727f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/1986591"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/1986591", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/1986591", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/1986591", "mined_sentences": [{"text": "Elevated levels of autoantibodies to the C-terminal region of ribosomal P proteins appear to be a specific marker for SLE, and are associated with both severe depression and psychosis in this disease.", "section": "abstract", "t_start": 72, "d_end": 168, "d_start": 159, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1991-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "47801699a56586d18be03280e7a2d0ad"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17394531"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17394531", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17394531", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17394531", "mined_sentences": [{"text": "Previously, we reported that overexpression of the mitochondrial antioxidant manganese superoxide dismutase (MnSOD or SOD2) attenuates cytotoxicity induced by expression of the G37R-SOD1 mutant in a human neuroblastoma cell culture model of ALS.", "section": "abstract", "t_start": 118, "d_end": 243, "d_start": 241, "t_end": 121}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "ab759b308ba8fc046b62d916ca1eb23a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23727323"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23727323", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23727323", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23727323", "mined_sentences": [{"text": "We review SOD2's potential involvement in the progression of neurodegenerative diseases such as stroke and Alzheimer and Parkinson diseases, as well as its potential role in \"normal\" age-related cognitive decline.", "section": "abstract", "t_start": 10, "d_end": 86, "d_start": 61, "t_end": 13}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "791975e188d3d68d24f54c560ad65a5d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23707711"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23707711", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23707711", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23707711", "mined_sentences": [{"text": "During the course of this project a parallel study identified mutations in SERAC1 as the genetic cause of the disease in 15 patients with MEGDEL syndrome, which was compatible with the clinical and biochemical phenotypes of the patient described here.", "section": "abstract", "t_start": 75, "d_end": 152, "d_start": 138, "t_end": 80}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "b1fba2ad6c553881e17e8ceaf408ec14"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/1986591"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/1986591", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/1986591", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/1986591", "mined_sentences": [{"text": "Elevated levels of autoantibodies to the C-terminal region of ribosomal P proteins appear to be a specific marker for SLE, and are associated with both severe depression and psychosis in this disease.", "section": "abstract", "t_start": 72, "d_end": 182, "d_start": 174, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1991-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "a543cc79563fe6bb5209691610d41b30"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19192119"}]}, "target": {"id": "ENSG00000135404", "gene_info": {"symbol": "CD63", "name": "CD63 molecule", "geneid": "ENSG00000135404"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["Depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19192119", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P08962"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19192119", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19192119", "mined_sentences": [{"text": "Depression was associated with increased platelet activation with a higher number of circulating CD62p (0.76x10(9) L(-1) vs. 0.46, P=0.019) and CD63 (P=0.05) positive platelets compared with controls.", "section": "abstract", "t_start": 144, "d_end": 9, "d_start": 0, "t_end": 147}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "0cecee5ea4e86231180c78db020c19db"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23289810"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23289810", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23289810", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23289810", "mined_sentences": [{"text": "Analysis of SOD2 haplotypes did not show any associations with risk of cataract.", "section": "abstract", "t_start": 12, "d_end": 78, "d_start": 71, "t_end": 15}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "e3958ce1bc07fd5f8f0a4324bfdba620"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25084356"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25084356", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25084356", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25084356", "mined_sentences": [{"text": "Our results indicated a significant statistical association of promoter methylation of the ABCG1 gene with increased risk of CHD (OR = 19.966; 95% CI, 7.319-54.468; P*<0.001; P*: adjusted for age, gender, smoking, lipid level, hypertension, and diabetes).", "section": "abstract", "t_start": 91, "d_end": 211, "d_start": 205, "t_end": 95}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "763830ba163a6f2c69f8a8cadba7d5dd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22683713"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22683713", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22683713", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22683713", "mined_sentences": [{"text": "Using exome sequencing, we identify SERAC1 mutations as the cause of MEGDEL syndrome, a recessive disorder of dystonia and deafness with Leigh-like syndrome, impaired oxidative phosphorylation and 3-methylglutaconic aciduria.", "section": "abstract", "t_start": 36, "d_end": 83, "d_start": 69, "t_end": 41}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "d5fcfb8f1ee1924a70233baeebab4362"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25417767"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25417767", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25417767", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25417767", "mined_sentences": [{"text": "Further work with a larger sample size and functional study is needed to confirm the importance of the SOD2 gene in the pathogenesis of glaucoma.", "section": "abstract", "t_start": 103, "d_end": 143, "d_start": 136, "t_end": 106}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "1f4b392276f3646d5a59e232d187c689"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23727323"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson diseases"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23727323", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23727323", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23727323", "mined_sentences": [{"text": "We review SOD2's potential involvement in the progression of neurodegenerative diseases such as stroke and Alzheimer and Parkinson diseases, as well as its potential role in \"normal\" age-related cognitive decline.", "section": "abstract", "t_start": 10, "d_end": 138, "d_start": 121, "t_end": 13}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "ee78c78112ef44378a659bf197a8edee"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24919441"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24919441", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24919441", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24919441", "mined_sentences": [{"text": "The gene-gene and gene-environment interactions associated with combined GSTP1/GSTT1 and combined GSTT1/SOD2 genetic polymorphisms along with cigarette smoking habit may play a significant role in BC risk modulation.", "section": "abstract", "t_start": 104, "d_end": 158, "d_start": 142, "t_end": 107}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "c2eaddb353e19b011fde36d8e4bf61a7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26294018"}]}, "target": {"id": "ENSG00000104164", "gene_info": {"symbol": "BLOC1S6", "name": "biogenesis of lysosomal organelles complex 1 subunit 6", "geneid": "ENSG00000104164"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26294018", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q9UL45"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26294018", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26294018", "mined_sentences": [{"text": "These results support the conclusion that deficits consistent with recognition memory impairment, a cognitive function that is impaired in schizophrenia, result from either pallidin or dysbindin mutations, possibly through degradation of BLOC-1 expression and/or function.", "section": "abstract", "t_start": 173, "d_end": 151, "d_start": 139, "t_end": 180}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "6e683851cb759ab39c68f2f549e457e7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25498354"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25498354", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25498354", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25498354", "mined_sentences": [{"text": "The top 5 RT AUROCs for all glaucoma patients and for a subset of early glaucoma patients were for the inferior quadrant of outer circumpapillary annulus of circular grid (OCA) 1 (0.959, 0.939), inferior quadrant of OCA2 (0.945, 0.921), superior quadrant of OCA1 (0.890, 0.811), inferior quadrant of OCA3 (0.887, 0.854), and superior quadrant of OCA2 (0.879, 0.807).", "section": "abstract", "t_start": 216, "d_end": 35, "d_start": 28, "t_end": 219}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "211dfbff42230d31890bb8a4ea6ec83c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/6833798"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423"], ["EFO_0000618", "EFO_0001423"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001423", "label": "encephalomyelitis"}, "name": ["encephalitis"], "id": "EFO_0001423"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/6833798", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001423", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/6833798", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/6833798", "mined_sentences": [{"text": "The acute encephalopathy induced by hamster neurotropic (HNT) measles virus in BALB/c mice was abolished, and a subacute encephalitis was induced instead, when antibody to Edmonston (Ed) measles virus was administered three days after inoculation of HNT virus.", "section": "abstract", "t_start": 57, "d_end": 132, "d_start": 121, "t_end": 59}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1983-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.078}, "type": "literature", "id": "a3df8a550b869bc7ee1b108c115bdd60"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16538226"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002461", "EFO_0000508"]}, "path": [["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_669", "label": "Otopalatodigital syndrome"}, "name": ["otopalatodigital syndrome"], "id": "Orphanet_669"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16538226", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_669", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16538226", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16538226", "mined_sentences": [{"text": "The otopalatodigital syndrome (OPD) spectrum disorders are a heterogeneous group of skeletal dysplasias caused by mutations in the X-linked gene, FLNA.", "section": "abstract", "t_start": 146, "d_end": 28, "d_start": 4, "t_end": 149}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "d250ad37f1dc0d0efcec943ce3f9dce0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19754948"}]}, "target": {"id": "ENSG00000104497", "gene_info": {"symbol": "SNX16", "name": "sorting nexin 16", "geneid": "ENSG00000104497"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0000516", "EFO_0004190", "EFO_1001022"], ["EFO_0000618", "EFO_0001058", "EFO_0000516", "EFO_0004190", "EFO_1001022"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001022", "label": "low tension glaucoma"}, "name": ["normal tension glaucoma"], "id": "EFO_1001022"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19754948", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001022", "target": "http://identifiers.org/uniprot/P57768"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19754948", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19754948", "mined_sentences": [{"text": "Results suggested that genetic variation in five of the candidate genes (RDX, SNX16, OPA1, SOD2 and CYP1B1) is unlikely to confer major risk to develop normal tension glaucoma in the German population.", "section": "abstract", "t_start": 78, "d_end": 174, "d_start": 152, "t_end": 82}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "fa1d85fbefb61ac0a663398dc1558479"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19259937"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia-telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19259937", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19259937", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19259937", "mined_sentences": [{"text": "S-phase arrest and expression of p21 could be inhibited by 7-hydroxystaurosporine, suggesting that the ataxia-telangiectasia and Rad-3-related-checkpoint kinase 1 (ATR-CHK1), and p21 pathways might play a role in the IR-mediated S-phase checkpoint in EC cells.", "section": "abstract", "t_start": 168, "d_end": 123, "d_start": 103, "t_end": 171}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "bbb1eeccfe6a3324171e4be7128f0e93"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17009344"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0002461", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669", "Orphanet_90652"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_90652", "label": "Otopalatodigital syndrome type 2"}, "name": ["otopalatodigital syndrome type 2"], "id": "Orphanet_90652"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17009344", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_90652", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17009344", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17009344", "mined_sentences": [{"text": "A diagnosis of otopalatodigital syndrome type 2, associated with mutations in FLNA, a gene encoding the cytoskeletal protein filamin A, was considered but discarded due to the severity of micromelia, early lethality, and the presence of generalised osteopenia instead of hyperostosis.", "section": "abstract", "t_start": 125, "d_end": 46, "d_start": 15, "t_end": 133}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "f74da82d0b8d45303278f3797f756800"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17560504"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17560504", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17560504", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17560504", "mined_sentences": [{"text": "We describe a 9-year-old girl with typical features of constriction band syndrome localized to the lower limbs who had also profound mental retardation and drug-resistant epilepsy associated with bilateral periventricular nodular heterotopia (a brain malformation of neuronal migration and proliferation caused by mutations in the X-linked filamin 1 gene [FLN1] on chromosome Xq28).", "section": "abstract", "t_start": 356, "d_end": 178, "d_start": 171, "t_end": 359}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "01141174c8b9004a020e2eaad7d52950"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22689267"}]}, "target": {"id": "ENSG00000074590", "gene_info": {"symbol": "NUAK1", "name": "NUAK family kinase 1", "geneid": "ENSG00000074590"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "EFO_0003105"], ["EFO_0000618", "EFO_0003105"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003105", "label": "spina bifida"}, "name": ["spina bifida"], "id": "EFO_0003105"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22689267", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003105", "target": "http://identifiers.org/uniprot/O60285"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22689267", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22689267", "mined_sentences": [{"text": "NUAK1 and NUAK2 double mutants exhibited exencephaly, facial clefting, and spina bifida.", "section": "abstract", "t_start": 0, "d_end": 86, "d_start": 75, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "413bbc69ce89620a9d1c409cad2794e1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20533062"}]}, "target": {"id": "ENSG00000090447", "gene_info": {"symbol": "TFAP4", "name": "transcription factor AP-4", "geneid": "ENSG00000090447"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20533062", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q01664"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20533062", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20533062", "mined_sentences": [{"text": "Together, our data provide evidence that CREB1, SP1, and TFAP4 play roles in modulating PPP2R2B expression, thus offering a mechanism of regulating PP2A activity as the treatment of neurodegenerative diseases associated with abnormal PP2A activity.", "section": "abstract", "t_start": 57, "d_end": 207, "d_start": 182, "t_end": 61}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "4de52f3e9ee7c9282bba3a5da1df6084"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20664703"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20664703", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20664703", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20664703", "mined_sentences": [{"text": "The genes differentially expressed in RB as compared to normal retina belong mainly to DNA damage-response pathways, including, but not limited to, breast cancer associated genes (BRCA1, BRCA2), ataxia telangiectasia mutated gene (ATM), ataxia telangiectasia and Rad3 related gene(ATR), E2F, checkpoint kinase 1 (CHK1) genes.", "section": "abstract", "t_start": 313, "d_end": 215, "d_start": 195, "t_end": 316}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "fcb2256161801cfe2d1a82a62f152226"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16538226"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0002461", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90650"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669", "Orphanet_90650"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669", "Orphanet_90650"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90650"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_90650", "label": "Otopalatodigital syndrome type 1"}, "name": ["otopalatodigital syndrome type 1"], "id": "Orphanet_90650"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16538226", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_90650", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16538226", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16538226", "mined_sentences": [{"text": "We also describe two brothers with otopalatodigital syndrome type 1 due to the FLNA mutation 620G>A.", "section": "abstract", "t_start": 79, "d_end": 66, "d_start": 35, "t_end": 82}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "0d8fd371205ba18747b145f5182104c7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25516156"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0004777"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004777", "label": "alcohol withdrawal"}, "name": ["alcohol withdrawal"], "id": "EFO_0004777"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25516156", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004777", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25516156", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25516156", "mined_sentences": [{"text": "The GWAS from COGA supported an association of SNPs in PPARA and PPARG with alcohol withdrawal and PPARGC1A with AD but found no association for PPARD with either phenotype.", "section": "abstract", "t_start": 145, "d_end": 93, "d_start": 76, "t_end": 149}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "77753a44793b7fed3057251259fa848d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25962492"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25962492", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25962492", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25962492", "mined_sentences": [{"text": "Western blot analyses showed that IR increased the phosphorylation of ataxia telangiectasia mutated (ATM) kinase, checkpoint kinase 2 (CHK2), ataxia telangiectasia and Rad3-related (ATR) protein, checkpoint kinase 1 (CHK1) and p53.", "section": "abstract", "t_start": 217, "d_end": 162, "d_start": 142, "t_end": 220}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "1eef1b1cb15578280287e924a28faa0f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27350734"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27350734", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27350734", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27350734", "mined_sentences": [{"text": "In addition, the risk was markedly lower for those who were carriers of MCM4 rs2305952 CC and were also HBsAg-positive and non-drinking and non-smoking (P < 0.05, respectively) and for those who were carriers of CHEK1 rs515255 TC, TT, TC/TT and were also HBsAg-negative and non-drinking (P < 0.05, respectively).", "section": "abstract", "t_start": 212, "d_end": 150, "d_start": 144, "t_end": 216}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "c69d321ed50b1b4dd8102e98d94e5906"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21831887"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathies"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21831887", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21831887", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21831887", "mined_sentences": [{"text": "We concluded that calnexin and ERp57, but not calreticulin, play an important role in the biology of peripheral myelin proteins PMP22 and P0, and, consequently, these chaperones may contribute to the pathogenesis of peripheral neuropathies and the diversity of these neurological disorders.", "section": "abstract", "t_start": 46, "d_end": 238, "d_start": 216, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "bdbf0ab8e451c797b85a0f3f5ce6a5fb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22689267"}]}, "target": {"id": "ENSG00000163545", "gene_info": {"symbol": "NUAK2", "name": "NUAK family kinase 2", "geneid": "ENSG00000163545"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "EFO_0003105"], ["EFO_0000618", "EFO_0003105"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003105", "label": "spina bifida"}, "name": ["spina bifida"], "id": "EFO_0003105"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22689267", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003105", "target": "http://identifiers.org/uniprot/Q9H093"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22689267", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22689267", "mined_sentences": [{"text": "NUAK1 and NUAK2 double mutants exhibited exencephaly, facial clefting, and spina bifida.", "section": "abstract", "t_start": 10, "d_end": 86, "d_start": 75, "t_end": 14}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "c59e3bf6d78b6f8341af835c34bcc9f1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25516156"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003829"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003829", "label": "alcohol dependence"}, "name": ["alcohol dependence"], "id": "EFO_0003829"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25516156", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003829", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25516156", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25516156", "mined_sentences": [{"text": "Data from a human genome-wide association study (GWAS) completed in the Collaborative Study on the Genetics of Alcoholism (COGA) were then used to analyze the association of single nucleotide polymorphisms (SNPs) in different PPAR genes (PPARA, PPARD, PPARG, and PPARGC1A) with 2 phenotypes: DSM-IV alcohol dependence (AD) and the DSM-IV criterion of withdrawal.", "section": "abstract", "t_start": 245, "d_end": 316, "d_start": 299, "t_end": 249}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "ad82b3cad3014e6e0e9178418bfaa70c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21689831"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21689831", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21689831", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21689831", "mined_sentences": [{"text": "Heterozygous mutations in its coding gene, PEO1, are associated with progressive external ophthalmoplegia (PEO) characterised by ptosis and ophthalmoparesis, with cytochrome c oxidase (COX)-deficient fibres, ragged-red fibres (RRF) and multiple mtDNA deletions in muscle.", "section": "abstract", "t_start": 43, "d_end": 109, "d_start": 107, "t_end": 46}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "c7934e9d7130aad1789550732b1010df"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21757921"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21757921", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21757921", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21757921", "mined_sentences": [{"text": "In epilepsy, HSP-27 is induced in patients' astrocytes and cerebral blood vessel walls, and \u03b1,\u03b2-crystallin is expressed in epileptic foci.", "section": "abstract", "t_start": 13, "d_end": 131, "d_start": 123, "t_end": 18}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "1eed2f0daab73b7f2e50a2ab887ef218"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16926176"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16926176", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16926176", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16926176", "mined_sentences": [{"text": "Data were also consistent with interactions between smoking and variation in SULT1A1, CYP1A1 and EPHX1 and between meat intake and variation in CYP1A1 and EPHX1.", "section": "abstract", "t_start": 97, "d_end": 58, "d_start": 52, "t_end": 101}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "1b594aa0b3d0fb605927d8db81e4afad"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25997407"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25997407", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25997407", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25997407", "mined_sentences": [{"text": "HSPB1, NRAS, immune response, defense response and the related genes LY86, C1QA/C1QB/C1QC may play an important role in the development of congenital cataract induced by TDRD7 deficiency.", "section": "abstract", "t_start": 0, "d_end": 157, "d_start": 150, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "743ebc6b464dcfb1cec36e433515aa36"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22734906"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22734906", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22734906", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22734906", "mined_sentences": [{"text": "dHMN and CMT2 are differentiated by the presence of a sensory neuropathy in the latter although in the case of HSPB1 this division is artificial as CMT2 secondary to HSPB1 mutations is predominantly a motor neuropathy with only minimal sensory involvement.", "section": "abstract", "t_start": 111, "d_end": 71, "d_start": 62, "t_end": 115}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "f4f446b16eccca4f0b7a372ba0fc0c41"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22545178"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22545178", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22545178", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22545178", "mined_sentences": [{"text": "Two recent studies show that mutations in the small heat shock protein HSPB1, which cause an axonal type of Charcot-Marie-Tooth (CMT) neuropathy, affect microtubule dynamics and impede axonal transport.", "section": "abstract", "t_start": 71, "d_end": 143, "d_start": 134, "t_end": 75}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "92e30ceb8d0128377b9592be0fe3d0d3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15774926"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["AMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15774926", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15774926", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15774926", "mined_sentences": [{"text": "This study suggests that a coding SNP in EPHX1 (Y113H) may be important in AMD and supports a previous observation of an association with exudative AMD.", "section": "abstract", "t_start": 41, "d_end": 77, "d_start": 75, "t_end": 45}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "09c01ca36df4dc4971d18edcbd3e61ad"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20659899"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["infantile-onset spinocerebellar ataxia"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20659899", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20659899", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20659899", "mined_sentences": [{"text": "Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia.", "section": "abstract", "t_start": 32, "d_end": 290, "d_start": 253, "t_end": 38}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "f80f9065224723d5c43883f465a92480"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21715529"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21715529", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21715529", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21715529", "mined_sentences": [{"text": "In male fetuses, maternal smoking was associated with a decrease in expression of three transcripts (GGT1, CYP2R1, CAR) and an increase in eight transcripts (CYP1A1, EPHX1, NQO1, GSTP1, GSTT1, AHR, AS3MT, GLRX2).", "section": "abstract", "t_start": 166, "d_end": 32, "d_start": 26, "t_end": 170}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "051a2fe50790175036ffdef917a0effb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14743045"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004992"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004992", "label": "Otitis media"}, "name": ["otitis media"], "id": "EFO_0004992"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14743045", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004992", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14743045", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14743045", "mined_sentences": [{"text": "Children attending day-care centers (DCCs) are at risk for Haemophilus influenzae nasopharyngeal colonization and acute otitis media.", "section": "abstract", "t_start": 37, "d_end": 131, "d_start": 120, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "419d6cd40b0f78d4f3adadff30fd5d40"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20659899"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20659899", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20659899", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20659899", "mined_sentences": [{"text": "Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia.", "section": "abstract", "t_start": 32, "d_end": 191, "d_start": 156, "t_end": 38}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "296ab74cf27649702c7348d6c0c4f42d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20091863"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20091863", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20091863", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20091863", "mined_sentences": [{"text": "Subgroup analysis revealed gender- and/or smoking-specific effects of EPHX1 rs2854455 (IV-1464C > T) and rs2234922 (His139Arg), GSTT1 deletion, GSTP1 rs1695 (Ile105Val), rs947895 (+991C > A) and rs4891 (Ser185Ser) and NQO1 rs1800566 (Pro187Ser) polymorphisms.", "section": "abstract", "t_start": 70, "d_end": 48, "d_start": 42, "t_end": 74}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "3925abe84a7407166430f6d791c624a4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20157854"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0003782"], ["EFO_0000618", "EFO_0003782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003782", "label": "motor neuron disease"}, "name": ["motor neuron diseases"], "id": "EFO_0003782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20157854", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003782", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20157854", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20157854", "mined_sentences": [{"text": "A number of missense mutations in the two related small heat shock proteins HspB8 (Hsp22) and HspB1 (Hsp27) have been associated with the inherited motor neuron diseases (MND) distal hereditary motor neuropathy and Charcot-Marie-Tooth disease.", "section": "abstract", "t_start": 94, "d_end": 168, "d_start": 148, "t_end": 98}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "123c1b90c26c831d532347db219be344"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18298806"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18298806", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18298806", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18298806", "mined_sentences": [{"text": "Genetic associations or gene-smoking interactions was found for GPX1(Pro200Leu) and EPHX1(His113Tyr).", "section": "abstract", "t_start": 84, "d_end": 35, "d_start": 29, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "68bd05b94fc15808eabae71921a8876e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16648970"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16648970", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16648970", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16648970", "mined_sentences": [{"text": "This article seeks to familiarize the reader with general characteristics of small HSPs (especially HSP-27, alphaA/B-crystallins), their tissue distribution with special regard on expression in malignant specimens, and biological properties of intracellular HSP-27 and alphaA/B-crystallins promoting tumor genesis and growth.", "section": "abstract", "t_start": 100, "d_end": 86, "d_start": 83, "t_end": 105}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "ee8aaedaeb4a43e0a3d22b6a4ed548d8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21757921"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21757921", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21757921", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21757921", "mined_sentences": [{"text": "In multiple sclerosis, serum HSP-27 antibodies are elevated during relapses providing disease activation marker, while \u03b1,\u03b2-crystallin expression in brain lesions indicates remission phase initiation.", "section": "abstract", "t_start": 29, "d_end": 20, "d_start": 3, "t_end": 34}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "01c828fbfd615dd06875db758a8b0317"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18989381"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18989381", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18989381", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18989381", "mined_sentences": [{"text": "Mutations in PEO1 may be of variable severity, being associated with clinical presentations ranging from late-onset \u201cpure\u201d PEO to PEO complicated by proximal limb and facial muscle weakness, dysphagia and dysphonia, mild ataxia, and peripheral neuropathy.", "section": "discussion", "t_start": 13, "d_end": 125, "d_start": 123, "t_end": 16}, {"text": "According to previous research [6,9,10,12-19], mutations of PEO1 are present in approximately 35% of familial PEO with multiple deletions of mtDNA.", "section": "discussion", "t_start": 60, "d_end": 112, "d_start": 110, "t_end": 63}, {"text": "Hence, mutations in both mitochondrial and nuclear encoded genes can cause mitochondrial dysfunction and disease. PEO1, which is responsible for adPEO, encodes a protein with homology to the T7 gene 4 protein (gp4) [6]. PEO1 is important for mtDNA maintenance, and its mutations are associated with progressive external ophthalmoplegia with multiple mtDNA deletions [21,22].", "section": "discussion", "t_start": 114, "d_end": 334, "d_start": 299, "t_end": 117}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "958311f04a452521385bd492f724dcfb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26878578"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0003782"], ["EFO_0000618", "EFO_0003782"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003782", "label": "motor neuron disease"}, "name": ["motor neuron disease"], "id": "EFO_0003782"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26878578", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003782", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26878578", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26878578", "mined_sentences": [{"text": "Mutations of HspB1, associated with hereditary motor neuron disease, can be accompanied by change of the size of HspB1 oligomers, by decreased stability under unfavorable conditions, by changes in the interaction with protein partners, and as a rule by decrease of chaperone-like activity.", "section": "abstract", "t_start": 13, "d_end": 66, "d_start": 47, "t_end": 17}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "d792800443415a3b5cf28c110bebdd41"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8222491"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8222491", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8222491", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8222491", "mined_sentences": [{"text": "Progabide was investigated as a potential inhibitor of microsomal epoxide hydrolase as a result of reports of elevated levels of carbamazepine-10,11-epoxide after coadministration of progabide and carbamazepine to patients with epilepsy.", "section": "abstract", "t_start": 55, "d_end": 235, "d_start": 228, "t_end": 82}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1993-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "1829772f23cd25857ff782e246431a32"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/7777477"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "endocrine system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0001379", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0002422", "EFO_0000232", "EFO_1000478"], ["EFO_0001379", "EFO_0003769", "EFO_1000478"], ["EFO_0000616", "EFO_0003833", "EFO_1000478"], ["EFO_0000616", "EFO_0003769", "EFO_1000478"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_1000478"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000478", "label": "Pituitary Gland Adenoma"}, "name": ["pituitary adenomas"], "id": "EFO_1000478"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/7777477", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000478", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/7777477", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/7777477", "mined_sentences": [{"text": "We propose that both IL-6 and HSP 27 may be markers of biologic aggression in pituitary adenomas.", "section": "abstract", "t_start": 30, "d_end": 95, "d_start": 78, "t_end": 35}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1995-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "9a17553b9b1a2f142da7472e157ad231"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24119114"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24119114", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24119114", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24119114", "mined_sentences": [{"text": "Logistic regression analysis including sex, duration of T2D, body mass index, systolic blood pressure, diastolic blood pressure, current and previous smoking, HbA1c, total cholesterol, HDL cholesterol, LDL cholesterol, previous diagnosis of hypertension, hypertension treatment with ACE or ARB, and the SOD2 gene Val16Ala polymorphism genotype. 1TT is the reference genotype.", "section": "table", "t_start": 303, "d_end": 156, "d_start": 150, "t_end": 306}, {"text": "The effect of the SOD2 gene Val16Ala polymorphism on macroalbuminuria was evaluated using a logistic regression model including sex, duration of T2D, body mass index, systolic blood pressure, diastolic blood pressure, current or previous smoking, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, previous diagnosis of hypertension and hypertension treatment as covariates (all these variables were significantly associated with macroalbuminuria in our preliminary univariate analyses).", "section": "other", "t_start": 18, "d_end": 244, "d_start": 238, "t_end": 21}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "e0cdfe918f4aed5cb28c9c1b2ba0b16b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16129095"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16129095", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16129095", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16129095", "mined_sentences": [{"text": "In model 3 combining the GPX1 and SOD2 deficiencies in the same animal did not advance cataract development beyond that of the GPX1 null alone.", "section": "abstract", "t_start": 34, "d_end": 94, "d_start": 87, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "0595d52ea28990d812415cd0a26b453f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24343710"}]}, "target": {"id": "ENSG00000125257", "gene_info": {"symbol": "ABCC4", "name": "ATP binding cassette subfamily C member 4", "geneid": "ENSG00000125257"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24343710", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O15439"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24343710", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24343710", "mined_sentences": [{"text": "Multivariable analysis adjusted for age, smoking, and co-medications revealed significant (P\u2009<\u20090.05) differences in efflux transporter mRNA between tissue types (vaginal ABCB1 3.9-fold\u2009>\u2009colorectal; vaginal ABCC2 2.9-fold\u2009>\u2009colorectal; colorectal ABCC4 2.0-fold\u2009>\u2009cervical).", "section": "abstract", "t_start": 247, "d_end": 47, "d_start": 41, "t_end": 251}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "95abf33f65ef8d63aff80a1fc69484f0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27331002"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27331002", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27331002", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27331002", "mined_sentences": [{"text": "MEGDEL syndrome was further confirmed by the identification of an already reported homozygous mutation in SERAC1.", "section": "abstract", "t_start": 106, "d_end": 14, "d_start": 0, "t_end": 111}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "2937adb60cedab9277251e468e56372e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22877234"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004238", "label": "hearing loss"}, "name": ["hearing loss"], "id": "EFO_0004238"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22877234", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004238", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22877234", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22877234", "mined_sentences": [{"text": "The C allele of SOD2 (rs4880) was more frequent in M\u00e9ni\u00e8re's disease cases with a hearing level over 50 dB compared with cases with a hearing level below 50 dB, suggesting that this polymorphism is associated with progression of a hearing loss in M\u00e9ni\u00e8re's disease.", "section": "abstract", "t_start": 16, "d_end": 242, "d_start": 231, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "200e1e09a792553c56a206cdb7d6f65d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26981778"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["malignant glioma"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26981778", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26981778", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26981778", "mined_sentences": [{"text": "Collectively, these results demonstrate that ABCG1 is critical for malignant glioma cell survival, and might serve as a future therapeutic target for these deadly brain cancers.", "section": "abstract", "t_start": 45, "d_end": 82, "d_start": 67, "t_end": 49}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "cec4f8d17a1c3840ff5d79cf5ce1570a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27331002"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_0001063"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001063", "label": "deafness"}, "name": ["deafness"], "id": "EFO_0001063"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27331002", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001063", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27331002", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27331002", "mined_sentences": [{"text": "MEGDEL (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome) syndrome is a mitochondrial disorder associated with recessive mutations in SERAC1.", "section": "abstract", "t_start": 168, "d_end": 48, "d_start": 41, "t_end": 173}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.076}, "type": "literature", "id": "2c0c972e40dfc0085faa9936bb146042"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12622665"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12622665", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12622665", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12622665", "mined_sentences": [{"text": "Specifically, we examined whether the D1 dopamine receptor-interacting protein calcyon and the D2 dopamine receptor-interacting proteins filamin-A and spinophilin are affected in the dorsolateral prefrontal cortex of patients with schizophrenia.", "section": "abstract", "t_start": 137, "d_end": 243, "d_start": 231, "t_end": 145}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "40ebbde9e01579c3186fb4c48fb59d22"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21234105"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21234105", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21234105", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21234105", "mined_sentences": [{"text": "PPAR-\u03b2/\u03b4-Specific Agonists and EAE", "section": "other", "t_start": 0, "d_end": 33, "d_start": 31, "t_end": 5}, {"text": "A protective effect in EAE was reported for a PPAR-\u03b2/\u03b4-specific agonist, and this protection was suggested to be due to a reduction in glial inflammation.", "section": "other", "t_start": 46, "d_end": 25, "d_start": 23, "t_end": 51}, {"text": "The protective effect of GW0742 was receptor dependent, since no amelioration of EAE clinical scores was observed in PPAR\u03b4-deficient mice [64].", "section": "other", "t_start": 117, "d_end": 83, "d_start": 81, "t_end": 121}, {"text": "Other than GW0742, two other PPAR\u03b2/\u03b4 agonists, GW501516 and L165041 were shown to ameliorate MOGp35-55-induced EAE in C57BL/6 mice by blocking IFN-\u03b3 and IL-17 production by Th1 and Th17 cells [65].", "section": "other", "t_start": 29, "d_end": 113, "d_start": 111, "t_end": 33}, {"text": "The regulation of EAE by PPAR\u03b2 was further confirmed by a study in Steroid receptor coactivator-3-(SRC-3) deficient mice.", "section": "other", "t_start": 25, "d_end": 20, "d_start": 18, "t_end": 29}, {"text": "However, a study showed that the PPAR\u03b4 agonists, GW501516 and L165041, ameliorated EAE by blocking IFN\u03b3 and IL-17 production by Th1 cells and Th17 cells and was associated with a decrease in IL-12 and IL-23 and an increase in IL-4 and IL-10 expression in the CNS and lymphoid organs [65].", "section": "other", "t_start": 33, "d_end": 85, "d_start": 83, "t_end": 37}, {"text": "PPAR-\u03b2/\u03b4-deficient mice developed a severe inflammatory response during EAE characterized by a striking accumulation of IFN-\u03b3+ IL17A- and IFN-\u03b3+ IL-17A+ CD4+ cells in the spinal cord, which resulted from immune system aberrations including enhanced Th cell expansion, cytokine production, and T-bet expression and enhanced expression of IL-12 family cytokines by myeloid cells.", "section": "other", "t_start": 0, "d_end": 74, "d_start": 72, "t_end": 5}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "e2b1d9cec8e19281389cb83eefdaa7af"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10454554"}]}, "target": {"id": "ENSG00000139083", "gene_info": {"symbol": "ETV6", "name": "ETS variant 6", "geneid": "ENSG00000139083"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10454554", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/P41212"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10454554", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10454554", "mined_sentences": [{"text": "Strains with a mutation of TEL1, a homolog of the human gene (ATM) mutated in patients with ataxia telangiectasia, have short but stable telomeric repeats.", "section": "abstract", "t_start": 27, "d_end": 112, "d_start": 92, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1999-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "890d82cd8b7117c2f7e3965da5161370"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23589718"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic seizures"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23589718", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23589718", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23589718", "mined_sentences": [{"text": "We found that (1) low- or high-frequency EA at different acupoints reduced epileptic seizures (P < 0.05 versus the control) with an exception of low-frequency EA at Neiguan (PC6) and Quchi (LI11); (2) low-frequency EA induced a better effect at Fenglong (ST40) plus Yongquan (KI1) than that of the other acupoints (P < 0.05); (3) there is no significant difference in the effects of high-frequency EA at these acupoints; and (4) the high-frequency EA elicited a greater effect than that of low-frequency EA in all groups (P < 0.05), with an exception at Jinsuo (DU8) + Yaoqi (EXB9).", "section": "abstract", "t_start": 174, "d_end": 92, "d_start": 75, "t_end": 176}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "50a1cc9614daec73509fbfb653ecd0ac"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19633697"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia-telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19633697", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19633697", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19633697", "mined_sentences": [{"text": "Here, we show that Cdc5L interacts physically with the cell-cycle checkpoint kinase ataxia-telangiectasia and Rad3-related (ATR).", "section": "abstract", "t_start": 55, "d_end": 104, "d_start": 84, "t_end": 82}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "9e1f4f3b238140c58fa85353fde1c350"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24345872"}]}, "target": {"id": "ENSG00000104497", "gene_info": {"symbol": "SNX16", "name": "sorting nexin 16", "geneid": "ENSG00000104497"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["immune system disease", "endocrine system disease", "genetic disorder", "cardiovascular disease", "nervous system disease", "metabolic disease"], "codes": ["EFO_0000589", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0001379", "EFO_0000319"]}, "path": [["EFO_0000508", "Orphanet_183530", "Orphanet_183539", "Orphanet_93547", "Orphanet_567"], ["EFO_0000319", "EFO_0003777", "Orphanet_98054", "Orphanet_156532", "Orphanet_567"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_331220", "Orphanet_567"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_363294", "Orphanet_138047", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183545", "Orphanet_96346", "Orphanet_117573", "Orphanet_567"], ["EFO_0000508", "Orphanet_98056", "Orphanet_183539", "Orphanet_93547", "Orphanet_567"], ["EFO_0000508", "Orphanet_156638", "Orphanet_183634", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_331220", "Orphanet_567"], ["EFO_0000508", "Orphanet_98054", "Orphanet_156532", "Orphanet_567"], ["EFO_0000508", "Orphanet_68335", "Orphanet_98127", "Orphanet_102020", "Orphanet_98142", "Orphanet_262182", "Orphanet_567"], ["EFO_0000589", "EFO_0005769", "EFO_0005754", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_330197", "Orphanet_567"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_567"], ["EFO_0001379", "Orphanet_156638", "Orphanet_183634", "Orphanet_208593", "Orphanet_181402", "Orphanet_567"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_363294", "Orphanet_138047", "Orphanet_567"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_567", "label": "22q11.2 deletion syndrome"}, "name": ["DiGeorge syndrome"], "id": "Orphanet_567"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24345872", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_567", "target": "http://identifiers.org/uniprot/P57768"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24345872", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24345872", "mined_sentences": [{"text": "Five positive genes, DiGeorge syndrome critical region gene 6 (DGCR6), sorting nexin 16 (SNX16), contactin 4 (CNTN4), baculoviral IAP repeat containing 3 (BIRC3), and baculoviral IAP repeat containing 2 (BIRC2), were selected and quantified.", "section": "abstract", "t_start": 89, "d_end": 37, "d_start": 21, "t_end": 93}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "93f99a159de2722ef982b29c31c7c75c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10725457"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10725457", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10725457", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10725457", "mined_sentences": [{"text": "So far, four classes of heat shock proteins (HSPs) preparation: gp96, HSP90 (hsp86, hsp84), HSP70 (hsc70, hsp70) and calreticulin have been used successfully.", "section": "abstract", "t_start": 117, "d_end": 48, "d_start": 45, "t_end": 128}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "89df8da153d15301fba74563d1bd413e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19429024"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19429024", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19429024", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19429024", "mined_sentences": [{"text": "These results demonstrated that stimulation of the PC6 acupoint suppresses the symptopathology of the hypoactivated HPA axis in chronic CORT-induced rat model of depression.", "section": "abstract", "t_start": 51, "d_end": 171, "d_start": 162, "t_end": 53}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "15fe459175a7067f02d7bddb46058021"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16899408"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16899408", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16899408", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16899408", "mined_sentences": [{"text": "DSBs are detected by ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3 related) proteins, which signal downstream to CHK1, CHK2 (checkpoint kinases) and p53.", "section": "abstract", "t_start": 143, "d_end": 86, "d_start": 66, "t_end": 146}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "9481e0568ab1a0098b4567d27d87d4e6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22193206"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22193206", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22193206", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22193206", "mined_sentences": [{"text": "Lens explant cultures were used to assess the mechanism of drug-induced cataractogenic potential of NVS001, a peroxisome proliferator-activated receptor delta (PPAR\u03b4) agonist, which resulted in cataract in all treated animals during a 13-week rat study.", "section": "abstract", "t_start": 160, "d_end": 201, "d_start": 194, "t_end": 164}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "7eeb7e546f5e6ad4eb8f2b51927707ce"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20385374"}]}, "target": {"id": "ENSG00000122545", "gene_info": {"symbol": "SEPT7", "name": "septin 7", "geneid": "ENSG00000122545"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20385374", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q16181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20385374", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20385374", "mined_sentences": [{"text": "The expression of CDC42EP3 mRNA was significantly increased by 19.7%, and SEPT7 mRNA was significantly decreased by 6.9% in subjects with schizophrenia.", "section": "abstract", "t_start": 74, "d_end": 150, "d_start": 138, "t_end": 78}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "964aad08c3148441b88141aa11aa1b16"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21602432"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21602432", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21602432", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21602432", "mined_sentences": [{"text": "Immunogenic cell death is characterized by the early surface exposure of chaperones including calreticulin and HSPs, which affect dendritic cell (DC) maturation and the uptake and presentation of tumor antigens.", "section": "abstract", "t_start": 94, "d_end": 114, "d_start": 111, "t_end": 105}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "5b72548ce9f15e98435e10edb0a1c22f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20190856"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20190856", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20190856", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20190856", "mined_sentences": [{"text": "Similarly, Periventricular Nodular Heterotopia, which includes cerebral malformation, epilepsy and cognitive disabilities, derives from disruption of the Filamin A gene.", "section": "abstract", "t_start": 154, "d_end": 93, "d_start": 86, "t_end": 162}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "7b7a4a2315b9d881a62bb743298944bc"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22498097"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22498097", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22498097", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22498097", "mined_sentences": [{"text": "The neuroprotective effects of the PPAR\u03b3 full agonist, pioglitazone (20 mg/kg), partial PPAR\u03b3 agonist GW855266X (15 mg/kg) and PPAR-\u03b4 full agonist GW610742X (10 mg/kg) were investigated in the 6-hydroxydopamine (6-OHDA) model of Parkinson's disease when administered prior to or post 6-OHDA lesioning.", "section": "abstract", "t_start": 127, "d_end": 247, "d_start": 229, "t_end": 132}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "1e13592ae2a1c417fb8731bd42ecf3cf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21267586"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastomas"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21267586", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21267586", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21267586", "mined_sentences": [{"text": "A cohort (n\u00a0=\u00a0235) of medulloblastomas from patients aged 0.4-52\u00a0years was studied for expression of four immunohistochemical markers: GAB1, \u03b2-catenin, filamin A, and YAP1.", "section": "abstract", "t_start": 152, "d_end": 37, "d_start": 22, "t_end": 160}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "163e99664ac173b10e517fde42485c9d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21412975"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder", "skeletal system disease"], "codes": ["EFO_0002461", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_404584", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_96333", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183524", "Orphanet_364803", "Orphanet_93425", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183583", "Orphanet_156237", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183576", "Orphanet_669", "Orphanet_90652"], ["EFO_0002461", "EFO_0004260", "Orphanet_183524", "Orphanet_364526", "Orphanet_364541", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_183530", "Orphanet_183533", "Orphanet_102283", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_669", "Orphanet_90652"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183757", "Orphanet_183763", "Orphanet_98464", "Orphanet_669", "Orphanet_90652"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_90652", "label": "Otopalatodigital syndrome type 2"}, "name": ["otopalatodigital syndrome type 2"], "id": "Orphanet_90652"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21412975", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_90652", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21412975", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21412975", "mined_sentences": [{"text": "We report on a male infant with otopalatodigital syndrome type 2 (OPD2) associated with a novel c.514C>G FLNA mutation and unusual clinical features including bifid tongue and congenital corneal clouding.", "section": "abstract", "t_start": 105, "d_end": 63, "d_start": 32, "t_end": 108}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "738797f8f84dc178b90db91072f98f76"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25174396"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25174396", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25174396", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25174396", "mined_sentences": [{"text": "Cytogenetic analysis of 1143 ovarian cancers showed that the degree of genomic instability was correlated to amplification of replication checkpoint genes ataxia telangiectasia and Rad3-related kinase (ATR) and CHEK1.", "section": "abstract", "t_start": 211, "d_end": 175, "d_start": 155, "t_end": 215}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "46530a02b48d04deaad33e4521b342b4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27336026"}]}, "target": {"id": "ENSG00000161955", "gene_info": {"symbol": "TNFSF13", "name": "tumor necrosis factor superfamily member 13", "geneid": "ENSG00000161955"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27336026", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/O75888"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27336026", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27336026", "mined_sentences": [{"text": "Inhibitory interneuron mRNAs (SST; PV: in situ hybridization, quantitative PCR (qPCR)) and death signaling mRNAs [FAS receptor (FASR); TNFSF13: qPCR] were measured in control and schizophrenia subjects (38/38).", "section": "abstract", "t_start": 135, "d_end": 191, "d_start": 179, "t_end": 141}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "05857b89d373284967a321fa6fb9a9f2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23981041"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["Schizophrenia-1"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23981041", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23981041", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23981041", "mined_sentences": [{"text": "Disrupted in Schizophrenia-1 (DISC-1) and 5-HT2C receptor levels were unaffected, as were the dependence receptors Unc5H1, Unc5H3 and Deleted in Colorectal Cancer (DCC), the inflammation-related transcription factor NFkB and the inducible oxidative enzyme cyclo-oxygenase-2 (COX-2).", "section": "abstract", "t_start": 164, "d_end": 27, "d_start": 13, "t_end": 166}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "7a7e36f80be660740bfeb4ba54799685"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22683760"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22683760", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22683760", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22683760", "mined_sentences": [{"text": "Although small HSPs (sHSPs) and in particular HSP27 (HSPB1) or \u03b1B-crystallin (HSPB5) display a wide range of cellular properties, they are mostly known for their ability to protect cells under stress conditions.", "section": "abstract", "t_start": 53, "d_end": 18, "d_start": 15, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "b73c3cf8ad9a51ed854174af4e0cc66a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17465707"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptics"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17465707", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17465707", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17465707", "mined_sentences": [{"text": "The genotypes of GSTM1 and GSTT1, and microsomal epoxide hydrolase-3 and -4, were determined in 192 Japanese epileptics treated with carbamazepine.", "section": "abstract", "t_start": 38, "d_end": 118, "d_start": 109, "t_end": 65}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "b6c1a18e30adce57ec244b0449511bd6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24307543"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24307543", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24307543", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24307543", "mined_sentences": [{"text": "High nuclear HSPB1 and HSPA expressions were found in invasive cells after DOX/EPI administration (P\u2009<\u20090.001), but the drug did not affect the cytoplasmic expression of the HSPs.", "section": "abstract", "t_start": 13, "d_end": 176, "d_start": 173, "t_end": 17}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "e07b1fb7e61d51a9c39b4383f6c43bc3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16203614"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathies"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16203614", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16203614", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16203614", "mined_sentences": [{"text": "Recently, mutations in HSPB1 (HSP27) and HSPB8 (HSP22), two members of the small HSP superfamily, have been associated with inherited peripheral neuropathies.", "section": "abstract", "t_start": 23, "d_end": 156, "d_start": 134, "t_end": 27}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "529310e8a417e7a40afab14111637d13"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17428599"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17428599", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17428599", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17428599", "mined_sentences": [{"text": "One hundred and forty two hospitalised patients, affected by major depression and treated with antidepressants drugs for a major depressive episode were evaluated for depressive severity at the baseline and at the discharge and genotyped for five SNPs within the genes HSPA1L, HSPA1A and HSPA1B.", "section": "abstract", "t_start": 269, "d_end": 76, "d_start": 67, "t_end": 274}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "b6a77cafa2d445c8cd6dc6ca265cadd5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19399179"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19399179", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19399179", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19399179", "mined_sentences": [{"text": "Expression of small HSPs such as HSPB8 and HSPB1 by GGA may be a new therapeutic strategy for patients with DRM.", "section": "abstract", "t_start": 43, "d_end": 23, "d_start": 20, "t_end": 47}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "80873593d765683a275896fbcc6c0d2b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18813331"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["NIHL"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18813331", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18813331", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18813331", "mined_sentences": [{"text": "One SNP, rs2227956 in HSP70-hom, resulted in a significant association with NIHL in both sample sets.", "section": "abstract", "t_start": 22, "d_end": 79, "d_start": 76, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "99bbb9bdd785677aa940aff60da1fc03"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23666708"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23666708", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23666708", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23666708", "mined_sentences": [{"text": "We investigated the association of the polymorphisms in HSPA1A, HSPA1B, and HSPA1L genes in the HSPs repair pathway with the risk of cataract in a Chinese population.", "section": "abstract", "t_start": 76, "d_end": 99, "d_start": 96, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "ace8d86bcbd1a837eb482be0f0c48315"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19788579"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19788579", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19788579", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19788579", "mined_sentences": [{"text": "We have previously shown that adult mice that develop with reduced levels of the netrin-1 receptor [deleted in colorectal cancer (DCC)] display selective reorganization of mesocortical DA circuitry, show enhanced mesocortical DA function and exhibit a behavioural phenotype opposite to that observed in animal models of schizophrenia.", "section": "abstract", "t_start": 130, "d_end": 332, "d_start": 320, "t_end": 132}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "0cf3cce14f5f44aeaad161220786cb2f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16203614"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16203614", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16203614", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16203614", "mined_sentences": [{"text": "In this review, we will summarize the current knowledge of small HSPs, in particular HSPB1 and HSPB8, and discuss their role in health and disease.", "section": "abstract", "t_start": 85, "d_end": 68, "d_start": 65, "t_end": 89}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "473e75f723edb1d0ed5b93c1b1a2dd20"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23252947"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23252947", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23252947", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23252947", "mined_sentences": [{"text": "Twenty-five SNPs within seven CBZ pathway genes, namely CYP3A4, CYP3A5, EPHX1, NR1I2, UGT2B7, ABCB1 and ABCC2, were analyzed for association with CBZ pharmacokinetics in 90 epilepsy patients.", "section": "abstract", "t_start": 72, "d_end": 180, "d_start": 173, "t_end": 76}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "162eb6a130334c1b1a2d044a42ee2aa6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27164557"}]}, "target": {"id": "ENSG00000100401", "gene_info": {"symbol": "RANGAP1", "name": "Ran GTPase activating protein 1", "geneid": "ENSG00000100401"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27164557", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P46060"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27164557", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27164557", "mined_sentences": [{"text": "In addition to some genes known to be associated with schizophrenia (HLA-B and MAD1L1), we also identified novel non-coding RNAs and RNA binding protein genes (DA376252, BX089737, LOC101927273, LINC01029, LOC101928622, HY157071, DA902558, RBFOX1 and TINCR), post-translation modification genes (MANBA, UBE2D3 and RANGAP1) and energy production genes (XYLB, MTRF1 and ENOX1).", "section": "results", "t_start": 313, "d_end": 66, "d_start": 54, "t_end": 319}, {"text": "Our analyses also identified some novel genes shared between schizophrenia and ND, including a group of long non-coding RNAs and RNA binding protein genes (DA376252, BX089737, LOC101927273, LINC01029, LOC101928622, HY157071, DA902558, RBFOX1 and TINCR), a group of post-translation modification genes (MANBA, UBE2D3, and RANGAP1) and a group of energy production genes (XYLB, MTRF1 and ENOX1).", "section": "discussion", "t_start": 321, "d_end": 73, "d_start": 61, "t_end": 327}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "f91a38b8ca7e6976e5c1f88bfd3c12c0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17183097"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17183097", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17183097", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17183097", "mined_sentences": [{"text": "The CLA-induced milk fat depression increased in magnitude with progressing DIM until reaching a plateau on d 18 for CLA-1 (43%) and on d 14 for CLA-2 (33%), although neither milk fat trans-10, cis-12 CLA content (1.8 mg/g) nor its transfer efficiency (6.3%) changed over time.", "section": "abstract", "t_start": 117, "d_end": 34, "d_start": 25, "t_end": 121}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "d657817cedef421208f0196d19eba727"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17418242"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17418242", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17418242", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17418242", "mined_sentences": [{"text": "Factors associated with an increased level of translocations by FISH included age, smoking, B[a]P-like DNA adducts (corresponding to the exposure of c-PAHs), folate, polymorphisms of CYP1A1*2C, GSTP1, EPHX1, p53 MspI and MTHFR.", "section": "abstract", "t_start": 201, "d_end": 89, "d_start": 83, "t_end": 205}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "80c8a1f4148fb0ac0feaee828166fdc9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23666708"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23666708", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23666708", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23666708", "mined_sentences": [{"text": "We investigated the association of the polymorphisms in HSPA1A, HSPA1B, and HSPA1L genes in the HSPs repair pathway with the risk of cataract in a Chinese population.", "section": "abstract", "t_start": 76, "d_end": 140, "d_start": 133, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "18a56de63944d2c0c478144e2ad5fbc8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22928142"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative disease"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22928142", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22928142", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22928142", "mined_sentences": [{"text": "This genetically and phenotypically heterogeneous group includes infantile onset spinocerebellar ataxia (OMIM# 271245) a neurodegenerative disease caused by mutations in the mtDNA helicase gene, c10orf2, with an increased frequency in the Finnish population due to a founder mutation.", "section": "abstract", "t_start": 195, "d_end": 145, "d_start": 121, "t_end": 201}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "e039d45baac2d6c8839967d8df5243d0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/1889446"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_1001457", "EFO_1001454"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001454", "label": "amnesia"}, "name": ["amnesia"], "id": "EFO_1001454"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/1889446", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001454", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/1889446", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/1889446", "mined_sentences": [{"text": "In conclusion, propofol may well prove to be the anaesthetic of choice for DCC in cardiac patients because of good amnesia, low incidence of side-effects and short recovery time (mean 5.3 min).", "section": "abstract", "t_start": 75, "d_end": 121, "d_start": 115, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1991-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "b97ed7f25c544ba9b7b44d4e11c13ac5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20602612"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20602612", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20602612", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20602612", "mined_sentences": [{"text": "Among all the polymorphisms studied, functional variants from genes encoding CYP2C19, EPHX1, ABCB1 and SCN1A were highly polymorphic in North Indian epilepsy patients, and might account for differential drug response to first-line antiepileptic drugs.", "section": "abstract", "t_start": 86, "d_end": 156, "d_start": 149, "t_end": 90}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "15cdbf44bb5987f23396d28a83609363"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26838077"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26838077", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26838077", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26838077", "mined_sentences": [{"text": "TWINKLE (c10orf2) gene is responsible for autosomal dominant progressive external ophthalmoplegia (PEO).", "section": "abstract", "t_start": 9, "d_end": 101, "d_start": 99, "t_end": 15}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "c79e7e5c7a07599feb9fa440b3c60512"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18299791"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18299791", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18299791", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18299791", "mined_sentences": [{"text": "Association between the three polymorphisms of HSP70-1 (HSPA1A), HSP70-hom (HSPA1L) and HSP70-2 (HSPA1B) and schizophrenia has been reported.", "section": "abstract", "t_start": 76, "d_end": 121, "d_start": 109, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "fdb980c245bfccd7d96d8d1848429376"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26005129"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["drug abuse"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26005129", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26005129", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26005129", "mined_sentences": [{"text": "Moreover, these findings suggest that DCC signaling determines adult susceptibility to drug abuse most likely by controlling prefrontal cortex development in adolescence.", "section": "abstract", "t_start": 38, "d_end": 96, "d_start": 87, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "969c56f2668f3b0c6fac05eee3ddd538"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25495409"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25495409", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25495409", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25495409", "mined_sentences": [{"text": "For 210 epileptic patients treated with CBZ as monotherapy, nine SNPs in candidate genes ABCB1, CYP3A4, CYP3A5, POR and EPHX1 were analyzed by PCR-RFLP or direct sequencing.", "section": "abstract", "t_start": 120, "d_end": 16, "d_start": 8, "t_end": 124}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "eb73f77eae0ebfe967a99dc484e44420"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20150644"}]}, "target": {"id": "ENSG00000135404", "gene_info": {"symbol": "CD63", "name": "CD63 molecule", "geneid": "ENSG00000135404"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0003833", "EFO_0005543"], ["EFO_0000616", "EFO_0005543"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005543", "label": "brain glioma"}, "name": ["malignant glioma"], "id": "EFO_0005543"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20150644", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005543", "target": "http://identifiers.org/uniprot/P08962"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20150644", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20150644", "mined_sentences": [{"text": "Five potential markers (CD44 antigen (CD44), growth arrest and DNA-damage-inducible, alpha (GADD45A), fibronectin 1 (FN1), CD63 antigen (CD63) and secreted phosphoprotein 1 (SPP1)) showed expression patterns that correlated significantly with malignant glioma.", "section": "abstract", "t_start": 137, "d_end": 258, "d_start": 243, "t_end": 140}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "91c33e317936d74acbd333fbbfd6af53"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16094314"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_1000845"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000845", "label": "brain edema"}, "name": ["Brain edema"], "id": "EFO_1000845"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16094314", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000845", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16094314", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16094314", "mined_sentences": [{"text": "Brain edema, LMWA, and SOD2 activity were measured along with histopathological analysis.", "section": "abstract", "t_start": 23, "d_end": 10, "d_start": 0, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "57a36ac085eb4c5bac6faace72e1d2ed"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19171463"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19171463", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19171463", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19171463", "mined_sentences": [{"text": "Abs to ribosomal P proteins are associated with psychosis and might be associated with peripheral nervous system complications.", "section": "abstract", "t_start": 17, "d_end": 56, "d_start": 48, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "218bb9f57c1740510f378eeb70c8b606"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23718983"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["Smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23718983", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23718983", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23718983", "mined_sentences": [{"text": "Smoking was also significantly associated with decreased seminal SOD activity (P < 0.05) and reduced NRF2 and SOD2 mRNA expression in heavy smokers with this variant genotype.", "section": "abstract", "t_start": 110, "d_end": 6, "d_start": 0, "t_end": 113}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "3bbe8973f35505ebe9b928c539fcd83d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21036197"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21036197", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21036197", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21036197", "mined_sentences": [{"text": "It has been reported that NTM might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and major depression.", "section": "abstract", "t_start": 26, "d_end": 153, "d_start": 144, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "e0ce6899fd7c8a8286775a90d44fcbcc"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24464805"}]}, "target": {"id": "ENSG00000125257", "gene_info": {"symbol": "ABCC4", "name": "ATP binding cassette subfamily C member 4", "geneid": "ENSG00000125257"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "hematological system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0005803", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_1000157"], ["EFO_0005803", "EFO_0001642", "EFO_0000574", "EFO_1000157"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_1000157"], ["EFO_0000616", "EFO_0000311", "EFO_0001642", "EFO_0000574", "EFO_1000157"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000157", "label": "Central Nervous System Lymphoma"}, "name": ["central nervous system lymphoma"], "id": "EFO_1000157"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24464805", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000157", "target": "http://identifiers.org/uniprot/O15439"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24464805", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24464805", "mined_sentences": [{"text": "Methotrexate (MTX) is the cornerstone of chemotherapy for primary central nervous system lymphoma, yet how the blood-brain barrier (BBB) efflux transporters ABCG2 and ABCC4 influence the required high-dose therapy is unknown.", "section": "abstract", "t_start": 167, "d_end": 96, "d_start": 66, "t_end": 171}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "626c77ac406517f8e1a4bee9b9f9f7c3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25217640"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25217640", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25217640", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25217640", "mined_sentences": [{"text": "Previous data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and insoluble amyloid-\u03b2 (A\u03b2) in Alzheimer disease (AD)-transgenic mice either by increasing the levels of mouse apolipoprotein E (apoE) or increasing ABCA1/ABCG1-induced apoE lipoprotein association/lipidation.", "section": "abstract", "t_start": 256, "d_end": 148, "d_start": 132, "t_end": 260}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "f272566ac2d656acaba65c427acded35"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19754948"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0000516", "EFO_0004190", "EFO_1001022"], ["EFO_0000618", "EFO_0001058", "EFO_0000516", "EFO_0004190", "EFO_1001022"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001022", "label": "low tension glaucoma"}, "name": ["normal tension glaucoma"], "id": "EFO_1001022"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19754948", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001022", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19754948", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19754948", "mined_sentences": [{"text": "Results suggested that genetic variation in five of the candidate genes (RDX, SNX16, OPA1, SOD2 and CYP1B1) is unlikely to confer major risk to develop normal tension glaucoma in the German population.", "section": "abstract", "t_start": 91, "d_end": 174, "d_start": 152, "t_end": 94}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "514e05c142c4945d8097e3d00490e4d7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21036197"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21036197", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21036197", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21036197", "mined_sentences": [{"text": "It has been reported that NTM might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and major depression.", "section": "abstract", "t_start": 26, "d_end": 78, "d_start": 62, "t_end": 28}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "4322d80c06b4b38f1aa97a4fa52588b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25125603"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["AMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25125603", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25125603", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25125603", "mined_sentences": [{"text": "The SNPs CFH Y402H rs1061170 and ARMS2 A69S rs10490924 were used to analyze genetic risk of AMD; OCA2 rs4778241 and HERC2 rs12913832 represented genetic determinants of eye color.", "section": "abstract", "t_start": 97, "d_end": 94, "d_start": 92, "t_end": 100}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "8f4dab6ff82d018a64b3ae2af6376a21"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14714911"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14714911", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14714911", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14714911", "mined_sentences": [{"text": "Within two years of the recognition of autoantibodies to ribosomal P proteins in patients with SLE) an association with anti-P autoantibodies with psychosis was noted.", "section": "abstract", "t_start": 67, "d_end": 155, "d_start": 147, "t_end": 76}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "787f794ea822b280e1561706c04a9d8b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23428672"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23428672", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23428672", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23428672", "mined_sentences": [{"text": "It has been reported that the Borna disease virus (BDV) encoded phosphoprotein (P protein) can inhibit the activity of Traf family member-associated NF-kappaB activator (TANK)-binding kinase 1 (TBK-1), thus preventing the induction of type I interferon (IFN).", "section": "abstract", "t_start": 80, "d_end": 42, "d_start": 30, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "932e555fa1048e4e8680bd443847d7cb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22001364"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22001364", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22001364", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22001364", "mined_sentences": [{"text": "We analyzed the RNA and protein levels of UCP2 in the dorsolateral prefrontal cortex (DLPFC) of subjects with BD and schizophrenia (SCZ) and assessed the potential relationship between the antioxidant superoxide dismutase (SOD1 and SOD2) and UCP2 in the same region.", "section": "abstract", "t_start": 232, "d_end": 129, "d_start": 117, "t_end": 235}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "dd2aaf92627867a79f8e5a220c7f5067"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20717685"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20717685", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20717685", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20717685", "mined_sentences": [{"text": "Our analysis showed correlation between BMI1 and PCGF2 gene's expression and survival in children with medulloblastoma.", "section": "abstract", "t_start": 40, "d_end": 117, "d_start": 103, "t_end": 43}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "029e00deb29c59facd4f9a0dbadee8c6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16820990"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": [], "codes": []}, "path": [["EFO_0000618"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000618", "label": "nervous system disease"}, "name": ["central nervous system disease"], "id": "EFO_0000618"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16820990", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000618", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16820990", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16820990", "mined_sentences": [{"text": "In addition, there is a strong relationship to central nervous system disease and nephritis of antibodies to ribosomal P proteins.", "section": "abstract", "t_start": 119, "d_end": 76, "d_start": 47, "t_end": 128}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "9522960fd10f72a42db53ef9f1919c6d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22119635"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22119635", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22119635", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22119635", "mined_sentences": [{"text": "The association between the superoxide dismutase 2 (SOD2) Val16Ala polymorphism and the serum aminotransferase levels was retrospectively investigated in 207 valproic acid-treated patients with epilepsy.", "section": "abstract", "t_start": 52, "d_end": 201, "d_start": 194, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "6efbf571c6ca3b50db4da731ca010383"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26247724"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26247724", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26247724", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26247724", "mined_sentences": [{"text": "Using a mouse model of glaucoma, DBA/2J (D2), which spontaneously develops elevated IOP, as well as an in vitro RGC culture system, we show here that oxidative stress, as evidenced by increasing superoxide dismutase 2 (SOD2) and mt transcription factor A (Tfam) protein expression, triggers mt fission and loss by increasing dynamin-related protein 1 (DRP1) in the retina of glaucomatous D2 mice as well as in cultured RGCs exposed to elevated hydrostatic pressure in vitro.", "section": "abstract", "t_start": 219, "d_end": 30, "d_start": 23, "t_end": 222}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "088c7621b93a7a3b8c3a59bb53915830"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26970947"}]}, "target": {"id": "ENSG00000146282", "gene_info": {"symbol": "RARS2", "name": "arginyl-tRNA synthetase 2, mitochondrial", "geneid": "ENSG00000146282"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative disease"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26970947", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q5T160"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26970947", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26970947", "mined_sentences": [{"text": "We suggest that RARS2 gene mutations can cause a metabolic neurodegenerative disease manifesting primarily as EOEE with post-natal microcephaly, without the distinctive radiological features of pontocerebellar hypoplasia.", "section": "abstract", "t_start": 16, "d_end": 83, "d_start": 59, "t_end": 20}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "b5f9163c0c5d2d81fe2627689f74a7af"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24670129"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24670129", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24670129", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24670129", "mined_sentences": [{"text": "Anti-ribosomal P protein antibody (anti-P) is detected in a fraction of SLE) patients, especially with lupus psychosis, lupus nephritis, and lupus hepatitis.", "section": "abstract", "t_start": 15, "d_end": 117, "d_start": 109, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "c7a7daba38484f1ac0f522801286c862"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/3753538"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/3753538", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/3753538", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/3753538", "mined_sentences": [{"text": "Analysis of the fine specificities of the anti-saline soluble cellular antigen antibodies revealed that the antiribosomal P protein antibody was present in 4 of 4 patients with lupus psychosis and was enriched in the CSF of 1 patient.", "section": "abstract", "t_start": 122, "d_end": 191, "d_start": 183, "t_end": 130}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1986-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "7a7434fb773bcc9c0ef8bd48195704bf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8961909"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": [], "codes": []}, "path": [["EFO_0000618"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000618", "label": "nervous system disease"}, "name": ["central nervous system disease"], "id": "EFO_0000618"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8961909", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000618", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8961909", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8961909", "mined_sentences": [{"text": "To examine cognitive and psychological functioning in relation to antiribosomal P protein autoantibodies in patients with SLE) who had no previous history of central nervous system disease (non-CNS SLE).", "section": "abstract", "t_start": 80, "d_end": 187, "d_start": 158, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "11d43b2a1496a72622f9387c3fd0b549"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/6335868"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "endocrine system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0001379", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0002422", "EFO_0000232", "EFO_1000478"], ["EFO_0001379", "EFO_0003769", "EFO_1000478"], ["EFO_0000616", "EFO_0003833", "EFO_1000478"], ["EFO_0000616", "EFO_0003769", "EFO_1000478"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_1000478"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000478", "label": "Pituitary Gland Adenoma"}, "name": ["pituitary adenoma"], "id": "EFO_1000478"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/6335868", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000478", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/6335868", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/6335868", "mined_sentences": [{"text": "CRF, at doses up to 100 ng/ml, has no effect on IR-ACTH, IR-hNT or IR-beta LPH secretion by the pituitary adenoma cells within the first week of monolayer culture.", "section": "abstract", "t_start": 60, "d_end": 112, "d_start": 96, "t_end": 62}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1984-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "611f12a093d9a47c378132516a4af529"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25801238"}]}, "target": {"id": "ENSG00000048740", "gene_info": {"symbol": "CELF2", "name": "CUGBP, Elav-like family member 2", "geneid": "ENSG00000048740"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25801238", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/O95319"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25801238", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25801238", "mined_sentences": [{"text": "Recently, candidate genetic studies revealed the single nucleotide polymorphisms (SNPs) of CUGBP2 (rs2242451) and DNMBP (rs11190305 and rs3740058) associated with Alzheimer's disease (AD).", "section": "abstract", "t_start": 91, "d_end": 181, "d_start": 163, "t_end": 96}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "a4c6ab9be25d1c7ea536e691bc5b0786"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25818327"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003821"], ["EFO_0000618", "EFO_0005774", "EFO_0003821"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003821", "label": "migraine disorder"}, "name": ["migraine"], "id": "EFO_0003821"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25818327", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003821", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25818327", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25818327", "mined_sentences": [{"text": "The SOD2 16 C/T genotype and C allele frequency differed significantly between controls and migraine (P = .047; P = .038).", "section": "abstract", "t_start": 4, "d_end": 99, "d_start": 92, "t_end": 7}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07400000000000001}, "type": "literature", "id": "23aca148bc34e5b897e3abd39e28d99c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15673657"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15673657", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15673657", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15673657", "mined_sentences": [{"text": "In addition to the cytoskeletal elements, several heat shock proteins (HSP27, HSP60, HSP70, grp75, alphaB crystallin), resident endoplasmic reticulum (ER) proteins (calreticulin, grp78/BiP, ERp29), proteins associated with neurodegenerative diseases (ubiquitin C-terminal hydrolase L1, rat ortholog of human DJ-1/Park7, gamma-synuclein, superoxide dismutase 1), anti-oxidant proteins (peroxiredoxins 1 and 6), and metabolic proteins (e.g., phosphoglycerate kinase 1 (PGK 1), alpha enolase, aldolase C/Zebrin II) were included among the axonally synthesized proteins.", "section": "abstract", "t_start": 165, "d_end": 248, "d_start": 223, "t_end": 176}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "ec6012ad06ca0633e299d99ac8e51f64"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26028469"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26028469", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26028469", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26028469", "mined_sentences": [{"text": "Activation of peroxisome proliferator-activated receptors (PPARs), namely PPAR\u03b3 and PPAR\u03b4, has been shown to provide neuroprotection in a number of neurodegenerative disorders, such as Alzheimer's and Parkinson's disease (PD).", "section": "abstract", "t_start": 84, "d_end": 219, "d_start": 201, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e93f9074686e6317cb912795a877afe0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15175264"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["Ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15175264", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15175264", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15175264", "mined_sentences": [{"text": "Downstream targets of both ATM (Ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) kinases were modified, but only the ablation of ATR, or the inhibition of CHK1, attenuated the arrest.", "section": "abstract", "t_start": 168, "d_end": 52, "d_start": 32, "t_end": 171}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8ed0a3247ac9a0a79b922138d30b0223"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12401949"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12401949", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12401949", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12401949", "mined_sentences": [{"text": "These proteins included two putative iron-binding proteins, hNFU1 and calreticulin; two proteins involved in metabolism of hydrogen peroxide, peroxiredoxin 2 and superoxide dismutase 1; and several proteins identified in inclusions in neurodegenerative diseases, including HSP27, UCHL1, actin and tropomyosin.", "section": "abstract", "t_start": 70, "d_end": 260, "d_start": 235, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8891a859964b5bb000b53a12ca171600"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22194214"}]}, "target": {"id": "ENSG00000153930", "gene_info": {"symbol": "ANKFN1", "name": "ankyrin repeat and fibronectin type III domain containing 1", "geneid": "ENSG00000153930"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22194214", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/Q8N957"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22194214", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22194214", "mined_sentences": [{"text": "Replication extended to the following polymorphisms: PKN2 (rs305217), GTF2B (rs7538427), EPHA4 (rs1517440), YTHDF3 (rs12115114), ANKFN1 (rs17758761) and PTPRM (rs4798571), which did not reach the threshold of significance in a follow-up of the first genome-wide association study (GWAS) conducted in multiple sclerosis; TMEM39A (rs1132200), which appeared as a newly identified susceptibility gene in the same study; a gene previously reaching GWAS significance in Italy, CBLB (rs9657904); IL12B (rs6887695, rs10045431), a susceptibility gene shared by diverse autoimmune diseases and, finally, another gene showing inconclusive association with multiple sclerosis, CNR1 (rs1049353).", "section": "abstract", "t_start": 129, "d_end": 317, "d_start": 300, "t_end": 134}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "deba2c11086c7401366cedb17bedb291"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23049896"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003888"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003888", "label": "attention deficit hyperactivity disorder"}, "name": ["ADHD"], "id": "EFO_0003888"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23049896", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003888", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23049896", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23049896", "mined_sentences": [{"text": "The most predictive SNPs for each phenotype were: a LGALS8 intronic SNP, rs4659682, associated with ADHD-IV Impulsivity (P=1.03 \u00d7 10(-6)); a PCSK5 intronic SNP, rs2261722, associated with CBCL/1.5-5 PDPs (P=1.11 \u00d7 10(-6)); and an intergenic SNP, rs11617488, 50 kb from FGF9, associated with CBCL/1.5-5 Total Problems (P=3.47 \u00d7 10(-7)).", "section": "abstract", "t_start": 141, "d_end": 103, "d_start": 100, "t_end": 145}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "09d32851069aba470623af45de895149"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15459826"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15459826", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15459826", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15459826", "mined_sentences": [{"text": "X-linked periventricular nodular heterotopia (PNH) (OMIM 300049) is a neuronal migration disorder, associated with mutations of the FLN1 gene (Xq28), accompanied by severe epilepsy and normal to mildly impaired cognitive function in affected women.", "section": "abstract", "t_start": 132, "d_end": 179, "d_start": 172, "t_end": 135}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "d9df7a6c25f058b85e11d73a6e77811e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23459936"}]}, "target": {"id": "ENSG00000074590", "gene_info": {"symbol": "NUAK1", "name": "NUAK family kinase 1", "geneid": "ENSG00000074590"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23459936", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O60285"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23459936", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23459936", "mined_sentences": [{"text": "A significant interaction of NUAK1 (rs11112872, interaction P = 2.9 \u00d7 10(-9)) with smoking in ARIC was not replicated in Health ABC, although estimates of heritable variance in severe CP explained by all single nucleotide polymorphisms increased from 18 to 52% with the inclusion of a genome-wide interaction term with smoking.", "section": "abstract", "t_start": 29, "d_end": 89, "d_start": 83, "t_end": 33}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e6d60eafc882a6b2eebc48da17d544da"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22402442"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22402442", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22402442", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22402442", "mined_sentences": [{"text": "The ssDNA attracts replication protein A (RPA), which initiates ATR-Chk1 (ataxia telangiectasia and Rad3-related/checkpoint kinase 1) G2-phase checkpoint signaling, and colocalizes with components of the RAD18 and RAD51 postreplication repair pathways.", "section": "abstract", "t_start": 113, "d_end": 94, "d_start": 74, "t_end": 131}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "7dc72053cc04ec8c541c47f4928d2ce4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22446183"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22446183", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22446183", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22446183", "mined_sentences": [{"text": "Previous studies have demonstrated that inhibition of the ataxia telangiectasia and Rad3-related (ATR) and checkpoint kinase 1 (Chk1) pathway in p53-deficient cells can induce such a synthetic lethal outcome.", "section": "abstract", "t_start": 107, "d_end": 78, "d_start": 58, "t_end": 125}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "a3ed4c52e818c9a4784f6510bb2169b4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21772061"}]}, "target": {"id": "ENSG00000122545", "gene_info": {"symbol": "SEPT7", "name": "septin 7", "geneid": "ENSG00000122545"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21772061", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q16181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21772061", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21772061", "mined_sentences": [{"text": "Additionally, the expression of septin 7 and OPA1, proteins downstream of truncated p35, is decreased in schizophrenia.", "section": "abstract", "t_start": 32, "d_end": 117, "d_start": 105, "t_end": 39}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "98befb5412fdd1e4e5b1f39c03bddc41"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19720113"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19720113", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19720113", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19720113", "mined_sentences": [{"text": "Various intracellular molecules like calreticulin (CRT), heat-shock proteins (HSPs), high-mobility group box-1 (HMGB1) protein, have been shown to be DAMPs exposed/secreted in a stress agent/factor-and cell death-specific manner.", "section": "abstract", "t_start": 37, "d_end": 81, "d_start": 78, "t_end": 48}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "a8cbed602ccbf2095d03e113ad5f21db"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10693161"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["major depressive disorder"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10693161", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10693161", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10693161", "mined_sentences": [{"text": "Indeed, increased levels of GRP78, GRP94, and calreticulin, a third member of the ER stress protein family, were found in temporal cortex of subjects with major depressive disorder who died by suicide compared with controls and subjects who died by other means.", "section": "abstract", "t_start": 46, "d_end": 179, "d_start": 155, "t_end": 57}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "2c34e5867e1d34d90eb4a4faac1b6229"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14528906"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "endocrine system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0001379", "EFO_0000618"]}, "path": [["EFO_0000616", "EFO_0002422", "EFO_0000232", "EFO_1000478"], ["EFO_0001379", "EFO_0003769", "EFO_1000478"], ["EFO_0000616", "EFO_0003833", "EFO_1000478"], ["EFO_0000616", "EFO_0003769", "EFO_1000478"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_1000478"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000478", "label": "Pituitary Gland Adenoma"}, "name": ["pituitary adenomas"], "id": "EFO_1000478"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14528906", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000478", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14528906", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14528906", "mined_sentences": [{"text": "Five differentially regulated proteins (prolactin, cellular retinoic acid-binding protein II, G-protein beta subunit 3, secretagogin and calreticulin) were also validated with results from a comparative transcriptomics study of pituitary adenomas and controls.", "section": "abstract", "t_start": 137, "d_end": 245, "d_start": 228, "t_end": 148}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8f4b80fd0700092843835a3364074284"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27359173"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0001358"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001358", "label": "post-traumatic stress disorder"}, "name": ["PTSD"], "id": "EFO_0001358"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27359173", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001358", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27359173", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27359173", "mined_sentences": [{"text": "Simulated PTSD also induced ERS in myocardium, demonstrated by up-regulation of protein levels of glucose-regulated protein 78 (0.64 versus 0.26, p = .017), calreticulin (p = .040), and CCAAT/enhancer-binding protein-homologous protein (0.95 versus 0.43, p = .047), phosphorylation of protein kinase RNA-like ER kinase (p = .003), and caspase 12 activation (0.30 versus 0.06, p < .001) in myocardium from the SPS rats.", "section": "abstract", "t_start": 157, "d_end": 13, "d_start": 10, "t_end": 168}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "239133a528b79bb0c8427109f31cc9a5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19073777"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19073777", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19073777", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19073777", "mined_sentences": [{"text": "Participants abstained from smoking for 26\u2009h, and were randomized to receive TEAS alternating between 2 and 100\u2009Hz at four acupoints (LI4 and PC8, PC6 and TE5) at four different intensities (10, 5, Intermittent 5 or 0\u2009mA).", "section": "abstract", "t_start": 147, "d_end": 34, "d_start": 28, "t_end": 149}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8265e16e30ecc33df26f6ef8011ab2a3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23615744"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23615744", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23615744", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23615744", "mined_sentences": [{"text": "A small interfering RNA (siRNA) expression vector against ataxia telangiectasia and Rad3 related (ATR), a cell cycle checkpoint kinase, was transfected into Chinese hamster ovary (CHO) cells.", "section": "abstract", "t_start": 106, "d_end": 78, "d_start": 58, "t_end": 133}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8093eab6c35f1b3360ae012765015e09"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14551530"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14551530", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14551530", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14551530", "mined_sentences": [{"text": "Other studies suggest that the presence of cataract is associated with the altered expression of specific genes including metallothionein IIa, osteonectin, transglutaminase 2, betaig-h3, multiple ribosomal proteins, ADAM9, and protein phosphatase 2A.", "section": "abstract", "t_start": 216, "d_end": 50, "d_start": 43, "t_end": 220}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e2b25016f21f768a5dc661685e255348"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18344416"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18344416", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18344416", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18344416", "mined_sentences": [{"text": "We have investigated the effect of hyperoxia on DNA damage signaling and show that hyperoxia is a unique stress that activates the ataxia telangiectasia mutant (ATM)- and Rad3-related protein kinase (ATR)-dependent p53 phosphorylations (Ser6, -15, -37, and -392), phosphorylation of histone H2AX (Ser139), and phosphorylation of checkpoint kinase 1 (Chk1).", "section": "abstract", "t_start": 329, "d_end": 151, "d_start": 131, "t_end": 347}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "efe24a03c31ce32ed0b7ce95240a2023"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16372260"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "nervous system disease", "endocrine system disease", "genetic disorder", "skin disease", "metabolic disease", "digestive system disease"], "codes": ["EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0000701", "EFO_0001379", "EFO_0000405", "EFO_0003966"]}, "path": [["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_79226", "Orphanet_79168", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98712", "Orphanet_909"], ["EFO_0001379", "Orphanet_156638", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98712", "Orphanet_909"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_909"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000405", "Orphanet_156601", "Orphanet_101940", "Orphanet_284385", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_156601", "Orphanet_101940", "Orphanet_284385", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_156638", "Orphanet_101953", "Orphanet_181437", "Orphanet_909"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_79226", "Orphanet_79168", "Orphanet_163631", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183484", "Orphanet_909"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183484", "Orphanet_909"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_909"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_909"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_909"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68356", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_98497", "Orphanet_207015", "Orphanet_207018", "Orphanet_909"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98096", "Orphanet_909"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_909", "label": "Cerebrotendinous xanthomatosis"}, "name": ["CTX"], "id": "Orphanet_909"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16372260", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_909", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16372260", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16372260", "mined_sentences": [{"text": "According to the results, the amount of vinculin, ABP-280, talin and vimentin in leukocytes of CTX patients had changed significantly, reflecting the changes in membrane dynamics concerning cholestanol accumulation.", "section": "abstract", "t_start": 50, "d_end": 97, "d_start": 95, "t_end": 56}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0864a9ca1a5c1dd4259658397e2c972a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23771339"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23771339", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23771339", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23771339", "mined_sentences": [{"text": "This study examined expression of Ca(V)1 subtypes and the calcium-binding proteins calbindin, calmodulin and calreticulin in areas vulnerable and resistant to neurodegeneration in Parkinson's disease, in brain from neurologically normal individuals and patients with Parkinson's disease.", "section": "abstract", "t_start": 109, "d_end": 198, "d_start": 180, "t_end": 120}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "edb4e4d72dcb03ee93d0dcf197d96e0c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22266465"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22266465", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22266465", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22266465", "mined_sentences": [{"text": "GSE selectively inhibited the growth and caused cell cycle arrest and apoptotic death in both Detroit 562 and FaDu cells by activating DNA damage checkpoint cascade, including ataxia telangiectasia mutated/ataxia telangiectasia-Rad3-related-checkpoint kinase 1/2-cell division cycle 25C as well as caspases 8, 9 and 3.", "section": "abstract", "t_start": 241, "d_end": 226, "d_start": 206, "t_end": 259}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0b1c05a8b79a4932982372401e6107a3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20212154"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["Ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20212154", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20212154", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20212154", "mined_sentences": [{"text": "These consist of the well-characterized ATR (Ataxia telangiectasia and Rad-3 related)/CHK1 and ATM (Ataxia telangiectasia mutated)/CHK2 pathways in addition to a newly identified ATM/ATR/p38MAPK/MK2 checkpoint.", "section": "abstract", "t_start": 86, "d_end": 65, "d_start": 45, "t_end": 89}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "120d4066ea65c2d77b995ac7c0de867a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24730569"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24730569", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24730569", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24730569", "mined_sentences": [{"text": "We report on the DNA damage response (DDR) of human melanocytes to UV and its enhancement by \u03b1-MSH. \u03b1-MSH up-regulated the levels of XPC, the enzyme that recognizes DNA damage sites, enhanced the UV-induced phosphorylation of the DNA damage sensors ataxia telangiectasia and Rad3-related (ATR) and ataxia telangiectasia mutated (ATM) and their respect-ive substrates checkpoint kinases 1 and 2, and increased phosphorylated H2AX (\u03b3H2AX) formation.", "section": "abstract", "t_start": 367, "d_end": 269, "d_start": 249, "t_end": 386}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "6f1150610106111ea369530f337d0b3d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26028469"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26028469", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26028469", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26028469", "mined_sentences": [{"text": "Activation of peroxisome proliferator-activated receptors (PPARs), namely PPAR\u03b3 and PPAR\u03b4, has been shown to provide neuroprotection in a number of neurodegenerative disorders, such as Alzheimer's and Parkinson's disease (PD).", "section": "abstract", "t_start": 84, "d_end": 195, "d_start": 185, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "67afbe669700b173b05c718911314541"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25940791"}]}, "target": {"id": "ENSG00000111961", "gene_info": {"symbol": "SASH1", "name": "SAM and SH3 domain containing 1", "geneid": "ENSG00000111961"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["tobacco smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25940791", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O94885"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25940791", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25940791", "mined_sentences": [{"text": "Associations of loci near SASH1 and KLHL6/KLHL24 with SBP may be modulated by tobacco smoking.", "section": "abstract", "t_start": 26, "d_end": 92, "d_start": 78, "t_end": 30}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "cf28b265c94d7c56226109778f487834"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25812484"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25812484", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25812484", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25812484", "mined_sentences": [{"text": "In addition, we observed that 8-ADEQ causes phosphorylation of the cell division cycle 25C (Cdc25C) protein through the activation of checkpoint kinases 1 (Chk1) and Chk2, which in turn were activated via ataxia telangiectasia mutated (ATM)/ataxia telangiectasia-Rad3-related (ATR) kinases in response to the DNA damage.", "section": "abstract", "t_start": 134, "d_end": 261, "d_start": 241, "t_end": 153}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "6c1c7ad7c9196bb7d5a8288489592aed"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22190899"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004238", "label": "hearing loss"}, "name": ["hearing loss"], "id": "EFO_0004238"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22190899", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004238", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22190899", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22190899", "mined_sentences": [{"text": "Among these, prominent supraorbital ridges and hearing loss suggested a filaminopathy, but no filamin A mutation was found.", "section": "abstract", "t_start": 94, "d_end": 58, "d_start": 47, "t_end": 102}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "254232ee62e9d02b3f6fd24c631fdd2a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26836193"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26836193", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26836193", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26836193", "mined_sentences": [{"text": "T3D-959, a dual PPAR-\u03b4/PPAR \u03b3 nuclear receptor agonist and former diabetes drug candidate, has been repositioned as an Alzheimer's disease (AD)-modifying therapy.", "section": "abstract", "t_start": 16, "d_end": 137, "d_start": 119, "t_end": 21}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "168a398497eb0ef9ad356892033025d5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26174813"}]}, "target": {"id": "ENSG00000074590", "gene_info": {"symbol": "NUAK1", "name": "NUAK family kinase 1", "geneid": "ENSG00000074590"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26174813", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/O60285"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26174813", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26174813", "mined_sentences": [{"text": "We detected other genes suggested to be involved in synaptic plasticity, cognitive function, neurological and neuropsychiatric disorders, and smoking behavior such as NUAK1, FGF20, NETO1, BTBD9, DLG2, TOP3B, and CHRNB4.", "section": "abstract", "t_start": 167, "d_end": 148, "d_start": 142, "t_end": 171}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "96a5d2f735129171cf23061a7c61700a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20155818"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20155818", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20155818", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20155818", "mined_sentences": [{"text": "Our results build up a link between lipid metabolic regulation and immune functions, and the modulation of the expression of SRC-3 or PPAR-beta may hopefully has therapeutic modality in MS and possibly other neurodegenerative diseases.", "section": "abstract", "t_start": 134, "d_end": 233, "d_start": 208, "t_end": 142}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "101cd048903e93bef8bc188b5667ad7a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17687332"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17687332", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17687332", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17687332", "mined_sentences": [{"text": "In addition, dysfunctional telomeres might induce an ATM-independent pathway, such as ataxia telangiectasia and Rad3-related (ATR) kinase signalling, as indicated by the phosphorylation of the ATR target CHK1 in senescent cells and the response of ATM-deficient cells to telomere dysfunction.", "section": "abstract", "t_start": 204, "d_end": 106, "d_start": 86, "t_end": 207}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "fcbf4a52aa33cfc6af158b5a7824c53f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21383502"}]}, "target": {"id": "ENSG00000149554", "gene_info": {"symbol": "CHEK1", "name": "checkpoint kinase 1", "geneid": "ENSG00000149554"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21383502", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O14757"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21383502", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21383502", "mined_sentences": [{"text": "Inhibition of ataxia telangiectasia and Rad3-related checkpoint kinase 1 (ATR-Chk1), but not ataxia telangiectasia mutated (ATM), promoted genomic DNA damage and overreplication in resistant and partially sensitive cells.", "section": "abstract", "t_start": 53, "d_end": 34, "d_start": 14, "t_end": 71}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "7656ab0e78cce44c3dfafcd5636a8eec"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21745477"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21745477", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21745477", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21745477", "mined_sentences": [{"text": "Recently, we identified a protective role of heat shock proteins (HSPs), especially the small HSPB1 member, against tachycardia remodeling in experimental AF models.", "section": "abstract", "t_start": 94, "d_end": 69, "d_start": 66, "t_end": 98}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0276fc8e606f849a1e9364542e81b2ac"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15296780"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathies"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15296780", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15296780", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15296780", "mined_sentences": [{"text": "Mutations in HSPB1 and HSPB8, members of the small heat shock protein family, have recently been shown to cause some distal motor neuropathies.", "section": "abstract", "t_start": 13, "d_end": 141, "d_start": 130, "t_end": 17}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "61e51101c63ad9ab7d2255ce1133a132"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14992466"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005595"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005595", "label": "toxic encephalopathy"}, "name": ["toxic encephalopathy"], "id": "EFO_0005595"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14992466", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005595", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14992466", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14992466", "mined_sentences": [{"text": "Therefore, we investigated the presence of null genotypes for glutathione S-transferases M1 and T1 (GSTM1, GSTT1) and two genetic polymorphisms of microsomal epoxide hydrolase (mEPHX) in relation to the risk for chronic toxic encephalopathy (CTE) when exposed to solvents and smoking.", "section": "abstract", "t_start": 147, "d_end": 239, "d_start": 220, "t_end": 174}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c3b7c7e042be85c0968d5978bc2d52d9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16919951"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16919951", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16919951", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16919951", "mined_sentences": [{"text": "Sensory ataxia with neuropathy, dysarthria and ophthalmoparesis represent the clinical triad of SANDO, a specific mitochondrial phenotype first reported in 1997 in association with multiple mitochondrial DNA deletions and mutations in POLG1 or more rarely in the C10orf2 (twinkle-helicase) gene.", "section": "abstract", "t_start": 263, "d_end": 29, "d_start": 20, "t_end": 269}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "4e5be11f0905c7d4e617f966428658c5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16135556"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["IOSCA"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16135556", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16135556", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16135556", "mined_sentences": [{"text": "After analyzing all positional candidate transcripts, we identified two point mutations in the gene C10orf2 encoding Twinkle, a mitochondrial deoxyribonucleic acid (mtDNA)-specific helicase, and a rarer splice variant Twinky, underlying IOSCA.", "section": "abstract", "t_start": 100, "d_end": 241, "d_start": 237, "t_end": 106}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "12509f76c25cdde5a2fc67503127902b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17888590"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17888590", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17888590", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17888590", "mined_sentences": [{"text": "Mutations in any one of a number of sHSPs, including HSP27 (HSPB1), HSP22 (HSPB8), alphaA-crystallin (HSPB4), or alphaB-crystallin (HSPB5) can result in neuronal degeneration, myopathy, and/or cataract in humans.", "section": "abstract", "t_start": 60, "d_end": 200, "d_start": 193, "t_end": 64}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "1a26a124ad4235f4b362eb35c72fbb2d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17548691"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17548691", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17548691", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17548691", "mined_sentences": [{"text": "We evaluated potential associations between smoking and polymorphisms in PAH metabolism [CYP1A1 Ile 462Val, CYP1B1 Ala 119Ser and Leu 432Val, microsomal epoxide hydrolase (mEH) Tyr 113His and His139Arg, CYP3A4 A(-392)G] and conjugation [glutathione S-transferase (GST) M1 null deletion, GSTP1 Ile 105Val] genes and PAH-DNA adduct levels (measured by immunohistochemistry) in tumor and nontumor prostate cells in 400 prostate cancer cases.", "section": "abstract", "t_start": 142, "d_end": 50, "d_start": 44, "t_end": 169}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "da2ef4ab34e8d7697d83d1e8d3721d24"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12160895"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12160895", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12160895", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12160895", "mined_sentences": [{"text": "To investigate if the polymorphisms of metabolic traits and DNA repair modulate smoking-related DNA damage, we used sister chromatid exchange (SCE) as a marker of genetic damage to explore the relationship of microsomal epoxide hydrolase (mEH), glutathione S-transferase M1 (GSTM1), and X-ray cross-complementing group 1 (XRCC1) and cigarette smoking-induced SCE.", "section": "abstract", "t_start": 209, "d_end": 349, "d_start": 333, "t_end": 236}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8e09b597c3f9f03646166445ad567344"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22721753"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22721753", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22721753", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22721753", "mined_sentences": [{"text": "Although initially somewhat ignored, recent studies have now clearly established that the diverse members of the human family of small HSPs (HSPB1-HSPB10) play crucial roles in a wide range of cell types to maintain the integrity and function of tissues, in particular that of nervous and muscular tissue.", "section": "abstract", "t_start": 141, "d_end": 138, "d_start": 135, "t_end": 145}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "311a45cdbd4f6ec93b115f3414a8e2e9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22610071"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_54247"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_54247"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_54247"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_54247", "label": "Posterior cortical atrophy"}, "name": ["PCA"], "id": "Orphanet_54247"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22610071", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_54247", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22610071", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22610071", "mined_sentences": [{"text": "Three polymorphisms, EPHX1 Tyr113His, CYP1B1 Leu432Val and GSTT1 null/present, were associated with localized PCA risk.", "section": "abstract", "t_start": 21, "d_end": 112, "d_start": 110, "t_end": 25}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "abcc71735f55a67c7719d44212bd3d3d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18479397"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic seizures"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18479397", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18479397", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18479397", "mined_sentences": [{"text": "Biochemical and histological alterations of GS, HSP-27, and GFAP were studied after pentylenetetrazole-induced repetitive epileptic seizures (PIRS) in rats using a topographical quantification of the GS-immunoreactivity (GSIR) in relation to the focal heat shock response (HSR).", "section": "abstract", "t_start": 48, "d_end": 139, "d_start": 122, "t_end": 53}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "f62dc5bca2ed3616816b2fc964299351"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24845160"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24845160", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24845160", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24845160", "mined_sentences": [{"text": "To investigate interactions on gestational age among two environmental risk factors and four maternal genetic polymorphisms: organic solvents, passive smoking, CYP1A1 rs4646903 (MspI), EPHX1 rs2234922 (His139Arg), GSTT1 and PON2 rs12026 (Ala148Gly).", "section": "abstract", "t_start": 185, "d_end": 157, "d_start": 151, "t_end": 189}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "443cc5d97538ffe8a0e9d31952eb4064"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/12141066"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/12141066", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/12141066", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/12141066", "mined_sentences": [{"text": "To investigate the role of microsomal epoxide hydrolase (mEH) polymorphisms in the aetiology of lung cancer and to assess the interaction between mEH polymorphisms and smoking, we performed a meta-analysis of seven published studies, which included 2078 cases and 3081 controls, and a pooled analysis of eight studies (four published and four unpublished at that time) with a total of 986 cases and 1633 controls.", "section": "abstract", "t_start": 27, "d_end": 174, "d_start": 168, "t_end": 54}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "763b521e38c346660371b4db1f35282a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19439993"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19439993", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19439993", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19439993", "mined_sentences": [{"text": "We previously investigated a group of single-nucleotide polymorphisms of a set of genes coding for heat shock proteins (HSPA1A, HSPA1B and HSPA1L) and found a significant association between one HSPA1B variation and schizophrenia (SZ).", "section": "abstract", "t_start": 139, "d_end": 228, "d_start": 216, "t_end": 144}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "3e0a04496b5d441e63486f182d1950f4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21594431"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["Depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21594431", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21594431", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21594431", "mined_sentences": [{"text": "Depression was evaluated by using DSM-III-R diagnostic criteria and MMPI psychometric test; estrogen receptor (ER) by DCC.", "section": "abstract", "t_start": 118, "d_end": 9, "d_start": 0, "t_end": 120}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "83af75eadb20629a8ea37765b46687f8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22353293"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["infantile onset spinocerebellar ataxia"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22353293", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22353293", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22353293", "mined_sentences": [{"text": "A novel homozygous missense mutation c.1366C>G (L456V) in C10orf2 (the Twinkle gene) was identified, confirming infantile onset spinocerebellar ataxia in the probands.", "section": "abstract", "t_start": 58, "d_end": 149, "d_start": 112, "t_end": 64}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "9c75b54333cf9986e037584fd27cff26"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17357142"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["chronic progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17357142", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17357142", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17357142", "mined_sentences": [{"text": "We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase gamma (POLG), adenine nucleotide translocase (ANT-1) or C10orf2 (Twinkle).", "section": "abstract", "t_start": 286, "d_end": 90, "d_start": 47, "t_end": 292}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e332398bf0680597a9eee526ce4c2ab0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23379525"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23379525", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23379525", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23379525", "mined_sentences": [{"text": "The data from the literature on HspB1 and HspB3 mutations are presented, and involvement of these mutations in development of certain neurodegenerative diseases is discussed.", "section": "abstract", "t_start": 32, "d_end": 159, "d_start": 134, "t_end": 36}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "505e0717a206673d59e6da8b5ed12d63"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22301281"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22301281", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22301281", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22301281", "mined_sentences": [{"text": "Significant interactions were observed between pack-years and EPHX1-415 (P = 0.04) and smoking status and N-acetyltransferase 2-857 (P = 0.03).", "section": "abstract", "t_start": 62, "d_end": 93, "d_start": 87, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "6334aaced6e09ad6c9dc09a8f68e0b39"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18195150"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18195150", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18195150", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18195150", "mined_sentences": [{"text": "The results of screening for mutations in the nuclear genes associated with PEO and multiple mitochondrial DNA deletions, including those in POLG (polymerase gamma gene), ANT1 (gene encoding adenine nucleotide translocator 1), and PEO1, were negative, but sequencing of POLG2 revealed a G1247C mutation in exon 7, resulting in the substitution of a highly conserved glycine with an alanine at codon 416 (G416A).", "section": "abstract", "t_start": 231, "d_end": 78, "d_start": 76, "t_end": 234}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "1f0b5edc71aa444a3d1849e267b66abf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17366478"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17366478", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17366478", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17366478", "mined_sentences": [{"text": "The most significantly up-regulated species in the experimental animals was identified as heat shock 27-kDa protein, in line with findings in humans and in other experimental models of epilepsy.", "section": "abstract", "t_start": 90, "d_end": 192, "d_start": 185, "t_end": 114}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "a1c073713e5298ca1ea4ade2169bdb8b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17420318"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17420318", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17420318", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17420318", "mined_sentences": [{"text": "Microsatellite analysis and screening of the progressive external ophthalmoplegia 1 (PEO1), adenine nucleotide translocator 1 (ANT1), and polymerase gamma-1 (POLG1) genes.", "section": "abstract", "t_start": 85, "d_end": 80, "d_start": 45, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "535c449d7230f639abdf950178ae6281"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10643291"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["ARMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10643291", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10643291", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10643291", "mined_sentences": [{"text": "Preliminary results suggest that the genetic polymorphism of microsomal epoxide hydrolase is related to potential risk of ARMD.", "section": "abstract", "t_start": 61, "d_end": 125, "d_start": 122, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1999-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e237b057bf0e3ad2168044055020ba3d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19841609"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19841609", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19841609", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19841609", "mined_sentences": [{"text": "A case-control association study of 125 epileptic dogs identified five genes with suggestive association to phenobarbital drug response: KCNQ3, P=0.0003; SNC2A2, P=0.0008; EPOX HYD, P=0.0005; ABCC4, P=0.0091; and GABRA2, P=0.0130.", "section": "abstract", "t_start": 172, "d_end": 48, "d_start": 40, "t_end": 175}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "6b4dd3da09253aac4d8588ff2eed4d4d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16614120"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16614120", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16614120", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16614120", "mined_sentences": [{"text": "To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).", "section": "abstract", "t_start": 234, "d_end": 82, "d_start": 76, "t_end": 261}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "409d3bb576f6be2ec189170d7acc45a4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24621945"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24621945", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24621945", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24621945", "mined_sentences": [{"text": "Abundance of cytoprotective proteins, including various HSPs (HSP 27 and 70), were unaffected by aging/sarcopenia.", "section": "abstract", "t_start": 62, "d_end": 59, "d_start": 56, "t_end": 67}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "86c06f6cd351d26915fa3a3cab8ee705"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15055294"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["tobacco smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15055294", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15055294", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15055294", "mined_sentences": [{"text": "We illustrate the approach by application to case-control data on colorectal polyps in relation to consumption of well-done red meat and tobacco smoking via pathways involving heterocyclic amines (regulated by the genes CYP1A2, NAT1 and NAT2) and polycyclic aromatic hydrocarbons (regulated by the genes CYP1A1, EPHX1 (also called mEH) and GSTM3).", "section": "abstract", "t_start": 312, "d_end": 151, "d_start": 137, "t_end": 316}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "436fcece51648a77edc9bd042577922e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16077734"}]}, "target": {"id": "ENSG00000165246", "gene_info": {"symbol": "NLGN4Y", "name": "neuroligin 4, Y-linked", "geneid": "ENSG00000165246"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16077734", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/Q8NFZ3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16077734", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16077734", "mined_sentences": [{"text": "The neuroligin gene family consists of five members (NLGN1 at 3q26, NLGN2 at 17p13, NLGN3 at Xq13, NLGN4 at Xp22, and NLGN4Y at Yq11), of which NLGN1 and NLGN3 are located within the best loci observed in our previous genome-wide scan for autism in the Finnish sample.", "section": "abstract", "t_start": 118, "d_end": 244, "d_start": 239, "t_end": 123}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "895cea8eadd2cc0ea94d63f7ca093e1a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11849215"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11849215", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11849215", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11849215", "mined_sentences": [{"text": "We tested the hypothesis that smoking as well as genetic polymorphisms in the microsomal epoxide hydrolase gene (HYL1), an enzyme involved in benzene metabolism, could be risk factors for AML with defined chromosomal abnormalities.", "section": "abstract", "t_start": 78, "d_end": 36, "d_start": 30, "t_end": 105}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "ff3fb5cf0bc4afa45e457cc67ae47d94"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19513767"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19513767", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19513767", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19513767", "mined_sentences": [{"text": "Variations in the mitochondrial helicase Twinkle (PEO1) gene are usually associated with autosomal dominant chronic progressive external ophthalmoplegia (PEO).", "section": "abstract", "t_start": 50, "d_end": 156, "d_start": 154, "t_end": 53}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "05ff5282690a05e9d62275259404c355"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10774938"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10774938", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10774938", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10774938", "mined_sentences": [{"text": "HSPs 27, 60, 72i, 90, 110 and heat shock constitutive (HSC)70 were expressed in normal skin, but the extent and distribution of these HSPs showed considerable variation.", "section": "abstract", "t_start": 0, "d_end": 137, "d_start": 134, "t_end": 6}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "95a65c9bb0b7ecf126acaf8d153d869a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11145923"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11145923", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11145923", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11145923", "mined_sentences": [{"text": "It is known that different HSPs are expressed in skeletal muscle, namely, small HSPs (including ubiquitin, alpha B- crystallin, HSP20 and HSP 27), HSP70, HSP60 and HSP90.", "section": "abstract", "t_start": 138, "d_end": 30, "d_start": 27, "t_end": 143}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "03b45a0cd8e7f658b8ff1b7060476b4a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17205118"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["drug abuse"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17205118", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17205118", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17205118", "mined_sentences": [{"text": "Common transcriptional changes were demonstrated for a majority of drug abuse cases (N = 34), representing a number of consistently changed functional classes: Calmodulin-related transcripts (CALM1, CALM2, CAMK2B) were decreased, while transcripts related to cholesterol biosynthesis and trafficking (FDFT1, APOL2, SCARB1), and Golgi/endoplasmic reticulum (ER) functions (SEMA3B, GCC1) were all increased.", "section": "abstract", "t_start": 315, "d_end": 76, "d_start": 67, "t_end": 320}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "82f25a9a4e0c57fad374489b61b024e2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19022413"}]}, "target": {"id": "ENSG00000179399", "gene_info": {"symbol": "GPC5", "name": "glypican 5", "geneid": "ENSG00000179399"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19022413", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P78333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19022413", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19022413", "mined_sentences": [{"text": "Further candidate genes are suspected to explain the malformations associated with cerebral anomalies in the hypothesis of a contiguous gene syndrome: SPRY2 in 13q31.1 is implicated in lens cell proliferation and differentiation for congenital cataract; GPC5 in 13q32 is mainly expressed in the mesenchyme of the developing limb bud for upper limb anomalies.", "section": "abstract", "t_start": 254, "d_end": 251, "d_start": 244, "t_end": 257}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "41b0f2f64200fd35305e6c395831fede"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14688473"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSP"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14688473", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14688473", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14688473", "mined_sentences": [{"text": "Thus, the results from this first study on the relationship between stress-inducible HSP expression and IR-induced apoptosis in lung cancer cells do not support a role for HSP 27 and 72 in the radioresistance of NSCLC cells.", "section": "abstract", "t_start": 172, "d_end": 87, "d_start": 85, "t_end": 177}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "847f0135a6fed0cb94f54350d14a4eb7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11281420"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11281420", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11281420", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11281420", "mined_sentences": [{"text": "A recent association study suggested that the His113 variant of microsomal epoxide hydrolase (mEPHX) may confer a risk for development of emphysema, presumably by increasing susceptibility to smoking injury.", "section": "abstract", "t_start": 64, "d_end": 198, "d_start": 192, "t_end": 91}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "1fb958e5e82572934172d72235e21e70"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20201924"}]}, "target": {"id": "ENSG00000021762", "gene_info": {"symbol": "OSBPL5", "name": "oxysterol binding protein like 5", "geneid": "ENSG00000021762"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003829"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003829", "label": "alcohol dependence"}, "name": ["alcohol dependence"], "id": "EFO_0003829"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20201924", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003829", "target": "http://identifiers.org/uniprot/Q9H0X9"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20201924", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20201924", "mined_sentences": [{"text": "Combining evidence from the case-control study, the follow-up in families, and gene expression provided strongest support for the association of a cluster of genes on chromosome 11 (SLC22A18, PHLDA2, NAP1L4, SNORA54, CARS, and OSBPL5) with alcohol dependence.", "section": "abstract", "t_start": 227, "d_end": 257, "d_start": 240, "t_end": 232}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "d704c6f17bcbfc1303e8a2e034632ee7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24765217"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24765217", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24765217", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24765217", "mined_sentences": [{"text": "Extracellular HSPs, including Hsp72 (HSPA), Hsp27 (HSPB1), Hsp90 (HSPC), Hsp60 (HSPD), and Chaperonin/Hsp10 (HSPE) are especially attractrive candidates for DAMPs or alarmins which may be particularly relevant in the pathophysiology of the sepsis syndrome.", "section": "abstract", "t_start": 51, "d_end": 17, "d_start": 14, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "733613f31f0f7ebf5d47fd7b094a08b9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18514628"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18514628", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18514628", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18514628", "mined_sentences": [{"text": "We investigated the effects of a specific oral mixture of amino acid (AA) supplements on the antioxidant defense system, superoxide dismutase (SOD), and heat shock proteins (HSPs: HspB1, similar to Hsp 20 kDa, and HspB7) in the soleus muscle of streptozotocin (STZ)-diabetic mice by bidimensional electrophoresis and mass spectrometry.", "section": "abstract", "t_start": 180, "d_end": 177, "d_start": 174, "t_end": 184}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "f337b10d8d8e41f9758bcd8f8367f7b8"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22738861"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22738861", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22738861", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22738861", "mined_sentences": [{"text": "For the first time, we found noteworthy gene-disease associations for the functional PON1 M55L and EPHX1 H139R polymorphisms and gene-environment associations for the functional COMT V158M and NQO1 P187S polymorphisms after stratification for maternal active smoking behaviour during pregnancy.", "section": "abstract", "t_start": 99, "d_end": 265, "d_start": 259, "t_end": 103}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "d996cfb8399d7dc99dd4a42cb0ff8325"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15746160"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15746160", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15746160", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15746160", "mined_sentences": [{"text": "Therefore, we also analyzed whether environmental and genetic factors associated with DNA damage, i.e. smoking and polymorphisms in the genes involved in the metabolism of genotoxic carcinogens (EPHX1, GSTA1, GSTM1, GSTP1, GSTT1, NAT1, NAT2 and NQO1) or DNA repair (APE1, NBS1, XPC, XPD, XRCC1, XRCC3 and XRCC4), could modify the association between telomere length and cancer risk.", "section": "abstract", "t_start": 195, "d_end": 109, "d_start": 103, "t_end": 199}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "1e3378c76f02e3603245de0d77826ca9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15592518"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15592518", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15592518", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15592518", "mined_sentences": [{"text": "A subset of the differentially regulated genes, including heat-shock proteins (HSPs) H11, HSPA1L, HSPA6, HSPA8, HSPE1 and AXIN1, BRCA1, CD14, CTGF (connective tissue growth factor), GABRE (gamma-aminobutyric acid A receptor epsilon), ICAM1, SNAI1, SRD5A1 (steroid-5-alpha-reductase 1) and THY1, were validated by real-time PCR and a majority showed reciprocal expression in response to ETS1 and SP100.", "section": "abstract", "t_start": 90, "d_end": 82, "d_start": 79, "t_end": 95}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "6a5622e1f6b0bf1f0c5aa65c013f3f74"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20510150"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["AMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20510150", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20510150", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20510150", "mined_sentences": [{"text": "The SCARB1 gene has also recently been associated to AMD.", "section": "abstract", "t_start": 4, "d_end": 55, "d_start": 53, "t_end": 9}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "1a2ad2831b02ee055975471626b481de"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24252779"}]}, "target": {"id": "ENSG00000158417", "gene_info": {"symbol": "EIF5B", "name": "eukaryotic translation initiation factor 5B", "geneid": "ENSG00000158417"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24252779", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/O60841"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24252779", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24252779", "mined_sentences": [{"text": "Our and other studies have demonstrated upregulation of ER stress markers CHOP, BiP, ATF4, XBP1 and phosphorylated e-IF2 alpha (p-eIF2 alpha) in biopsy and post-mortem human multiple sclerosis (MS) samples.", "section": "abstract", "t_start": 117, "d_end": 191, "d_start": 174, "t_end": 119}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "aee5e4948646e1c7ed1750fc50a0c1ea"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16541790"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16541790", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16541790", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16541790", "mined_sentences": [{"text": "Genetic studies have revealed the following gene mutations as the causes of inherited neuropathies; PMP22, MPZ, EGR2, SOX10, SIMPLE/LITAF, ARHGEF10 for CMT1 (autosomal dominant demyelinating form); GDAP1, MTMR2, SBF2/MTMR13, KIAA1985, NDRG1 PRX for CMT4 (autosomal recessive demyelinating form), MFN2, KIF1B, RAB7, GARS, NEFL, HSPB1, HSPB8 for CMT2 (autosomal dominant axonal form); LMNA, GAN1, KCC3, TDP1, APTX, SETX for AR-CMT2 (autosomal recessive axonal form); GIB1 for CMTX (X-linked CMT); DNM2 for CMT-DI (autosomal dominant CMT with intermediate nerve conduction velocities); and DHH for minifascicular neuropathy.", "section": "abstract", "t_start": 327, "d_end": 619, "d_start": 610, "t_end": 331}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "43739961eb4aa4773b233f4640514758"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23893339"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23893339", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23893339", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23893339", "mined_sentences": [{"text": "In this study, we analyzed the potential implication of HSPA1A +190G/C, HSPA1B +1267A/G, and HSPA1L +2437T/C polymorphisms in the susceptibility to paranoid schizophrenia in a homogenous Caucasian Polish population.", "section": "abstract", "t_start": 93, "d_end": 169, "d_start": 157, "t_end": 98}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "68a0122f781b04ca9d263c5e6d01ed9e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18775955"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["IOSCA"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18775955", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18775955", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18775955", "mined_sentences": [{"text": "Infantile-onset spinocerebellar ataxia (IOSCA) is a severe neurodegenerative disorder caused by the recessive mutation in PEO1, leading to an Y508C change in the mitochondrial helicase Twinkle, in its helicase domain.", "section": "abstract", "t_start": 122, "d_end": 44, "d_start": 40, "t_end": 125}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e2c8a2dc63a1742b308aa52f33e071f3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25847151"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25847151", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25847151", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25847151", "mined_sentences": [{"text": "Microtubules, neurofilaments, and chaperones such as heat shock proteins (HSPs) also have a fundamental role in mitochondrial transport and mutations in some of related encoding genes cause peripheral neuropathy (TUBB3, NEFL, HSPB1, HSPB8, HSPB3, DNAJB2).", "section": "abstract", "t_start": 226, "d_end": 77, "d_start": 74, "t_end": 230}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "7da3cb776bfb7edf56471eb45116abe3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18647502"}]}, "target": {"id": "ENSG00000167996", "gene_info": {"symbol": "FTH1", "name": "ferritin heavy chain 1", "geneid": "ENSG00000167996"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0005815"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005815", "label": "tauopathy"}, "name": ["tauopathies"], "id": "EFO_0005815"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18647502", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005815", "target": "http://identifiers.org/uniprot/P02794"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18647502", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18647502", "mined_sentences": [{"text": "Glyceraldehyde 3-phosphate dehydrogenase, uracil DNA glycosylase, human superoxide dismutase, isocitrate dehydrogenase subunit, synaptotagmin I, thioredoxin peroxidase 1, glial fibrillary acidic protein, P25 alpha, enoyl coenzyme A hydratase short chain 1, pyridoxine-5'-phosphate oxidase, Mn-superoxide dismutase and alpha enolase were significantly upregulated in tauopathies brains, whereas antioxidant protein 2, ferritin heavy chain, glutamate dehydrogenase precursor, peptidyl-prolyl cis-trans isomerase A, serum albumin precursor and dihydropyrimidinase-related protein 2 were lowly expressed in tauopathies brains.", "section": "abstract", "t_start": 417, "d_end": 376, "d_start": 366, "t_end": 436}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "122222804e0572efac6ead8d23af773e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24294842"}]}, "target": {"id": "ENSG00000147044", "gene_info": {"symbol": "CASK", "name": "calcium/calmodulin dependent serine protein kinase", "geneid": "ENSG00000147044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003821"], ["EFO_0000618", "EFO_0005774", "EFO_0003821"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003821", "label": "migraine disorder"}, "name": ["migraine"], "id": "EFO_0003821"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24294842", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003821", "target": "http://identifiers.org/uniprot/O14936"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24294842", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24294842", "mined_sentences": [{"text": "The present study investigated the role of calcium/calmodulin-dependent serine protein kinase (CASK) in controlling P2X3 receptor expression and function in trigeminal ganglia from Cacna1a R192Q-mutated knock-in (KI) mice, a genetic model for familial hemiplegic migraine type-1.", "section": "abstract", "t_start": 43, "d_end": 270, "d_start": 263, "t_end": 92}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "635010a667e3be603bf04b032f86b889"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25178427"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["hereditary spastic paraplegia"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25178427", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25178427", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25178427", "mined_sentences": [{"text": "Boucher-Neuh\u00e4user/Gordon Holmes syndrome (PNPLA6), PHARC syndrome (ABHD12), hereditary spastic paraplegia type 28, 54 and 56 (HSP28, DDHD1; HSP54, DDHD2; HSP56, CYP2U1), Lenz Majewski syndrome (PTDSS1), spondylometaphyseal dysplasia with cone-rod dystrophy (PCYT1A), atypical haemolytic-uremic syndrome due to DGKE deficiency (DGKE).", "section": "abstract", "t_start": 126, "d_end": 104, "d_start": 76, "t_end": 130}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "895369f193b7736370aacebdd7d69b13"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25847151"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25847151", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25847151", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25847151", "mined_sentences": [{"text": "Microtubules, neurofilaments, and chaperones such as heat shock proteins (HSPs) also have a fundamental role in mitochondrial transport and mutations in some of related encoding genes cause peripheral neuropathy (TUBB3, NEFL, HSPB1, HSPB8, HSPB3, DNAJB2).", "section": "abstract", "t_start": 226, "d_end": 210, "d_start": 190, "t_end": 230}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e573d15bf0090c4c205ee2742031c333"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26728796"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26728796", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26728796", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26728796", "mined_sentences": [{"text": "Therefore, the aim of this study was to investigate the effect of Se against Pb on the messenger RNA (mRNA) expression levels of HSPs (HSP 27, 40, 60, 70, and 90); heme oxygenase-1 (HO-1); and the inflammatory cytokines nuclear factor kappa B (NF-\u03baB), tumor necrosis factor alpha (TNF-\u03b1), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) in the peripheral blood lymphocytes of chickens.", "section": "abstract", "t_start": 135, "d_end": 132, "d_start": 129, "t_end": 140}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "bba918966c7a38ef918e8158e43b1cdd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17568569"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17568569", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17568569", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17568569", "mined_sentences": [{"text": "We speculate that the overexpression of SERPINA3, IFITM1, IFITM2, IFITM3, CHI3L1, MT2A, CD14, HSPB1, HSPA1B, and HSPA1A in schizophrenia subjects represents a long-lasting and correlated signature of an early environmental insult during development that actively contributes to the pathophysiology of prefrontal dysfunction.", "section": "abstract", "t_start": 94, "d_end": 135, "d_start": 123, "t_end": 98}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "70abd68b054b7ad67b171caf401c4d6b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20142617"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20142617", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20142617", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20142617", "mined_sentences": [{"text": "The promoter region and all exonic and intronic sequences of the 10 sHSP genes (HSPB1-HSPB10) were screened in a cohort of presumed nonacquired, axonal motor and motor/sensory neuropathy patients seen at the Ohio State University Neuromuscular Clinic.", "section": "abstract", "t_start": 80, "d_end": 185, "d_start": 176, "t_end": 84}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "447515ec84e62bd91e2ea78d7288f4d3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14635118"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14635118", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14635118", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14635118", "mined_sentences": [{"text": "At least three nuclear genes are responsible for these disorders: ANT1 and C10orf2 cause autosomal dominant PEO, while mutations of DNA polymerase gammaA (POLG1 or POLG) gene on chromosome 15q25 causes both autosomal dominant and recessive forms of PEO.", "section": "abstract", "t_start": 75, "d_end": 110, "d_start": 108, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2003-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0daf623cf1817c3236a686fec0c639c9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10913664"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["ARMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10913664", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10913664", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10913664", "mined_sentences": [{"text": "Preliminary results suggest that the genetic polymorphism of microsomal epoxide hydrolase is related to potential risk of ARMD.", "section": "abstract", "t_start": 61, "d_end": 125, "d_start": 122, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "81119f55f8d83c7d57d772e040848e25"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11916503"}]}, "target": {"id": "ENSG00000158417", "gene_info": {"symbol": "EIF5B", "name": "eukaryotic translation initiation factor 5B", "geneid": "ENSG00000158417"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastomas"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11916503", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/O60841"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11916503", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11916503", "mined_sentences": [{"text": "We have analyzed cerebellar medulloblastomas from 51 adults (>16 years of age) for MDM2 gene amplification (by differential polymerase chain reaction assay), TP53 gene mutation (by polymerase chain reaction single-strand conformation polymorphism analysis of exons 5-8), and immunohistochemical expression of p53 (clone DO1) and MDM2 (clone IF2).", "section": "abstract", "t_start": 341, "d_end": 43, "d_start": 28, "t_end": 343}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "27d2d77af4f98a8d86f297ae2609ad3a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19496026"}]}, "target": {"id": "ENSG00000204390", "gene_info": {"symbol": "HSPA1L", "name": "heat shock protein family A (Hsp70) member 1 like", "geneid": "ENSG00000204390"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSP"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19496026", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P34931"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19496026", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19496026", "mined_sentences": [{"text": "Twelve sequences demonstrated temperature-dependent responses that differed significantly between patients with sepsis and noninfectious SIRS: CXCL-13; heat shock proteins DNAJB12 and DNAJC4; the F11 receptor; folate hydrolase 1; HSF-2; HSP 70 proteins HSPA1A, HSPA1B, and HSPA1L; interleukin 8; lipopolysaccharide binding protein; and prostaglandin E synthase.", "section": "abstract", "t_start": 273, "d_end": 239, "d_start": 237, "t_end": 278}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "5db4175ad63c67051d9676998cd85740"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24327207"}]}, "target": {"id": "ENSG00000167996", "gene_info": {"symbol": "FTH1", "name": "ferritin heavy chain 1", "geneid": "ENSG00000167996"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease", "genetic disorder"], "codes": ["EFO_0003966", "EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98694", "Orphanet_95"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_95"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98694", "Orphanet_95"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_95"], ["EFO_0000508", "Orphanet_71859", "Orphanet_98497", "Orphanet_207015", "Orphanet_207025", "Orphanet_207028", "Orphanet_95"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_95", "label": "Friedreich ataxia"}, "name": ["FRDA"], "id": "Orphanet_95"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24327207", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_95", "target": "http://identifiers.org/uniprot/P02794"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24327207", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24327207", "mined_sentences": [{"text": "Silencing of FXN expressions occurred both in somatic FRDA-skin fibroblasts and two of the induced pluripotent stem cells (iPSC) clones; a sign of stress condition was shown in FRDA-iPSC cardiomyocytes with disorganized mitochondrial network and mitochondrial DNA (mtDNA) depletion; hypertrophic cardiac stress responses were observed by an increase in \u03b1-actinin-positive cell sizes revealed by FACS analysis as well as elevation in brain natriuretic peptide (BNP) gene expression; the intracellular iron accumulated in FRDA cardiomyocytes might be due to attenuated negative feedback response of transferring receptor (TSFR) expression and positive feedback response of ferritin (FTH1); energy synthesis dynamics, in terms of ATP production rate, was impaired in FRDA-iPSC cardiomyocytes, which were prone to iron overload condition.", "section": "abstract", "t_start": 681, "d_end": 57, "d_start": 54, "t_end": 684}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "9a0ff01cfad74d02189201f5e11405c7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27220440"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005595"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005595", "label": "toxic encephalopathy"}, "name": ["toxic encephalopathy"], "id": "EFO_0005595"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27220440", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005595", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27220440", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27220440", "mined_sentences": [{"text": "Therefore, this research we observed the glutathione transferase M1 and T1 (GSTM1, GSTT1) deletion mutation genotype, two kinds of microsomal epoxide hydrolase (mEPHX) genetic polymorphism, organic solvents exposure and smoking effection in chronic cases of toxic encephalopathy (CTE) correlation.", "section": "abstract", "t_start": 131, "d_end": 277, "d_start": 258, "t_end": 158}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "a95bde7dc22b4aaba171c735ebccc2a6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27220440"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27220440", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27220440", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27220440", "mined_sentences": [{"text": "Therefore, this research we observed the glutathione transferase M1 and T1 (GSTM1, GSTT1) deletion mutation genotype, two kinds of microsomal epoxide hydrolase (mEPHX) genetic polymorphism, organic solvents exposure and smoking effection in chronic cases of toxic encephalopathy (CTE) correlation.", "section": "abstract", "t_start": 131, "d_end": 226, "d_start": 220, "t_end": 158}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "142377fef77fc371af2617be412e5844"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/14992466"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/14992466", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/14992466", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/14992466", "mined_sentences": [{"text": "Therefore, we investigated the presence of null genotypes for glutathione S-transferases M1 and T1 (GSTM1, GSTT1) and two genetic polymorphisms of microsomal epoxide hydrolase (mEPHX) in relation to the risk for chronic toxic encephalopathy (CTE) when exposed to solvents and smoking.", "section": "abstract", "t_start": 147, "d_end": 282, "d_start": 276, "t_end": 174}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2002-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "83e740f1928c793b7670f0d7d91772bd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15349030"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15349030", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15349030", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15349030", "mined_sentences": [{"text": "These studies implicate variation in the genes encoding the alpha(2)-adrenergic receptor, interleukin-10, glutathione S-transferase M1, interleukin-1 beta and interleukin-1 receptor antagonist, matrix metalloproteinases 1 and 12, interleukin-4 receptor alpha-chain, alpha(1)-antitrypsin, and microsomal epoxide hydrolase, as well as unknown genes on chromosomes 1p, 5q and 17p as contributing toward susceptibility in smoking exposed individuals.", "section": "abstract", "t_start": 292, "d_end": 424, "d_start": 418, "t_end": 319}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "9bb52da24796cab236ef55d6de3818c1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20627326"}]}, "target": {"id": "ENSG00000167996", "gene_info": {"symbol": "FTH1", "name": "ferritin heavy chain 1", "geneid": "ENSG00000167996"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["drug abuse"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20627326", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P02794"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20627326", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20627326", "mined_sentences": [{"text": "This paper will review recently identified mechanisms of opiate-induced CXCR4 impairment in neurons and introduce results from pilot studies in human brain tissue, which highlight the role of the protein ferritin heavy chain in HIV neuropathology in patients with history of drug abuse.", "section": "abstract", "t_start": 204, "d_end": 284, "d_start": 275, "t_end": 223}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0f34c9b62e40dc2c08fcb4be4faa3f6a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26556829"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26556829", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26556829", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26556829", "mined_sentences": [{"text": "Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6).", "section": "abstract", "t_start": 188, "d_end": 436, "d_start": 416, "t_end": 192}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "717e9d8062557c80dc34efc90182d570"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26556829"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["hereditary spastic paraplegia"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26556829", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26556829", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26556829", "mined_sentences": [{"text": "Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6).", "section": "abstract", "t_start": 188, "d_end": 377, "d_start": 349, "t_end": 192}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "ef8aaa4387d8b02dbf7916f135275294"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25178427"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "eye disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0003966", "EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352309", "Orphanet_171848"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98657", "Orphanet_71862", "Orphanet_98661", "Orphanet_171848"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98657", "Orphanet_71862", "Orphanet_98661", "Orphanet_171848"], ["EFO_0000508", "Orphanet_71859", "Orphanet_98497", "Orphanet_207015", "Orphanet_171848"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_171848"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352309", "Orphanet_171848"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_171848"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_171848", "label": "Polyneuropathy - hearing loss - ataxia - retinitis pigmentosa - cataract"}, "name": ["PHARC syndrome"], "id": "Orphanet_171848"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25178427", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_171848", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25178427", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25178427", "mined_sentences": [{"text": "Boucher-Neuh\u00e4user/Gordon Holmes syndrome (PNPLA6), PHARC syndrome (ABHD12), hereditary spastic paraplegia type 28, 54 and 56 (HSP28, DDHD1; HSP54, DDHD2; HSP56, CYP2U1), Lenz Majewski syndrome (PTDSS1), spondylometaphyseal dysplasia with cone-rod dystrophy (PCYT1A), atypical haemolytic-uremic syndrome due to DGKE deficiency (DGKE).", "section": "abstract", "t_start": 126, "d_end": 64, "d_start": 51, "t_end": 130}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "b4cf71c2e8d630fab44fa619c889c513"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26782567"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26782567", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26782567", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26782567", "mined_sentences": [{"text": "Three of the differentially expressed HSPs, namely HP90A, HSPB1, and HSPB2, were upregulated.", "section": "abstract", "t_start": 58, "d_end": 41, "d_start": 38, "t_end": 62}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "2515c4d3ec8b98a80814d2691dc739f7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/27421065"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/27421065", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/27421065", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/27421065", "mined_sentences": [{"text": "We investigated the potential role of genetic variants of xenobiotic-metabolising enzymes (glutathione-S-transferase M1, GSTM1; glutathione-S-transferase T1, GSTT1; microsomal epoxide hydrolase, mEH), oxidative stress (assessed by urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxodG/creatinine), sex, ageing and smoking habits on susceptibility to development of COPD and its severity in Serbian population.", "section": "abstract", "t_start": 165, "d_end": 319, "d_start": 313, "t_end": 192}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "f624b9b7125bc21fa4e838e348ddb4f0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/9426298"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/9426298", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/9426298", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/9426298", "mined_sentences": [{"text": "Two types of organic substances are believed to counteract the adverse effects of high intracellular urea concentrations: specific organic osmolytes of the trimethylamine family [betaine and glycerophosphorylcholine (GPC)], which accumulate in renal medullary cells during prolonged periods of antidiuresis and cytoprotective heat shock proteins (HSPs), the tissue content of two of which (HSPs 27 and 72) is much higher in the inner medulla than in the iso-osmotic renal cortex.", "section": "abstract", "t_start": 390, "d_end": 350, "d_start": 347, "t_end": 396}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1998-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "5a6dfbd4e048adcf1ff163e92aae6425"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19461950"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19461950", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19461950", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19461950", "mined_sentences": [{"text": "Ectopic expression studies reveal that even small changes in expression of IDO, HMOX-1, or mitochondrial superoxide dismutase (SOD2) can prevent demyelination in experimental autoimmune encephalomyelitis (EAE) animal models of MS.", "section": "abstract", "t_start": 127, "d_end": 207, "d_start": 205, "t_end": 130}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "4da2968651743ee165e5bd2c4b91629e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23761047"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23761047", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23761047", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23761047", "mined_sentences": [{"text": "To study mitochondrial aerobic metabolism function and protein expression in platelets of multiple sclerosis (MS) patients and control subjects, mitochondrial aconitase, mitochondrial superoxide dismutases 1 and 2 (SOD1 and SOD2), and respiratory complex enzyme activities in platelets of MS patients and control subjects were determined.", "section": "abstract", "t_start": 224, "d_end": 107, "d_start": 90, "t_end": 227}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "5152ad23af068f1586b9e6d1c5d07647"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22283595"}]}, "target": {"id": "ENSG00000146282", "gene_info": {"symbol": "RARS2", "name": "arginyl-tRNA synthetase 2, mitochondrial", "geneid": "ENSG00000146282"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22283595", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q5T160"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22283595", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22283595", "mined_sentences": [{"text": "The major genetic causes of mitochondrial epilepsy are mitochondrial DNA mutations (including those typically associated with the mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS] and myoclonic epilepsy with ragged red fibres [MERRF] syndromes); mutations in POLG (classically associated with Alpers syndrome but also presenting as the mitochondrial recessive ataxia syndrome [MIRAS], spinocerebellar ataxia with epilepsy [SCAE], and myoclonus, epilepsy, myopathy, sensory ataxia [MEMSA] syndromes in older individuals) and other disorders of mitochondrial DNA maintenance; complex I deficiency; disorders of coenzyme Q(10) biosynthesis; and disorders of mitochondrial translation such as RARS2 mutations.", "section": "abstract", "t_start": 722, "d_end": 49, "d_start": 42, "t_end": 726}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "80f708aaf06738c1fb4ba691e327aa38"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25052559"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25052559", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25052559", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25052559", "mined_sentences": [{"text": "Several statistically significant interactions were observed between smoking and genetic variants (CYP1A2 1548C>T, CYP1A1 3801T>C, CYP1B1 4326G>C, NAT1 c.-85-1014T>A, UGT1A7 W208R 622T>C, SOD2 c.47T>C, GSTT1 deletion).", "section": "abstract", "t_start": 188, "d_end": 75, "d_start": 69, "t_end": 191}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "815de6a9d8ea8be06e3d0afd6238805b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/11519163"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/11519163", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/11519163", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/11519163", "mined_sentences": [{"text": "Antibodies to ribosomal P protein appear to be a specific marker for SLE with depression.", "section": "abstract", "t_start": 24, "d_end": 87, "d_start": 78, "t_end": 32}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2001-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "18c29e91e0d76070971f8e8b179424be"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10363321"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10363321", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10363321", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10363321", "mined_sentences": [{"text": "As a biological marker, antiribosomal P protein antibodies have been closely related to SLE psychosis although their pathogenic role and specificity is under discussion.", "section": "abstract", "t_start": 38, "d_end": 100, "d_start": 92, "t_end": 46}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1999-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "14a4ce19f419635fec375c30b1a5f5f3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10561523"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10561523", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10561523", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10561523", "mined_sentences": [{"text": "Hydroxyl radical (.OH) levels in blood, superoxide dismutase (SOD) activity in plasma (plasma-SOD) and in red blood cells (RBC) relative to Cu,Zn-SOD (SOD1) protein (RBC-SOD/SOD1), SOD1 protein in RBC (SOD1/RBC) and plasma (SOD1/plasma), and Mn-SOD protein in plasma (SOD2/plasma) were measured in patients with Parkinson's disease (PD), multiple-system atrophy (MSA) with parkinsonism, and in control subjects.", "section": "abstract", "t_start": 268, "d_end": 330, "d_start": 312, "t_end": 271}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1999-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "7fb8f5ad2415a6010799855464df59b3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18521840"}]}, "target": {"id": "ENSG00000160305", "gene_info": {"symbol": "DIP2A", "name": "disco interacting protein 2 homolog A", "geneid": "ENSG00000160305"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005424"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005424", "label": "dyslexia"}, "name": ["dyslexia"], "id": "EFO_0005424"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18521840", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005424", "target": "http://identifiers.org/uniprot/Q14689"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18521840", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18521840", "mined_sentences": [{"text": "In this article, we report the identification of four new dyslexia candidate genes (PCNT, DIP2A, S100B, and PRMT2) on chromosome region 21q22.3 by FISH and SNP microarray analyses of a very small deletion in this region, which cosegregates with dyslexia in a father and his three sons.", "section": "abstract", "t_start": 90, "d_end": 65, "d_start": 58, "t_end": 94}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "2407ba694741cde9f1697719dd3603ea"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24757000"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24757000", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24757000", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24757000", "mined_sentences": [{"text": "For all other subtypes, also denoted \"Secondary 3-methylglutaconic acidurias\" (TAZ defect or Barth syndrome, SERAC1 defect or MEGDEL syndrome, OPA3 defect or Costeff syndrome, DNAJC19 defect or DCMA syndrome, TMEM70 defect, \"not otherwise specified (NOS) 3-MGA-uria\"), the origin of 3-methylglutaconic aciduria remains enigmatic but is hypothesized to be independent from leucine catabolism.", "section": "abstract", "t_start": 109, "d_end": 140, "d_start": 126, "t_end": 114}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "21943d891ac73fc4f59cdee49ec517dd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17359361"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17359361", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17359361", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17359361", "mined_sentences": [{"text": "In ALS muscles we found normal levels of manganese superoxide dismutase (SOD2) that is assumed as related to mitochondrial DNA abnormalities.", "section": "abstract", "t_start": 73, "d_end": 5, "d_start": 3, "t_end": 76}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "2ec033075b954841df7d5af165c390c1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24204716"}]}, "target": {"id": "ENSG00000101680", "gene_info": {"symbol": "LAMA1", "name": "laminin subunit alpha 1", "geneid": "ENSG00000101680"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756", "EFO_0003758"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003758", "label": "autism"}, "name": ["autism"], "id": "EFO_0003758"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24204716", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003758", "target": "http://identifiers.org/uniprot/P25391"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24204716", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24204716", "mined_sentences": [{"text": "Some of these maternal and maternal-child associations were in or adjacent to autism candidate genes including: PCDH9, FOXP1, GABRB3, NRXN1, RELN, MACROD2, FHIT, RORA, CNTN4, CNTNAP2, FAM135B, LAMA1, NFIA, NLGN4X, RAPGEF4, and SDK1.", "section": "abstract", "t_start": 193, "d_end": 83, "d_start": 78, "t_end": 197}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0ba1a26c24be10e9f1ed041bcf39f259"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18759352"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003096"], ["EFO_0000618", "EFO_0005774", "EFO_0003096"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0003096"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003096", "label": "Pick disease"}, "name": ["frontotemporal lobar degeneration"], "id": "EFO_0003096"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18759352", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003096", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18759352", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18759352", "mined_sentences": [{"text": "Direct sequencing analyses were performed in 19 genes, including ALS/frontotemporal lobar degeneration (FTLD)-related genes (SOD2, SOD3, ALS2/alsin, SMN1, PGRN, ANG, VEGF, VCP, VAPB, DCTN1, CHMP2B, and TARDBP or TDP-43), tauopathy-related gene (GSK3beta), and parkinsonism-related genes (alpha-synuclein, LRRK2, parkin, DJ-1, PINK1, and ATP13A2).", "section": "abstract", "t_start": 125, "d_end": 101, "d_start": 69, "t_end": 128}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c14c371dfab534cc0319c0daa71b7335"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/17289545"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/17289545", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/17289545", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/17289545", "mined_sentences": [{"text": "In this respect, anti-ribosomal P protein antibodies were shown by many to occur in association with SLE neuropsychiatric manifestations, mainly psychosis.", "section": "abstract", "t_start": 32, "d_end": 153, "d_start": 145, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2007-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8be5a0cdfaf682b5b7f1653087161fb4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19841609"}]}, "target": {"id": "ENSG00000125257", "gene_info": {"symbol": "ABCC4", "name": "ATP binding cassette subfamily C member 4", "geneid": "ENSG00000125257"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epileptic"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19841609", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/O15439"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19841609", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19841609", "mined_sentences": [{"text": "A case-control association study of 125 epileptic dogs identified five genes with suggestive association to phenobarbital drug response: KCNQ3, P=0.0003; SNC2A2, P=0.0008; EPOX HYD, P=0.0005; ABCC4, P=0.0091; and GABRA2, P=0.0130.", "section": "abstract", "t_start": 192, "d_end": 48, "d_start": 40, "t_end": 196}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "2c1295429a0f44223edd76febc4fe9a9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18759352"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0005815"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005815", "label": "tauopathy"}, "name": ["tauopathy"], "id": "EFO_0005815"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18759352", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005815", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18759352", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18759352", "mined_sentences": [{"text": "Direct sequencing analyses were performed in 19 genes, including ALS/frontotemporal lobar degeneration (FTLD)-related genes (SOD2, SOD3, ALS2/alsin, SMN1, PGRN, ANG, VEGF, VCP, VAPB, DCTN1, CHMP2B, and TARDBP or TDP-43), tauopathy-related gene (GSK3beta), and parkinsonism-related genes (alpha-synuclein, LRRK2, parkin, DJ-1, PINK1, and ATP13A2).", "section": "abstract", "t_start": 125, "d_end": 229, "d_start": 221, "t_end": 128}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "def36c7397f922645ec6fe9eb312622e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22283595"}]}, "target": {"id": "ENSG00000146282", "gene_info": {"symbol": "RARS2", "name": "arginyl-tRNA synthetase 2, mitochondrial", "geneid": "ENSG00000146282"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "nervous system disease", "genetic disorder", "muscular disease", "metabolic disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_726"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_726"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_726"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_726"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_726"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_726"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_726"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_726"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_726"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_726"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_726"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_726"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_726"], ["EFO_0000618", "EFO_0005774", "Orphanet_726"], ["EFO_0000508", "Orphanet_71859", "Orphanet_98497", "Orphanet_207015", "Orphanet_207018", "Orphanet_225703", "Orphanet_726"], ["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_726"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_726", "label": "Alpers syndrome"}, "name": ["Alpers syndrome"], "id": "Orphanet_726"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22283595", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_726", "target": "http://identifiers.org/uniprot/Q5T160"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22283595", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22283595", "mined_sentences": [{"text": "The major genetic causes of mitochondrial epilepsy are mitochondrial DNA mutations (including those typically associated with the mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS] and myoclonic epilepsy with ragged red fibres [MERRF] syndromes); mutations in POLG (classically associated with Alpers syndrome but also presenting as the mitochondrial recessive ataxia syndrome [MIRAS], spinocerebellar ataxia with epilepsy [SCAE], and myoclonus, epilepsy, myopathy, sensory ataxia [MEMSA] syndromes in older individuals) and other disorders of mitochondrial DNA maintenance; complex I deficiency; disorders of coenzyme Q(10) biosynthesis; and disorders of mitochondrial translation such as RARS2 mutations.", "section": "abstract", "t_start": 722, "d_end": 340, "d_start": 326, "t_end": 726}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "376c57045291f68212cfb427781552b2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26020962"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26020962", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26020962", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26020962", "mined_sentences": [{"text": "Compared to healthy individuals, SOD2 activity is lower in the brain and spinal cord of ALS patients [66].", "section": "discussion", "t_start": 33, "d_end": 90, "d_start": 88, "t_end": 36}, {"text": "Peroxynitrite, which is highly prevalent in ALS spinal cord, is the only known biological oxidant to inactivate enzymatic activity, nitrate important tyrosine residues and cause dityrosine formation in SOD2 [68].", "section": "discussion", "t_start": 202, "d_end": 46, "d_start": 44, "t_end": 205}, {"text": "In ALS, activated microglia use the NF-\u03baB pathway to induce mitochondrial dysfunction inhibition of SOD2 and motor neuron death [70,71].", "section": "discussion", "t_start": 100, "d_end": 5, "d_start": 3, "t_end": 103}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "a24e7045690a00792aa1dc79f7e47c7d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22244747"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22244747", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22244747", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22244747", "mined_sentences": [{"text": "The changes in mitochondrial activity in brain and reduced expressions of superoxide dismutase (SOD1, SOD2), mitofusin (Mfn1, Mfn2) as well as brain-derived neurotrophic factor (BDNF) suggest that both CORT and CUMS may impair mitochondrial function and/or expressions of mitofusion and antioxidant enzymes that, in turn, may increase oxidative stress and reduce energy production in brain with depression-like behaviors.", "section": "abstract", "t_start": 102, "d_end": 404, "d_start": 395, "t_end": 105}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "d02bbf3515ae5c9887fd4bafc961651a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19048113"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastomas"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19048113", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19048113", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19048113", "mined_sentences": [{"text": "Inappropriate Hedgehog (Hh) signaling underlies development of a subset of medulloblastomas, and tumors with elevated HH signaling activity express the stem cell self-renewal gene BMI1.", "section": "abstract", "t_start": 180, "d_end": 90, "d_start": 75, "t_end": 183}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "2378b0d09c1abd51107851a39d45284a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16385548"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16385548", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16385548", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16385548", "mined_sentences": [{"text": "To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P proteins (anti-P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for psychosis, mood disorder, or both, and for other diffuse manifestations.", "section": "abstract", "t_start": 78, "d_end": 180, "d_start": 172, "t_end": 87}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "9577b8086dd5e1a395099ca2d76587fe"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10909150"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10909150", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10909150", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10909150", "mined_sentences": [{"text": "Autoantibodies directed against the ribosomal P proteins, P0, P1 and P2 (anti-P), have been related to lupus-related psychosis and/or depression.", "section": "abstract", "t_start": 46, "d_end": 143, "d_start": 134, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "fa01353b069cc0f3f6f9645b868bcaca"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23335992"}]}, "target": {"id": "ENSG00000157456", "gene_info": {"symbol": "CCNB2", "name": "cyclin B2", "geneid": "ENSG00000157456"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "reproductive system disease", "immune system disease", "endocrine system disease", "genetic disorder", "skin disease", "nervous system disease"], "codes": ["EFO_0000512", "EFO_0000618", "EFO_0000540", "EFO_0000508", "EFO_0000701", "EFO_0003966", "EFO_0001379"]}, "path": [["EFO_0000508", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000701", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_140162", "Orphanet_183422", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000540", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183598", "Orphanet_98610", "Orphanet_98611", "Orphanet_98613", "Orphanet_100"], ["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_100"], ["EFO_0000508", "Orphanet_183770", "Orphanet_101997", "Orphanet_179006", "Orphanet_331217", "Orphanet_169346", "Orphanet_100"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139027", "Orphanet_100"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_68346", "Orphanet_183472", "Orphanet_183478", "Orphanet_100"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_100"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_100"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98097", "Orphanet_100"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98688", "Orphanet_100"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_100", "label": "Ataxia-telangiectasia"}, "name": ["ataxia-telangiectasia"], "id": "Orphanet_100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23335992", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_100", "target": "http://identifiers.org/uniprot/O95067"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23335992", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23335992", "mined_sentences": [{"text": "Using quantitative PCR, we found that MIR promoted the expression levels of ATM (ataxia telangiectasia mutated), ATR (ataxia-telangiectasia and Rad3-related and Rad3-related), TP53 (tumor protein p53), p21 (CDKN1A, cyclin-dependent kinase inhibitor 1A) and GADD45 (growth arrest and DNA-damage inducible), but decreased the expression levels of cyclin B coding genes, CCNB1 and CCNB2, as well as CDK1 (Cyclin-dependent kinase 1).", "section": "abstract", "t_start": 378, "d_end": 138, "d_start": 118, "t_end": 382}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c2ba0b42e6fec9bfc347fcdb52698bfa"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/2410442"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0007542"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007542", "label": "visna"}, "name": ["visna"], "id": "EFO_0007542"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/2410442", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007542", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/2410442", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/2410442", "mined_sentences": [{"text": "The double labeling technique was also applied to sections of paraffin-embedded tissues from a sheep infected with visna virus and mice infected with the HNT strain of measles virus.", "section": "abstract", "t_start": 154, "d_end": 119, "d_start": 115, "t_end": 156}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1985-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "662e0d3777aacfa6fddd58c3f4a8da67"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16505602"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16505602", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16505602", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16505602", "mined_sentences": [{"text": "Three months later she developed depression with positive anti-ribosomal P protein antibody that was indicative of central nervous system lupus.", "section": "abstract", "t_start": 73, "d_end": 42, "d_start": 33, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "dc70cb3e0650406a32a89a67dde09225"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23552370"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0003885"], ["EFO_0000540", "EFO_0005140", "EFO_0003885"], ["EFO_0000618", "EFO_0003885"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003885", "label": "multiple sclerosis"}, "name": ["multiple sclerosis"], "id": "EFO_0003885"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23552370", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003885", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23552370", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23552370", "mined_sentences": [{"text": "The amyloid-forming proteins tau, \u03b1B crystallin, and amyloid P protein are all found in lesions of multiple sclerosis (MS).", "section": "abstract", "t_start": 61, "d_end": 116, "d_start": 99, "t_end": 69}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "d01ce6852cb42692f36372392d204f7d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25178427"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25178427", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25178427", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25178427", "mined_sentences": [{"text": "Here we provide an overview on both pathophysiology and the extremely heterogeneous clinical presentations of the disorders reported so far (Sengers syndrome (due to mutations in AGK), MEGDEL syndrome (or SERAC defect, SERAC1), Barth syndrome (or TAZ defect, TAZ), congenital muscular dystrophy due to CHKB deficiency (CHKB).", "section": "abstract", "t_start": 219, "d_end": 199, "d_start": 185, "t_end": 224}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "086e17c98202ca3d29b09b35c075f085"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25595726"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25595726", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25595726", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25595726", "mined_sentences": [{"text": "A common mitochondrial cause for 3-methylglutaconic aciduria appears to be disruption of the architecture of the mitochondrial membranes, as in Barth syndrome (tafazzin deficiency), Sengers syndrome (acylglycerol kinase deficiency) and MEGDEL syndrome (impaired remodelling of the mitochondrial membrane lipids because of SERAC1 mutations).", "section": "abstract", "t_start": 322, "d_end": 250, "d_start": 236, "t_end": 327}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "26f16ce72267f6fab4b7530a5509e1c3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23563589"}]}, "target": {"id": "ENSG00000104164", "gene_info": {"symbol": "BLOC1S6", "name": "biogenesis of lysosomal organelles complex 1 subunit 6", "geneid": "ENSG00000104164"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23563589", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q9UL45"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23563589", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23563589", "mined_sentences": [{"text": "As it is known that HPS is caused by a local mutation in one of the human genes, named HPS1 to HPS8 and PLDN (HPS9), encoding subunit proteins involved in endosomal trafficking pathways, here, we report the mutation causing the siblings disease and a case-control association study of schizophrenia using polymorphisms of a gene to be screened in the mutation analysis.", "section": "abstract", "t_start": 104, "d_end": 297, "d_start": 285, "t_end": 107}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "f925e01848f4159376bcbcec8b0573bc"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/10909150"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/10909150", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/10909150", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/10909150", "mined_sentences": [{"text": "Autoantibodies directed against the ribosomal P proteins, P0, P1 and P2 (anti-P), have been related to lupus-related psychosis and/or depression.", "section": "abstract", "t_start": 46, "d_end": 125, "d_start": 117, "t_end": 55}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2000-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c5a839cd8bf5dc983a1fa04b1a9c4f9b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15349865"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0005855"], ["EFO_0000618", "EFO_0005855"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005855", "label": "narcolepsy without cataplexy"}, "name": ["narcolepsy"], "id": "EFO_0005855"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15349865", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005855", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15349865", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15349865", "mined_sentences": [{"text": "A single haplotype was shared by all affected individuals and informative crossovers indicated that the elusive gene that confers susceptibility to narcolepsy is likely to be located between markers D21S267 and ABCG1, in a 5.15 Mb region of 21q.", "section": "abstract", "t_start": 211, "d_end": 157, "d_start": 148, "t_end": 215}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "cc5fb5b490ee76dad98e3a45d33cee07"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25877001"}]}, "target": {"id": "ENSG00000160305", "gene_info": {"symbol": "DIP2A", "name": "disco interacting protein 2 homolog A", "geneid": "ENSG00000160305"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005424"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005424", "label": "dyslexia"}, "name": ["dyslexia"], "id": "EFO_0005424"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25877001", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005424", "target": "http://identifiers.org/uniprot/Q14689"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25877001", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25877001", "mined_sentences": [{"text": "We aimed at discovering single nucleotide variation present in known and new candidate genes for developmental dyslexia: CYP19A1, DCDC2, DIP2A, DYX1C1, GCFC2 (also known as C2orf3), KIAA0319, MRPL19, PCNT, PRMT2, ROBO1 and S100B.", "section": "abstract", "t_start": 137, "d_end": 118, "d_start": 111, "t_end": 141}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "57df5bce18eb0e6f03bce317be1c78b5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18411704"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18411704", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18411704", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18411704", "mined_sentences": [{"text": "As to risks of rapid onset of methamphetamine psychosis, worse prognosis or complication of spontaneous relapse, the dopamine D2 receptors, dopamine transporter, monoamine oxidase-A, catechol-O-methyltransferese, SOD2, NQO2, PICK1 gene were identified.", "section": "abstract", "t_start": 213, "d_end": 54, "d_start": 46, "t_end": 216}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "0d436cd3d8541a6aa75ec6ab96bf656e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23583561"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_0001063"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001063", "label": "deafness"}, "name": ["deafness"], "id": "EFO_0001063"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23583561", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001063", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23583561", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23583561", "mined_sentences": [{"text": "Whereas similar disorders and similar-looking coat colour phenotypes sometimes have a different genetic background (e.g., deafness [EDN3/EDNRB, MITF, PAX and SNAI2] and visual diseases [OCA2, RAB38, SLC24A5, SLC45A2, TRPM1 and TYR]).", "section": "abstract", "t_start": 186, "d_end": 129, "d_start": 122, "t_end": 189}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-06-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "88f0bb7701d5d7da987f508cc3127184"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16618365"}]}, "target": {"id": "ENSG00000135404", "gene_info": {"symbol": "CD63", "name": "CD63 molecule", "geneid": "ENSG00000135404"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "EFO_0003105"], ["EFO_0000618", "EFO_0003105"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003105", "label": "spina bifida"}, "name": ["spina bifida"], "id": "EFO_0003105"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16618365", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003105", "target": "http://identifiers.org/uniprot/P08962"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16618365", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16618365", "mined_sentences": [{"text": "The aim of this work was to evaluate the sensitization profile to single NRL allergens in children without spina bifida and without repeated surgical interventions, by using different recombinant and natural latex allergens in two analytical techniques: specific serum immunoglobulin E (IgE) quantification and flow cytometry determination of activated basophils expressing CD63, after stimulating cells from patients with NRL allergens.", "section": "abstract", "t_start": 374, "d_end": 118, "d_start": 107, "t_end": 377}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8d78b7c923a5267370bed6a227d6698d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21215776"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21215776", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21215776", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21215776", "mined_sentences": [{"text": "The results indicated that: (1) SKNBE neuroblastoma cells treated with sodium selenite, sodium selenate and seleno-methionine (0.1, 0.5 and 0.5 \u03bcM, respectively) for 24h exhibited a viability decrease, unlike kidney or prostatic cells; (2) the PARP (poly-ADP-ribose-polymerase) degradation and caspase activation detected by Western blot and flow cytometry fluorimetric examination showed induction of apoptosis; (3) during selenium treatment, a ROS/RNS increase occurred despite the GSH increment, as revealed by fluorimetric analysis; (4) the RNS production could be blocked by a peroxynitrite scavenger; (5) after exposure to selenium compounds, the concentration of nitric oxide synthase, manganese superoxide dismutase (SOD2), P-NF-kB (phospho nuclear factor kB), glutathione reductase and glutathione peroxidase increased, whereas that of P-ERK (phospho extracellular signal-regulated kinase) decreased; (6) selenium presence induced copper/zinc superoxide dismutase (SOD1) translocation into mitochondria, in a way similar to what is observed in amyotrophic lateral sclerosis (ALS).", "section": "abstract", "t_start": 725, "d_end": 1086, "d_start": 1084, "t_end": 728}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e81403b415ffa745754f498e21cd9dc1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23295227"}]}, "target": {"id": "ENSG00000117448", "gene_info": {"symbol": "AKR1A1", "name": "aldo-keto reductase family 1 member A1", "geneid": "ENSG00000117448"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100", "EFO_1000783"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000783", "label": "diabetic neuropathy"}, "name": ["diabetic neuropathy"], "id": "EFO_1000783"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23295227", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000783", "target": "http://identifiers.org/uniprot/P14550"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23295227", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23295227", "mined_sentences": [{"text": "Previously, fidarestat was found to be safe in phase III trials for diabetic neuropathy and, consistent with its low in vivo side effects, was highly selective for aldose reductase (AR or AKR1B1) versus aldehyde reductase (AKR1A1).", "section": "abstract", "t_start": 223, "d_end": 86, "d_start": 68, "t_end": 228}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "482f088650741af18e5909cd5280fbf1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15751081"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15751081", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15751081", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15751081", "mined_sentences": [{"text": "Autoantibodies to ribosomal P proteins (anti-P antibodies) are detected in 12-16% of patients with SLE) and have been found to be associated with some manifestations of the disease, including lupus psychosis and hepatitis.", "section": "abstract", "t_start": 28, "d_end": 206, "d_start": 198, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "59adeb6d32902b3bb02487204749b61f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20864405"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20864405", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20864405", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20864405", "mined_sentences": [{"text": "In late-onset bortezomib-induced peripheral neuropathy, the significant genes were SOD2 (upregulated by 1\u00b718 times; p=9\u00b76\u00d710(-3)) and MYO5A (1\u00b793 times; p=3\u00b72\u00d710(-2)), involved in development and function of the nervous system.", "section": "abstract", "t_start": 83, "d_end": 53, "d_start": 33, "t_end": 86}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c169d28400f7453e1ecdb229e8996623"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19219857"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19219857", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19219857", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19219857", "mined_sentences": [{"text": "Three genes (COMT, DRD4, and GABRA1) were associated with METH abuse, nine (ARRB2, BDNF, CYP2D6, GLYT1, GSTM1, GSTP1, PDYN, PICK1, and SLC22A3) with METH dependence, two (AKT1 and GABRG2) with METH abuse/dependence, and four (DTNBP1, OPRM1, SNCA, and SOD2) with METH psychosis.", "section": "abstract", "t_start": 251, "d_end": 275, "d_start": 267, "t_end": 254}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c51bbcef544a7c41444978b1f6b0205c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20464337"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "immune system disease"], "codes": ["EFO_0000540", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0007200"], ["EFO_0000540", "EFO_0007200"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007200", "label": "cerebral toxoplasmosis"}, "name": ["cerebral toxoplasmosis"], "id": "EFO_0007200"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20464337", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007200", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20464337", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20464337", "mined_sentences": [{"text": "We describe the clinical and radiological findings in an 25yr old AIDS patient presenting with new onset seizures as the primary manifestation of cerebral toxoplasmosis and Non Tuberculous Mycobacterial [NTM] co-infection.", "section": "abstract", "t_start": 204, "d_end": 167, "d_start": 146, "t_end": 206}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "1752d94fa290b137bf384d58c61e94fb"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16650481"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16650481", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16650481", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16650481", "mined_sentences": [{"text": "LIMITATION AND CONCLUSIONS: Although our results were obtained in a selected sample of outpatients at an University Mental Health Center, they are indicative of psychopathological differences between TM and NTM in the core symptoms of depression.", "section": "abstract", "t_start": 207, "d_end": 244, "d_start": 235, "t_end": 209}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "7f91c7040a6327ba6a2cb5cfb9c254f4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23939143"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23939143", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23939143", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23939143", "mined_sentences": [{"text": "Hepatic gene expression analysis suggested enhanced activation of NF\u03baB and MAPK pathways and up-regulation of co-stimulatory molecules (IL-1\u03b2, TNF-\u03b1, CINC-1) by LPS/Dcl and PIC/Dcl, while protective factors (HSPs, SOD2) were down-regulated.", "section": "abstract", "t_start": 214, "d_end": 211, "d_start": 208, "t_end": 217}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "cc2907e48224d9e395c36157be443383"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20956978"}]}, "target": {"id": "ENSG00000160305", "gene_info": {"symbol": "DIP2A", "name": "disco interacting protein 2 homolog A", "geneid": "ENSG00000160305"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005424"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005424", "label": "dyslexia"}, "name": ["dyslexia"], "id": "EFO_0005424"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20956978", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005424", "target": "http://identifiers.org/uniprot/Q14689"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20956978", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20956978", "mined_sentences": [{"text": "We found that 10 of the 14 dyslexia candidate genes (ROBO1, KIAA0319, KIAA0319L, S100B, DOCK4, FMR1, DIP2A, GTF2I, DYX1C1 and DCDC2) fit into a theoretical molecular network involved in neuronal migration and neurite outgrowth.", "section": "abstract", "t_start": 101, "d_end": 34, "d_start": 27, "t_end": 105}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "f0e0f5f3f841ba3eb7e3c7eaee6911c4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/16385548"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0004247"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004247", "label": "mood disorder"}, "name": ["mood disorder"], "id": "EFO_0004247"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/16385548", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004247", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/16385548", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/16385548", "mined_sentences": [{"text": "To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P proteins (anti-P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for psychosis, mood disorder, or both, and for other diffuse manifestations.", "section": "abstract", "t_start": 78, "d_end": 195, "d_start": 183, "t_end": 87}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2006-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "eeebd0065ea5a637f64668d96d2b0573"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23296368"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23296368", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23296368", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23296368", "mined_sentences": [{"text": "The latter should be further classified and named by their defective protein or the historical name as follows: i) defective phospholipid remodelling (TAZ defect or Barth syndrome, SERAC1 defect or MEGDEL syndrome) and ii) mitochondrial membrane associated disorders (OPA3 defect or Costeff syndrome, DNAJC19 defect or DCMA syndrome, TMEM70 defect).", "section": "abstract", "t_start": 181, "d_end": 212, "d_start": 198, "t_end": 186}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "ed1d512fcf3b17943600ec372c36d10a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/20824297"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/20824297", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/20824297", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/20824297", "mined_sentences": [{"text": "Autoantibodies to ribosomal P proteins (anti-P) are detected in 12-16% of patients with systemic lupus erythematosus (SLE), and have been found to be associated with some manifestations, including lupus psychosis, nephritis and hepatitis.", "section": "abstract", "t_start": 28, "d_end": 211, "d_start": 203, "t_end": 37}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "68551729acca300a5657e14eac7d4a5a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25644384"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25644384", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25644384", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25644384", "mined_sentences": [{"text": "In hypothesis-driven tests, there was significant association between general cognitive function and four genes previously associated with Alzheimer's disease: TOMM40, APOE, ABCG1 and MEF2C.", "section": "abstract", "t_start": 174, "d_end": 157, "d_start": 139, "t_end": 178}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "5f0de771e7c7ffd8a9c38be1e95129cf"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25792222"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25792222", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25792222", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25792222", "mined_sentences": [{"text": "Our results revealed that Gomafu plays a role in mediating anxiety-like behavior and suggest that this may occur through an interaction with a key member of the polycomb repressive complex 1, BMI1, which regulates the expression of the schizophrenia-related gene beta crystallin (Crybb1).", "section": "abstract", "t_start": 192, "d_end": 248, "d_start": 236, "t_end": 195}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "8769b70e8b2ad6451a48983374fe0b2a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26599961"}]}, "target": {"id": "ENSG00000101680", "gene_info": {"symbol": "LAMA1", "name": "laminin subunit alpha 1", "geneid": "ENSG00000101680"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000618", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_183530", "Orphanet_183506", "Orphanet_269564", "Orphanet_314597"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_314597"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_314597"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183506", "Orphanet_269564", "Orphanet_314597"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_314597", "label": "Chudley-McCullough syndrome"}, "name": ["Chudley-McCullough syndrome"], "id": "Orphanet_314597"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26599961", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_314597", "target": "http://identifiers.org/uniprot/P25391"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26599961", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26599961", "mined_sentences": [{"text": "Cerebellar dysplasias are seen in Chudley-McCullough syndrome, associated with LAMA1 mutations and GPR56 mutations; Lhermitte-Duclos disease; and focal cerebellar dysplasias.", "section": "abstract", "t_start": 79, "d_end": 60, "d_start": 34, "t_end": 83}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2016-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "027bdfc0247351348c2dca871a5914d6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/3531224"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "infectious disease"], "codes": ["EFO_0005741", "EFO_0000618"]}, "path": [["EFO_0005741", "EFO_0000763", "EFO_0007502"], ["EFO_0000618", "EFO_0005774", "EFO_0007502"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007502", "label": "subacute sclerosing panencephalitis"}, "name": ["subacute sclerosing panencephalitis"], "id": "EFO_0007502"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/3531224", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007502", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/3531224", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/3531224", "mined_sentences": [{"text": "Finally, persons with subacute sclerosing panencephalitis and atypical measles mounted abnormally high antibody responses to measles virus polypeptides, in particular the P protein.", "section": "abstract", "t_start": 171, "d_end": 56, "d_start": 22, "t_end": 179}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1986-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "c16d0ca71a251287ef7bf32d4d23bf36"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25129674"}]}, "target": {"id": "ENSG00000177272", "gene_info": {"symbol": "KCNA3", "name": "potassium voltage-gated channel subfamily A member 3", "geneid": "ENSG00000177272"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003829"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003829", "label": "alcohol dependence"}, "name": ["alcoholism"], "id": "EFO_0003829"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25129674", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003829", "target": "http://identifiers.org/uniprot/P22001"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25129674", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25129674", "mined_sentences": [{"text": "Differences in expression between LCLs from alcoholics and controls included 13 genes previously identified as associated with alcoholism or related traits, including KCNA3, DICER1, ZNF415, CAT, SLC9A9, and PPARGC1B.", "section": "abstract", "t_start": 167, "d_end": 136, "d_start": 127, "t_end": 171}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "d4ef908a614ca70bb1d85e4041b65a3f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25601961"}]}, "target": {"id": "ENSG00000160179", "gene_info": {"symbol": "ABCG1", "name": "ATP binding cassette subfamily G member 1", "geneid": "ENSG00000160179"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25601961", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P45844"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25601961", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25601961", "mined_sentences": [{"text": "However, ABCG1 expression and function did not change after smoking cessation.", "section": "abstract", "t_start": 9, "d_end": 66, "d_start": 60, "t_end": 13}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "67a47be42b7a9df53fbfe275640f9e5a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18759352"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18759352", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18759352", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18759352", "mined_sentences": [{"text": "Direct sequencing analyses were performed in 19 genes, including ALS/frontotemporal lobar degeneration (FTLD)-related genes (SOD2, SOD3, ALS2/alsin, SMN1, PGRN, ANG, VEGF, VCP, VAPB, DCTN1, CHMP2B, and TARDBP or TDP-43), tauopathy-related gene (GSK3beta), and parkinsonism-related genes (alpha-synuclein, LRRK2, parkin, DJ-1, PINK1, and ATP13A2).", "section": "abstract", "t_start": 125, "d_end": 67, "d_start": 65, "t_end": 128}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "e626cd6d88ecd8d54e41520fa23e00b2"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8523585"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0007178"], ["EFO_0000618", "EFO_0001423", "EFO_0007178"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0007178", "label": "borna disease"}, "name": ["Borna disease"], "id": "EFO_0007178"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8523585", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0007178", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8523585", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8523585", "mined_sentences": [{"text": "A cDNA fragment of the Borna disease virus (BDV) open reading frame II (ORF-II), which encodes a 24-kDa phosphoprotein (p24 [P protein]), was amplified from total RNA of peripheral blood mononuclear cells (PBMC) from three psychiatric inpatients.", "section": "abstract", "t_start": 125, "d_end": 35, "d_start": 23, "t_end": 133}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "249e822e27c33f3d4439e98f4e9b9e2e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/8814059"}]}, "target": {"id": "ENSG00000104044", "gene_info": {"symbol": "OCA2", "name": "OCA2 melanosomal transmembrane protein", "geneid": "ENSG00000104044"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0005407"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005407", "label": "psychosis"}, "name": ["psychosis"], "id": "EFO_0005407"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/8814059", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005407", "target": "http://identifiers.org/uniprot/Q04671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/8814059", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/8814059", "mined_sentences": [{"text": "Although it has been reported that anti-ribosomal P protein antibodies (anti-P) are highly specific for lupus psychosis, there have been discrepancies among the studies regarding the clinical correlation of these antibodies with systemic lupus erythematosus (SLE).", "section": "abstract", "t_start": 50, "d_end": 118, "d_start": 110, "t_end": 58}]}, "provenance_type": {"database": {"version": "2016-07-25", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "1996-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07200000000000001}, "type": "literature", "id": "13645bcb2aeb1bfa21e09c0bcdce1e99"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22474521"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0005611"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005611", "label": "opiate dependence"}, "name": ["opiate addiction"], "id": "EFO_0005611"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22474521", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005611", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22474521", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22474521", "mined_sentences": [{"text": "In China, the acupoints of Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4), and Neiguan (PC6) were most frequently used for the treatment of opiate addiction.", "section": "results", "t_start": 86, "d_end": 153, "d_start": 138, "t_end": 88}, {"text": "The most frequently used points or sites for the treatment of opiate addiction by acupuncturists are grouped below based on their locations: points on the extremities: Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4), and Neiguan (PC6); points and areas on the trunk: Jiaji (EX-B2), Shenshu (BL23), Sishencong (EX-HN1), Baihui (GV20), and Dazhui (GV14); and points on the ear: sympathetic, shenmen, kidney, and lung.", "section": "discussion", "t_start": 227, "d_end": 77, "d_start": 62, "t_end": 229}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07}, "type": "literature", "id": "b6b7c4d82cb2cf5df2ba78362e4abce5"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25368556"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25368556", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25368556", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25368556", "mined_sentences": [{"text": "Abbreviations: CSPG-chondroitin sulfate proteoglycans; GAG chains-glycosaminoglycan side chains; MD-monocular deprivation; OD-ocular dominance; LTP-long term potentiation; LTD-long term depression; chABC-chondroitinase ABC; CP-critical period; RGD peptide-Arginine-Glycine-Aspartate peptide; DCC-deleted in colorectal cancer (netrin receptor); tPA-tissue plasminogen activator; TNR/C-tenascin R or C; MMP-matrix metalloproteinase; FXS-Fragile X syndrome.", "section": "conclusion_and_future_work", "t_start": 292, "d_end": 195, "d_start": 186, "t_end": 294}, {"text": "Abbreviations: CSPG-chondroitin sulfate proteoglycans; GAG chains-glycosaminoglycan side chains; MD-monocular deprivation; OD-ocular dominance; LTP-long term potentiation; LTD-long term depression; chABC-chondroitinase ABC; CP-critical period; RGD peptide-Arginine-Glycine-Aspartate peptide; DCC-deleted in colorectal cancer (netrin receptor); tPA-tissue plasminogen activator; TNR/C-tenascin R or C; MMP-matrix metalloproteinase; FXS-Fragile X syndrome.", "section": "table", "t_start": 292, "d_end": 195, "d_start": 186, "t_end": 294}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07}, "type": "literature", "id": "3d789715e260d620943cdb39551972df"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26381753"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26381753", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26381753", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26381753", "mined_sentences": [{"text": "Other genotypes in the cohort in which no epilepsy was found were: PEO1 (n\u2009=\u200913), OPA1 (n\u2009=\u20097), m.14709T>C (n\u2009=\u20095), RRM2B (n\u2009=\u20094), m.12258A>G (n\u2009=\u20092), succinate dehydrogenase deficiency (n\u2009=\u20092), SPG7 (n\u2009=\u20092), m.4298G>A, m.7587T>C, m.7989T>C, m.618T>G, m.12283G>A, m.1624C>T, TYMP, and YARS2 (all n\u2009=\u20091).", "section": "results", "t_start": 67, "d_end": 49, "d_start": 42, "t_end": 70}, {"text": "In many genotypes, such as m.14709T>C, OPA1, and PEO1, no patients with epilepsy were found.", "section": "discussion", "t_start": 49, "d_end": 79, "d_start": 72, "t_end": 52}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07}, "type": "literature", "id": "726d4eed46be79423e1dcd35e7291d5d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24327604"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24327604", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24327604", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24327604", "mined_sentences": [{"text": "HSPs (HSP90, HSP70, HSP72, HSP-27, HSF-1)HSPs function as buffering systems to safe guard various client targets (e.g. oncogenes) and signaling pathways (e.g. apoptosis) involved in cell survival.", "section": "introduction_and_background", "t_start": 27, "d_end": 3, "d_start": 0, "t_end": 32}, {"text": "HSPs (HSP90, HSP70, HSP72, HSP-27, HSF-1)HSPs function as buffering systems to safe guard various client targets (e.g. oncogenes) and signaling pathways (e.g. apoptosis) involved in cell survival.", "section": "table", "t_start": 27, "d_end": 3, "d_start": 0, "t_end": 32}, {"text": "For instance, HSP90 inhibitors prove to be effective with other drugs (including bortezomib), but may induce upregulation of HSP-70 or HSP-27 leading to DR and requires including the inhibitors of latter HSPs [141, 252].", "section": "other", "t_start": 135, "d_end": 207, "d_start": 204, "t_end": 140}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07}, "type": "literature", "id": "ddb20d3bb56048a547134dd39d9dd851"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24356439"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24356439", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24356439", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24356439", "mined_sentences": [{"text": "The latter finding is in agreement with the recent demonstration that FOXG1 can bind to the BMI1 promoter in medulloblastoma-derived tumour-initiating cells41.", "section": "results", "t_start": 92, "d_end": 123, "d_start": 109, "t_end": 95}, {"text": "The latter finding is consistent with the recent observation that FOXG1 binds to the BMI1 promoter in medulloblastoma stem-like cells and that knockdown of FOXG1 causes decreased BMI1 transcription in these cells41.", "section": "discussion", "t_start": 85, "d_end": 116, "d_start": 102, "t_end": 88}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 7.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.07}, "type": "literature", "id": "c1a18160282ea25c2e3d3b76babdf52f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24782985"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24782985", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24782985", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24782985", "mined_sentences": [{"text": "However, recent studies have shown that cancer cells treated with certain cytotoxic agents (some chemotherapeutic agents and oncolytic viruses) lead to the cell surface exposure of calreticulin (ecto-CRT) and heat-shock proteins (HSPs) prior to apoptosis, and other DAMPs released in the later phase of apoptosis, danger signals to DCs.", "section": "figure", "t_start": 181, "d_end": 233, "d_start": 230, "t_end": 192}, {"text": "For cells undergoing pre-apoptotic phase, they may express \u201cdanger\u201d and \u201ceat-me\u201d signals on the cell surface (calreticulin and HSPs) or can secrete/release immunostimulatory factors (cytokines, ATP, and HMGB1) to stimulate innate immune effectors (46).", "section": "other", "t_start": 110, "d_end": 130, "d_start": 127, "t_end": 121}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.064}, "type": "literature", "id": "13922dd41092f97aeb90275b04800062"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19009042"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19009042", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19009042", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19009042", "mined_sentences": [{"text": "Alternatively, PPAR\u03b2 could also act via the regulation of IL-1\u03b2 to reduce astroglial and microglial inflammatory activation, as suggested in experimental autoimmune encephalomyelitis (EAE) [70].", "section": "other", "t_start": 15, "d_end": 186, "d_start": 184, "t_end": 19}, {"text": "The GW0742 PPAR\u03b2 agonist has also beneficial effects, demonstrated in a mouse model of EAE, in which mice were immunized with an encephalitogenic myelin oligodendrocyte glycoprotein (MOG) peptide [70].", "section": "other", "t_start": 11, "d_end": 89, "d_start": 87, "t_end": 15}, {"text": "The absence of PPAR\u03b2 agonist action on oligodendrocyte maturation or survival in this model of EAE is surprising (see Section 4).", "section": "other", "t_start": 15, "d_end": 97, "d_start": 95, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.062}, "type": "literature", "id": "6ec4c58d94332525af78a10bbcf1cb14"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26155783"}]}, "target": {"id": "ENSG00000182667", "gene_info": {"symbol": "NTM", "name": "neurotrimin", "geneid": "ENSG00000182667"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26155783", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/Q9P121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26155783", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26155783", "mined_sentences": [{"text": "Further, MAC patients had significantly less severe underlying diseases and they were more often non-smoking females as compared to other NTM patients.", "section": "discussion", "t_start": 138, "d_end": 107, "d_start": 101, "t_end": 140}, {"text": "Plausibly, smoking is a contributing factor in the prognosis of NTM infection.", "section": "discussion", "t_start": 64, "d_end": 17, "d_start": 11, "t_end": 66}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.062}, "type": "literature", "id": "977596a786976c2fb5f94e1a6ab7f76f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24167764"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24167764", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24167764", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24167764", "mined_sentences": [{"text": "The treatment of neoplastic cells with ethanol results in the emission/exposure of calreticulin (CRT), heat-shock proteins (HSPs) and high-mobility group box 1 (HMGB1) as well as in the blockade of transforming growth factor \u03b21 (TGF\u03b21) signaling, but not in decreased expression of MHC class I molecules and tumor-associated antigens such as mucin 1 (MUC1).", "section": "figure", "t_start": 83, "d_end": 127, "d_start": 124, "t_end": 94}, {"text": "The strategy of using ethanol-treated neoplastic cells for forming DC/cancer cell fusion-based vaccines may have some biological benefits, including 1) an improved sterility and safety; 2) an increased immunogenicity, presumably ensuing the denaturation, modification or aggregation of TAAs by ethanol and hence the exposure of previously concealed, hydrophobic epitopes; 3) a higher immunostimulatory potential, originating from the ability of ethanol to favor the emission of danger signals such as those conveyed by heat-shock proteins (HSPs) and calreticulin (CRT), both serving as \u201ceat-me\u201d signals that allow TAAs to traffic to the antigen-presenting compartment of DC/tumor fusions, as well as by high-mobility group box 1 (HMGB1), which is released from ethanol-treated neoplastic cells to activate DC/cancer cell fusions.", "section": "other", "t_start": 550, "d_end": 543, "d_start": 540, "t_end": 561}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "a941b95e3068909377605144c3be718b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19728866"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's disease"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19728866", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19728866", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19728866", "mined_sentences": [{"text": "The following disease nodes mentioned in the text are labeled: ovarian cancer (OC), prostate cancer (PC), Leber congenital amaurosis (LC), cone or cone-rod dystrophy (CD), retinitis pigmentosa (RP), night blindness (NB), Leigh syndrome (LS), mitochondrial DNA depletion syndrome (MD), combined oxidative phosphorylation deficiency (CO), mitochondrial complex I/II/III deficiency (MC), Alzheimer's disease (AZ), hypercholesterolemia (HC), pseudohypoaldosteronism (PH), Bartter syndrome (BS), holoprosencephaly (HP), Waardenburg syndrome (WS), central hypoventilation syndrome (CH), Hirschsprung disease (HD), ceroid-lipofuscinosis (CL), and glaucoma (GC). (b) Functional links among Alzheimer's disease genes (purple nodes) and hypercholesterolemia disease genes (blue nodes) in the FLN.", "section": "figure", "t_start": 782, "d_end": 403, "d_start": 385, "t_end": 784}, {"text": "Besides Alzheimer's disease and hypercholesterolemia, there are diverse disease-disease associations that are identified only by the FLN but not by the disease gene sharing method.", "section": "other", "t_start": 133, "d_end": 26, "d_start": 8, "t_end": 135}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "fdebdfe19503ee88fede5cdea397cd1f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22203863"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22203863", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22203863", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22203863", "mined_sentences": [{"text": "Kanakasabai et al. further demonstrated that the PPAR\u03b4 agonists ameliorate EAE by blocking IFN\u03b3 and IL17 production by Th1 and Th17 cells.", "section": "discussion", "t_start": 49, "d_end": 77, "d_start": 75, "t_end": 53}, {"text": "The inhibition of EAE by PPAR\u03b4 agonists is also associated with reductions in IL12 and IL23 and increases in IL4 and IL10 expression in the CNS and lymphoid organs.", "section": "discussion", "t_start": 25, "d_end": 20, "d_start": 18, "t_end": 29}, {"text": "This indicates that PPAR\u03b4 agonists modulate the Th1 and Th17 responses in EAE, and suggests their use in the treatment of MS and other autoimmune diseases [161].", "section": "discussion", "t_start": 20, "d_end": 76, "d_start": 74, "t_end": 24}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "fc6f90021210a209f0557f2b29362da3"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18670616"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18670616", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18670616", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18670616", "mined_sentences": [{"text": "PPAR\u03b2/\u03b4 agonists reduce the severity of EAE and stroke by inhibiting NF-\u03baB and Jak-Stat signaling pathways in immune cells from MS and stroke models", "section": "table", "t_start": 0, "d_end": 42, "d_start": 40, "t_end": 4}, {"text": "Moreover, oral treatment with selective PPAR\u03b2/\u03b4 agonist GW0742 exerted beneficial effects in the MOGp35-55-induced EAE model [66].", "section": "other", "t_start": 40, "d_end": 117, "d_start": 115, "t_end": 44}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "e8e08fce1a2b7d9fdf457ae4ae9d0f91"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25824949"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["eye disease", "skeletal system disease", "metabolic disease", "genetic disorder", "muscular disease", "nervous system disease", "digestive system disease"], "codes": ["EFO_0002970", "EFO_0000589", "EFO_0000618", "EFO_0000508", "EFO_0002461", "EFO_0003966", "EFO_0000405"]}, "path": [["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183518", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000405", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98710", "Orphanet_98695", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0002970", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98692", "Orphanet_98693", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_165652", "Orphanet_165655", "Orphanet_104013", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_352456", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_206634", "Orphanet_206656", "Orphanet_98486", "Orphanet_206953", "Orphanet_206966", "Orphanet_35698", "Orphanet_254871", "Orphanet_1186"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_98538", "Orphanet_98539", "Orphanet_1172", "Orphanet_98098", "Orphanet_1186"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_1186", "label": "Infantile onset spinocerebellar ataxia"}, "name": ["IOSCA"], "id": "Orphanet_1186"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25824949", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_1186", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25824949", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25824949", "mined_sentences": [{"text": "(B) Representation of disease-causing mutations of human c10orf2 gene on a scheme showing the Twinkle domains (IOSCA, red; adPEO, blue; MDS, black; Perrault Syndrome, purple; Renal Tubulopathy, green) (references in Supplementary Table S1).", "section": "introduction_and_background", "t_start": 57, "d_end": 115, "d_start": 111, "t_end": 63}, {"text": "(B) Representation of disease-causing mutations of human c10orf2 gene on a scheme showing the Twinkle domains (IOSCA, red; adPEO, blue; MDS, black; Perrault Syndrome, purple; Renal Tubulopathy, green) (references in Supplementary Table S1).", "section": "figure", "t_start": 57, "d_end": 115, "d_start": 111, "t_end": 63}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "7aa1ecc27b630bf5bbabf8adb679037e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25824949"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["reproductive system disease", "metabolic disease", "endocrine system disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0001379", "EFO_0000618", "EFO_0000589", "EFO_0000512", "EFO_0000508"]}, "path": [["EFO_0000512", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_2855"], ["EFO_0001379", "Orphanet_156638", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000508", "Orphanet_275742", "Orphanet_400008", "Orphanet_399877", "Orphanet_2855"], ["EFO_0000512", "EFO_0005771", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183731", "Orphanet_325665", "Orphanet_325638", "Orphanet_2855"], ["EFO_0000508", "Orphanet_156619", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"], ["EFO_0000512", "Orphanet_275742", "Orphanet_400008", "Orphanet_399877", "Orphanet_2855"], ["EFO_0000508", "Orphanet_156638", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000512", "Orphanet_183731", "Orphanet_325665", "Orphanet_325638", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183731", "Orphanet_202940", "Orphanet_95710", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_35696", "Orphanet_2855"], ["EFO_0000508", "Orphanet_156638", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_35696", "Orphanet_2855"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_35696", "Orphanet_2855"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_2855"], ["EFO_0000508", "Orphanet_183530", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_2855"], ["EFO_0001379", "Orphanet_156638", "Orphanet_325690", "Orphanet_325697", "Orphanet_325109", "Orphanet_2855"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_2855", "label": "Perrault syndrome"}, "name": ["Perrault Syndrome"], "id": "Orphanet_2855"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25824949", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_2855", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25824949", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25824949", "mined_sentences": [{"text": "(B) Representation of disease-causing mutations of human c10orf2 gene on a scheme showing the Twinkle domains (IOSCA, red; adPEO, blue; MDS, black; Perrault Syndrome, purple; Renal Tubulopathy, green) (references in Supplementary Table S1).", "section": "introduction_and_background", "t_start": 57, "d_end": 164, "d_start": 148, "t_end": 63}, {"text": "(B) Representation of disease-causing mutations of human c10orf2 gene on a scheme showing the Twinkle domains (IOSCA, red; adPEO, blue; MDS, black; Perrault Syndrome, purple; Renal Tubulopathy, green) (references in Supplementary Table S1).", "section": "figure", "t_start": 57, "d_end": 164, "d_start": 148, "t_end": 63}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "e39edc8745d0b16b44bc3206a46386d4"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25299611"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25299611", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25299611", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25299611", "mined_sentences": [{"text": "Number of variants in ALS and control samples for fourteen SNPs in ten genes (ALAD, ANG, APEX1, APOE, HFE, OGG1, PON1, PON2, PVR and SOD2) previously linked with ALS [54]\u2013[86].", "section": "table", "t_start": 133, "d_end": 24, "d_start": 22, "t_end": 136}, {"text": "Although many identified SNPs reside outside of exons, we were able to analyze fourteen SNPs located within exons in ten genes (ALAD, ANG, APEX1, APOE, HFE, OGG1, PON1, PON2, PVR and SOD2) and, with the exception of APOE, which is discussed further below, we were unable to find an association between any of these SNPs and ALS in our cohort [54]\u2013[86] (Table 3).", "section": "other", "t_start": 183, "d_end": 326, "d_start": 324, "t_end": 186}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-10-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "475a93fa53f894405908fbd001fb2a2d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22427329"}]}, "target": {"id": "ENSG00000146282", "gene_info": {"symbol": "RARS2", "name": "arginyl-tRNA synthetase 2, mitochondrial", "geneid": "ENSG00000146282"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease", "genetic disorder", "skin disease"], "codes": ["EFO_0003966", "EFO_0000508", "EFO_0000701", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_2836"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_2836"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183512", "Orphanet_166463", "Orphanet_2836"], ["EFO_0000508", "Orphanet_68346", "Orphanet_79383", "Orphanet_89832", "Orphanet_2836"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_2836"], ["EFO_0000508", "Orphanet_101435", "Orphanet_98671", "Orphanet_103", "Orphanet_98675", "Orphanet_98677", "Orphanet_2836"], ["EFO_0003966", "Orphanet_101435", "Orphanet_98671", "Orphanet_103", "Orphanet_98675", "Orphanet_98677", "Orphanet_2836"], ["EFO_0000701", "Orphanet_68346", "Orphanet_79383", "Orphanet_89832", "Orphanet_2836"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_2836", "label": "PEHO syndrome"}, "name": ["PEHO syndrome"], "id": "Orphanet_2836"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22427329", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_2836", "target": "http://identifiers.org/uniprot/Q5T160"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22427329", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22427329", "mined_sentences": [{"text": "POSTMIGRATIONAL DEVELOPMENTAL MICROCEPHALY (PREVIOUSLY POSTNATAL MIC) WITH BIRTH OFC \u20133 SD OR LARGER, LATER OFC BELOW \u20134 SD AND NO EVIDENCE OF BRAIN INJURY Postmigrational MIC with limited functional deficits\u2003\u2003\u2003\u2003\u2003\u2003\u2003Clinically defined Postmigrational MIC with no cause or syndrome identified\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AD inheritance (sporadic new mutations)MIC and mild ID with SHH mutation (Ginocchio et al., 2008)MIC and variable ACC with deletion 1q43q44 (includes AKT3) (Hill et al., 2007)Postmigrational MIC with broad functional deficits consistent with a \u2018developmental encephalopathy\u2019 (Angelman-like, Rett-like class of disorders)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Clinically defined with AR inheritance PEHO syndrome (Salonen et al., 1991; Vanhatalo et al., 2002)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AD inheritance (sporadic new mutations)Pitt\u2013Hopkins syndrome with mutations of TCF4 at 18q21.1 (Zweier et al., 2007)FOXG1 syndrome with deletions or mutations of FOXG1 at 14q13 (Kort\u00fcm et al., 2011)Duplication of FOXG1 at 14q13 (Brunetti-Pierri et al., 2011)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AD inheritance (or pathogenic de novo copy number variant) and imprinting effectsMaternal duplication 15q11.2 (Kitsiou-Tzeli et al., 2010)Angelman syndrome with maternally deletion 15q11.2 or mutation of UBE3A at 15q11.2 (Matsuura et al., 1997)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AR inheritancePitt\u2013Hopkins like syndrome with mutations of NRXN1 at 2p16.3 (Zweier et al., 2009)Pitt\u2013Hopkins-like syndrome with mutations of CNTNAP2 at 7q35-q36 (Zweier et al., 2009)Pontocerebellar hypoplasia with mutations of TSEN54 at 17q25.1, TSEN2 at 3p25.1, TSEN34 at 19q13.4, RARS2 at 6q16.1 (Namavar et al., 2011)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with XL inheritanceRett syndrome with mutations of MECP2 at Xq28 (Amir et al., 1999)Angelman-like syndrome with mutations of SLC9A6 at Xq26.3 (Gilfillan et al., 2008)X-linked mental retardation and autistic features with mutations of JARID1C at xp11.22\u2013p11.21 (Jensen et al., 2005; Abidi et al., 2008)X-linked MIC with disproportionate cerebellar hypoplasia with mutations of CASK at Xp11.4 (in females) (Najm et al., 2008)", "section": "table", "t_start": 1628, "d_end": 700, "d_start": 688, "t_end": 1632}, {"text": "POSTMIGRATIONAL DEVELOPMENTAL MICROCEPHALY (PREVIOUSLY POSTNATAL MIC) WITH BIRTH OFC \u20133 SD OR LARGER, LATER OFC BELOW \u20134 SD AND NO EVIDENCE OF BRAIN INJURY Postmigrational MIC with limited functional deficits\u2003\u2003\u2003\u2003\u2003\u2003\u2003Clinically defined Postmigrational MIC with no cause or syndrome identified\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AD inheritance (sporadic new mutations)MIC and mild ID with SHH mutation (Ginocchio et al., 2008)MIC and variable ACC with deletion 1q43q44 (includes AKT3) (Hill et al., 2007)Postmigrational MIC with broad functional deficits consistent with a \u2018developmental encephalopathy\u2019 (Angelman-like, Rett-like class of disorders)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Clinically defined with AR inheritance PEHO syndrome (Salonen et al., 1991; Vanhatalo et al., 2002)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AD inheritance (sporadic new mutations)Pitt\u2013Hopkins syndrome with mutations of TCF4 at 18q21.1 (Zweier et al., 2007)FOXG1 syndrome with deletions or mutations of FOXG1 at 14q13 (Kort\u00fcm et al., 2011)Duplication of FOXG1 at 14q13 (Brunetti-Pierri et al., 2011)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AD inheritance (or pathogenic de novo copy number variant) and imprinting effectsMaternal duplication 15q11.2 (Kitsiou-Tzeli et al., 2010)Angelman syndrome with maternally deletion 15q11.2 or mutation of UBE3A at 15q11.2 (Matsuura et al., 1997)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with AR inheritancePitt\u2013Hopkins like syndrome with mutations of NRXN1 at 2p16.3 (Zweier et al., 2009)Pitt\u2013Hopkins-like syndrome with mutations of CNTNAP2 at 7q35-q36 (Zweier et al., 2009)Pontocerebellar hypoplasia with mutations of TSEN54 at 17q25.1, TSEN2 at 3p25.1, TSEN34 at 19q13.4, RARS2 at 6q16.1 (Namavar et al., 2011)\u2003\u2003\u2003\u2003\u2003\u2003\u2003Genetically defined with XL inheritanceRett syndrome with mutations of MECP2 at Xq28 (Amir et al., 1999)Angelman-like syndrome with mutations of SLC9A6 at Xq26.3 (Gilfillan et al., 2008)X-linked mental retardation and autistic features with mutations of JARID1C at xp11.22\u2013p11.21 (Jensen et al., 2005; Abidi et al., 2008)X-linked MIC with disproportionate cerebellar hypoplasia with mutations of CASK at Xp11.4 (in females) (Najm et al., 2008)", "section": "appendix", "t_start": 1628, "d_end": 700, "d_start": 688, "t_end": 1632}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 6.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.06}, "type": "literature", "id": "d31cf0947d72cb56ae2525b2379f89c6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19754948"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19754948", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19754948", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19754948", "mined_sentences": [{"text": "Oxidative stress is proposed to be involved in the etiology of glaucoma [26] and increased expression of the SOD2 gene was observed in the aqueous humor of glaucoma patients [27].", "section": "introduction_and_background", "t_start": 109, "d_end": 70, "d_start": 63, "t_end": 112}, {"text": "No association study with RDX, SNX16 and SOD2 has been performed in glaucoma patients before.", "section": "discussion", "t_start": 41, "d_end": 75, "d_start": 68, "t_end": 44}, {"text": "The objective of this study was to investigate association of several genes that have not been subject to an association study with glaucoma cases so far but might be functionally linked to glaucoma pathogenesis (RDX, SNX16, MFN1, MFN2, PARL, SOD2).", "section": "conclusion_and_future_work", "t_start": 243, "d_end": 139, "d_start": 132, "t_end": 246}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.057999999999999996}, "type": "literature", "id": "327635a66f250e8a337e4b892a46889c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25944616"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25944616", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25944616", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25944616", "mined_sentences": [{"text": "After stratifying the lung cancer patients based on their status of cigarette smoking, e.g., never-smoked or smoked, it was found that higher expression level of filamin A predicts poorer overall survival of the patients who were never-smoked (Fig. 6A).", "section": "other", "t_start": 162, "d_end": 84, "d_start": 68, "t_end": 170}, {"text": "Since it had been well-documented that cigarette smoking contributes to different histological subtypes of the lung cancer [30], we believed that the opposite predictive power of filamin A expression between smoked and never-smoked might be a reflection of the different histological subtypes of the lung cancers.", "section": "other", "t_start": 179, "d_end": 55, "d_start": 39, "t_end": 187}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.055999999999999994}, "type": "literature", "id": "7d426adb89fd1d780a6fd5ad48b533c9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22206013"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004149", "label": "neuropathy"}, "name": ["neuropathy"], "id": "EFO_0004149"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22206013", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004149", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22206013", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22206013", "mined_sentences": [{"text": "The phenotypes of the HSPB1 mutations that have been reported to date are motor-predominant neuropathy either with or without mild sensory involvement.", "section": "discussion", "t_start": 22, "d_end": 101, "d_start": 92, "t_end": 26}, {"text": "This feature broadens the clinical spectrum of HSPB1 neuropathy.", "section": "discussion", "t_start": 47, "d_end": 62, "d_start": 53, "t_end": 51}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.055999999999999994}, "type": "literature", "id": "5ecc01704451176977e43d82620625d7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23046527"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastomas"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23046527", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23046527", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23046527", "mined_sentences": [{"text": "Recent studies have documented increased BMI1 expression in a variety of human cancers, such as non-small cell lung cancers [21], medulloblastomas [22], prostate carcinomas [23], colorectal cancers [24], breast carcinomas [25], and oesophageal squamous cell carcinomas (ESCCs) [26].", "section": "introduction_and_background", "t_start": 41, "d_end": 145, "d_start": 130, "t_end": 44}, {"text": "Hence, aberrant BMI1 expression might also be involved in the characteristics of the \u2018more aggressive\u2019 cancer cell population after CRT, because BMI1 is thought to be a downstream target in the Hh pathway in medulloblastoma [22].", "section": "introduction_and_background", "t_start": 16, "d_end": 222, "d_start": 208, "t_end": 19}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.055999999999999994}, "type": "literature", "id": "89511d6c555ecf30f22ddbdb1bfe2d0a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21197111"}]}, "target": {"id": "ENSG00000168615", "gene_info": {"symbol": "ADAM9", "name": "ADAM metallopeptidase domain 9", "geneid": "ENSG00000168615"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21197111", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/Q13443"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21197111", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21197111", "mined_sentences": [{"text": "One can therefore conclude that ADAM-9 and \u221215, which are elevated following surgery, may potentially be involved in the processes that propagate a wound response in lens cells, which may ultimately lead to the development of PCO secondary to cataract surgery.", "section": "discussion", "t_start": 32, "d_end": 250, "d_start": 243, "t_end": 37}, {"text": "The \u03b16\u03b21 integrins are suggested to be potential ADAM-9 receptors [29]. \u03b21 integrins are expressed by lens cells [30-32] and TGF-\u03b21 down-regulates ADAM-9 and the \u03b16 integrin subunit [13,58], which highlights that a down-regulation of ADAM-9 could be involved in a loss of cell-cell contact during the pathogenesis of anterior sub-capsular cataract (ASC) and potentially also PCO, as they are phenotypically similar [59,60].", "section": "discussion", "t_start": 49, "d_end": 346, "d_start": 339, "t_end": 54}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.052000000000000005}, "type": "literature", "id": "58acff022dacc5f4eb135dfd3281b3ed"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/19754948"}]}, "target": {"id": "ENSG00000104497", "gene_info": {"symbol": "SNX16", "name": "sorting nexin 16", "geneid": "ENSG00000104497"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0000516"], ["EFO_0003966", "EFO_0000516"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000516", "label": "glaucoma"}, "name": ["glaucoma"], "id": "EFO_0000516"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/19754948", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000516", "target": "http://identifiers.org/uniprot/P57768"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/19754948", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/19754948", "mined_sentences": [{"text": "No association study with RDX, SNX16 and SOD2 has been performed in glaucoma patients before.", "section": "discussion", "t_start": 31, "d_end": 75, "d_start": 68, "t_end": 35}, {"text": "The objective of this study was to investigate association of several genes that have not been subject to an association study with glaucoma cases so far but might be functionally linked to glaucoma pathogenesis (RDX, SNX16, MFN1, MFN2, PARL, SOD2).", "section": "conclusion_and_future_work", "t_start": 218, "d_end": 139, "d_start": 132, "t_end": 222}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.052000000000000005}, "type": "literature", "id": "1a1546c881563b05f8489cdf7d9a5454"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26301039"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26301039", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26301039", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26301039", "mined_sentences": [{"text": "Furthermore, Liang et al. reported that SOD2 heterozygous knockout mice exhibited epilepsy via astrocyte dysfunction [30].", "section": "discussion", "t_start": 40, "d_end": 89, "d_start": 82, "t_end": 43}, {"text": "They showed that a reduction of the SOD2 level induced the downregulation of glutamate transporter 1 (GLT-1) and glutamate-aspartate transporter (GLAST), both of which are glutamate transporters that clear glutamate from synapse, which increased the levels of glutamate at the synapse and led to epileptic conditions [30].", "section": "discussion", "t_start": 36, "d_end": 304, "d_start": 296, "t_end": 39}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.052000000000000005}, "type": "literature", "id": "2d6e9379b6bd94af7e99dc32c7db2d1d"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23826100"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23826100", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23826100", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23826100", "mined_sentences": [{"text": "In 2004 we found that mutations in HSPB1 cause a peripheral neuropathy called Charcot-Marie-Tooth disease (CMT) [3].", "section": "introduction_and_background", "t_start": 35, "d_end": 69, "d_start": 49, "t_end": 39}, {"text": "We previously showed that peripheral neuropathy causing HSPB1 mutants are hyperactive and bind more strongly to MTs causing their stabilization [5].", "section": "discussion", "t_start": 56, "d_end": 46, "d_start": 26, "t_end": 60}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 5.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.05}, "type": "literature", "id": "95a9f9255c84f4afb95ec656c1dafa83"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21869897"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21869897", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21869897", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21869897", "mined_sentences": [{"text": "Lee et al. [36] reported that stimulation on acupoint PC6 suppressed the symptopathology of the hypo-activated hypothalamus-pituitary-adrenaline axis in chronic CORT-induced rat model of depression.", "section": "discussion", "t_start": 54, "d_end": 196, "d_start": 187, "t_end": 56}, {"text": "PC6 is the Luo Connecting point of Pericardium Channel of Hand Jue-Yin, has also been widely used to treat mental disorders such as insomnia and depression [38, 58].", "section": "discussion", "t_start": 0, "d_end": 154, "d_start": 145, "t_end": 2}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.048}, "type": "literature", "id": "47dfcaf9f80dd0f83e7cef3ec5e62688"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21869897"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0004698"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004698", "label": "insomnia"}, "name": ["insomnia"], "id": "EFO_0004698"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21869897", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004698", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21869897", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21869897", "mined_sentences": [{"text": "Lee et al. [38] demonstrated acupuncture at HT7 and PC6 is a useful therapeutic method for post-stroke-onset insomnia as it reduces sympathetic hyperactivities.", "section": "discussion", "t_start": 52, "d_end": 116, "d_start": 109, "t_end": 54}, {"text": "PC6 is the Luo Connecting point of Pericardium Channel of Hand Jue-Yin, has also been widely used to treat mental disorders such as insomnia and depression [38, 58].", "section": "discussion", "t_start": 0, "d_end": 139, "d_start": 132, "t_end": 2}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.048}, "type": "literature", "id": "93c8afe6924155b9b662db351d33c190"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22135673"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22135673", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22135673", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22135673", "mined_sentences": [{"text": "To date, the neuroprotective benefits of PPAR\u03b4 agonists have been observed in models of stroke, multiple sclerosis, Alzheimer's disease, Parkinson's disease, radiation-induced brain injury, and spinal cord injury [12, 17\u201323].", "section": "introduction_and_background", "t_start": 41, "d_end": 155, "d_start": 137, "t_end": 45}, {"text": "PPAR\u03b4 agonists may exert therapeutic benefits in patients with Parkinson's disease (PD), a neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra.", "section": "other", "t_start": 0, "d_end": 81, "d_start": 63, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.044000000000000004}, "type": "literature", "id": "4d7722c6ffe742a24a3b55d44dbcae7e"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23922650"}]}, "target": {"id": "ENSG00000185532", "gene_info": {"symbol": "PRKG1", "name": "protein kinase, cGMP-dependent, type I", "geneid": "ENSG00000185532"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23922650", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/Q13976"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23922650", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23922650", "mined_sentences": [{"text": "PRKG1 is dependent on cyclic GMP for activation while PRKCE is activated by calcium and the second messenger diacylglycerol. PRKG1 has previously shown its association with schizophrenia with the 21st most significant SNP in the CATIE GWAS [30].", "section": "discussion", "t_start": 0, "d_end": 185, "d_start": 173, "t_end": 4}, {"text": "PRKG1 also interacts with RGS2 and GABRR1, which have shown modest association with schizophrenia symptoms [39] and schizoaffective disorder [40], respectively.", "section": "discussion", "t_start": 0, "d_end": 96, "d_start": 84, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.044000000000000004}, "type": "literature", "id": "9de4036b94b2bdaa87b019fab08f4516"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23107649"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0004238", "label": "hearing loss"}, "name": ["hearing loss"], "id": "EFO_0004238"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23107649", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0004238", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23107649", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23107649", "mined_sentences": [{"text": "The presence of significant bulbar weakness, hearing loss and gastrointestinal symptoms should guide clinicians towards RRM2B genetic analysis before POLG and PEO1, given that these key features are more common components of the clinical spectrum (bulbar dysfunction 42% versus 37% and 12%; sensorineural hearing loss 36% versus 11% and 9%; and gastrointestinal symptoms 19% versus unreported and 9% in RRM2B versus POLG and PEO1-related PEO syndromes, respectively) (Horvath et al., 2006; Fratter et al., 2011).", "section": "discussion", "t_start": 159, "d_end": 56, "d_start": 45, "t_end": 162}, {"text": "Thus, the prominence of bulbar dysfunction, gastrointestinal problems and hearing loss, in the absence of conspicuous CNS features, would support early prioritization of screening of RRM2B over POLG and PEO1 in adults with PEO and muscle-restricted multiple mitochondrial DNA deletions.", "section": "conclusion_and_future_work", "t_start": 203, "d_end": 85, "d_start": 74, "t_end": 206}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.044000000000000004}, "type": "literature", "id": "95eb1cd135f3f1acfb99d338b8033f2f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21951382"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21951382", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21951382", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21951382", "mined_sentences": [{"text": "In the screening of RRM2B variants in 50 mitochondrial disease patients without causative variants in POLG1 and C10orf2, one Kearns-Sayre syndrome (MIM 530000) patient who carried two different novel missense variants and one PEO patient who carried an in-frame deletion were identified [25].", "section": "discussion", "t_start": 112, "d_end": 228, "d_start": 226, "t_end": 118}, {"text": "So far, rare variants of POLG1, C10orf2 and SLC25A4 have been reported in inherited PEO pedigrees with frequent comorbidity of mood disorders [28].", "section": "discussion", "t_start": 32, "d_end": 86, "d_start": 84, "t_end": 38}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.044000000000000004}, "type": "literature", "id": "3c1bebbbfa2f4b3039121a2f62aacf55"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23728742"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0004149", "EFO_0003100"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003100", "label": "peripheral neuropathy"}, "name": ["peripheral neuropathy"], "id": "EFO_0003100"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23728742", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003100", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23728742", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23728742", "mined_sentences": [{"text": "However, the pleiotropic nature of the HSPB1 protein suggests that some neuron-specific functions could contribute to peripheral neuropathy.", "section": "introduction_and_background", "t_start": 39, "d_end": 138, "d_start": 118, "t_end": 43}, {"text": "Patients carrying an HSPB1 mutation are characterized by an axonal peripheral neuropathy associated with a decrease in the amplitude of the compound muscle action potentials, which is consistent with the observed decrease in the amount, density and diameter of myelinated nerve fibers [11, 38, 39, 62].", "section": "discussion", "t_start": 21, "d_end": 87, "d_start": 67, "t_end": 25}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.042}, "type": "literature", "id": "25e68247bba7b4153b0c9c5a863fb2e0"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26400460"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_1001455", "EFO_0004238", "EFO_1001254"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1001254", "label": "noise-induced hearing loss"}, "name": ["noise-induced hearing loss"], "id": "EFO_1001254"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26400460", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1001254", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26400460", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26400460", "mined_sentences": [{"text": "Variation in the gene encoding for MnSOD, SOD2, has been implicated in noise-induced hearing loss but has not been explored in the context of treatment-related ototoxicity 16.", "section": "introduction_and_background", "t_start": 42, "d_end": 96, "d_start": 71, "t_end": 45}, {"text": "In this assessment, pediatric medulloblastoma patients who received cisplatin chemotherapy and had the C-allele of SOD2 rs4880, which has been associated with noise-induced hearing loss 16, had an increased susceptibility to ototoxicity.", "section": "discussion", "t_start": 115, "d_end": 184, "d_start": 159, "t_end": 118}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.2}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.042}, "type": "literature", "id": "1ec2d3ffb15d4f1191c954ffd90546ca"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24719117"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSP"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24719117", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24719117", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24719117", "mined_sentences": [{"text": "Upregulation of individual members from HSF-1-regulated HSP families (e.g. HSPA1A, DNAJB1, HSPB1) was effective in preventing polyQ aggregation or the associated toxicity in vitro and in cellular models (Fig. 2).", "section": "other", "t_start": 91, "d_end": 58, "d_start": 56, "t_end": 95}, {"text": "The same is true for the canonical small HSP HSPB1.", "section": "other", "t_start": 45, "d_end": 43, "d_start": 41, "t_end": 49}, {"text": "Regarding the effects of individual HSPs on SOD1 aggregation and toxicity, data in cell lines expressing mutant SOD1 suggest protective effects of HSPA1, DNAJB1, DNAJB2, HSPB1 and HSPB8 (Fig. 2).", "section": "other", "t_start": 170, "d_end": 39, "d_start": 36, "t_end": 174}, {"text": "Multiple HSPs alleviated tau toxicity in cells, including HSPA8, HSPA1, Hsp90s/HSPC, DNAJA1 and HSPB1 (Fig. 2).", "section": "other", "t_start": 96, "d_end": 12, "d_start": 9, "t_end": 100}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 4.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-04-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.04}, "type": "literature", "id": "3b1b2264205ec69b0a62010580dfca50"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22500060"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["cigarette-smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22500060", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22500060", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22500060", "mined_sentences": [{"text": "Moreover, cigarette-smoking status may influence the association of EPHX1 enzyme activity and the related cancer risk 83.", "section": "discussion", "t_start": 68, "d_end": 26, "d_start": 10, "t_end": 72}, {"text": "Human microsomal epoxide hydrolase (EPHX1) plays an important role during xenobiotic detoxification of exogenous chemicals such as polycyclic aromatic hydrocarbons (PAHs), which are produced during the use of coal tar, coke, bitumen or during cigarette smoking 32 83.", "section": "other", "t_start": 36, "d_end": 259, "d_start": 243, "t_end": 40}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-02-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.038}, "type": "literature", "id": "a061f342cb6f81243be8cb8e8ec20ead"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18776931"}]}, "target": {"id": "ENSG00000134644", "gene_info": {"symbol": "PUM1", "name": "pumilio RNA binding family member 1", "geneid": "ENSG00000134644"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18776931", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/Q14671"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18776931", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18776931", "mined_sentences": [{"text": "For instance, angiogenesis-related proteins were mainly enriched among PUM1 targets whereas the transcripts coding for proteins linked to Parkinson's disease were solely enriched among PUM2 targets.", "section": "discussion", "t_start": 71, "d_end": 156, "d_start": 138, "t_end": 74}, {"text": "The analysis for PUM2 targets revealed only two terms with weak statistical significance: the p53 pathway (p<10\u22122), which was also weakly enriched among PUM1 targets (p<10\u22123), and several messages coding for proteins related to Parkinson's disease (p<2\u00d710\u22122) (Table 1, Table S4).", "section": "other", "t_start": 153, "d_end": 246, "d_start": 228, "t_end": 156}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2008-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.038}, "type": "literature", "id": "c388ce7bf2d8da7c96e03303158c7c78"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23922496"}]}, "target": {"id": "ENSG00000101680", "gene_info": {"symbol": "LAMA1", "name": "laminin subunit alpha 1", "geneid": "ENSG00000101680"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23922496", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P25391"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23922496", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23922496", "mined_sentences": [{"text": "After patients quit smoking and start to lead healthier lifestyles, long-acting bronchodilators, such as long-acting beta-adrenergic agents (LABA) and long-acting antimuscarinic agents (LAMA), are recommended as the cornerstone of treatment for COPD, either as monotherapy or in combination.", "section": "abstract", "t_start": 186, "d_end": 26, "d_start": 20, "t_end": 189}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.8}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.038}, "type": "literature", "id": "9cb90d4515598c4f333cca9619063a64"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25526772"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "neoplasm"], "codes": ["EFO_0000616", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000326", "EFO_0002939"], ["EFO_0000616", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0005784", "EFO_0002939"], ["EFO_0000618", "EFO_0005774", "EFO_0003833", "EFO_0002939"], ["EFO_0000616", "EFO_0000311", "EFO_0000326", "EFO_0002939"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002939", "label": "medulloblastoma"}, "name": ["medulloblastoma"], "id": "EFO_0002939"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25526772", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002939", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25526772", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25526772", "mined_sentences": [{"text": "Over-expression of BMI1 has been reported in many different human cancers, including medulloblastoma [23-25] and adult GBM [26-28].", "section": "introduction_and_background", "t_start": 19, "d_end": 99, "d_start": 85, "t_end": 22}, {"text": "High level of BMI1 is associated with medulloblastoma invasion [29] and is also considered to be a poor prognostic marker in multiple human cancers [30-34], and is significantly involved in chemoresistance and tumor recurrence [35-38].", "section": "introduction_and_background", "t_start": 14, "d_end": 52, "d_start": 38, "t_end": 17}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.6}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2014-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.036000000000000004}, "type": "literature", "id": "20bb3730933919a075ba53261d6552a7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23934111"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0003756"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003756", "label": "autism spectrum disorder"}, "name": ["autism spectrum disorders"], "id": "EFO_0003756"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23934111", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003756", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23934111", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23934111", "mined_sentences": [{"text": "Other genes with de novo mutations in this cohort include: CACNA1A, CHD2, FLNA, GABRA1, GRIN1, GRIN2B, HDAC4, HNRNPU, IQSEC2, MTOR, and NEDD4L. Finally, we show that the de novo mutations observed are enriched in specific gene sets including genes regulated by the Fragile X protein (p<10\u22128), as was reported for autism spectrum disorders (ASD)1.", "section": "abstract", "t_start": 74, "d_end": 337, "d_start": 313, "t_end": 77}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.034}, "type": "literature", "id": "468bfa7dbb1032b5d68f90c1ad6292ad"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15298707"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSP"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15298707", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15298707", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15298707", "mined_sentences": [{"text": "These included antigen chaperone molecules (HSP-70, HSP-110, Calreticulin, gp96), pro-inflammatory cytokines (Interleukin (IL)-18, IL-15, IL-8, IL-24, IL-7) and cytotoxic mediators (Granulysin, Granzyme A).", "section": "abstract", "t_start": 61, "d_end": 46, "d_start": 44, "t_end": 72}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2004-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.034}, "type": "literature", "id": "6b6bda0ae6c42f1fccc8bd241f2be0de"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22158479"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0005772", "label": "neurodegenerative disease"}, "name": ["neurodegenerative diseases"], "id": "EFO_0005772"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22158479", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0005772", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22158479", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22158479", "mined_sentences": [{"text": "Intervention in this vicious cycle, by blockade of NMDA receptor activation, enhancement of SOD2 expression, or inhibition of the downstream apoptotic cascade may provide new strategies to protect neurons in neurodegenerative diseases, and in particular RGCs in optic neuropathies.", "section": "discussion", "t_start": 92, "d_end": 233, "d_start": 208, "t_end": 95}, {"text": "Reactive oxygen species including superoxide radicals (O2\u2212) induce oxidative stress in many neurodegenerative diseases including optic neuropathies.26, 27 Superoxide dismutases (SODs), cytosolic SOD1, and mitochondrial SOD2 are expressed in the ganglion cell layer (GCL) and inner plexiform layer (IPL) in the rodent retina.28 Emerging evidence suggests that SOD2 has a protective role against neuronal cell death that induced by glutamate excitotoxicity and oxidative stress.21 However, the relationship--between OPA1 mutation and SOD2 in the retina remain unknown.", "section": "other", "t_start": 219, "d_end": 117, "d_start": 92, "t_end": 222}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.034}, "type": "literature", "id": "cc53fba0aae5106961059ee5cea0ef54"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24039908"}]}, "target": {"id": "ENSG00000196924", "gene_info": {"symbol": "FLNA", "name": "filamin A", "geneid": "ENSG00000196924"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24039908", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P21333"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24039908", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24039908", "mined_sentences": [{"text": "Several epilepsy candidate genes are downstream targets of Rbfox proteins (FLNA, SLC1A3, DCX, GABRB3, GAD2, KCNQ2, SCN8A, SLC12A5, SV2B, SYN1) and their regulation of expression and splicing has been demonstrated [18], [19].", "section": "introduction_and_background", "t_start": 75, "d_end": 15, "d_start": 8, "t_end": 78}, {"text": "As a model for haploinsufficiency in vitro knock down of RBFOX1 in primary human neural stem cells resulted in an altered expression and splicing of several epilepsy candidate genes (FLNA, SLC1A3, DCX, GABRB3, GAD2, KCNQ2, SLC12A5, SV2B, SYN1) [19].", "section": "discussion", "t_start": 183, "d_end": 164, "d_start": 157, "t_end": 186}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "e5d7b786c32b858cebffcf811a2ead0c"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26241350"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000692"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000692", "label": "schizophrenia"}, "name": ["schizophrenia"], "id": "EFO_0000692"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26241350", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000692", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26241350", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26241350", "mined_sentences": [{"text": "N-glycosylation has an essential role in proper protein folding and assembly, endoplasmic reticulum (ER) quality control mechanisms and forward trafficking from the ER to the plasma membrane.41, 42, 43, 44, 45, 46, 47, 48 Previous studies suggested that these functional processes are disrupted in schizophrenia, and we have identified alterations of N-linked glycosylation of multiple neurotransmitter-associated proteins that are consistent with abnormal ER function.36, 49, 50, 51 A smaller immature N-glycan has been observed attached to the \u03b11 GABAAR subunit in schizophrenia, which suggests that this subunit undergoes early glycoprotein processing and may be retained in the calnexin\u2013calreticulin protein folding cycle in the ER.", "section": "introduction_and_background", "t_start": 691, "d_end": 310, "d_start": 298, "t_end": 702}, {"text": "On the basis of prior findings that the \u03b12 GABAAR subunit is expressed more highly in intact GABAARs in axosomatic synapses of pyramidal neurons in the dorsolateral prefrontal cortex in schizophrenia,60 in conjunction with our prior report demonstrating a smaller immature N-glycan attached to the \u03b11 GABAAR subunit in schizophrenia,36 we anticipated finding increased abundance of \u03b11 GABAAR subunits in the ER fraction, consistent with retention of this subunit in the calnexin\u2013calreticulin protein-folding cycle, and a decreased ratio of \u03b11:\u03b12 GABAAR subunits in both the ER and SYN fractions.", "section": "discussion", "t_start": 479, "d_end": 198, "d_start": 186, "t_end": 490}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "e772b3085ef27ffd6fd537cfc358e598"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22570670"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003761"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003761", "label": "unipolar depression"}, "name": ["depression"], "id": "EFO_0003761"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22570670", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003761", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22570670", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22570670", "mined_sentences": [{"text": "The first study in patients with depression was performed using the acupuncture point Jianshi (PC5) [2] and the present study the acupoint Baihui (GV20).", "section": "introduction_and_background", "t_start": 95, "d_end": 42, "d_start": 33, "t_end": 97}, {"text": "We have shown that teleacupuncture at the acupoint Baihui in patients with depression shows similar effects in neurovegetative parameters like acupoint stimulation of Jianshi (PC5).", "section": "discussion", "t_start": 176, "d_end": 84, "d_start": 75, "t_end": 178}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "500b3204429c34ed15a41beb4e3b19fc"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22566955"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson\u2019s disease"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22566955", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22566955", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22566955", "mined_sentences": [{"text": "HSPB1 and HSPB5 are upregulated in the cortex of Parkinson\u2019s disease patients (Renkawek et al., 1994a, 1999).", "section": "other", "t_start": 0, "d_end": 67, "d_start": 49, "t_end": 4}, {"text": "Mouse data corroborated the human data, and showed similar elevations in both HSPB1 and HSPB5 using the transgenic Parkinson\u2019s model, alpha-SynA53T (Wang et al., 2008).", "section": "other", "t_start": 78, "d_end": 125, "d_start": 115, "t_end": 82}, {"text": "Using a viral vector, HSPB1 has been shown to have a positive effect in an in vitro model of Parkinson\u2019s disease by protecting against alpha-synuclein induced cell death (Zourlidou et al., 2004).", "section": "other", "t_start": 22, "d_end": 111, "d_start": 93, "t_end": 26}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "d846a86908da7ace7cc9b58aa3510086"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22566955"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22566955", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22566955", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22566955", "mined_sentences": [{"text": "They also found that mRNA levels of HSPB1 remained unchanged despite lower protein levels, highlighting the need for further studies to clarify what the role of sHSPs might be in ALS.", "section": "other", "t_start": 36, "d_end": 181, "d_start": 179, "t_end": 40}, {"text": "One study demonstrates that overexpression of transgenic HSPB1 in the SOD1G93A mouse model of ALS by crossing SOD1G93A mice with HSPB1 overexpressing mice did not delay disease onset or decrease disease severity (Krishnan et al., 2008), despite the fact that HSPB1 overexpression was protective in acute motor neuron injury (Sharp et al., 2006).", "section": "other", "t_start": 57, "d_end": 96, "d_start": 94, "t_end": 61}, {"text": "However, another study by Sharp et al. (2008) indicates that HSPB1 does have a positive effect early in the disease course in the same mouse model of ALS.", "section": "other", "t_start": 61, "d_end": 152, "d_start": 150, "t_end": 65}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "71733adce9614a17835b57b22ca19501"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22375124"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22375124", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22375124", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22375124", "mined_sentences": [{"text": "It has been recognized that heat shock transcription factor 1 (HSF1) is an important regulator of proteostasis by controlling the expression of major HSPs, including HSPB1 (HSP27), HSPA1A (HSP70), and HSPC1 (HSP90), that facilitate protein folding, localization, and function (Balch et al., 2008; Powers et al., 2009).", "section": "other", "t_start": 166, "d_end": 153, "d_start": 150, "t_end": 170}, {"text": "Furthermore, several HSPs (including HSPB1) were shown to provide protection against oxidative stress, thereby potentially preventing or restoring the redox status of the ion channels (Kalmar and Greensmith, 2009).", "section": "other", "t_start": 37, "d_end": 24, "d_start": 21, "t_end": 41}, {"text": "Glucocorticoids and statins have been reported to induce several HSPs (HSPB1, HSPB5, and HSPA1A; N\u00e8gre-Aminou et al., 2002; Son et al., 2005), leaving open the possibility that part of their protective pleiotropic effects is due to overexpression of HSPs.", "section": "other", "t_start": 71, "d_end": 68, "d_start": 65, "t_end": 75}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "58039c1e623b707047870f4a22dfc399"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24136235"}]}, "target": {"id": "ENSG00000187323", "gene_info": {"symbol": "DCC", "name": "DCC netrin 1 receptor", "geneid": "ENSG00000187323"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003890", "label": "drug dependence"}, "name": ["addiction"], "id": "EFO_0003890"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24136235", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003890", "target": "http://identifiers.org/uniprot/P43146"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24136235", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24136235", "mined_sentences": [{"text": "For instance, upon ligand withdrawal, DCC is cleaved by a first round of local caspase activation, which leads to the exposure of an addiction or dependence domain (ADD).", "section": "discussion", "t_start": 38, "d_end": 141, "d_start": 133, "t_end": 40}, {"text": "Caspase cleavages of DCC, Patched and UNC5 release fragments containing addiction or dependence domains (ADD) \u2013 that is, interacting domains promoting recruitment of pro-apoptotic factors.", "section": "other", "t_start": 21, "d_end": 80, "d_start": 72, "t_end": 23}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "327388d94e5a761d554e647fdcba5463"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25652200"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25652200", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25652200", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25652200", "mined_sentences": [{"text": "To date, 14 nuclear encoded genes, TYMP (thymidine phosphorylase), SLC25A4 (solute carrier family 25 [mitochondrial carrier; adenine nucleotide translocator], member 4), POLG, PEO1, OPA1, POLG2, RRM2B, TK2 (thymidine kinase 2), DGUOK (deoxyguanosine kinase), MPV17 (mitochondrial inner membrane protein), MGME1 (mitochondrial genome maintenance exonuclease), DNA2 (DNA replication helicase/nuclease 2), SPG7, and AFG3L2 (AFG3\u2010like AAA ATPase 2),19, 20 have been reported to be associated with ophthalmoparesis and multiple mtDNA deletions in muscle in adult onset PEO patients.", "section": "discussion", "t_start": 176, "d_end": 566, "d_start": 564, "t_end": 179}, {"text": "Recessive mutations in SPG7 (spastic paraplegia 7) and dominant mutations in PEO1 (progressive external ophthalmoplegia 1) were the most common pathogenic nDNA mutations identified in clinically affected individuals (SPG7: minimum prevalence\u2009=\u20090.8 \u00d7 10\u22125, 95% CI\u2009=\u20090.5\u20131.3 \u00d7 10\u22125; PEO1: minimum prevalence\u2009=\u20090.7 \u00d7 10\u22125, 95% CI\u2009=\u20090.4\u20101.2 \u00d7 10\u22125).", "section": "other", "t_start": 77, "d_end": 118, "d_start": 83, "t_end": 80}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 3.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.03}, "type": "literature", "id": "cd76be7b6cbf7a16329c22ea93f4a441"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21234105"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423"], ["EFO_0000618", "EFO_0001423"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001423", "label": "encephalomyelitis"}, "name": ["encephalomyelitis"], "id": "EFO_0001423"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21234105", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001423", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21234105", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21234105", "mined_sentences": [{"text": "In the next three sections, we are going to discuss the regulation of autoimmune encephalomyelitis by PPAR\u03b3, PPAR\u03b1, and PPAR\u03b2/\u03b4, respectively.", "section": "other", "t_start": 120, "d_end": 97, "d_start": 81, "t_end": 124}, {"text": "Regulation of Autoimmune Encephalomyelitis by PPAR\u03b2/\u03b4", "section": "other", "t_start": 46, "d_end": 41, "d_start": 25, "t_end": 50}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.024}, "type": "literature", "id": "b2e993d2f92f554a0033b09bce77a145"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/articles/PMC4033946"}]}, "target": {"id": "ENSG00000143819", "gene_info": {"symbol": "EPHX1", "name": "epoxide hydrolase 1", "geneid": "ENSG00000143819"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000474"], ["EFO_0000618", "EFO_0005774", "EFO_0000474"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000474", "label": "epilepsy"}, "name": ["epilepsy"], "id": "EFO_0000474"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/articles/PMC4033946", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000474", "target": "http://identifiers.org/uniprot/P07099"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/articles/PMC4033946", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/articles/PMC4033946", "mined_sentences": [{"text": "In a recent study of 70 patients with epilepsy in Scotland, a multivariate model incorporating patient age and EPHX1 Try113His and His139Arg polymorphisms, revealed a significant association between the genotypes and the maintenance dose of carbamazepine [84].", "section": "other", "t_start": 111, "d_end": 45, "d_start": 38, "t_end": 115}, {"text": "A retrospective study in Japanese patients with epilepsy implicated the GSTM1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity, whereas the EPHX1 polymorphisms did not lead to any elevation of transaminases in 192 Japanese patients treated with carbamazepine [88].", "section": "other", "t_start": 168, "d_end": 55, "d_start": 48, "t_end": 172}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2010-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.024}, "type": "literature", "id": "e5290cf741221c66935dc7ba2f166ef6"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22937105"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22937105", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22937105", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22937105", "mined_sentences": [{"text": "Since mild oxidative stress together with stress protein induction often result in cell death in vertebrate cells [29], we determined the mRNA levels of antioxidative-related genes (two major isomers encoded SOD, i.e., SOD1, SOD2) as well as a set of stress response genes (Table S1) which are induced to synthesize a group of heat shock proteins (HSPs).", "section": "other", "t_start": 225, "d_end": 351, "d_start": 348, "t_end": 228}, {"text": "At first, one should note several biomarkers reliable for measuring oxidative stress (Fig. 6), including LDH, MDA, SOD, HSPs, SOD1 and SOD2.", "section": "other", "t_start": 135, "d_end": 123, "d_start": 120, "t_end": 138}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.4}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.024}, "type": "literature", "id": "ee9736218d65537ae50a85779b11432a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21382489"}]}, "target": {"id": "ENSG00000112033", "gene_info": {"symbol": "PPARD", "name": "peroxisome proliferator activated receptor delta", "geneid": "ENSG00000112033"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_1001456", "EFO_0001423", "EFO_0001066"], ["EFO_0000618", "EFO_0001423", "EFO_0001066"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001066", "label": "experimental autoimmune encephalomyelitis"}, "name": ["EAE"], "id": "EFO_0001066"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21382489", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001066", "target": "http://identifiers.org/uniprot/Q03181"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21382489", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21382489", "mined_sentences": [{"text": "Another animal model in which PPAR\u03b2/\u03b4 shows overlapping functions with other PPARs is EAE [143].", "section": "other", "t_start": 30, "d_end": 88, "d_start": 86, "t_end": 34}, {"text": "In the EAE model, PPAR\u03b2/\u03b4\u2212/\u2212 animals displayed more inflammatory foci in the central nervous system.", "section": "other", "t_start": 18, "d_end": 9, "d_start": 7, "t_end": 22}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-08-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "a27067beb042e601addf9e32ce0e963f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23162777"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23162777", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23162777", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23162777", "mined_sentences": [{"text": "In addition to the CLEC9A ligand, other potential DAMP molecules include cellular DNA and RNA, possibly in complexes with bactericidal peptide LL-37 (cathelicidin), HSPs, and calreticulin.6,7 Oppenheim first coined the term alarmins to describe one subset of these endogenous innate activators that are rapidly secreted from innate immune cells, particularly neutrophils, or released by tissue damage and necrotic cells.8 They include bactericidal peptides (defensin and cathelicidin), inflammatory cytokines (IL-1\u03b1, IL-33), high mobility group box proteins (HMGB1, HMGN1), and cytosolic calcium-binding proteins of the S100 family.", "section": "other", "t_start": 175, "d_end": 168, "d_start": 165, "t_end": 186}, {"text": "Multiple HSPs, High mobility group box 1 protein (HMGBs) and calreticulin are present in autophagosomes.", "section": "other", "t_start": 61, "d_end": 12, "d_start": 9, "t_end": 72}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-09-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "0da2adb1bff7f47de73012002a83d0cd"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24336086"}]}, "target": {"id": "ENSG00000179218", "gene_info": {"symbol": "CALR", "name": "calreticulin", "geneid": "ENSG00000179218"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24336086", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P27797"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24336086", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24336086", "mined_sentences": [{"text": "Calreticulin, HMGB1/HSPs, and ATP then interact with the receptors CD91, Toll-like receptor 4(TLR4), and purinergic P2X7 receptors, respectively, which are present on the surface of DCs.", "section": "other", "t_start": 0, "d_end": 23, "d_start": 20, "t_end": 11}, {"text": "Surface-exposed HSP70/HSP90 with calreticulin can mediate T-cell-based antitumor immunity and contribute to IDC.21, 22 The mechanism of export and uptake of HSPs between immunogenic tumor cells with immature DCs remains to be elucidated.", "section": "other", "t_start": 33, "d_end": 160, "d_start": 157, "t_end": 44}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "491c366cc9ec5288a288457e258418b1"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24396277"}]}, "target": {"id": "ENSG00000099139", "gene_info": {"symbol": "PCSK5", "name": "proprotein convertase subtilisin/kexin type 5", "geneid": "ENSG00000099139"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000253"], ["EFO_0000618", "EFO_0005772", "EFO_0003782", "EFO_0000253"], ["EFO_0000618", "EFO_0003782", "EFO_0000253"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000253", "label": "amyotrophic lateral sclerosis"}, "name": ["ALS"], "id": "EFO_0000253"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24396277", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000253", "target": "http://identifiers.org/uniprot/Q92824"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24396277", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24396277", "mined_sentences": [{"text": "Also, a recent meta-analysis of GWA studies linked PCSK5 to another neurodegenerative disorder, amyotrophic lateral sclerosis (ALS).", "section": "other", "t_start": 51, "d_end": 129, "d_start": 127, "t_end": 55}, {"text": "When several sample collections were studied together, it was found that two PCSK5 SNPs (rs7047865 and rs1258095) associated with the age of ALS onset [126].", "section": "other", "t_start": 77, "d_end": 143, "d_start": 141, "t_end": 81}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-11-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "809c485259f4500eb679a74a2075cbe9"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23060810"}]}, "target": {"id": "ENSG00000151726", "gene_info": {"symbol": "ACSL1", "name": "acyl-CoA synthetase long-chain family member 1", "geneid": "ENSG00000151726"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0000289"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000289", "label": "bipolar disorder"}, "name": ["bipolar disorders"], "id": "EFO_0000289"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23060810", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000289", "target": "http://identifiers.org/uniprot/P33121"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23060810", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23060810", "mined_sentences": [{"text": "In addition CD36 and LACS can be considered as potential therapeutic targets to treat AD, bipolar disorders or Refsum disease (RfD), which is an autosomal recessive neurologic disorder of the lipid metabolism.", "section": "other", "t_start": 21, "d_end": 106, "d_start": 90, "t_end": 24}, {"text": "In bipolar disorders, valproic acid is used as a treatment by acting as a non-competitive inhibitor of brain microsomal LACS (Bazinet et al., 2006).", "section": "other", "t_start": 120, "d_end": 19, "d_start": 3, "t_end": 123}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "22937834ce97661760f21d69d5215c81"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22465036"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "genetic disorder"], "codes": ["EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_685"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_685"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_685"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_685", "label": "Hereditary spastic paraplegia"}, "name": ["HSPs"], "id": "Orphanet_685"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22465036", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_685", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22465036", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22465036", "mined_sentences": [{"text": "The human genome encodes 10 different small HSPs (HSPB1\u2013HSPB10).", "section": "other", "t_start": 50, "d_end": 47, "d_start": 44, "t_end": 54}, {"text": "In line with the fact that small HSPs form homo- and hetero-oligomeric complexes, HSP22 interacts with HSP27 (HSPB1), MKBP (HSPB2), HSPB3, \u03b1B-crystallin (HSPB5), HSP20 (HSPB6) and cvHSP (HSPB7) (Fontaine et al., 2005; Sun et al., 2004).", "section": "other", "t_start": 110, "d_end": 36, "d_start": 33, "t_end": 114}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-12-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "ef100d9d4bb21c1023dfa9673aa0fb77"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24278676"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0000249"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "EFO_0000249"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0000249", "label": "Alzheimers disease"}, "name": ["Alzheimer's"], "id": "EFO_0000249"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24278676", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0000249", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24278676", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24278676", "mined_sentences": [{"text": "Numerous studies have reported that elevated levels of constitutively expressed HspB1 and HspB5 are observed in pathological cells in which protein folding homeostasis is impaired by the accumulation of pathological proteins that are prone to aggregate, such as \u03b1-synuclein, \u03b2-amyloid peptide as well as polyQ mutants of huntingtin polypeptide that are responsive of Parkinson's, Alzheimer's and huntington, neurodegenerative diseases, respectively.", "section": "other", "t_start": 80, "d_end": 390, "d_start": 380, "t_end": 84}, {"text": "HspB1 and/or HspB5 accumulate in cortical Lewy bodies, Alzheimer disease plaques, neurofibrillary tangles, Rosenthal fibers of Alexander's-disease, Creutzfeldt-Jakob altered neurones as well as in synuclein deposit associated to Parkinson's disease or myopathy-associated inclusion body [102\u2013106].", "section": "other", "t_start": 0, "d_end": 71, "d_start": 55, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "4b2b955748f5dc814e5ead7e236dc050"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/24278676"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "EFO_0002508"], ["EFO_0000618", "EFO_0002508"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002508", "label": "Parkinson's disease"}, "name": ["Parkinson's"], "id": "EFO_0002508"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/24278676", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002508", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/24278676", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/24278676", "mined_sentences": [{"text": "Numerous studies have reported that elevated levels of constitutively expressed HspB1 and HspB5 are observed in pathological cells in which protein folding homeostasis is impaired by the accumulation of pathological proteins that are prone to aggregate, such as \u03b1-synuclein, \u03b2-amyloid peptide as well as polyQ mutants of huntingtin polypeptide that are responsive of Parkinson's, Alzheimer's and huntington, neurodegenerative diseases, respectively.", "section": "other", "t_start": 80, "d_end": 377, "d_start": 367, "t_end": 84}, {"text": "HspB1 and/or HspB5 accumulate in cortical Lewy bodies, Alzheimer disease plaques, neurofibrillary tangles, Rosenthal fibers of Alexander's-disease, Creutzfeldt-Jakob altered neurones as well as in synuclein deposit associated to Parkinson's disease or myopathy-associated inclusion body [102\u2013106].", "section": "other", "t_start": 0, "d_end": 247, "d_start": 229, "t_end": 4}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "99f9b9f3b49bb4c5160bd95621713723"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25780754"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25780754", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25780754", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25780754", "mined_sentences": [{"text": "Alternatively, HSPB1 might be involved in cataract, because HSPB1, CRYAA and CRYAB interact with each other and all can negatively regulate the apoptotic process (Table 4).", "section": "other", "t_start": 15, "d_end": 49, "d_start": 42, "t_end": 19}, {"text": "Our results here argue for further experimental studies to test the possible role of HSPB1 CNVs in cardiomyopathy or cataract/blindness in African Americans.", "section": "other", "t_start": 85, "d_end": 124, "d_start": 117, "t_end": 89}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "35c18fdcd11c536847c936550e37a97f"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26251896"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["PEO"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26251896", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26251896", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26251896", "mined_sentences": [{"text": "As for POLG mutations, PEO1 defects have been found to segregate with Parkinsonism and additional syndromic features in dominant PEO families [61,62].", "section": "other", "t_start": 23, "d_end": 131, "d_start": 129, "t_end": 26}, {"text": "Kearns\u2013Sayre syndrome (KSS) and MNGIE are rarer manifestations. RRM2B mutations were observed as the third most common molecular cause of PEO in a large cohort of British adult patients, following POLG and PEO1 [92].", "section": "other", "t_start": 206, "d_end": 140, "d_start": 138, "t_end": 209}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "790c3f3388ae1ae9878d5631f5a33de7"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/23698168"}]}, "target": {"id": "ENSG00000073060", "gene_info": {"symbol": "SCARB1", "name": "scavenger receptor class B member 1", "geneid": "ENSG00000073060"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["AMD"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/23698168", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/Q8WTV0"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/23698168", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/23698168", "mined_sentences": [{"text": "A large case-control genetic study on French and North American patients with and without AMD analyzed single nucleotide polymorphism (SNP) rs5888 of the SCARB1 gene, coding for SRBI, which is involved in the lipid and lutein pathways.", "section": "other", "t_start": 178, "d_end": 92, "d_start": 90, "t_end": 181}, {"text": "They showed that in French and pooled populations (French and North American) without these known mutations, there is a strong association between AMD and SCARB1 gene.", "section": "other", "t_start": 155, "d_end": 149, "d_start": 147, "t_end": 160}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2013-05-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "789d02e8c179df6c1afcf72f4027b767"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/22566955"}]}, "target": {"id": "ENSG00000106211", "gene_info": {"symbol": "HSPB1", "name": "heat shock protein family B (small) member 1", "geneid": "ENSG00000106211"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease", "genetic disorder"], "codes": ["EFO_0003966", "EFO_0000508", "EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_101435", "Orphanet_183616", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_158124", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183521", "Orphanet_307058", "Orphanet_306708", "Orphanet_683"], ["EFO_0003966", "Orphanet_101435", "Orphanet_183616", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_1000631", "Orphanet_98685", "Orphanet_98687", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "EFO_0005815", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_683"], ["EFO_0000618", "EFO_0005774", "Orphanet_158124", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"], ["EFO_0000618", "EFO_0005772", "Orphanet_307058", "Orphanet_306708", "Orphanet_683"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_276058", "Orphanet_276061", "Orphanet_683"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_683", "label": "Progressive supranuclear palsy"}, "name": ["PSP"], "id": "Orphanet_683"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/22566955", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_683", "target": "http://identifiers.org/uniprot/P04792"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/22566955", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/22566955", "mined_sentences": [{"text": "However, another study did not find upregulation of HSPB1 or HSPB5 in neurons, but rather that localization of these sHSPs is specific to glial cells in sporadic CBD and PSP and familial FTDP-17 (Dabir et al., 2004).", "section": "other", "t_start": 52, "d_end": 172, "d_start": 170, "t_end": 56}, {"text": "The specificity to astrocytes was confirmed by a study that found elevated levels of HSPB1 in astrocytes in PSP and CBD (Schwarz et al., 2010).", "section": "other", "t_start": 85, "d_end": 110, "d_start": 108, "t_end": 89}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2012-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "4403bb0d19fccc66396ec030dc15967a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/21112411"}]}, "target": {"id": "ENSG00000107815", "gene_info": {"symbol": "C10orf2", "name": "chromosome 10 open reading frame 2", "geneid": "ENSG00000107815"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0001058", "EFO_0002509"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0002509", "label": "progressive external ophthalmoplegia"}, "name": ["chronic progressive external ophthalmoplegia"], "id": "EFO_0002509"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/21112411", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0002509", "target": "http://identifiers.org/uniprot/Q96RR1"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/21112411", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/21112411", "mined_sentences": [{"text": "In 2001, the first nuclear genes, POLG1 and PEO1, were identified among families with autosomal-dominant chronic progressive external ophthalmoplegia (CPEO) associated with multiple mtDNA deletions (Spelbrink et\u00a0al., 2001; Van Goethem et\u00a0al., 2001).", "section": "other", "t_start": 44, "d_end": 148, "d_start": 105, "t_end": 47}, {"text": "These sometimes rare neurodegenerative and metabolic disorders have also provided important insights into the molecular components required for mtDNA maintenance, and the translational machinery that regulates intra-mitochondrial protein synthesis.Table 1Nuclear mitochondrial disorders.Mutations involving structural subunits of the mitochondrial respiratory chainLeigh syndrome: with complex I deficiency \u2013 mutations in NDUFS1, NDUFS4, NDUFS7, NDUFS8, NDUFV1; with complex II deficiency \u2013 mutations in SDHACardiomyopathy and encephalopathy with complex I deficiency \u2013 mutations in NDFUS2Optic atrophy and ataxia with complex II deficiency\u2013mutations in SDHAHypokalaemia and lactic acidosis with complex III deficiency \u2013 mutations in UQCRB\u2028\u2028Mutations involving assembly factors of the mitochondrial respiratory chainLeigh syndrome\u2013mutations in SURF I and LRPPRCHepatopathy and ketoacidosis \u2013 mutations in SCO1Cardiomyopathy and encephalopathy \u2013 mutations in SCO2Leukodystrophy and renal tubulopathy \u2013 mutations in COX10Hypertrophic cardiomyopathy \u2013 mutations in COX15Encephalopathy, liver failure, and renal tubulopathy with complex III deficiency \u2013 mutations in BCS1LEncephalopathy with complex V deficiency \u2013 mutations in ATP12\u2028\u2028Nuclear genetic disorders of intra-mitochondrial protein synthesisLeigh syndrome, liver failure, and lactic acidosis \u2013 mutations in EFG1Lactic acidosis, developmental failure, and dysmorphism \u2013 mutations in MRPS16Myopathy and sideroblastic anaemia \u2013 mutations in PUS1Leukodystrophy and polymicrogyria \u2013 mutations in EFTuEncephalomyopathy and hypertrophic cardiomyopathy \u2013 mutations in EFTsOedema, hypotonia, cardiomyopathy, and tubulopathy\u2013mutations in MRPS22Hypotonia, renal tubulopathy, and lactic acidosis \u2013 mutations in RRM2B\u2028\u2028Nuclear genetic disorders of mitochondrial protein importMohr\u2013Tranebjaerg syndrome or deafness-dystonia-optic neuronopathy (DDON) syndrome \u2013 mutations in TIMM8A (DDP)Early-onset dilated cardiomyopathy with ataxia (DCMA) or 3-methylglutaconic aciduria, type V\u2013mutations in DNAJC19\u2028\u2028Nuclear genetic disorders of mitochondrial DNA maintenanceChronic progressive external ophthalmoplegia \u2013 mutations in POLG1, POLG2, PEO1, SLC25A4, RRM2B, and OPA1)Mitochondrial neurogastrointestinal encephalomyopathy \u2013 mutations in TYMPAlpers syndrome\u2013mutations in POLG1 and MPV17Infantile myopathy and spinal muscular atrophy \u2013 mutations in TK2Encephalomyopathy and liver failure \u2013 mutations in DGUOKHypotonia, movement disorder and/or Leigh syndrome with methylmalonic aciduria \u2013 mutations in SUCLA2 and SUCLG1Optic atrophy, deafness, chronic progressive external ophthalmoplegia, myopathy, ataxia, and peripheral neuropathy \u2013 mutations in OPA1\u2028\u2028MiscellaneousCo-enzyme Q10 deficiency \u2013 mutations in PDSS2, APTX, COQ2, and ETFDHBarth syndrome \u2013mutations in TAZCardiomyopathy and lactic acidosis associated with mitochondrial phosphate carrier deficiency \u2013 mutations in SLC25A3Alpers syndrome: epilepsy, cortical blindness, micronodular hepatic cirrhosis, episodic psychomotor regression; Barth syndrome: cardiomyopathy, hypotonia, weakness, and neutropenia.", "section": "other", "t_start": 2175, "d_end": 2623, "d_start": 2580, "t_end": 2178}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2011-03-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "deb5be6b0d5889c8a720161c279edc1a"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25691889"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25691889", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25691889", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25691889", "mined_sentences": [{"text": "Evidence that PG, like CL, undergoes physiologically important remodeling was recently provided by the identification of serine active site containing 1 (SERAC1) mutations that cause autosomal-recessive MEGDEL syndrome [3-MGA, sensorineural deafness, encephalopathy, and neuroradiological evidence of progressive Leigh-like syndrome (Wortmann et al., 2006, 2012)].", "section": "other", "t_start": 154, "d_end": 217, "d_start": 203, "t_end": 159}, {"text": "As our understanding of how SERAC1 regulates the acyl chain composition of CL and the production of BMP is in its infancy, future basic work is needed to develop assorted models designed to better understand these processes and how their disturbance cause the numerous MEGDEL syndrome phenotypes.", "section": "other", "t_start": 28, "d_end": 283, "d_start": 269, "t_end": 33}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "9855c2ffc830895e55a37daa82dd7651"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/26306184"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_1000845"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_1000845", "label": "brain edema"}, "name": ["brain edema"], "id": "EFO_1000845"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/26306184", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_1000845", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/26306184", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/26306184", "mined_sentences": [{"text": "sNBO did not decrease infarct volume and cNBO did not improve protection over iNBO or nNBO[69]MCAO (90\u00a0min) and reperfusion (22.5\u00a0h) in ratsNBO (100\u00a0% O2) given for 2,4 or 8\u00a0h 30\u00a0min after MCAONBO (2,4 and 8\u00a0h) significantly reduced 8-OHdG and gp91phox production (greatest reduction with 8\u00a0h NBO)NBO (2,4 and 8\u00a0h) significantly reduced total infarct volume and infarct volume in the cortex and subcortex (8\u00a0h NBO offered the greatest efficacy)[70]MCAO (90\u00a0min) and reperfusion (22.5\u00a0h) in ratsNBO (95\u00a0% O2) given during MCAONBO significantly inhibited gp91phox expression, NADPH oxidase activity, and MMP-9 inductionNBO significantly decreased BBB permeability coefficient (MRI) and brain edema[71]MCAO (90\u00a0min) in WT and SOD2-KO miceNBO (100\u00a0% O2) (60\u00a0min) started 25\u00a0min after MCAONBO significantly decreased O2\u00b7\u2212 generation (Het) in WT mice.NBO does not affect infarct size in SOD2-KO mice and the effect of NBO on infarct size in WT mice was not presented[72]MCAO (10,30,60 or 90\u00a0min) in ratsNBO (95\u00a0% O2) given during MCAONBO significantly delayed and attenuated \u00b7NO\u2009production (NOx\u2212:nitrite plus nitrate) and significantly reduced 3-NT formationNBO significantly decreased total infarct volume, particularly in the cortex, but not significantly in the striatum[73] MCAO middle cerebral artery occlusion, HO-1 heme oxygenase-1, O 2 \u00b7 \u2212 superoxide, Het dihydroethidium, dNBO during MCAO, rNBO during reperfusion, 4HNE 4-hydroxynonenal, NT nitrotyrosine, 8-OHdG 8-hydroxy-2\u2032\u2013deoxyguanosine, BCAO bilateral carotid artery occlusion, WT wild-type, KO knock-out, iNBO Intermittent, sNBO Short, nNBO normal or continuous, cNBO combination, \u00b7NO nitric oxide a see reference for details", "section": "introduction_and_background", "t_start": 723, "d_end": 694, "d_start": 684, "t_end": 726}, {"text": "Additionally, NBO given during MCAO was shown to reduce BBB damage and brain edema, a measure of oxidative damage [70], and more recently, Sun et al. indicated that NBO therapy had no effect on infarct volume in SOD2 knockout mice, again suggesting that NBO did not appear to promote damage inflicted by ROS [72].", "section": "introduction_and_background", "t_start": 212, "d_end": 81, "d_start": 71, "t_end": 215}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "5355270d9d4ded547504ce081f3dc953"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25778941"}]}, "target": {"id": "ENSG00000122335", "gene_info": {"symbol": "SERAC1", "name": "serine active site containing 1", "geneid": "ENSG00000122335"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["metabolic disease", "genetic disorder", "nervous system disease"], "codes": ["EFO_0000618", "EFO_0000589", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_71859", "Orphanet_68385", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79062", "Orphanet_289899", "Orphanet_79163", "Orphanet_289902", "Orphanet_352328"], ["EFO_0000618", "EFO_0001058", "EFO_1001455", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_183530", "Orphanet_139009", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000589", "Orphanet_68367", "Orphanet_79200", "Orphanet_68380", "Orphanet_223713", "Orphanet_2443", "Orphanet_309136", "Orphanet_352328"], ["EFO_0000508", "Orphanet_96210", "Orphanet_90642", "Orphanet_352328"], ["EFO_0000508", "Orphanet_68367", "Orphanet_309005", "Orphanet_352301", "Orphanet_352306", "Orphanet_352328"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_352328", "label": "MEGDEL syndrome"}, "name": ["MEGDEL syndrome"], "id": "Orphanet_352328"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25778941", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_352328", "target": "http://identifiers.org/uniprot/Q96JX3"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25778941", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25778941", "mined_sentences": [{"text": "An abnormal fatty acid composition of phosphatidylglycerol and decreased bis(monoacylglycero)phosphate (BMP) concentration have been found in patients with MEGDEL syndrome and SERAC1 deficiency (Wortmann et al 2012).", "section": "other", "t_start": 176, "d_end": 170, "d_start": 156, "t_end": 181}, {"text": "Furthermore, hepatopathy is also a relatively common feature in MEGDEL syndrome with SERAC1 deficiency, which involves lipid metabolism (Wortmann et al 1993).Table 2Characteristic clinical manifestations found in some gene defects associated with combined OXPHOS deficiencyHepatopathyNephropathyPerrault syndromeHaematologic manifestationLeigh-(like) POLG  RRM2B  HARS2  PUS1  TYMP  C10orf2 (Twinkle)  C10orf2 (Twinkle)  LARS2  YARS2  MTPAP  DGUOK  TSFM  CLPP  TRNT1  LRPPRC  MPV  MRPS22  C10orf2 (Twinkle)  SFXN4  PNPT1  SUCLG1  SARS2  GLRX5  TUFM  TRMU  ADCK4  FBXL4 (partially)  GFM1  EARS2  COQ2  CYCS  C12orf65  FARS2  COQ6  TAZ  MT-TI  TSFM  COQ9  MT-TL1  MT-TK  GFM1  PDSS2 mtDNA deletions MT-TL1  SERAC1  XPNPEP3  MT-TV  MT-TF  MT-TW  MT-TI  MTFMT  MT-TL1  PDSS1  MT-TN  SERAC1  MT-TY  AIFM1 mtDNA deletions", "section": "other", "t_start": 85, "d_end": 78, "d_start": 64, "t_end": 90}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-07-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "3d3f383ee1263012ebe1f4f4e5f7c971"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25636376"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001059"], ["EFO_0000618", "EFO_0001058", "EFO_0001059"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001059", "label": "cataract"}, "name": ["cataract"], "id": "EFO_0001059"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25636376", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001059", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25636376", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25636376", "mined_sentences": [{"text": "When cataract status was added to multivariate models, AMD status, VA, and CS remained associated with daily MVPA (p\u2009<\u20090.05 for all), while the presence of cataract/PCO was also associated with less MVPA (44% less MVPA when present, 95% CI\u2009=\u200922% - 60%, p\u2009=\u20090.001 in multivariate models containing cataract/PCO, AMD, and other non-visual predictors as independent variables).Table 3 Effect of AMD and vision metrics on time spent in moderate-to-vigorous physical activity (MVPA) per day VariableIntervalUnivariate analysisMultivariate analysisRR PvalueRR* Pvalue Vision \u2003\u00a0AMDPresent0.52 <0.001 0.65 <0.001 \u2003\u00a0Better eye VA0.1 logMAR worse0.87 <0.001 0.89 <0.001 \u2003\u00a0Binocular CS0.1 log decrement0.85 <0.001 0.87 <0.001 \u2003\u00a0Sig. cataract/PCOPresent0.58 0.001 \u00a7\u00a7\u00a7\u00a7 Demographics \u2003\u00a0Age10\u00a0years older0.63 <0.001 1.000.98\u2003\u00a0GenderFemale vs. male0.71 0.02 0.62 <0.01 \u2003\u00a0RaceWhite vs. non-White1.63 0.01 2.01 <0.001 \u2003\u00a0Education4\u00a0years more2.22 <0.001 2.33 <0.001 \u2003\u00a0EmployedYes vs. No1.94 <0.001 \u00a7\u00a7\u00a7\u00a7 Health/cognition \u2003\u00a0Comorbidities1 or more illness0.73 <0.001 0.73 <0.001 \u2003\u00a0Depressive symptomsPresent vs. absent0.08 <0.001 \u00a7\u00a7\u00a7\u00a7\u2003\u00a0BMI1 unit higher0.90 <0.001 \u2021\u2021\u2021\u2021\u2003\u00a0MMSE \u2013 VI score5 points lower0.960.87------ Weather \u2003\u00a0Temperature <45\u00b0FYes vs. No0.040.93------\u2003\u00a0Rainfall\u2009>\u20090.2\u00a0mmYes vs. No0.070.57------RR\u2009=\u2009Rate ratios; AMD\u2009=\u2009age-related macular degeneration; VA\u2009=\u2009visual acuity; CS\u2009=\u2009contrast sensitivity; logMAR\u2009=\u2009logarithm of the minimum angle of resolution; PCO\u2009=\u2009Posterior Capsular Opacification; BMI\u2009=\u2009body mass index; MMSE-VI\u2009=\u2009Mini-mental status examination for the visually impaired; \u00b0F\u2009=\u2009degrees Fahrenheit; mm\u2009=\u2009millimeters.*RR for vision variables were each derived from separate multivariate models including all non-visual covariates shown.", "section": "other", "t_start": 1114, "d_end": 12, "d_start": 5, "t_end": 1117}, {"text": "The presence of AMD, worse VA, and worse CS were each associated with less time spent away from home in separate multivariate models, though these associations were not statistically significant (p\u2009=\u20090.11, 0.09, and 0.33, respectively).Table 5 Effect of AMD and AMD severity on time spent outside the home VariableIntervalUnivariate analysisMultivariate analysisRR PvalueRR* Pvalue Vision \u2003\u00a0AMDPresent0.82 0.001 0.910.11\u2003\u00a0Better eye VA0.1logMAR worse0.93 0.003 0.970.09\u2003\u00a0Binocular CS0.1 log decrement0.95 0.03 0.980.33\u2003\u00a0Sig. cataract/PCOPresent1.000.98------ Demographics \u2003\u00a0Age10\u00a0years older0.59 <0.001 0.66 <0.001 \u2003\u00a0GenderFemale vs. male1.190.161.40 0.04 \u2003\u00a0RaceWhite vs. non-White0.950.460.940.26\u2003\u00a0Education4\u00a0years more0.870.37------\u2003\u00a0EmployedYes vs. No1.22 0.02 \u00a7\u00a7\u00a7\u00a7 Health/cognition /driving \u2003\u00a0Comorbidities1 or more illness0.970.411.000.98\u2003\u00a0Depressive symptomsPresent vs. absent0.940.78------\u2003\u00a0BMI1 unit higher0.990.86------\u2003\u00a0MMSE \u2013 VI score5 points higher0.830.281.080.63\u2003\u00a0Grip strength5\u00a0kg less0.970.360.91 0.02  Weather \u2003\u00a0Temperature <45\u00b0FYes vs. No1.000.97------\u2003\u00a0Rainfall >0.2\u00a0mmYes vs. No0.990.83------RR\u2009=\u2009Rate ratios; AMD\u2009=\u2009age-related macular degeneration; VA\u2009=\u2009visual acuity; CS\u2009=\u2009contrast sensitivity; logMAR\u2009=\u2009logarithm of the minimum angle of resolution; PCO\u2009=\u2009Posterior Capsular Opacification; BMI\u2009=\u2009body mass index; MMSE-VI\u2009=\u2009Mini-mental status examination for the visually impaired; \u00b0F\u2009=\u2009degrees Fahrenheit; mm\u2009=\u2009millimeters.*RR for vision variables were each derived from separate multivariate models including all non-visual covariates shown.", "section": "other", "t_start": 898, "d_end": 532, "d_start": 525, "t_end": 901}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "cf213a2c41800d4151b5d12d10153093"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/15740629"}]}, "target": {"id": "ENSG00000135404", "gene_info": {"symbol": "CD63", "name": "CD63 molecule", "geneid": "ENSG00000135404"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease"], "codes": ["EFO_0000618"]}, "path": [["EFO_0000618", "EFO_0005774", "EFO_0000677", "EFO_0003890", "EFO_0003768"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0003768", "label": "nicotine dependence"}, "name": ["smoking"], "id": "EFO_0003768"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/15740629", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0003768", "target": "http://identifiers.org/uniprot/P08962"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/15740629", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/15740629", "mined_sentences": [{"text": "There was no significant difference in the expression of CD11b, CD63 and HLA-DR on CD14 high and CD14 low cells between smoking and no smoking (data not shown).", "section": "other", "t_start": 64, "d_end": 126, "d_start": 120, "t_end": 67}, {"text": "Smoking had also no significant effect on the levels of inflammatory mediators in sputum (additional file 1, table 3) and the expression of CD11b, CD63 and HLA-DR on CD14 high and CD14 low cells and the number of iNOS positive macrophages (data not shown).", "section": "other", "t_start": 147, "d_end": 6, "d_start": 0, "t_end": 150}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2005-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "970ded93a769f49f86d03998d57f733b"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/18824496"}]}, "target": {"id": "ENSG00000112096", "gene_info": {"symbol": "SOD2", "name": "superoxide dismutase 2, mitochondrial", "geneid": "ENSG00000112096"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["reproductive system disease", "nervous system disease", "genetic disorder", "muscular disease", "skeletal system disease"], "codes": ["EFO_0000618", "EFO_0002970", "EFO_0002461", "EFO_0000512", "EFO_0000508"]}, "path": [["EFO_0000508", "Orphanet_275742", "Orphanet_399980", "Orphanet_399983", "Orphanet_399685", "Orphanet_481"], ["EFO_0002461", "EFO_0002970", "Orphanet_183497", "Orphanet_98505", "Orphanet_206701", "Orphanet_206707", "Orphanet_481"], ["EFO_0000512", "Orphanet_275742", "Orphanet_399980", "Orphanet_399983", "Orphanet_399685", "Orphanet_481"], ["EFO_0000618", "EFO_0005774", "Orphanet_183500", "Orphanet_481"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183500", "Orphanet_481"], ["EFO_0002970", "Orphanet_183497", "Orphanet_98505", "Orphanet_206701", "Orphanet_206707", "Orphanet_481"], ["EFO_0000618", "EFO_0005772", "Orphanet_183500", "Orphanet_481"], ["EFO_0000508", "Orphanet_71859", "Orphanet_183497", "Orphanet_98505", "Orphanet_206701", "Orphanet_206707", "Orphanet_481"]], "efo_id": "http://www.orpha.net/ORDO/Orphanet_481", "label": "Kennedy disease"}, "name": ["SBMA"], "id": "Orphanet_481"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/18824496", "disease_uri": "http://www.orpha.net/ORDO/Orphanet_481", "target": "http://identifiers.org/uniprot/P04179"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/18824496", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/18824496", "mined_sentences": [{"text": "Moreover, we observed decreased levels of PGC-1\u03b2 and mitochondrial superoxide dismutase (SOD2) in MN-1 cells and in the tissues of a knock-in mouse model of SBMA.", "section": "introduction_and_background", "t_start": 89, "d_end": 160, "d_start": 157, "t_end": 92}, {"text": "We did not see a general decrease in transcript levels of cellular antioxidants, but the mitochondrial antioxidant, SOD2, was specifically and consistently reduced in all three affected tissues, indicating the importance of mitochondria-associated oxidative stress in SBMA.", "section": "other", "t_start": 116, "d_end": 271, "d_start": 268, "t_end": 119}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2009-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "84c40417f00bc1f4b17632896aa2e425"}, {"literature": {"references": [{"lit_id": "http://europepmc.org/abstract/MED/25636376"}]}, "target": {"id": "ENSG00000168283", "gene_info": {"symbol": "BMI1", "name": "BMI1 proto-oncogene, polycomb ring finger", "geneid": "ENSG00000168283"}, "target_type": "protein_evidence", "activity": "up_or_down"}, "validated_against_schema_version": "1.2.3", "sourceID": "europepmc", "disease": {"efo_info": {"therapeutic_area": {"labels": ["nervous system disease", "eye disease"], "codes": ["EFO_0003966", "EFO_0000618"]}, "path": [["EFO_0003966", "EFO_0001365"], ["EFO_0000618", "EFO_0001058", "EFO_0001365"]], "efo_id": "http://www.ebi.ac.uk/efo/EFO_0001365", "label": "age-related macular degeneration"}, "name": ["age-related macular degeneration"], "id": "EFO_0001365"}, "unique_association_fields": {"publicationIDs": "http://europepmc.org/abstract/MED/25636376", "disease_uri": "http://www.ebi.ac.uk/efo/EFO_0001365", "target": "http://identifiers.org/uniprot/P35226"}, "evidence": {"unique_experiment_reference": "http://europepmc.org/abstract/MED/25636376", "evidence_codes_info": [[{"eco_id": "literature_mining", "label": "Literature mining"}], [{"eco_id": "ECO_0000213", "label": "combinatorial evidence used in automatic assertion"}]], "literature_ref": {"lit_id": "http://europepmc.org/abstract/MED/25636376", "mined_sentences": [{"text": "When cataract status was added to multivariate models, AMD status, VA, and CS remained associated with daily MVPA (p\u2009<\u20090.05 for all), while the presence of cataract/PCO was also associated with less MVPA (44% less MVPA when present, 95% CI\u2009=\u200922% - 60%, p\u2009=\u20090.001 in multivariate models containing cataract/PCO, AMD, and other non-visual predictors as independent variables).Table 3 Effect of AMD and vision metrics on time spent in moderate-to-vigorous physical activity (MVPA) per day VariableIntervalUnivariate analysisMultivariate analysisRR PvalueRR* Pvalue Vision \u2003\u00a0AMDPresent0.52 <0.001 0.65 <0.001 \u2003\u00a0Better eye VA0.1 logMAR worse0.87 <0.001 0.89 <0.001 \u2003\u00a0Binocular CS0.1 log decrement0.85 <0.001 0.87 <0.001 \u2003\u00a0Sig. cataract/PCOPresent0.58 0.001 \u00a7\u00a7\u00a7\u00a7 Demographics \u2003\u00a0Age10\u00a0years older0.63 <0.001 1.000.98\u2003\u00a0GenderFemale vs. male0.71 0.02 0.62 <0.01 \u2003\u00a0RaceWhite vs. non-White1.63 0.01 2.01 <0.001 \u2003\u00a0Education4\u00a0years more2.22 <0.001 2.33 <0.001 \u2003\u00a0EmployedYes vs. No1.94 <0.001 \u00a7\u00a7\u00a7\u00a7 Health/cognition \u2003\u00a0Comorbidities1 or more illness0.73 <0.001 0.73 <0.001 \u2003\u00a0Depressive symptomsPresent vs. absent0.08 <0.001 \u00a7\u00a7\u00a7\u00a7\u2003\u00a0BMI1 unit higher0.90 <0.001 \u2021\u2021\u2021\u2021\u2003\u00a0MMSE \u2013 VI score5 points lower0.960.87------ Weather \u2003\u00a0Temperature <45\u00b0FYes vs. No0.040.93------\u2003\u00a0Rainfall\u2009>\u20090.2\u00a0mmYes vs. No0.070.57------RR\u2009=\u2009Rate ratios; AMD\u2009=\u2009age-related macular degeneration; VA\u2009=\u2009visual acuity; CS\u2009=\u2009contrast sensitivity; logMAR\u2009=\u2009logarithm of the minimum angle of resolution; PCO\u2009=\u2009Posterior Capsular Opacification; BMI\u2009=\u2009body mass index; MMSE-VI\u2009=\u2009Mini-mental status examination for the visually impaired; \u00b0F\u2009=\u2009degrees Fahrenheit; mm\u2009=\u2009millimeters.*RR for vision variables were each derived from separate multivariate models including all non-visual covariates shown.", "section": "other", "t_start": 1114, "d_end": 1341, "d_start": 1310, "t_end": 1117}, {"text": "The presence of AMD, worse VA, and worse CS were each associated with less time spent away from home in separate multivariate models, though these associations were not statistically significant (p\u2009=\u20090.11, 0.09, and 0.33, respectively).Table 5 Effect of AMD and AMD severity on time spent outside the home VariableIntervalUnivariate analysisMultivariate analysisRR PvalueRR* Pvalue Vision \u2003\u00a0AMDPresent0.82 0.001 0.910.11\u2003\u00a0Better eye VA0.1logMAR worse0.93 0.003 0.970.09\u2003\u00a0Binocular CS0.1 log decrement0.95 0.03 0.980.33\u2003\u00a0Sig. cataract/PCOPresent1.000.98------ Demographics \u2003\u00a0Age10\u00a0years older0.59 <0.001 0.66 <0.001 \u2003\u00a0GenderFemale vs. male1.190.161.40 0.04 \u2003\u00a0RaceWhite vs. non-White0.950.460.940.26\u2003\u00a0Education4\u00a0years more0.870.37------\u2003\u00a0EmployedYes vs. No1.22 0.02 \u00a7\u00a7\u00a7\u00a7 Health/cognition /driving \u2003\u00a0Comorbidities1 or more illness0.970.411.000.98\u2003\u00a0Depressive symptomsPresent vs. absent0.940.78------\u2003\u00a0BMI1 unit higher0.990.86------\u2003\u00a0MMSE \u2013 VI score5 points higher0.830.281.080.63\u2003\u00a0Grip strength5\u00a0kg less0.970.360.91 0.02  Weather \u2003\u00a0Temperature <45\u00b0FYes vs. No1.000.97------\u2003\u00a0Rainfall >0.2\u00a0mmYes vs. No0.990.83------RR\u2009=\u2009Rate ratios; AMD\u2009=\u2009age-related macular degeneration; VA\u2009=\u2009visual acuity; CS\u2009=\u2009contrast sensitivity; logMAR\u2009=\u2009logarithm of the minimum angle of resolution; PCO\u2009=\u2009Posterior Capsular Opacification; BMI\u2009=\u2009body mass index; MMSE-VI\u2009=\u2009Mini-mental status examination for the visually impaired; \u00b0F\u2009=\u2009degrees Fahrenheit; mm\u2009=\u2009millimeters.*RR for vision variables were each derived from separate multivariate models including all non-visual covariates shown.", "section": "other", "t_start": 898, "d_end": 1167, "d_start": 1136, "t_end": 901}]}, "provenance_type": {"database": {"version": "2016-07-26", "id": "EuropePMC"}}, "is_associated": true, "resource_score": {"type": "summed_total", "method": {"description": "Custom text-mining method for target-disease association"}, "value": 2.0}, "evidence_codes": ["literature_mining", "ECO_0000213"], "date_asserted": "2015-01-01T00:00:00Z"}, "access_level": "public", "scores": {"association_score": 0.02}, "type": "literature", "id": "d36fe2b2821fb48c9f80bcc12ef071e4"}], "size": 746}